<SEC-DOCUMENT>0001047469-14-003582.txt : 20140409
<SEC-HEADER>0001047469-14-003582.hdr.sgml : 20140409
<ACCEPTANCE-DATETIME>20140409090145
ACCESSION NUMBER:		0001047469-14-003582
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20140528
FILED AS OF DATE:		20140409
DATE AS OF CHANGE:		20140409
EFFECTIVENESS DATE:		20140409

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celldex Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000744218
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				133191702
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15006
		FILM NUMBER:		14752536

	BUSINESS ADDRESS:	
		STREET 1:		119 FOURTH AVE
		CITY:			NEEDHAM
		STATE:			MA
		ZIP:			02494
		BUSINESS PHONE:		7814330771

	MAIL ADDRESS:	
		STREET 1:		119 FOURTH AVE
		CITY:			NEEDHAM
		STATE:			MA
		ZIP:			02494-2725

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AVANT IMMUNOTHERAPEUTICS INC
		DATE OF NAME CHANGE:	19980828

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	T CELL SCIENCES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>a2219467zdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#14ZAE79801_1">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B> SCHEDULE 14A</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Proxy
Statement Pursuant to Section 14(a) of<BR>
the Securities Exchange Act of 1934 (Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;) </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2> Filed by the Registrant <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Filed by a Party other than the Registrant <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2><BR>
Check the appropriate box:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Preliminary Proxy Statement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Definitive Proxy Statement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Definitive Additional Materials</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Soliciting Material under &sect;240.14a-12<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> Celldex Therapeutics, Inc.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> (Name of Registrant as Specified In Its Charter)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> (Name of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 style="font-family:times;"><FONT SIZE=2><BR>
Payment of Filing Fee (Check the appropriate box):</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>No fee required.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and&nbsp;0-11.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Title of each class of securities to which transaction applies:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Aggregate number of securities to which transaction applies:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Proposed maximum aggregate value of transaction:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(5)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Total fee paid:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Fee paid previously with preliminary materials.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Check box if any part of the fee is offset as provided by Exchange Act Rule&nbsp;0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its filing.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><BR><FONT SIZE=2>Amount Previously Paid:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Form, Schedule or Registration Statement No.:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Filing Party:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Date Filed:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=628658,FOLIO='blank',FILE='DISK132:[14ZAE1.14ZAE79801]BA79801A.;4',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=4><B>CELLDEX THERAPEUTICS,&nbsp;INC.<BR>  </B></FONT><FONT SIZE=2><B>Perryville III Building<BR>
53 Frontage Road, Suite&nbsp;220<BR>
Hampton, NJ 08827  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS<BR>
To be held on May&nbsp;28, 2014  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>To the Stockholders of<BR>
Celldex Therapeutics,&nbsp;Inc. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>NOTICE IS HEREBY GIVEN</B></FONT><FONT SIZE=2> that the Annual Meeting of Stockholders of Celldex Therapeutics,&nbsp;Inc. (the "Company" or "we" or "us") will
be held at the Olde Mill Inn, 225 Route 202, Basking Ridge, New Jersey 07920, on May&nbsp;28, 2014 beginning at 9:00&nbsp;a.m. local time. At the meeting, stockholders will act on the following
matters to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>elect seven directors to serve until the next Annual Meeting of Stockholders and until their respective successors shall
have been duly elected and qualified; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>ratify the appointment of PricewaterhouseCoopers&nbsp;LLP as our independent registered public accounting firm for the
year ending December&nbsp;31, 2014; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in this proxy
statement; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>address any other matters that may properly come before the meeting. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Only
stockholders of record at the close of business on April&nbsp;2, 2014 are entitled to receive notice of and to vote at the Annual Meeting or any postponement or adjournment
thereof. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your
vote is important. Whether you plan to attend the meeting or not, you may vote your shares by marking, signing, dating and mailing the enclosed proxy card in the envelope provided.
If you attend the meeting and prefer to vote in person, you may do so even if you have already voted your shares. You may revoke your proxy in the manner described in the proxy statement at any time
before it has been voted at the meeting. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>By Order of the Board of Directors</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2>Avery W. Catlin<BR></FONT> <FONT SIZE=2><I>Chief Financial Officer and Secretary</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<P style="font-family:times;"><FONT SIZE=2>April&nbsp;11,
2014<BR>
Hampton, NJ </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=2,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=717832,FOLIO='blank',FILE='DISK132:[14ZAE1.14ZAE79801]BE79801A.;5',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B>CELLDEX THERAPEUTICS,&nbsp;INC.<BR>  </B></FONT><FONT SIZE=2><B>Perryville III Building<BR>
53 Frontage Road, Suite&nbsp;220<BR>
Hampton, NJ 08827  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="CENTER" >


  </I></FONT><FONT SIZE=2><B>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR>  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><B>PROXY STATEMENT  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="CENTER" >


 </I></FONT><FONT SIZE=3><B>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR>  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This proxy statement contains information related to the Annual Meeting of Stockholders to be held on May&nbsp;28, 2014 at 9:00&nbsp;a.m.
local time, at the Olde Mill Inn, 225 Route 202, Basking Ridge, New Jersey 07920, or at such other time and place to which the Annual Meeting may be adjourned or postponed. The enclosed proxy is
solicited by the Board of Directors of Celldex Therapeutics,&nbsp;Inc. The proxy materials relating to the Annual Meeting are being mailed to stockholders entitled to vote at the meeting on or about
April&nbsp;11, 2014. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Important Notice of Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on May&nbsp;28, 2014.</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Our proxy materials, including our Proxy Statement for the 2014 Annual Meeting, 2013 Annual Report to Stockholders (which contains our Annual Report on
Form&nbsp;10-K) and proxy card, are available on the Internet at www.proxyvote.com.</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dc79801_about_the_meeting"> </A>
<A NAME="toc_dc79801_1"> </A>
<BR></FONT><FONT SIZE=2><B>  ABOUT THE MEETING    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Why are we calling this Annual Meeting?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are calling the Annual Meeting to seek the approval of our stockholders to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>elect seven directors to serve until the next Annual Meeting of Stockholders and until their respective successors shall
have been duly elected and qualified; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>ratify the appointment of PricewaterhouseCoopers&nbsp;LLP as our independent registered public accounting firm for the
year ending December&nbsp;31, 2014; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in this proxy
statement; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>address any other matters that may properly come before the meeting. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2><B><I> What are the Board's recommendations?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Board of Directors recommends that you vote:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B><I>FOR</I></B></FONT><FONT SIZE=2> the election of each of the seven director nominees; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B><I>FOR</I></B></FONT><FONT SIZE=2> the ratification of the appointment of
PricewaterhouseCoopers&nbsp;LLP as our independent registered public accounting firm for the year ending December&nbsp;31, 2014; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B><I>FOR</I></B></FONT><FONT SIZE=2> an advisory vote on the compensation of the named executive officers
as described in this proxy statement. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2><B><I> Who is entitled to vote at the meeting?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Only stockholders of record at the close of business on the record date, April&nbsp;2, 2014, are entitled to receive notice of the
Annual Meeting and to vote the shares of common stock that they held on that date at the meeting, or any postponement or adjournment of the meeting. Holders of our common stock are entitled to one
vote per share on each matter to be voted upon. As of the record date, we had 89,357,843 outstanding shares of common stock. </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=3,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=183776,FOLIO='blank',FILE='DISK132:[14ZAE1.14ZAE79801]DC79801A.;7',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<A NAME="page_dc79801_1_2"> </A>

<P style="font-family:times;"><FONT SIZE=2><B><I> Who can attend the meeting?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All stockholders as of the record date, or their duly appointed proxies, may attend the Annual Meeting. Please note that if you hold
your shares in "street name" (that is, through a broker or other nominee), you will need to bring a copy of your proxy card delivered to you by your broker or a legal proxy given to you by your broker
and check in at the registration desk at the meeting. For security reasons, you must comply with our pre-registration requirements, you must present a form of government issued photograph
identification on the day of the Annual Meeting and you must arrive at least thirty minutes prior to the meeting in order to attend the Annual Meeting. If you are a stockholder of record and plan to
attend the Annual Meeting, please contact Kathy Reamer by email at kreamer@celldex.com or by phone at 908-200-7500 ext. 7508 to register to attend the Annual Meeting. If you hold shares through an
intermediary, such as a bank or broker, and you plan to attend, you must send a written request to attend either by regular mail or email, along with proof of share ownership, such as a bank or
brokerage firm account statement, confirming ownership to: Celldex Therapeutics, Inc., Perryville III Building, 53 Frontage Road, Suite&nbsp;220, Hampton, NJ 08827, Attn: Kathy Reamer or
kreamer@celldex.com. Attendance at the Annual Meeting will be limited to persons who pre-registered on or before May&nbsp;23, 2014, who present a form of government-issued photograph identification
on the day of the Annual Meeting, and who arrive by 8:30 am local time. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> What constitutes a quorum?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The presence at the Annual Meeting, in person or by proxy, of the holders of a majority of our common stock outstanding on the record
date will constitute a quorum for our meeting. Signed proxies received but not voted and broker non-votes will be included in the calculation of the number of shares considered to be present at the
meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> How do I vote?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You can vote on matters that come before the Annual Meeting by completing, dating and signing the enclosed proxy card and returning it
in the enclosed postage-paid envelope. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your
shares will be voted as you indicate on your proxy card. If you vote the enclosed proxy but you do not indicate your voting preferences, and with respect to any other matter that
properly comes before the meeting, the individuals named on the proxy card will vote your shares FOR the matters submitted at the meeting, or if no recommendation is given, in their own discretion. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you are a stockholder of record, to submit your proxy by telephone or via the Internet, follow the instructions on the proxy card. If you hold your shares in street name, you may vote
by telephone or via the Internet as instructed by your broker, bank or other nominee. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you attend the Annual Meeting and prefer to vote in person, you may do so even if you have already voted your shares by proxy. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B><I> What if I vote and then change my mind?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You may revoke your proxy at any time before it is exercised by:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>filing with the Secretary of the Company a notice of revocation; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>sending in another duly executed proxy bearing a later date; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>attending the meeting and casting your vote in person. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your
latest vote will be the vote that is counted. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=4,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=994244,FOLIO='2',FILE='DISK132:[14ZAE1.14ZAE79801]DC79801A.;7',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<A NAME="page_dc79801_1_3"> </A>

<P style="font-family:times;"><FONT SIZE=2><B><I> What is the difference between holding shares as a stockholder of record and as a beneficial owner?  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Many of our stockholders hold their shares through a stockbroker, bank or other nominee rather than directly in their own name. As
summarized below, there are some distinctions between shares held of record and those owned beneficially. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Stockholder of Record  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If your shares are registered directly in your name with our transfer agent, Computershare Trust Company, N.A., you are considered,
with respect to those shares, the stockholder of record. As the stockholder of record, you have the right to grant your voting proxy directly to us or to vote in person at the Annual Meeting. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Beneficial Owner  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If your shares are held in a stock brokerage account or by a bank or other nominee, you are considered the beneficial owner of shares
held in street name, and these proxy materials are being forwarded to you by your broker, bank or nominee which is considered, with respect to those shares, the stockholder of record. As the
beneficial owner, you have the right to direct your broker as to how to vote and are also invited to attend the Annual Meeting. However, because you are not the stockholder of record, you may not vote
these shares in person at the Annual Meeting
unless you obtain a signed proxy from the record holder giving you the right to vote the shares. If you do not vote your shares or otherwise provide the stockholder of record with voting instructions,
your shares may constitute broker non-votes. The effect of broker non-votes is more specifically described in "What vote is required to approve each proposal?" below. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> What are "broker non-votes"?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Broker non-votes occur when nominees, such as banks and brokers holding shares on behalf of beneficial owners, do not receive voting
instructions from the beneficial holders at least ten days before the meeting. If that happens, the nominees may vote those shares only on matters deemed "routine", such as the ratification of
auditors. Nominees cannot vote on non-routine matters unless they receive voting instructions from beneficial holders, resulting in so-called "broker non-votes." </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
election of directors (Proposal No.&nbsp;1) and the advisory vote on the compensation of our named executive officers (Proposal No.&nbsp;3) are not considered to be "routine"
matters and brokers are not permitted to vote on those matters if the broker has not received instructions from the beneficial owner. Accordingly, it is particularly important that beneficial owners
instruct their brokers how they wish to vote their shares. The ratification of our independent registered public accounting firm (Proposal No.&nbsp;2) is considered to be a "routine" matter, and
hence your brokerage firm will be able to vote on Proposal No.&nbsp;2 even if it does not receive instructions from you, so long as it holds your shares in its name. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abstentions
and broker non-votes will be treated as shares present for the purpose of determining the presence of a quorum for the transaction of business. Abstentions and broker
non-votes are not counted for the purpose of determining the number of votes cast and will therefore not have any effect with respect to any of the proposals. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> What vote is required to approve each proposal?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders of a majority of the outstanding shares entitled to vote must be present, in person or by proxy, at the Annual Meeting in order
to have the required quorum for the transaction of business. Pursuant to Delaware corporate law, abstentions and broker non-votes will be counted for the purpose of determining whether a quorum is
present. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=5,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=178577,FOLIO='3',FILE='DISK132:[14ZAE1.14ZAE79801]DC79801A.;7',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<A NAME="page_dc79801_1_4"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assuming
that a quorum is present, the following votes will be required:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>With respect to the election of directors (Proposal No.&nbsp;1), the seven nominees receiving the highest number of FOR
votes (from the holders of shares present in person or represented by proxy) will be elected as directors. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>With respect to the ratification of the appointment of PricewaterhouseCoopers&nbsp;LLP as our independent registered
public accounting firm (Proposal No.&nbsp;2), approval will require the affirmative vote of a majority of the votes cast in person or by proxy at the Annual Meeting. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>With respect to the advisory vote on the compensation of our named executive officers as disclosed in this proxy statement
(Proposal No.&nbsp;3), approval will require the affirmative vote of a majority of the votes cast in person or by proxy at the Annual Meeting. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders
of the common stock will not have any dissenters' rights of appraisal in connection with any of the matters to be voted on at the meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> How are we soliciting this proxy</I></B></FONT><FONT SIZE=2>? </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are soliciting this proxy on behalf of our Board of Directors by mail and will pay all expenses associated therewith. Some of our officers and other
employees also may, but without compensation other than their regular compensation, solicit proxies by further mailing or personal conversations, or by telephone, facsimile or other electronic means.
We will also, upon request, reimburse brokers and other persons holding stock in their names, or in the names of nominees, for their reasonable out-of-pocket expenses for forwarding proxy materials to
the beneficial owners of the capital stock and to obtain proxies. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=6,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=922968,FOLIO='4',FILE='DISK132:[14ZAE1.14ZAE79801]DC79801A.;7',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_de79801_1_5"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de79801_proposal_1__to_elect_seven_dir__pro05596"> </A>
<A NAME="toc_de79801_1"> </A>
<BR></FONT><FONT SIZE=2><B>  PROPOSAL 1: TO ELECT SEVEN DIRECTORS TO SERVE UNTIL THE NEXT ANNUAL MEETING<BR>  AND UNTIL THEIR SUCCESSORS HAVE BEEN DULY<BR>  ELECTED AND QUALIFIED    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de79801_(proposal_no._1)"> </A>
<A NAME="toc_de79801_2"> </A></FONT> <FONT SIZE=2><B>  (Proposal No.&nbsp;1)    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At the Annual Meeting, seven directors are to be elected. All directors of the Company hold office until the next Annual Meeting of
Stockholders or until their respective successors are duly elected and qualified or their earlier resignation or removal. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It
is the intention of the persons named in the proxies for the holders of common stock to vote the proxies for the election of the nominees named below, unless otherwise specified in
any particular proxy. Our management does not contemplate that the nominees will become unavailable for any reason, but if that should occur before the meeting, proxies will be voted for another
nominee, or other nominees, to be selected by our Board of Directors. In accordance with our by-laws and Delaware law, a stockholder entitled to vote for the election of directors may withhold
authority to vote for certain nominees for directors or may withhold authority to vote for all nominees for directors. The director nominees receiving a plurality of the votes of the holders of shares
of common stock present in person or by proxy at the meeting and entitled to vote on the election of directors will be elected directors. Broker non-votes will not be treated as a vote for or against
any particular director nominee and will
not affect the outcome of the election. Stockholders may not vote, or submit a proxy, for a greater number of nominees than the seven nominees named below. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Nominees for Election  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The persons listed below are our current directors and have been nominated for re-election (the "Director Nominees") to fill the seven
director positions to be elected by the holders of the common stock. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:33pt;"><FONT SIZE=1><B>Directors

<!-- COMMAND=ADD_SCROPPEDRULE,33pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Age </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year First<BR>
Became<BR>
Director </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Larry Ellberger (Chairman of the Board)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>66</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2003</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony S. Marucci (Chief Executive Officer)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>52</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2008</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Herbert J. Conrad</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>81</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2008</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>George O. Elston</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>49</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2008</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Harry H. Penner, Jr.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>68</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1997</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Timothy M. Shannon, M.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2009</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Karen L. Shoos</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2001</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following biographical descriptions set forth certain information with respect to the Director Nominees, based on information furnished to Celldex by each Director Nominee. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Director Nominees  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B>Larry Ellberger</B></FONT><FONT SIZE=2> was appointed Chairman of the Board of Directors in September 2009 and
has been a director of Celldex since August 2003. From 2003 to July 2012, Mr.&nbsp;Ellberger was Founding Partner of HVA,&nbsp;Inc. a consulting firm specializing in business development, product
acquisition and licensing, and mergers and acquisitions for pharmaceutical, biotechnology, drug delivery, and medical device companies. From October 2005 to May 2006, Mr.&nbsp;Ellberger was Interim
Chief Executive Officer of PDI,&nbsp;Inc., a provider of sales and marketing services to the biopharmaceutical industry. Previously, he was a member of the Board of Directors of PDI and Chairman of
the Audit Committee. From 2000 to 2003, Mr.&nbsp;Ellberger was Senior Vice President of Powderject&nbsp;PLC, a U.K. vaccine company. He was also a member of the Board of Directors of Powderject.
From 1995 to 1999, Mr.&nbsp;Ellberger held several </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=7,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=562613,FOLIO='5',FILE='DISK132:[14ZAE1.14ZAE79801]DE79801A.;10',USER='HYUNG',CD=';7-APR-2014;11:51' -->
<A NAME="page_de79801_1_6"> </A>

<P style="font-family:times;"><FONT SIZE=2>positions
at W.R. Grace&nbsp;&amp;&nbsp;Co. including Interim Chief Executive Officer, Chief Financial Officer and Senior Vice President, Strategic Planning and Development. From 1975 to 1995,
Mr.&nbsp;Ellberger held numerous senior executive positions at American Cyanamid Company, serving the last four years as Vice President, Corporate Development. Mr.&nbsp;Ellberger currently serves
on the Board of Directors of The Jewish Children's Museum and NeuroDerm,&nbsp;Ltd., a privately-held Israeli biotech company. Mr.&nbsp;Ellberger was formerly Chairman of the Board of Omrix
BioPharmaceuticals,&nbsp;Inc. until its acquisition by Johnson&nbsp;&amp; Johnson in 2008. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Anthony S. Marucci</B></FONT><FONT SIZE=2> was appointed as permanent President and Chief Executive Officer of Celldex in September 2008 and as a director of
Celldex in December 2008. From May 2008 to September 2008 Mr.&nbsp;Marucci served as the Chief Executive Officer and President on an interim basis in addition to his role as Executive Vice
President, Corporate Development which he assumed upon consummation of the merger of Celldex Research Corporation (formerly known as Celldex Therapeutics,&nbsp;Inc.) ("Celldex Research") and Celldex
(formerly known as AVANT Immunotherapeutics,&nbsp;Inc.) (the "AVANT Merger") in March 2008. Prior to the AVANT Merger, Mr.&nbsp;Marucci had been Celldex Research's Acting Chief Executive Officer
since October 2007 and its Vice President, Chief Financial Officer, Treasurer and Secretary since May 2003. In addition, he was Treasurer of Medarex,&nbsp;Inc. from December 1998 to March 2004.
Mr.&nbsp;Marucci held a series of senior financial positions at Medarex from December 1998 to May 2003. Mr.&nbsp;Marucci is a member of the Board of Trustees of BioNJ&nbsp;Inc. and also served
as its Treasurer through 2010. Mr.&nbsp;Marucci received his M.B.A. from Columbia University. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Herbert J. Conrad</B></FONT><FONT SIZE=2> became a director of Celldex in March 2008 upon consummation of the AVANT Merger. Mr.&nbsp;Conrad had been a director
of Celldex Research since March 2004. Mr.&nbsp;Conrad was President of the U.S. Pharmaceuticals Division of Hoffmann-La Roche,&nbsp;Inc., a pharmaceutical company, from 1982 until his retirement
in 1993. Mr.&nbsp;Conrad currently serves as Chairman of the Board of
Matinas BioPharma, a publicly-held biopharmaceutical company. Mr.&nbsp;Conrad serves as an Advisor to the Seaver Autism Center at Mount Sinai Hospital. In addition to serving on the board of
directors of privately held biotechnology companies, Mr.&nbsp;Conrad has served as Chairman of the Board of Directors of Pharmasset,&nbsp;Inc., GenVec,&nbsp;Inc. and Bone Care
International,&nbsp;Inc. Mr.&nbsp;Conrad has also served as director of Savient Pharmaceuticals,&nbsp;Inc. and was a director and co-founder of Reliant Pharmaceuticals,&nbsp;Inc. He received
B.S. and M.S. degrees from the Brooklyn College of Pharmacy and an honorary Doctorate in Humane Letters from Long Island University. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>George O. Elston</B></FONT><FONT SIZE=2> became a director of Celldex in March 2008 upon consummation of the AVANT Merger. Mr.&nbsp;Elston had been a director
of Celldex Research since March 2004. Since February 2013, Mr.&nbsp;Elston has been the Senior Vice President and Chief Financial Officer of KBI Biopharma,&nbsp;Inc., a contract research firm to
the biopharmaceutical industry. Mr.&nbsp;Elston has served as the managing partner of Chatham Street Partners, a strategic advisory firm to the Life Science industry since January 2010. From January
2008 to January 2010, Mr.&nbsp;Elston was Chief Financial Officer of Optherion,&nbsp;Inc., a privately held biopharmaceutical company. From May 2000 to September 2007, Mr.&nbsp;Elston held
several senior executive roles at Elusys Therapeutics,&nbsp;Inc., a privately held biopharmaceutical company. Before joining Elusys, Mr.&nbsp;Elston was Chief Financial Officer of Trillium
USA,&nbsp;Inc. Prior to Trillium, Mr.&nbsp;Elston was with C.R. Bard,&nbsp;Inc., an international manufacturer and distributor of medical devices, and with PricewaterhouseCoopers.
Mr.&nbsp;Elston serves as a Trustee and is a member of the Audit and Nominating Committees of the Deutsche Bank DBX ETF Trust, an investment management company. Mr.&nbsp;Elston received his B.B.A.
in Public Accounting from Pace University and is a Certified Public Accountant. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Harry H. Penner, Jr.</B></FONT><FONT SIZE=2> has been a director of Celldex since January 1997 and was Chairman of AVANT prior to the consummation of the AVANT
Merger. Mr.&nbsp;Penner has served as Chairman and Chief Executive Officer of Nascent BioScience,&nbsp;LLC, a firm engaged in the creation and development of new biotechnology companies since
2001. From 1993 to 2001, Mr.&nbsp;Penner was President, Chief Executive Officer and Vice Chairman of Neurogen Corporation. From 1985 to 1993, Mr.&nbsp;Penner was </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=8,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=933919,FOLIO='6',FILE='DISK132:[14ZAE1.14ZAE79801]DE79801A.;10',USER='HYUNG',CD=';7-APR-2014;11:51' -->
<A NAME="page_de79801_1_7"> </A>

<P style="font-family:times;"><FONT SIZE=2>an
Executive Vice President of Novo Nordisk A/S, serving from 1988 to 1993 as Executive Vice President for North America and President, Novo Nordisk of North America, and from 1985 to 1988 as the
company's Executive Vice President and General Counsel in Denmark. He has served as BioScience Advisor to the Governor and the State of Connecticut, as Co-Chairman of Connecticut United for Research
Excellence, and as Chairman of the Connecticut Board of Governors of Higher Education and the Connecticut Technology Council. Mr.&nbsp;Penner is currently on the Board of Directors of New Haven
Pharmaceuticals,&nbsp;Inc. (of which he is Executive Chairman), Prevention Pharmaceuticals,&nbsp;Inc., and Affinimark Technologies,&nbsp;Inc., all privately held companies of which he is a
founder. In addition to having served on the board of directors of several public and privately held life science companies, Mr.&nbsp;Penner served on the Board of Directors and Audit Committee of
Altus Pharmaceuticals,&nbsp;Inc. until October 2009. Mr.&nbsp;Penner received a B.A. from the University of Virginia, a J.D. from Fordham University, and an L.L.M. in International Law from New
York University. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Timothy M. Shannon, M.D.</B></FONT><FONT SIZE=2> became a director of Celldex in October 2009 upon the acquisition of CuraGen Corporation ("CuraGen") by Celldex
(the "CuraGen Acquisition"). Since December 2009, Dr.&nbsp;Shannon has been a Venture Partner at Canaan Partners, a global venture capital firm. Since July 2013, Dr.&nbsp;Shannon has been the
Chief Executive Officer and member of the Board of Directors of Arvinas&nbsp;Inc., a privately held biotechnology company. From September 2011 to September 2013, Dr.&nbsp;Shannon was the interim
President and Chief Executive Officer of ALDEA Pharmaceuticals,&nbsp;Inc., a privately held biotechnology company. From September 2007 to October 2009, Dr.&nbsp;Shannon served as CuraGen's
President and Chief Executive Officer and a member of its board of directors. From January 2004 until September 2007, Dr.&nbsp;Shannon served as CuraGen's Executive Vice President and Chief Medical
Officer. From September 2002 until December 2003, Dr.&nbsp;Shannon served as CuraGen's Senior Vice President of Research and Development. Prior to joining CuraGen, Dr.&nbsp;Shannon worked in
positions of increasing responsibility for Bayer's Pharmaceutical Business Group, where his last position was Head and Senior Vice President of Global Medical Development. Dr.&nbsp;Shannon currently
serves as a director of ALDEA Pharmaceuticals,&nbsp;Inc., Civitas Therapeutics,&nbsp;Inc., Novira Therapeutics&nbsp;Inc. and CytomX Therapeutics,&nbsp;Inc., all privately held biotechnology
companies. Dr.&nbsp;Shannon earned his B.A. in Chemistry from Amherst College and his M.D. from the University of Connecticut School of Medicine. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Karen L. Shoos</B></FONT><FONT SIZE=2> has been a director of Celldex since May 2001. Since May 2013, Ms.&nbsp;Shoos has been Principal Investigator, AABB
International Technical Assistance. From October 1994 to May 2013, Ms.&nbsp;Shoos was Chief Executive Officer of AABB. AABB is a professional standards setting and accrediting organization in the
fields of blood and cellular therapies. Prior to AABB, from 1984 to 1994, Ms.&nbsp;Shoos held senior positions at the American Red Cross, including Acting Senior Vice President, Biomedical Services
(1993-1994) and Secretary and General Counsel (1990-1993). Prior to the American Red Cross, Ms.&nbsp;Shoos was a lawyer in private practice. Ms.&nbsp;Shoos earned her B.A. from Yale University and
her J.D. from Case Western Reserve University. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Family Relationships  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There are no family relationships among our Director Nominees, management and other key personnel. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> The Board of Directors and Its Committees  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B><I> Board of Directors  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are currently managed by a seven member Board of Directors, a majority of whom are "independent" as that term is defined in the
applicable NASDAQ listing standards. Other than Mr.&nbsp;Marucci, each of our directors is deemed "independent" as that term is defined in the applicable NASDAQ listing standards. Our Board of
Directors met six times in 2013. Each of the directors attended at least 75% of the aggregate of (i)&nbsp;the total number of meetings of our Board of Directors </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>7</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=9,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=497425,FOLIO='7',FILE='DISK132:[14ZAE1.14ZAE79801]DE79801A.;10',USER='HYUNG',CD=';7-APR-2014;11:51' -->
<A NAME="page_de79801_1_8"> </A>

<P style="font-family:times;"><FONT SIZE=2>(held
during the period for which such directors served on the Board of Directors) and (ii)&nbsp;the total number of meetings of all committees of our Board of Directors on which the Director served
(during the periods for which the director served on such committee or committees). Our annual meeting of stockholders is generally held to coincide with one of the Board's regularly scheduled
meetings. We do not have a formal policy requiring members of the Board of Directors to attend our annual meetings, although our directors typically attend the annual meeting. Each of the then current
directors attended the 2013 Annual Meeting of Stockholders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Audit Committee  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors has established an Audit Committee currently consisting of George O. Elston, Chair, Larry Ellberger, and Harry
H. Penner, Jr. The Audit Committee makes recommendations concerning the engagement of independent public accountants, reviews with the independent public accountants the scope and results of the audit
engagement, approves professional services provided by the independent public accountants, reviews the independence of the independent public accountants, considers the range of audit and non-audit
fees, and reviews the adequacy of our internal accounting controls. Each member of the Audit Committee is "independent" as that term is defined in the rules of the SEC and the applicable NASDAQ
listing standards. The Board has determined that each Audit Committee member has sufficient knowledge in financial and auditing matters to serve on the Committee. The Board has designated George O.
Elston as an "audit committee financial expert," as defined under the applicable rules of the SEC and the applicable NASDAQ listing standards. The Audit Committee met six times during 2013. Our Board
has adopted an Audit Committee Charter, which is available for viewing at </FONT><FONT SIZE=2><I>www.celldex.com</I></FONT><FONT SIZE=2>. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Compensation Committee  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors has established a Compensation Committee currently consisting of Karen&nbsp;L.&nbsp;Shoos, Chair, George O.
Elston and Harry H. Penner, Jr. The primary function of the Compensation Committee is to assist the Board in the establishment of compensation for the Chief Executive Officer, to approve the
compensation of other officers and senior employees and to approve certain other personnel and employee benefit matters. Each member of the Compensation Committee is "independent" as that term is
defined in the rules of the SEC and the applicable NASDAQ listing standards. In 2013, the Compensation Committee engaged Radford, an Aon Hewitt Company, to provide guidance on various aspects of the
company's director compensation programs. The Compensation Committee has assessed the independence of Radford and concluded that no conflict of interests exists under applicable SEC rules. The
Compensation Committee met five times during 2013. Our Board has adopted a Compensation Committee Charter, which is available for viewing at </FONT> <FONT SIZE=2><I>www.celldex.com.</I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Nominating and Corporate Governance Committee  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors has established a Nominating and Corporate Governance Committee consisting of Herbert J. Conrad, Chair, Larry
Ellberger and Karen L. Shoos. The primary function of the Nominating and Corporate Governance Committee is to assist the Board in reviewing, investigating and addressing issues regarding Board
composition, policy and structure; membership on Board committees; and other matters regarding our governance. Each member of the Nominating and Corporate Governance Committee is "independent" as that
term is defined in the rules of the SEC and the applicable NASDAQ listing standards. The Nominating and Corporate Governance Committee met three times during 2013. Our Board has adopted a Nominating
and Corporate Governance Charter, which is available for viewing at </FONT><FONT SIZE=2><I>www.celldex.com</I></FONT><FONT SIZE=2>. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=10,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=441439,FOLIO='8',FILE='DISK132:[14ZAE1.14ZAE79801]DE79801A.;10',USER='HYUNG',CD=';7-APR-2014;11:51' -->
<A NAME="page_de79801_1_9"> </A>


<P style="font-family:times;"><FONT SIZE=2><B><I> Scientific Advisory Committee  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors has established a Scientific Advisory Committee consisting of Dr.&nbsp;Timothy Shannon, Chair. The primary
function of the Scientific Advisory Committee is
to assist the Board in undertaking periodic reviews of our research and development efforts, and clinical trials, and reporting to the Board about developments and strategy, at such times as the
Committee determines to be appropriate. The sole member of that Committee shall also be invited to attend meetings of our Scientific Advisory Board (the
"</FONT><FONT SIZE=2><I>SAB</I></FONT><FONT SIZE=2>") and shall serve as the primary liaison between the Board and the SAB. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B><I> Director selection criteria  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Nominating and Corporate Governance Committee is responsible for reviewing, on an annual basis, the appropriate mix of professional
competencies, key attributes, skills and experiences required of board members to work together as a team to properly oversee our strategies and operations. The process followed by the Nominating and
Corporate Governance Committee to evaluate any candidates whether identified or recommended by board members, management, members of the Nominating and Corporate Governance Committee, stockholders or
other external sources, includes meetings from time to time to evaluate biographical information and background material relating to potential candidates to the Board and interviews of selected
candidates by members of the Committee and the Board. All nominees must have, at a minimum, high personal and professional integrity, exceptional ability and judgment, and be effective in collectively
serving the long-term interests of all stockholders, all as described above. Other qualifications that may be considered by the Committee are described in the Nominating and Corporate Governance
Committee's Charter. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
board members are expected to possess certain key attributes necessary to creating a functional board: high personal and professional ethics, integrity and values; practical wisdom
and mature judgment; an inquisitive and objective perspective; professional experience at a policy-making level in business, government, education or medicine; time availability for in-person
participation at board and committee meetings; and a commitment to representing the long-term interests of our stockholders. We look for directors with professional competencies that include senior
management operational experience, accounting and finance capabilities, deep industry-related experience, biologic development and manufacturing expertise, business development leadership, medical and
scientific proficiencies, and government and public policy experience. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
of our directors brings unique perspectives and experiences to the Board of Directors and contributes in guiding and directing our strategies to meet our business objectives and to
provide value to our stockholders. For example, Messrs.&nbsp;Conrad, Ellberger, Marucci, Penner, Shannon and Ms.&nbsp;Shoos have all either currently or formerly been chief executive officers of
life sciences or healthcare-related companies and have experienced the challenges of such a position. Similarly, Dr.&nbsp;Shannon has formerly been chief medical officer of a biotechnology company
and has the experience of guiding and directing the research and development efforts at that company. Messrs.&nbsp;Ellberger, Elston and Marucci have all formerly been chief financial and chief
corporate development officers at pharmaceutical and life sciences companies and have completed a significant number of financing and business development transactions. Ms.&nbsp;Shoos has experience
in the highly regulated blood supply sector which is similar to our regulated biologics industry. Mr.&nbsp;Penner has been the chief legal officer at a large public pharmaceutical company and for
that company and for life sciences companies has completed a
significant number of financing and business development transactions. Messrs.&nbsp;Conrad and Ellberger have many years of experience on the boards of directors of larger public pharmaceutical and
life sciences companies. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Independence
also is an important selection criterion for nomination to our Board. Independent directors should be free of any relationship with us, our management, other directors or
other parties </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>9</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=11,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=679449,FOLIO='9',FILE='DISK132:[14ZAE1.14ZAE79801]DE79801A.;10',USER='HYUNG',CD=';7-APR-2014;11:51' -->
<A NAME="page_de79801_1_10"> </A>

<P style="font-family:times;"><FONT SIZE=2>that
may impair, or appear to impair, the director's ability to make independent judgments. Independent directors must satisfy the criteria for independence established by NASDAQ. Currently all of our
directors are independent except for our Chief Executive Officer, Mr.&nbsp;Marucci. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
all board members are expected to act in our best interests and the best interests of our stockholders and to avoid any conflicts of interest in accordance with our Code of
Business Conduct and Ethics. In selecting director nominees, the Nominating and Corporate Governance Committee seeks individuals who are free from conflicts of interest. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finally,
candidates should be enthusiastic and excited about their service on our Board and working collaboratively with existing board members to create value for all of our
stockholders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Stockholder nominations for directorships  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stockholders may propose a potential director candidate for consideration by the Nominating and Corporate Governance Committee by
submitting their names and background to the Secretary of Celldex at Perryville III Building, 53&nbsp;Frontage Road, Suite&nbsp;220, Hampton, NJ 08827. All such recommendations will be forwarded
to the Nominating and Corporate Governance Committee, which will review and consider only such recommendations if appropriate biographical and other information is provided, as described below, on a
timely basis. All security holder recommendations for director candidates must be submitted to us not less than 120 calendar days prior to the date on which our proxy statement is released to
stockholders in connection with our annual meeting, and must include the following information:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the name and address of record of the security holder; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>a representation that the security holder is a record holder of our securities, or if the security holder is not a record
holder, evidence of ownership in accordance with Rule&nbsp;14a-8(b)(2) of the Securities Exchange Act of 1934; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the name, age, business and residential address, educational background, current principal occupation or employment, and
principal occupation or employment for the preceding five (5)&nbsp;full fiscal years of the proposed director candidate; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>a description of the qualifications and background of the proposed director candidate which addresses the minimum
qualifications and other criteria for Board membership approved by the Board from time to time and set forth in the Nominating and Corporate Governance Committee's written charter; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>a description of any arrangements or understandings between the security holder and the proposed director candidate; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the consent of the proposed director candidate to be named in the proxy statement relating to our annual meeting of
stockholders and to serve as a director if elected at such annual meeting. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assuming
that appropriate information is provided for candidates recommended by stockholders, the Nominating and Corporate Governance Committee will evaluate those candidates by
following substantially the same process, and applying substantially the same criteria, as for candidates submitted by Board members or other persons, as described above and as set forth in its
written charter. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Board Leadership Structure  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board recognizes that one of its key responsibilities is to evaluate and determine its optimal leadership structure so as to
provide independent oversight of management. The Board understands that there is no single, generally accepted approach to providing Board leadership and that given the dynamic and competitive
environment in which we operate, the right Board leadership structure may </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=12,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=645387,FOLIO='10',FILE='DISK132:[14ZAE1.14ZAE79801]DE79801A.;10',USER='HYUNG',CD=';7-APR-2014;11:51' -->
<A NAME="page_de79801_1_11"> </A>

<P style="font-family:times;"><FONT SIZE=2>vary
as circumstances warrant. Consistent with this understanding, the Nominating and Corporate Governance Committee considers the Board's leadership structure on an annual basis. This consideration
includes the pros and cons of alternative leadership structures in light of the Company's operating and governance environment at the time, with the goal of achieving the optimal model for effective
oversight of management by the Board. Currently, the roles of Chief Executive Officer and Chairman of the Board are separate. Mr.&nbsp;Marucci, our Chief Executive Officer, is a member of our Board.
Mr.&nbsp;Ellberger, an independent director, serves as Chairman of the Board. The Board believes that its current leadership structure provides independent board leadership, engagement, and
oversight. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, our independent committee chairs are responsible for leading committee meetings, determining committee meeting schedules, agenda and information flow, and reporting to the
full Board on the committee's actions and areas of responsibilities. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B><I> Risk Oversight  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our management is responsible for assessing and managing risk and the Board of Directors oversees and reviews certain aspects of our
risk management processes. The Board of Directors is involved in risk oversight through direct decision- making authority with respect to significant matters and the oversight of management by the
Board of Directors and its committees. The Board is responsible for overseeing risks related to our overall operations and strategy, including, among others, product development, potential asset
acquisitions, financial reporting, business continuity (including succession planning) and reputational risks faced by us. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
committees of the Board execute their oversight responsibility for risk management as follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The Audit Committee is responsible for overseeing our internal financial and accounting controls and the work performed by
the independent registered public accounting firm. As part of its oversight function, the Audit Committee regularly discusses with management and the independent registered public accounting firm our
major financial and controls-related risk exposures and steps that management has taken to monitor and control such exposures. The Audit Committee also reviews our risk management insurance programs. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The Compensation Committee is responsible for overseeing risks related to our cash and equity-based compensation programs
and practices. As part of its oversight function, the Compensation Committee periodically discusses with the President and Chief Executive Officer as well as the Board of Directors, as necessary, the
compensation plan for both executive officers and the independent directors, performance goals and objectives for the period and related achievement, peer group and other relevant compensation
benchmarks and practices and other matters to ensure our compensation practices are in our best interest and that of our shareholders. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The Nominating and Corporate Governance Committee is responsible for overseeing risks related to the composition and
structure of the Board of Directors and its committees and our corporate governance. In this regard, the Nominating and Corporate Governance Committee assesses the qualifications and independence of
members of the Board, makes annual recommendations regarding Board and committee membership, and reviews any transactions between us and our officers, directors, affiliates of officers and directors
or other related parties for conflicts of interest. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2><B><I> Corporate Governance Matters  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the recommendation of our Nominating and Corporate Governance Committee, we adopted amended and restated by-laws to among other
things replace with plurality voting standard with a majority voting standard for uncontested elections of directors and eliminate the mandatory retirement age for directors. As a result, beginning
with the 2015 annual meeting of stockholders, all director </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=13,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=52613,FOLIO='11',FILE='DISK132:[14ZAE1.14ZAE79801]DE79801A.;10',USER='HYUNG',CD=';7-APR-2014;11:51' -->
<A NAME="page_de79801_1_12"> </A>

<P style="font-family:times;"><FONT SIZE=2>nominees
in uncontested elections would be required to receive a number of "FOR" votes representing at least a majority of votes cast in the election. If such a director nominee fails to receive "FOR"
votes representing at least a majority of votes cast and is an incumbent director, the by-laws would require the director to promptly tender his or her resignation to the Board, subject to acceptance
by the Board. The Nominating and Corporate Governance Committee of the Board would then be charged with making a recommendation to the Board as to whether to accept or reject the tendered resignation,
or whether other action should be taken. In contested elections, where the number of nominees exceeds the number of directors to be elected, the plurality voting standard would continue to apply. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, upon the recommendation of our Nominating and Corporate Governance Committee, we adopted corporate governance guidelines in April 2014. A copy of our corporate governance
guidelines has been posted to our corporate website. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Stockholder Communications  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors will give appropriate attention to written communications that are submitted by stockholders, and will respond
if and as appropriate. Absent unusual circumstances or as contemplated by committee charters, and subject to advice from legal counsel, the Secretary of Celldex is primarily responsible for monitoring
communications from stockholders and for providing copies or summaries of such communications to the Board of Directors as he considers appropriate. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Communications
from stockholders will be forwarded to all directors if they relate to important substantive matters or if they include suggestions or comments that the Secretary
considers to be important for the Board of Directors to know. Communication relating to corporate governance and corporate strategy are more likely to be forwarded to the Board of Directors than
communications regarding personal grievances, ordinary business matters, and matters as to which Celldex tends to receive repetitive or duplicative communications. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stockholders
who wish to send communications to the Board of Directors should address such communications to: The Board of Directors, Celldex Therapeutics,&nbsp;Inc., Perryville III
Building, 53&nbsp;Frontage Road, Suite&nbsp;220, Hampton, NJ 08827, Attention: Secretary. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Code of Business Conduct and Ethics  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have adopted a Code of Business Conduct and Ethics that applies to our directors, officers, and employees. The purpose of the Code
of Business Conduct and Ethics is to deter wrongdoing and to promote, among other things, honest and ethical conduct and to ensure to the extent possible that our business is conducted in a
consistently legal and ethical manner. Our Code of Business Conduct and Ethics is publicly available on our website at www.celldex.com. If we make any substantive amendments to the Code of Business
Conduct and Ethics or grant any waiver, including any implicit waiver from a provision of the Code of Business Conduct and Ethics to our Directors or Executive Officers, we will disclose the nature of
such amendments or waiver on our website or in a current report on Form&nbsp;8-K. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>12</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=14,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=434798,FOLIO='12',FILE='DISK132:[14ZAE1.14ZAE79801]DE79801A.;10',USER='HYUNG',CD=';7-APR-2014;11:51' -->
<A NAME="page_de79801_1_13"> </A>

<P style="font-family:times;"><FONT SIZE=2><B> Executive Officers  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth certain information regarding our current executive officers: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="157pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:69pt;"><FONT SIZE=1><B>Name of Individual

<!-- COMMAND=ADD_SCROPPEDRULE,69pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Age </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Position and Office </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>52</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>President, Chief Executive Officer and Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Avery W. Catlin</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>66</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Senior Vice President, Chief Financial Officer and Secretary</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Thomas Davis, M.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>50</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Senior Vice President and Chief Medical Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>55</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Senior Vice President and Chief Scientific Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Ronald Pepin, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>58</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Senior Vice President and Chief Business Officer</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Anthony S. Marucci</B></FONT><FONT SIZE=2> was appointed as permanent President and Chief Executive Officer of Celldex in September 2008 and as a director of the
Company in December 2008. See Mr.&nbsp;Marucci's biography under </FONT><FONT SIZE=2><I>Director Nominees</I></FONT><FONT SIZE=2> above. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Avery W. Catlin</B></FONT><FONT SIZE=2> joined Celldex in January 2000. Mr.&nbsp;Catlin has more than 25&nbsp;years of financial and business expertise in the
biotechnology and medical device industries. Prior to joining Celldex, he served as Vice President, Operations and Finance, and Chief Financial Officer of Endogen,&nbsp;Inc., a public life science
research products company, from 1996 to 1999. From 1992 to 1996, Mr.&nbsp;Catlin held various financial positions at Repligen Corporation, a public biopharmaceutical company, serving the last two
years as Chief Financial Officer. Earlier in his career, Mr.&nbsp;Catlin held the position of Chief Financial Officer at MediSense,&nbsp;Inc., a Massachusetts-based medical device company.
Mr.&nbsp;Catlin received his B.A. degree from the University of Virginia and his M.B.A. from Babson College and is a Certified Public Accountant. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Thomas Davis, M.D.</B></FONT><FONT SIZE=2> became Senior Vice President and Chief Medical Officer of Celldex in March 2008 upon consummation of the AVANT Merger.
Dr.&nbsp;Davis was Vice President of Clinical Development and Chief Medical Officer of Celldex Research since April 2006 and Chief Medical Officer at GenVec from July 2005 to April 2006.
Dr.&nbsp;Davis was also Senior Director of Clinical Science at Medarex. He has supervised clinical efforts in adult hematologic malignancies and marrow transplantation and therapeutic antibodies at
the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI) and worked with Dr.&nbsp;Ron Levy on the development of rituximab and idiotype vaccines at Stanford University.
Dr.&nbsp;Davis received his B.A. degree in Biophysics from Johns Hopkins University, his M.S. degree in Physiology from Georgetown University and his M.D. from Georgetown University School of
Medicine. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Tibor Keler, Ph.D.</B></FONT><FONT SIZE=2> became Senior Vice President and Chief Scientific Officer of Celldex in March 2008 upon consummation of the AVANT
Merger. Dr.&nbsp;Keler had been Celldex Research's Vice President, Research and Discovery and Chief Scientific Officer since May 2003. In addition, he was Senior Director of Preclinical Development
and Principal Scientist at Medarex from September 1993 to March 2004. While at Medarex, he was responsible for the development of Celldex's technology and products, as well as for the preclinical
development and testing of numerous Medarex products now in clinical trials. Dr.&nbsp;Keler received his Ph.D. in Microbiology from the University of Pennsylvania. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Ronald Pepin, Ph.D.</B></FONT><FONT SIZE=2> became Senior Vice President and Chief Business Officer of Celldex in July 2011. From June 2010 to April 2011,
Dr.&nbsp;Pepin served as Vice President at Shire Pharmaceuticals. From August 2000 to December 2009, Dr.&nbsp;Pepin was Senior Vice President, Business Development at Medarex,&nbsp;Inc. Earlier
in his career, Dr.&nbsp;Pepin was Executive Director of External Science and Technology at Bristol-Myers Squibb Company. Dr.&nbsp;Pepin received his B.A. from Tufts University and his Ph.D. in
Genetics from Georgetown University. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>13</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=15,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=713297,FOLIO='13',FILE='DISK132:[14ZAE1.14ZAE79801]DE79801A.;10',USER='HYUNG',CD=';7-APR-2014;11:51' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dg79801_1_14"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><B> EXECUTIVE COMPENSATION  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dg79801_compensation_discussion_and_analysis"> </A>
<A NAME="toc_dg79801_1"> </A></FONT> <FONT SIZE=2><B>  Compensation Discussion and Analysis    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B><I> Introduction  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Compensation Committee oversees and administers our executive compensation programs. The Committee's complete roles and
responsibilities are set forth in the written charter of the Compensation Committee adopted by our Board of Directors, which can be found at our website, </FONT> <FONT SIZE=2><I>www.celldex.com</I></FONT><FONT SIZE=2>. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Overview  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our executive compensation programs are designed to deliver compensation that is competitive with our peer group and that allows us to
attract and retain superior talent who can perform effectively and succeed in a demanding business environment. Our compensation programs are also designed to reward performance against
pre-established goals and align the interests of our executives with our stockholders. We believe that the compensation of our executive officers should focus executive behavior on the achievement of
near-term corporate targets as well as long-term business objectives and strategies. We believe that pay-for-performance compensation programs, which reward our executives when they achieve individual
and/or corporate goals, create stockholder value and thus have emphasized company and individual performance in setting compensation. We use a combination of base salary, annual cash incentive
compensation programs, a long-term equity incentive compensation program and a broad based benefits program to create a competitive compensation package for our executive management team. We describe
below our compensation philosophy, policies and practices with respect to our Chief Executive Officer, Chief Financial Officer and our other executive officers, who are collectively referred to as our
Named Executive Officers. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a biopharmaceutical company focusing on the development of several immunotherapy technologies, we establish corporate goals that are designed to contribute to the development of our
lead programs, rindopepimut and glembatumumab vedotin, to ensure that we manage our cash effectively and have sufficient funding to complete near term development activities for our lead drug
candidates and, where appropriate, to pursue partnerships and collaborations through which we can leverage the value of our drug candidates. We seek to link the financial interests of our Named
Executive Officers to those of our stockholders by tying compensation to the achievement of these strategic corporate goals, which we believe will drive long-term stockholder value. Each year we
establish corporate goals the achievement of which we believe are essential to the long-term success of our business. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee has adopted a compensation philosophy of targeting our executive compensation to the 50<SUP>th</SUP>&nbsp;percentile of executive compensation of our peer
group and the Radford Global Life Sciences Survey results. Executive compensation may be above or below the 50<SUP>th</SUP>&nbsp;percentile based on an executive's experience, scope of position,
individual performance and company constraints. The Compensation Committee increased annual base salary for our existing executive officers by 2.9% to 3.3% in mid-2013, depending on the position. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Compensation Committee reviewed our performance relative to our 2013 corporate goals and concluded that we had achieved greater than 100% of our business and financial operations
goals. In particular, based on its determination that our executive officers over-achieved their goals with respect to progress in our clinical programs, particularly our rindopepimut and
glembatumumab vedotin programs, and to corporate development activities, our Compensation Committee decided to increase the annual bonus payments for our executive officers, which resulted in a payout
of 105% to 144% of our executive officers' 2013 bonus target, depending on the position. Further, stock options granted to our executive officers in 2013 have exercise prices equal to 100% of the fair
value on the date of grant </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>14</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=16,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=777291,FOLIO='14',FILE='DISK132:[14ZAE1.14ZAE79801]DG79801A.;10',USER='HYUNG',CD=';7-APR-2014;08:30' -->
<A NAME="page_dg79801_1_15"> </A>

<P style="font-family:times;"><FONT SIZE=2>and
vest over four years, beginning with 25% vesting one year after the date of grant, then pro-rata vesting quarterly thereafter based on continued service. We believe that stock options structured
in this manner encourage our executive officers to focus on increasing stockholder value and stock price appreciation over the long term and limit unnecessary risk taking behavior, while promoting
retention. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2013, we (i)&nbsp;raised net proceeds of $295.7&nbsp;million through sales of our common stock and we ended 2013 with cash, cash equivalents and marketable securities of
$303.0&nbsp;million and (ii)&nbsp;accomplished the following significant clinical milestones during the year:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Continued to actively enroll newly diagnosed patients with glioblastoma (GBM) in the ACT IV Phase&nbsp;3 registration
study. More than 200 sites are currently open to enrollment across 24&nbsp;countries. The Company anticipates completion of enrollment in mid-2014. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Announced impressive four- and five-year survival data across three Phase&nbsp;2 studies of rindopepimut in
EGFRvIII-positive glioblastoma at the Society for Neuro-Oncology Annual Meeting in November 2013. Survival data suggests a substantial and continuing survival benefit in comparison to a matched
historical control dataset, at the median and at all other time points evaluated. 18% of patients from the Phase&nbsp;2 frontline rindopepimut program were alive at four years and 14% were alive at
five years. No patients in the matched historical control dataset survived beyond three years. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Presented positive interim data from the ReACT study in recurrent GBM in an oral session at the Annual Meeting of the
Society for Neuro-Oncology. The data demonstrated promising signs of clinical activity in advanced patient populations, including patients both na&iuml;ve and refractory to
Avastin&reg;. Enrollment in ReACT is expected to be completed in late 2014 with data anticipated by year-end 2014. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Initiated a randomized, accelerated approval study (METRIC) of glembatumumab vedotin (CDX-011) in patients with metastatic
triple negative breast cancer that overexpresses the tumor associated marker gpNMB. The METRIC study is expected to include up to 100 sites in the United States, Canada and Australia. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Presented interim data from the Phase&nbsp;1 dose-escalation study of varlilumab (CDX-1127) at the Society for
Immunotherapy of Cancer Meeting. The data established an excellent safety profile, clear biologic activity and promising signs of clinical activity in an advanced, refractory patient population,
including activation of helper and effector lymphocytes as well as decreasing regulatory T cells (Tregs). The Company also presented preclinical data on combination studies of varlilumab, including
with chemotherapy or checkpoint inhibitors. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Completed the Phase&nbsp;1 study of CDX-1401, including longer-term patient follow up. CDX-1401 was well-tolerated and
elicited robust antibody and T cell responses in patients with advanced cancer that had progressed after any available curative and/or salvage therapies. Some patients had evidence of clinical benefit
with significant stable disease and measurable tumor shrinkage, despite their advanced stage of metastatic disease. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Presented positive results from a preclinical combination study of CDX-301 (rhuFlt3L) and Mozobil&reg;
demonstrating that the combination of these agents significantly increased hematopoietic stem cell mobilization and resulted in improved transplantation of mobilized cells at the American Society of
Hematology Annual Meeting in December 2013. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2><B><I> Independent Compensation Consultants  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee believes that independent advice is important in developing Celldex's director and executive compensation
programs and in 2013 and 2012 engaged Radford as its independent compensation consultant. In 2013, Radford focused on director compensation and in 2012 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>15</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=17,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=813120,FOLIO='15',FILE='DISK132:[14ZAE1.14ZAE79801]DG79801A.;10',USER='HYUNG',CD=';7-APR-2014;08:30' -->
<A NAME="page_dg79801_1_16"> </A>

<P style="font-family:times;"><FONT SIZE=2>Radford
focused on executive compensation. Radford reports directly to the Committee and provides guidance on trends in executive and non-employee director compensation, the development of specific
executive compensation programs, the composition of the Company's compensation peer group and
other matters as directed by the Committee. During 2013 and 2012, the Company paid Radford approximately $15,400 and $49,100, respectively, in consulting fees directly related to these services. In
2013 and 2012, Radford did not provide any other services to Celldex. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Data Used to Make Compensation Determinations  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In making decisions regarding the compensation of our executive officers, the Compensation Committee generally considers compensation
and survey data for similarly situated executives at a comparison group of companies it considers our peer group. These comparison data are primarily used to gauge the reasonableness and
competitiveness of executive compensation decisions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
draw upon a pool of talent that is highly sought after by large and established pharmaceutical and biotechnology companies as well as by other development-stage life science
companies, both within and outside our geographic areas. We believe that the compensation practices of our industry in general and of our select peer group in particular provide useful information to
help us establish compensation practices that allow us to attract, retain, and motivate a highly talented executive team. We believe we must offer a compensation package to all of our officers and our
other employees that is competitive with our peer group, as well as larger pharmaceutical and biotechnology companies from whom we frequently recruit. In addition, the comparator companies should be
aligned with our current stage of development and have similar short and long-term growth objectives. In 2013, the Compensation Committee set the target level of total executive compensation, as well
as the key elements of compensation, at the 50<SUP>th</SUP>&nbsp;percentile of our peer group, but then adjusted each of the elements based on an individual's performance and contribution to our
strategic objectives. The Committee may need to adjust these levels in the future to attract or retain specific individuals. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
review the levels of cash, equity, and total compensation for all comparable officers in our peer group relative to the elements of compensation paid to our officers. In considering
how these data relate to our existing compensation structure, we take into account our size, stage of development, performance, and geographic location as compared to these peer companies, as well as
what we know about the comparable scope of responsibilities of our officers versus those of comparable executives at such peer group companies. With the assistance of our compensation consultant,
Radford, we used two primary market frames of reference (which we refer to as the "market") against which to compare our total executive compensation practices and levels and inform our decisions
regarding compensation of our officers as follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Select Peer Group&#151;A select group of national biotechnology companies at a similar stage of development as our
company with similar headcount, market capitalization and in most cases, similar therapeutic targets, and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Radford Global Life Sciences Survey&#151;A national survey of executive compensation levels and practices that
covers approximately sixty executive positions in over 600 multinational life sciences organizations. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
do not apply a specific weighting to either data source when making compensation comparisons. Instead, we develop competitive market guidelines using these data sources. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
review our peer group each year to ensure continued relevance as we grow and develop and the Compensation Committee approves our peer group prior to its adoption. The select peer
group as </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>16</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=18,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=413227,FOLIO='16',FILE='DISK132:[14ZAE1.14ZAE79801]DG79801A.;10',USER='HYUNG',CD=';7-APR-2014;08:30' -->
<A NAME="page_dg79801_1_17"> </A>

<P style="font-family:times;"><FONT SIZE=2>of
May 2013 was analyzed and used to inform our decisions affecting executive compensation based on 2013 performance consisted of the following companies: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="39%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="39%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>ArQule,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Merrimack Pharmaceuticals,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Array BioPharma,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Neurocrine Biosciences,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>AVEO Pharmaceuticals,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>NewLink Genetics Corporation</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Clovis Oncology,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Novavax&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>Dynavax Technologies Corporation</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>Oncothyreon,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Endocyte,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Puma Biotechnology,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Exelixis,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Synta Pharmaceuticals Corp.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>ImmunoGen,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Tesaro&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Infinity Pharmaceuticals,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Threshold Pharmaceuticals,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Lexicon Pharmaceuticals,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Vical Incorporated</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
peer group consisted of public companies in the biopharmaceutical industry with product candidates generally in late-stage development, annual revenues generally less than
$100&nbsp;million (average of $23.5&nbsp;million), and market capitalization of at least $100&nbsp;million (average of $654&nbsp;million). We believe that, as of May 2013, this list was
representative of the companies with whom we generally compete for talent. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B><I> Administration and Objectives of Our Executive Compensation Program  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee of the Board of Directors, which is comprised of independent, non-employee directors, is responsible for
establishing and administering the policies governing the compensation of our employees, including salary, bonus and stock option grants. The policy of the Compensation Committee is to compensate our
employees with competitive salaries based on their level of experience and job performance. All permanent employees, including executive officers, are eligible for annual bonus awards based on
achievement of our strategic corporate goals and participation in our stock option program. The stock option grants are made in accordance with our 2008 Stock Option and Incentive Plan, as amended
(the "2008 Plan"). The Compensation Committee is also responsible for the administration of our 2004 Employee Stock Purchase Plan, as amended (the "2004 Plan"), in which employees participate on a
voluntary basis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Compensation Committee has designed our overall executive compensation program to achieve the following objectives:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>attract and retain talented and experienced executives; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>motivate and reward executives whose knowledge, skills and performance are critical to our success; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>provide a competitive compensation package that aligns the interests of our executive officers and stockholders by
including a significant variable component which is weighted heavily towards performance-based rewards, based upon achievement of pre-determined goals; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>ensure fairness among the executive management team by recognizing the contributions each executive makes to our success; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>foster a shared commitment among executives by aligning our and their individual goals; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>compensate our executives to manage our business to meet our near-term and long-term objectives. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
use a mix of short-term compensation (base salaries and cash incentive bonuses) and long-term compensation (equity incentive compensation) to provide a total compensation structure
that is designed to achieve these objectives. We determine the percentage mix of compensation structures that </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>17</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=19,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=79165,FOLIO='17',FILE='DISK132:[14ZAE1.14ZAE79801]DG79801A.;10',USER='HYUNG',CD=';7-APR-2014;08:30' -->
<A NAME="page_dg79801_1_18"> </A>

<P style="font-family:times;"><FONT SIZE=2>we
think is appropriate for each of our executive officers. In general, the Compensation Committee believes that a substantial percentage of the compensation of our executive officers should be
performance based. The Compensation Committee uses its judgment and experience and the recommendations of the chief executive officer (except for his own compensation) to determine the appropriate mix
of compensation for each individual. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
determining whether to adjust the compensation of any of our Named Executive Officers, we annually take into account the changes, if any, in the
following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>market compensation levels; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the contributions made by each executive officer; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the performance of each executive officer; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the increases or decreases in responsibilities and roles of each executive officer; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the business needs for each executive officer; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the relevance of each executive officer's experience to other potential employers; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the readiness of each executive officer to assume a more significant role within the organization. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, with respect to new executive officers, we take into account their prior base salary and annual cash incentives, their expected contribution and our business needs. We
believe that our executive officers should be fairly compensated each year relative to market pay levels within our industry. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Executive Compensation Components  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In order to both attract and retain experienced and qualified executives to manage us, the Compensation Committee's policy on executive
compensation is to (i)&nbsp;pay salaries which are competitive with the salaries of executives in comparable positions in the biotechnology industry, and (ii)&nbsp;allow for additional
incentive-based compensation through the payment of annual cash bonuses and the grant of stock-based incentive awards. This policy is designed to have a significant portion of each executive's total
compensation be tied to our progress in order to incentivize the executive to fully dedicate himself or herself to achievement of corporate goals, and to align the executive's interest with those of
our stockholders through equity incentive compensation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
executive compensation program is primarily composed of base salary, annual incentive cash compensation payable on an annual basis and equity compensation. In addition, we provide
our executives with benefits that are generally available to our salaried employees, including medical, dental, group life and accidental death and dismemberment insurance, short- and long-term
disability coverage and our 401(k) plan. Within the context of the overall objectives of our compensation programs, we determined the specific amounts of compensation to be paid to each of our
executives in 2013 based on a number of factors including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>our understanding of the amount of compensation generally paid by similarly situated companies to their executives with
similar roles and responsibilities; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the roles and responsibilities of our executives; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the individual experience and skills of, and expected contributions from, our executives; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the amounts of compensation being paid to our other executives; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>our executives' historical compensation. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>18</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=20,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=742341,FOLIO='18',FILE='DISK132:[14ZAE1.14ZAE79801]DG79801A.;10',USER='HYUNG',CD=';7-APR-2014;08:30' -->
<A NAME="page_dg79801_1_19"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
discuss each of the primary elements of our executive compensation in detail below. While we have identified particular compensation objectives that each element of executive
compensation serves, our compensation programs complement each other and collectively serve all of our executive compensation objectives described above. Accordingly, whether or not specifically
mentioned below, we believe that, as a part of our overall executive compensation, each element to a greater or lesser extent serves each of our objectives. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Base salary  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each executive officer (except the chief executive officer whose performance is reviewed by the Compensation Committee) has an annual
performance review with the chief executive officer who makes recommendations on salary increases, promotions and stock option grants to the Compensation Committee. We have historically established
base salaries for each of our executives based on many factors, including average salary increases expected in the biotechnology industry in the Boston, Massachusetts and central New Jersey areas,
competition in the marketplace to hire and retain executives, experiences of our Board members and leadership team with respect to salaries and compensation of executives in similarly situated
companies in our industry and other similar industries, as well as additional factors which we believe enables us to hire and retain our leadership team in an extremely competitive environment. Our
Compensation Committee annually reviews salary ranges and individual salaries for our executive officers. For 2013, the Compensation Committee increased annual base salary for our existing executive
officers by 2.9% to 3.3%. For 2012, the Compensation Committee increased annual base salary by 2.0% to 2.8% for our named executive officers. For 2011, we limited annual base salary increases for our
existing named executive officers to only 1%. Dr.&nbsp;Pepin joined us in July 2011 and his base salary was the result of arms length negotiations as part of his hiring process. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Annual Performance-Based Cash Bonus  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have designed our annual cash bonuses to reward our executive officers for their actual performance and contributions to our
corporate goals for each year, as approved in advance by our Compensation Committee and Board of Directors. The corporate goals are allocated between specific product and financial performance
targets. Achievement of our corporate goals was, in 2013, the primary factor considered by our Compensation Committee in determining the annual bonuses for our executive officers. However, the
Compensation Committee retains discretion to adjust any individual bonus as a result of exceptional individual performance. Our performance-based bonus plan emphasizes the contributions of each of our
executive officers to the achievement of our corporate goals. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the beginning of each calendar year, the Compensation Committee establishes annual corporate performance goals and target bonuses. In 2012 based on Radford's recommendation, the
Compensation Committee established new target bonuses of 55% of base salary for Mr.&nbsp;Marucci, 40% of base salary for Dr.&nbsp;Keler, 35% of base salary for each of Mr.&nbsp;Catlin and
Dr.&nbsp;Davis and 30% of base salary for Dr.&nbsp;Pepin. Corporate goals are proposed by management, reviewed and approved by the Compensation Committee and also approved by the Board of
Directors on an annual basis. The Compensation Committee considers and assigns a relative weight to appropriately focus efforts on corporate goals that are intended to enhance shareholder value. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee reviewed the 2013 corporate goals at meetings held in March, June, September and December 2013, to gauge our levels of achievement and to assess whether the
corporate goals approved earlier in the year remained relevant and complete. In December 2013 and January 2014, prior to approving 2013 incentive bonuses, the Compensation Committee evaluated our 2013
performance by assessing if, and the extent to which, we achieved or failed to achieve the corporate goals approved by the Board of Directors for 2013. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>19</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=21,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=1031565,FOLIO='19',FILE='DISK132:[14ZAE1.14ZAE79801]DG79801A.;10',USER='HYUNG',CD=';7-APR-2014;08:30' -->
<A NAME="page_dg79801_1_20"> </A>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
corporate goals for 2013 and the level at which the Compensation Committee determined they were achieved are as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Corporate Goal </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Relative<BR>
Weight </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2013<BR>
Achievement </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><B>(1)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> Late Stage Development Activities:</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>45</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&gt; 100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Rindopepimut Development Activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Open
remaining worldwide clinical sites in the pivotal rindopepimut Phase&nbsp;3 ACT IV study</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Begin
execution of the commercial manufacturing plan for rindopepimut at selected CMO partners</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Report out
preliminary results from the Phase&nbsp;2 ReACT study in recurrent glioblastoma and define next clinical and regulatory activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Glembatumumab Vedotin (CDX-011) Development Activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Execute
appropriate clinical development activities following End-of-Phase&nbsp;2 meeting with FDA</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Complete
manufacture of the CR011 antibody in our Fall River facility and conjugation with the vcMMAE toxin to provide drug product for Phase&nbsp;2 studies in new indications</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>CDX-1135 Development Activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Efforts to
enroll patients in the pilot study in Dense Deposit Disease</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><B>(2)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> Early Stage Development Activities:</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Varlilumab (CDX-1127) Development Activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Report out
data from the CDX-1127 Phase&nbsp;1 dose escalation study and define future development plans for solid tumors and hematologic cancers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Complete
manufacture of CDX-1127 drug product in our Fall River facility at 1000L scale for Phase&nbsp;2 studies</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>CDX-1401 Development Activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Support
3<SUP>rd</SUP>&nbsp;party sponsored studies of CDX-1401</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>CDX-301 Development Activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Report out
final results from the Phase&nbsp;1 healthy volunteer study</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Support
3<SUP>rd</SUP>&nbsp;party sponsored studies of CDX-301</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>CDX-014 or Other Product Candidate Development Activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Determine
next product candidate to be moved into preclinical testing and human clinical development</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><B>(3)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> Business and Financial Operations:</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Provide
sufficient cash through either financings or partnerships and cost reductions to extend runway into 2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Position the
Company to complete a licensing transaction with respect to rindopepimut outside North America, CDX-011 and/or CDX-1127 in 2013</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2> </font> &#149; </font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"> <font size=2> </FONT><FONT SIZE=2>Advance
commercialization planning for rindopepimut</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> Totals:</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&gt; 100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the Compensation Committee's December 2013 and January 2014 meetings, Mr.&nbsp;Marucci reviewed in detail the performance of each executive officer, excluding himself, and
considered such individual's contributions to our success in 2013. Mr.&nbsp;Marucci's bonus recommendations were primarily driven by the fact that the Company achieved greater than 100% of its
pre-determined corporate goals </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>20</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=22,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=408841,FOLIO='20',FILE='DISK132:[14ZAE1.14ZAE79801]DG79801A.;10',USER='HYUNG',CD=';7-APR-2014;08:30' -->
<A NAME="page_dg79801_1_21"> </A>

<P style="font-family:times;"><FONT SIZE=2>in
2013 and each employee, including the executive officers, contributed to our success in achieving the 2013 corporate goals. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee discussed Mr.&nbsp;Marucci's recommendations for the Named Executive Officers and reviewed Mr.&nbsp;Marucci's performance for fiscal 2013. In particular,
the Compensation Committee determined that our executive officers over-achieved their goals with respect to progress in our clinical programs, particularly our rindopepimut and glembatumumab vedotin
programs, and to corporate development activities. Based on Mr.&nbsp;Marucci's recommendations for each of the Named Executive Officers, the Compensation Committee's review of Mr.&nbsp;Marucci's
performance and the Compensation Committee's determination that greater than 100% achievement of the corporate goals for 2013, the Compensation Committee determined that the annual cash incentives
approved for each Named Executive Officer (including Mr.&nbsp;Marucci) should be set at 105% to 144% of the targets established for each Named Executive Officer, depending on the position. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee determined that annual incentive bonuses paid to the Named Executive Officers for 2013, were fair, reasonable and appropriate based on the factors described
above. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Equity Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We also use stock options and equity-based incentive programs to attract, retain, motivate and reward our executive officers. Through
our equity-based grants, we seek to align the interests of our executive officers with our stockholders, reward and motivate both near-term and long-term executive performance and provide an incentive
for retention. Our decisions regarding the amount and type of equity incentive compensation and relative weighting of these awards among total executive compensation have been based on our
understanding of market practices of similarly situated companies and our negotiations with our executives in connection with their initial employment or promotion. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have adopted an equity grant policy that formalizes how we grant equity awards by setting a regular schedule for granting equity awards in connection with the hiring or promotion of
any of our employees, granting annual equity awards and granting equity awards to non-employee directors. Such policy also outlines grant approval requirements and specifies the vesting schedule and
exercise prices for restricted stock units and stock option awards. We believe that this policy will mitigate the risk that issues or concerns would be raised in the future regarding the timing of
grants of equity awards to our officers, directors and employees. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
such grants to our Named Executive Officers are subject to prior approval by the Compensation Committee at a regularly scheduled meeting during the year. The date of grant and the
fair market value of the award are based upon the date of the Compensation Committee meeting approving such grant. When granting equity-based awards, the Compensation Committee considers a number of
factors in determining the amount of equity incentive awards, if any, to grant to our executives, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the existing levels of stock ownership among the executive officers relative to each other and to our employees as a
whole; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>previous grants of stock options to such executive officers; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>vesting schedules of previously granted options; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the performance of the executives and their contributions to our overall performance; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>an outside survey of stock option grants and restricted common stock awards in the biotechnology industry; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>21</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=23,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=762061,FOLIO='21',FILE='DISK132:[14ZAE1.14ZAE79801]DG79801A.;10',USER='HYUNG',CD=';7-APR-2014;08:30' -->
<A NAME="page_dg79801_1_22"> </A>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>an internally prepared survey of similarly situated biotechnology companies' proxy statements; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>personal knowledge of the Compensation Committee members regarding executive stock options and restricted common stock
awards at comparable companies; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the financial statement impact of stock option awards on our results of operations; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the amount and percentage of our total equity on a diluted basis held by our executives. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity
compensation awards to our Named Executive Officers primarily consist of stock option awards. Stock option awards provide our executive officers with the right to purchase shares
of our common stock at a fixed exercise price typically for a period of up to ten years, subject to continued employment
with us. Stock options are earned on the basis of continued service to us and generally vest over four years, beginning with 25% vesting one year after the date of grant, then pro-rata vesting
quarterly thereafter. All historical option grants were made at what our Compensation Committee and Board of Directors determined to be the fair market value of our shares of our common stock on the
respective grant dates. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
July&nbsp;1, 2013, the Compensation Committee awarded stock options to all qualified employees, including stock options to purchase 280,000 shares, 115,000 shares, 115,000 shares,
90,000 shares and 90,000 shares of our common stock to each of Messrs.&nbsp;Marucci, Keler, Davis, Catlin and Pepin, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Other Benefits  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe that establishing competitive benefit packages for our employees is an important factor in attracting and retaining highly
qualified personnel. Executive officers are eligible to participate in all of our employee benefit plans, such as medical, dental, group life and accidental death and dismemberment insurance, short-
and long-term disability coverage and our 401(k) plan, in each case on the same basis as other employees. We provide a matching contribution under our 401(k) plan. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Employment Agreements and Post-Termination Compensation and Benefits  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We depend greatly on the intellectual capabilities and experience of our key executives. Our success is dependent on our ability to
attract and retain highly skilled executives with significant experience in the biotechnology industry, particularly as we expand our activities in clinical trials, the regulatory approval process and
sales and manufacturing. Therefore we have entered into new employment agreements with our existing executives effective January&nbsp;1, 2013. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
general, each employment arrangement provides for cash severance, 100% acceleration of any unvested options, restricted stock and/or other equity awards and continuation of certain
employee benefits in the event that an executive's employment is terminated without cause or is terminated by the executive for good reason within a one year period immediately following a change of
control. The cash severance consists of a single lump sum payment equal to (i)&nbsp;twenty-four (24)&nbsp;times Executive's highest monthly base compensation paid hereunder during the preceding
twenty-four month period, plus (ii)&nbsp;150% (200%, in the case of Mr.&nbsp;Marucci) of the highest one-year Annual Bonus actually received by the Executive during the preceding two full fiscal
years prior to the date of termination. We use a "double trigger" with respect to benefits that are to be provided in connection with a change of control. A change of control does not itself trigger
benefits; rather, benefits are paid only if the
employment of the executive is terminated by us other than for cause, death or disability or by the executive for good reason during the one year period immediately following the change of control. We
believe a "double trigger" benefit maximizes shareholder value because it prevents a windfall to executives in the event of a change of control in which the executive retains significant
responsibility as defined in his or her individual agreement, while still providing our executives appropriate incentives to cooperate in negotiating any change of control that may put their jobs at
risk. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>22</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=24,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=137959,FOLIO='22',FILE='DISK132:[14ZAE1.14ZAE79801]DG79801A.;10',USER='HYUNG',CD=';7-APR-2014;08:30' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_di79801_1_23"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to the benefits that only accrue in connection with a change of control, our agreements with the Named Executive Officers provide for cash severance, 25% acceleration of
unvested options, restricted stock and/or other equity awards and continuation of certain employee benefits if we terminate their employment with us without cause or they terminate their employment
with us for good reason, as such terms are defined in the applicable agreement with the executive officer. The cash severance consists of a lump sum cash payment equal to 100% (200% in the case of
Mr.&nbsp;Marucci) of the executive's then existing base salary. A further discussion of the terms and projected payments under each of these agreements is set forth below under the heading </FONT> <FONT SIZE=2><I>Potential Payments upon Termination
of Employment or Change in Control.</I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Committee Consideration of the Company's 2013 Shareholder Advisory Vote on Executive Compensation  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At our 2013 Annual Meeting of Shareholders, approximately 96% of the shares voted at the meeting approved, on an advisory basis, the
compensation of the Named Executive Officers. Given that a majority of the shares voted approved the 'say on pay' advisory proposal, the Committee did not implement specific changes and continued with
its performance-based compensation philosophy and its balanced approach to various components of its compensation program. However, the Compensation Committee does monitor the results of the annual
advisory 'say-on-pay' proposal and refers to such results as one of many factors considered in connection with the discharge of its responsibilities, although the Committee does not assign a
quantitative weighting to any such factors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Board of Directors has determined that an advisory vote will be conducted on an annual basis. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="di79801_summary_compensation_table"> </A>
<A NAME="toc_di79801_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Summary Compensation Table    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following summary compensation table reflects certain information concerning compensation for services in all capacities awarded
to, earned by or paid during the years ended December&nbsp;31, 2013, 2012 and 2011 to each person who served as our Chief Executive Officer and Chief Financial Officer at </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>23</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=25,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=538264,FOLIO='23',FILE='DISK132:[14ZAE1.14ZAE79801]DI79801A.;11',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<A NAME="page_di79801_1_24"> </A>

<P style="font-family:times;"><FONT SIZE=2>any
time during the year ended December&nbsp;31, 2013 and the three other executive officers employed by us as of December&nbsp;31, 2013 (collectively, the "Named Executive Officers"). </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="26pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="35pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="35pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="34pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:96pt;"><FONT SIZE=1><B>Name and Principal Position

<!-- COMMAND=ADD_SCROPPEDRULE,96pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Years </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Salary<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Bonus<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock<BR>
Awards<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Awards<BR>
($)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Non-Equity<BR>
Incentive<BR>
Plan<BR>
Compensation<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Change in<BR>
Pension<BR>
Value and<BR>
Nonqualified<BR>
Deferred<BR>
Compensation<BR>
Earnings<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Compensation<BR>
($)(3) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>496,388</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>375,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,940,280</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>15,120</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,826,788</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>President and Chief</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2012</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>478,556</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>290,913</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,001,392</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9,643</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,780,504</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Executive Officer</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2011</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>469,535</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>127,407</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>317,071</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9,033</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>923,046</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Avery W. Catlin</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
307,735</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
130,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
945,090</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
5,767</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,388,592</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><I>Senior Vice President and</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2012</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>299,986</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>85,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>321,876</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5,643</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>712,505</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><I>Chief Financial Officer</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2011</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>295,544</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>65,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>140,608</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5,572</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>506,724</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Thomas Davis, M.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
389,404</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
200,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,207,615</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
8,364</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,805,383</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Senior Vice President and</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2012</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>378,120</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>155,182</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>411,286</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,407</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>951,995</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Chief Medical Officer</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2011</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>371,248</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>100,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>183,669</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,185</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>662,102</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler., Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
367,484</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
186,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,207,615</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
3,651</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,764,750</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><I>Senior Vice President and</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2012</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>356,835</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>162,924</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>411,286</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,627</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>934,672</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><I>Chief Scientific Officer</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2011</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>350,350</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>97,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>174,002</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,528</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>624,880</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Ronald Pepin, Ph.D.(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
311,654</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
100,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
945,090</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
6,474</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,363,218</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Senior Vice President and</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2012</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>303,461</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>80,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>321,876</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5,924</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>711,261</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Chief Business Officer</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2011</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>145,385</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>33,750</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>223,460</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,129</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>405,724</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
amounts in the Bonus column include annual bonus amounts earned by each of our Named Executive Officers in 2013, 2012 and 2011.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
amounts in the Option Awards column reflect the dollar amounts for the aggregate grant date fair value of stock option awards made in fiscal years ended
December&nbsp;31, 2013, 2012 and 2011 for annual awards pursuant to the 2008 Plan.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
amounts listed in the All Other Compensation column includes our matching contribution to the 401(k) Savings Plan of each named executive officer and
premiums paid for life insurance under our nondiscriminatory group plan for each named executive officer. In addition, Mr.&nbsp;Marucci's compensation includes the annual premium of $2,550 in 2013,
2012 and 2011 for a $1,000,000 term life insurance policy and $4,260, $689 and $352 for the personal use of a Company car in 2013, 2012 and 2011.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Dr.&nbsp;Pepin
joined us on July&nbsp;1, 2011 with an annual base salary of $300,000. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="di79801_grants_of_plan-based_awards"> </A>
<A NAME="toc_di79801_2"> </A>
<BR></FONT><FONT SIZE=2><B>  Grants of Plan-Based Awards    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table provides information on stock options and stock awards granted in 2013 to each of our Named Executive Officers. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=4 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=4 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Option<BR>
Awards:<BR>
Number of<BR>
Securities<BR>
Underlying<BR>
Options<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Estimated Future<BR>
Payouts Under<BR>
Equity Incentive Plan Awards </B></FONT></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Stock<BR>
Awards:<BR>
Number of<BR>
Shares or<BR>
Units<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant Date<BR>
Fair Value of<BR>
Stock and<BR>
Option<BR>
Awards<BR>
($)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exercise or<BR>
Base Price of<BR>
Option<BR>
Awards<BR>
($/Sh)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:21pt;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,21pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant<BR>
Date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Threshold<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Target<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Maximum<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7/1/13</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>280,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,940,280</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Avery W. Catlin</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7/1/13</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>90,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>945,090</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Thomas Davis, M.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7/1/13</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>115,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,207,615</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7/1/13</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>115,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,207,615</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Ronald Pepin, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7/1/13</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>90,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>945,090</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
exercise prices reflect the closing price of our common stock on the grant date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
grant date fair value is generally the amount we would expense in our financial statements over the award's service period, but does not include a
reduction for forfeitures. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>24</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=26,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=888033,FOLIO='24',FILE='DISK132:[14ZAE1.14ZAE79801]DI79801A.;11',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<A NAME="page_di79801_1_25"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="di79801_outstanding_equity_awards_at_fiscal_year-end"> </A>
<A NAME="toc_di79801_3"> </A>
<BR></FONT><FONT SIZE=2><B>  Outstanding Equity Awards at Fiscal Year-End    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth certain information regarding the stock option grants and stock awards to our Named Executive Officers
at December&nbsp;31, 2013. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:18pt;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,18pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options (#)<BR>
Exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options (#)<BR>
Unexercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Equity<BR>
Incentive<BR>
Plan<BR>
Awards:<BR>
Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Unearned<BR>
Options (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Exercise<BR>
Price ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Expiration<BR>
Date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Shares or<BR>
Units of<BR>
Stock<BR>
That<BR>
Have Not<BR>
Vested (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Market<BR>
Value of<BR>
Shares or<BR>
Units of<BR>
Stock<BR>
That<BR>
Have Not<BR>
Vested ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Equity<BR>
Incentive<BR>
Plan<BR>
Awards:<BR>
Number of<BR>
Unearned<BR>
Shares,<BR>
Units or<BR>
Other<BR>
Rights<BR>
That<BR>
Have Not<BR>
Vested (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Equity<BR>
Incentive<BR>
Plan<BR>
Awards:<BR>
Market or<BR>
Payout<BR>
Value of<BR>
Unearned<BR>
Shares,<BR>
Units or<BR>
Other<BR>
Rights<BR>
That<BR>
Have Not<BR>
Vested (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>280,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7/1/23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>87,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>192,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5.69</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9/12/22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>101,475</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>78,925</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2.80</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/5/21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>153,750</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>10,250</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4.50</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1/21/20</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>129,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8.52</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1/6/19</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>254,243</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8.16</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3/7/18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Avery W. Catlin(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>90,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7/1/23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Avery W. Catlin(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>28,125</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>61,875</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5.69</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9/12/22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Avery W. Catlin(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>45,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>35,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2.80</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/5/21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Avery W. Catlin(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>84,375</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5,625</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4.50</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1/21/20</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Avery W. Catlin</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>61,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8.52</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1/6/19</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Thomas Davis, M.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>115,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7/1/23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Thomas Davis, M.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>35,937</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>79,063</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5.69</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9/12/22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Thomas Davis, M.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>58,781</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>45,719</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2.80</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/5/21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Thomas Davis, M.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>89,062</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5,938</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4.50</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1/21/20</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Thomas Davis, M.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>76,400</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8.52</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1/6/19</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Thomas Davis, M.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>148,825</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8.16</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3/7/18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>115,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7/1/23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>35,937</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>79,063</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5.69</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9/12/22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>55,687</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>43,313</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2.80</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/5/21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>84,375</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5,625</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4.50</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1/21/20</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>72,250</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8.52</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1/6/19</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>254,243</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8.16</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3/7/18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Ronald Pepin, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>90,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7/1/23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Ronald Pepin, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>28,125</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>61,875</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5.69</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9/12/22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Ronald Pepin, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>56,250</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>43,750</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3.52</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7/1/21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>25%
of the options vest on the first anniversary of the grant date and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="di79801_option_exercises_and_stock_vested"> </A>
<A NAME="toc_di79801_4"> </A>
<BR></FONT><FONT SIZE=2><B>  Option Exercises and Stock Vested    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth certain information regarding the number of option exercises in fiscal 2013 and the number of shares of
stock issued under the 2008 Plan that vested in fiscal 2013 and the corresponding amounts realized by our Named Executive Officers. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:62%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"130%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="130%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="98pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="69pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="93pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="69pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:21pt;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,21pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of Shares<BR>
Acquired on Exercise<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Value Realized<BR>
on Exercise<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of Shares<BR>
Acquired on Vesting<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Value Realized<BR>
on Vesting<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony S. Marucci</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Avery W. Catlin</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>183,333</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,863,661</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Thomas Davis, M.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Ronald Pepin, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Represents
the aggregate dollar amount realized by the named executive officer upon exercise of the options, calculated by determining the difference
between the closing price on the date of exercise and the exercise price. These amounts do not correspond to the actual value received by the named executive officers. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>25</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=27,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=886151,FOLIO='25',FILE='DISK132:[14ZAE1.14ZAE79801]DI79801A.;11',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dk79801_1_26"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk79801_employment_agreements"> </A>
<A NAME="toc_dk79801_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Employment Agreements    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The terms and conditions of the employment agreements of Mr.&nbsp;Marucci, Mr.&nbsp;Catlin, Dr.&nbsp;Davis, Dr.&nbsp;Keler, and
Dr.&nbsp;Pepin are governed by written employment contracts which became effective on January&nbsp;1, 2013. The employment agreements provide, among other things, for:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>annual base salary ($484,855 in the case of Mr.&nbsp;Marucci, $303,187 in the case of Mr.&nbsp;Catlin, $383,649 in the
case of Mr.&nbsp;Davis, $362,053 in the case of Mr.&nbsp;Keler and $307,500 in the case of Mr.&nbsp;Pepin) or such greater amount as may from time to time be determined by the Board of Directors
or the Compensation Committee thereof; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>eligibility for an annual bonus with a defined bonus target (55% of base salary in the case of Mr.&nbsp;Marucci, 35% of
base salary in the case of Mr.&nbsp;Catlin, 35% of base salary in the case of Mr.&nbsp;Davis, 40% of base salary in the case of Mr.&nbsp;Keler and 30% of base salary in the case of
Mr.&nbsp;Pepin); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>a lump sum severance payment equal to 100% (200% in the case of Mr.&nbsp;Marucci only) of the executive's then-existing
annual base salary in the event that his employment is terminated without cause or he resigns "for good reason" (as defined in the employment agreement) and 25% accelerated vesting of any unvested
equity awards; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>accelerated vesting of any unvested equity awards (as defined in the employment agreement) and a lump sum cash payment
equal to twenty-four (24)&nbsp;times the executive's highest monthly base compensation (not including bonus) during the twenty-four month period preceding the date of termination plus 150% (200% in
the case of Mr.&nbsp;Marucci only) of the highest one-year annual bonus actually received by the executive during the two full fiscal years preceding the date of termination in the event of
termination without cause or resignation "for good reason" by the executive within one year immediately following a change in control (as defined in the employment agreement). </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
employment agreements have an initial term through December&nbsp;31, 2015 and shall automatically renew for additional one year terms unless either party gives ninety
(90)&nbsp;days prior written notice of its intent not to renew. The Company may terminate the employment agreements without cause, on 90-days' prior notice, or for cause, subject to a 30-day cure
period in certain circumstances. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk79801_pension_benefits"> </A>
<A NAME="toc_dk79801_2"> </A>
<BR></FONT><FONT SIZE=2><B>  Pension Benefits    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None of our Named Executive Officers participate in qualified or nonqualified defined benefit plans sponsored by us. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk79801_nonqualified_deferred_compensation"> </A>
<A NAME="toc_dk79801_3"> </A>
<BR></FONT><FONT SIZE=2><B>  Nonqualified Deferred Compensation    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None of our Named Executive Officers are covered by a defined contribution or other plan that provides for the deferral of compensation
on a basis that is not tax-qualified. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>26</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=28,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=751088,FOLIO='26',FILE='DISK132:[14ZAE1.14ZAE79801]DK79801A.;7',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dm79801_1_27"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm79801_potential_payments_upon_termin__pot02940"> </A>
<A NAME="toc_dm79801_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Potential Payments upon Termination of Employment or Change in Control    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Named Executive Officers have provisions in their employment agreements regarding severance upon certain termination events or
acceleration of stock options in the event of our change of control or termination following a change of control. These severance and acceleration provisions are described in "Employment Agreements,"
and certain estimates of these change of control benefits are provided in the tables below. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table describes the potential payments and benefits upon employment termination for our Named Executive Officers as if their employment had terminated as of
December&nbsp;31, 2013. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:57%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"140%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="140%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="102pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:115pt;"><FONT SIZE=1><B>Executive benefits and payments<BR>
upon termination

<!-- COMMAND=ADD_SCROPPEDRULE,115pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Voluntary<BR>
resignation<BR>
for no good<BR>
reason </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Voluntary<BR>
resignation<BR>
for good<BR>
reason(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Termination<BR>
by Celldex not<BR>
for cause(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Termination<BR>
by Celldex<BR>
for cause </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Voluntary termination<BR>
by the executive<BR>
for good reason<BR>
or termination by<BR>
Celldex without<BR>
cause in connection<BR>
with or following<BR>
change of control(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><U>Anthony S. Marucci</U></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Base salary</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,001,224</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,001,224</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,001,224</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bonus</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>750,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity Awards Acceleration(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,913,728</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,913,728</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,654,912</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Continuation of Health Benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,413</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,413</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,413</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,954,365</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,954,365</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,445,549</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><U>Avery W. Catlin</U></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Base salary</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>313,040</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>313,040</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>626,080</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bonus</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>195,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity Awards Acceleration(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>678,161</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>678,161</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,712,644</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Continuation of Health Benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>30,230</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>30,230</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>30,230</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,021,431</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,021,431</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,563,954</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><U>Thomas Davis, M.D.</U></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Base salary</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>396,118</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>396,118</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>792,236</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bonus</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>300,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity Awards Acceleration(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>865,720</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>865,720</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,462,879</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Continuation of Health Benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,413</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,413</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,413</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,301,251</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,301,251</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,594,528</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><U>Tibor Keler, Ph.D.</U></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Base salary</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>373,820</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>373,820</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>747,640</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bonus</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>279,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity Awards Acceleration(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>851,299</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>851,299</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,405,197</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Continuation of Health Benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,413</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,413</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,413</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,264,532</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,264,532</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,471,250</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>27</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=29,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=29272,FOLIO='27',FILE='DISK132:[14ZAE1.14ZAE79801]DM79801A.;9',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<A NAME="page_dm79801_1_28"> </A>
 <DIV style="padding:0pt;position:relative;width:57%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"140%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="140%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="102pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:115pt;"><FONT SIZE=1><B>Executive benefits and payments<BR>
upon termination

<!-- COMMAND=ADD_SCROPPEDRULE,115pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Voluntary<BR>
resignation<BR>
for no good<BR>
reason </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Voluntary<BR>
resignation<BR>
for good<BR>
reason(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Termination<BR>
by Celldex not<BR>
for cause(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Termination<BR>
by Celldex<BR>
for cause </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Voluntary termination<BR>
by the executive<BR>
for good reason<BR>
or termination by<BR>
Celldex without<BR>
cause in connection<BR>
with or following<BR>
change of control(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><U>Ronald Pepin, Ph.D.</U></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Base salary</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>316,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>316,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>633,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bonus</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>150,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity Awards Acceleration(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>689,403</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>689,403</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,757,613</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Continuation of Health Benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,413</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,413</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,413</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,045,316</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,045,316</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,580,026</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Upon
termination without cause or resignation for good reason, the employee is generally entitled to a lump sum payment equal to 100% (200% in the case of
Mr.&nbsp;Marucci only) of the employee's then annual base salary, continuation of certain employee benefits and 25% accelerated vesting of any unvested equity awards.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
employee is generally entitled to accelerated vesting of any unvested equity awards (as defined in the employment agreement) and a lump sum cash payment
equal to twenty-four (24)&nbsp;times the executive's highest monthly base compensation (not including bonus) during the twenty-four month period preceding the date of termination plus 150% (200% in
the case of Mr.&nbsp;Marucci only) of the highest one-year annual bonus actually received by the executive during the two full fiscal years preceding the date of termination in the event of
termination without cause or resignation "for good reason" by the executive within one year immediately following a change in control (as defined in the employment agreement).
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
value of each share subject to an option to purchase common stock that would be accelerated in the circumstances described above equals $24.21 per share
(the closing price on the last trading day of 2013), minus the exercise price per share;  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm79801_director_compensation"> </A>
<A NAME="toc_dm79801_2"> </A>
<BR></FONT><FONT SIZE=2><B>  Director Compensation    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Directors who are not our employees are each entitled to receive a retainer fee of $50,000 each fiscal year ("Annual Retainer"). The
Chairman of the Board is entitled to receive an annual retainer fee of $40,000 in addition to his or her Annual Retainer and any retainer for committee service. The Chairperson of each committee of
the Board of Directors is entitled to receive an annual retainer fee of $30,000 in addition to his or her Annual Retainer. Each committee member (other than the Chairperson of a committee) will
receive an annual retainer of $20,000 in addition to his or her Annual Retainer. Stipends and retainers are paid in advance on a quarterly basis. The Directors shall be reimbursed for necessary travel
and business expenses as incurred but will not receive any additional fees for attending meetings or calls of the Board of Directors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New
board members receive an initial stock option grant to purchase 8,000 shares of the Company's common stock upon joining the Board and all non-employee directors receive an annual
grant of 2,000 shares of restricted stock each year following the annual stockholders' meeting. To further align the interests of the members of the Board with the stockholders of the Company, the
Board, at the recommendation of the Compensation Committee, amended its compensation policy on June&nbsp;12, 2013 to provide that all non-employee directors will also receive an annual stock option
grant to purchase 2,000 shares of the Company's common stock each year following the annual stockholders' meeting. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>28</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=30,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=832920,FOLIO='28',FILE='DISK132:[14ZAE1.14ZAE79801]DM79801A.;9',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<A NAME="page_dm79801_1_29"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2013, our non-employee directors had the following stock options outstanding: Larry Ellberger&#151;14,000, Herbert J. Conrad&#151;31,879, George
O. Elston&#151;31,879, Harry H. Penner, Jr.&#151;14,000, Timothy M. Shannon, M.D.&#151;302,936 and Karen L. Shoos&#151;14,000. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table summarizes the annual compensation for our non-employee directors during 2013. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:21pt;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,21pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fees<BR>
Earned or<BR>
Paid in Cash<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock<BR>
Awards<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Awards<BR>
($)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Non-Equity<BR>
Incentive Plan<BR>
Compensation<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Change in<BR>
Pension<BR>
Value and<BR>
Nonqualified<BR>
Deferred<BR>
Compensation<BR>
Earnings </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Compensation<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Larry Ellberger</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>130,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>30,400</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,481</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>179,881</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Herbert J. Conrad</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>80,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>30,400</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,481</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>129,881</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>George O. Elston</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>100,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>30,400</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,481</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>149,881</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Harry H. Penner, Jr.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>90,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>30,400</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,481</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>139,881</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Timothy M. Shannon, M.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>80,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>30,400</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,481</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>129,881</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Karen L. Shoos</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>100,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>30,400</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,481</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>149,881</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
amounts in the Stock Awards column reflect the grant date fair value of restricted stock awards of 2,000 shares made in 2013 to each of our non-employee
directors for awards pursuant to the 2008 Plan subject to a vesting schedule whereby an equal number of the shares of common stock shall become vested and no longer be subject to risk of forfeiture on
each of September&nbsp;19, 2013, December&nbsp;19, 2013, March&nbsp;19, 2014 and June&nbsp;19, 2014 (so long as the director remains a member of the Board as of such date).
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
amounts in the Option Awards column reflect the grant date fair value of stock option awards made in 2013 of 2,000 shares made to each of our
non-employee directors for awards pursuant to the 2008 Plan subject to a vesting schedule whereby an equal number of the shares of common stock shall become vested and no longer be subject to risk of
forfeiture on each of September&nbsp;19, 2013, December&nbsp;19, 2013, March&nbsp;19, 2014 and June&nbsp;19, 2014 (so long as the director remains a member of the Board as of such date). </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm79801_compensation_committee__dm702494"> </A>
<A NAME="toc_dm79801_3"> </A>
<BR></FONT><FONT SIZE=2><B>  Compensation Committee Interlocks and Insider Participation    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee of the Board of Directors is currently composed of the following three non-employee directors: Karen L.
Shoos, Chair, George O. Elston and Harry H. Penner, Jr. None of these Compensation Committee members was an officer or employee of us during the year. No Compensation Committee interlocks between us
and another entity existed. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm79801_risk_considerations"> </A>
<A NAME="toc_dm79801_4"> </A>
<BR></FONT><FONT SIZE=2><B>  Risk Considerations    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We do not believe that our compensation practices and policies for our employees, including our executive officers, create risks or are
likely to create risks that are reasonably likely to have a material adverse effect on our results of operations or financial condition. The Compensation Committee considered our strategic goals and
operational practices and evaluated our
incentive program design to assess whether these programs foster a business environment that might drive inappropriate decision-making or behavior. We are a biopharmaceutical company that is
generating a pipeline of drug candidates to treat cancer and other difficult-to-treat diseases and do not yet generate earnings. While a significant portion of our executives' compensation is
performance-based, we believe several features of our program mitigate inappropriate or excessive risk-taking that could harm shareholder value: we set performance goals that we believe are reasonable
and set targets with payouts at multiple levels of performance, rather than an "all or nothing" approach. As discussed above in our Compensation Discussion and Analysis section we use a mix of
performance goals in our annual and long-term incentive programs to align incentive compensation with a broad set of measures important to the creation of shareholder value. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>29</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=31,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=747041,FOLIO='29',FILE='DISK132:[14ZAE1.14ZAE79801]DM79801A.;9',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_do79801_1_30"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="do79801_compensation_committee_report"> </A>
<A NAME="toc_do79801_1"> </A>
<BR></FONT><FONT SIZE=2><B>  COMPENSATION COMMITTEE REPORT*    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Compensation Committee has reviewed the Compensation Discussion and Analysis with management and based on a review of the Compensation Discussion Analysis, the Compensation Committee
recommended to the Board that the Compensation Discussion and Analysis be included in this proxy statement. </FONT></P>

<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>Compensation
Committee:<BR>
Karen L. Shoos, Chair<BR>
George O. Elston<BR>
Harry H. Penner, Jr. </FONT></P>

</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
<HR NOSHADE COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT"> </FONT></P>

 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
foregoing report of the Compensation Committee is not to be deemed "filed" with the SEC (irrespective of any general incorporation language in any
document filed with the SEC) or subject to Regulation&nbsp;14A of the Securities Exchange Act of 1934, as amended, or to the liabilities of Section&nbsp;18 of the Securities Exchange Act of 1934,
except to the extent we specifically incorporate it by reference into a document filed with the SEC. </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>30</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=32,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=588893,FOLIO='30',FILE='DISK132:[14ZAE1.14ZAE79801]DO79801A.;5',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dq79801_1_31"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dq79801_report_of_the_audit_committee"> </A>
<A NAME="toc_dq79801_1"> </A>
<BR></FONT><FONT SIZE=2><B>  REPORT OF THE AUDIT COMMITTEE*    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned members of the Audit Committee of the Board of Directors of Celldex submit this report in connection with the
committee's review of the financial reports for the fiscal year ended December&nbsp;31, 2013 as follows: </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>1.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
Audit Committee has reviewed and discussed with management the audited financial statements for Celldex for the fiscal year ended December&nbsp;31,
2013.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>2.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
Audit Committee has discussed with representatives of PricewaterhouseCoopers&nbsp;LLP the matters which are required to be discussed with them under
the provisions of Auditing Standard No.&nbsp;16, </FONT><FONT SIZE=2><I>Communications with Audit Committees</I></FONT><FONT SIZE=2>. That Auditing Standard requires the auditors to ensure that the
Audit Committee received information regarding the scope and results of the audit. PricewaterhouseCoopers&nbsp;LLP has also communicated with the Audit Committee on matters required by
Rule&nbsp;2-07 of Regulation&nbsp;S-X.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>3.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
Audit Committee has discussed with PricewaterhouseCoopers&nbsp;LLP, the independent registered public accounting firm, the auditors' independence from
management and Celldex including the matters in the written disclosures and the letter from the independent auditors required by PCAOB rule&nbsp;3526. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, the Audit Committee considered whether the provision of information technology services or other non-audit services by PricewaterhouseCoopers&nbsp;LLP is compatible with
maintaining its independence. In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board of Directors (and the Board of Directors has approved) that the
audited financial statements be included in Celldex's Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2013 for filing with the Securities and Exchange Commission. </FONT></P>

<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>Audit
Committee:<BR>
George O. Elston, Chair<BR>
Larry Ellberger<BR>
Harry H. Penner, Jr. </FONT></P>

</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>

<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
<HR NOSHADE COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT"> </FONT></P>

 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
foregoing report of the Audit Committee is not to be deemed "soliciting material" or deemed to be "filed" with the Securities and Exchange Commission
(irrespective of any general incorporation language in any document filed with the Securities and Exchange Commission) or subject to Regulation&nbsp;14A of the Securities Exchange Act of 1934, as
amended, or to the liabilities of Section&nbsp;18 of the Securities Exchange Act of 1934, except to the extent we specifically incorporate it by reference into a document filed with the Securities
and Exchange Commission. </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>31</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=33,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=996708,FOLIO='31',FILE='DISK132:[14ZAE1.14ZAE79801]DQ79801A.;5',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ds79801_1_32"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Security Ownership of Certain Beneficial Owners and Management  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth certain information as of March&nbsp;31, 2014 with respect to the beneficial ownership of common stock
of the Company by the following: (i)&nbsp;each of the Company's current directors; (ii)&nbsp;each of the Named Executive Officers; (iii)&nbsp;the current executive officers; (iv)&nbsp;all of
the executive officers and directors as a group; and (v)&nbsp;each person known by the Company to own beneficially more than five percent (5%) of the outstanding shares of the Company's common
stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of the following table, beneficial ownership is determined in accordance with the applicable SEC rules and the information is not necessarily indicative of beneficial
ownership for any other purpose. Except as otherwise noted in the footnotes to the table, we believe that each person or entity named in the table has sole voting and investment power with respect to
all shares of the Company's common stock shown as beneficially owned by that person or entity (or shares such power with his or her spouse). Under the SEC's rules, shares of the Company's common stock
issuable under options that are exercisable on or within 60&nbsp;days after March&nbsp;31, 2014 ("Presently Exercisable Options") are deemed outstanding and therefore included in the number of
shares reported as beneficially owned by a person or entity named in the table and are used to compute the percentage of the common stock beneficially owned by that person or entity. These shares are
not, however, deemed outstanding for computing the percentage of the common stock beneficially owned by any other person or entity. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>32</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=34,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=235526,FOLIO='32',FILE='DISK132:[14ZAE1.14ZAE79801]DS79801A.;11',USER='HYUNG',CD=';7-APR-2014;08:30' -->
<A NAME="page_ds79801_1_33"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
percentage of the common stock beneficially owned by each person or entity named in the following table is based on 89,357,843 shares of common stock outstanding as of
March&nbsp;31, 2014 plus any shares issuable upon exercise of Presently Exercisable Options held by such person or entity. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="93pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="84pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:180pt;"><FONT SIZE=1><B>Name and Business Address of Beneficial Owners*

<!-- COMMAND=ADD_SCROPPEDRULE,180pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount and Nature<BR>
of Beneficial<BR>
Ownership(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Percentage of<BR>
Common Stock(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>5% Holders</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>FMR&nbsp;LLC<BR>
245 Summer Street<BR>
Boston, MA 02210</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>12,157,327</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>13.6</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Franklin Resources,&nbsp;Inc.<BR>
One Franklin Parkway<BR>
San Mateo, CA 94403-1906</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>7,930,026</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>8.9</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BlackRock,&nbsp;Inc.<BR>
40 East 52<SUP>nd</SUP>&nbsp;Street<BR>
New York, NY 10022</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>5,891,176</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(5)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>6.6</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>The Vanguard Group<BR>
100 Vanguard Blvd.<BR>
Malvern, PA 19355</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>4,972,275</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(6)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>5.6</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Directors and Executive Officers</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Larry Ellberger</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>38,000</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(7)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Herbert J. Conrad</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>40,879</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(8)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>George O. Elston</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>40,879</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(9)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Harry H. Penner, Jr.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>26,416</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(10)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Timothy M. Shannon, M.D.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>383,148</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(11)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Karen L. Shoos</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>26,333</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(12)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony S. Marucci</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>819,635</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(13)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Avery W. Catlin</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>253,859</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(14)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Thomas Davis, M.D.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>443,561</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(15)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>543,548</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(16)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Ronald Pepin, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>102,500</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>(17)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>All Directors and Executive Officers as a group (11&nbsp;persons)</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,718,758</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(18)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3.0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Unless
otherwise indicated, the address is c/o Celldex Therapeutics,&nbsp;Inc., Perryville III Building, 53 Frontage Road, Suite&nbsp;220, Hampton, NJ
08827.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>**</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Less
than 1%.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Unless
otherwise indicated, the persons shown have sole voting and investment power over the shares listed.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Common
stock includes all outstanding common stock plus, as required for the purpose of determining beneficial ownership (in accordance with
Rule&nbsp;13d-3(d)(1) of the Securities Exchange Act of 1934, as amended), all common stock subject to any right of acquisition, through exercise or conversion of any security, within 60&nbsp;days
of the record date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
solely on information set forth in a Schedule&nbsp;13G/A filed with the SEC on February&nbsp;14, 2014 by FMR&nbsp;LLC ("FMR") reporting sole
power to vote or direct the vote over 1,384,940 shares and the sole power to dispose or to direct the disposition of 12,157,327 shares. Fidelity Management&nbsp;&amp; Research Company, a wholly-owned
subsidiary </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>33</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=35,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=127575,FOLIO='33',FILE='DISK132:[14ZAE1.14ZAE79801]DS79801A.;11',USER='HYUNG',CD=';7-APR-2014;08:30' -->
<A NAME="page_ds79801_1_34"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <UL>

<P style="font-family:times;"><FONT SIZE=2>of
FMR ("FMRC"), is the beneficial owner of 7,057,001 shares as a result of acting as investment adviser. Edward C. Johnson 3d ("ECJ") and FMR, through its control of FMRC and the funds, each has sole
power to dispose of the 7,057,001 shares owned by the funds. Neither FMR nor ECJ has the sole power to vote or direct the voting of the shares owned directly by the funds, which power resides with the
funds' Boards of Trustees. Fidelity SelectCo,&nbsp;LLC, a wholly-owned subsidiary of FMR ("SelectCo"), is the beneficial owner of 3,464,586 shares as a result of acting as an investment adviser. ECJ
and FMR, through its control of SelectCo and the SelectCo funds, each has sole power to dispose of the 3,464,586 shares owned by the SelectCo funds. Pyramis Global Advisors,&nbsp;LLC ("PGALLC"), an
indirect wholly-owned subsidiary of FMR, is the beneficial owner of 255,160 shares as a result of its serving as investment adviser to institutional accounts, non-U.S. mutual funds and investment
companies owning such shares. ECJ and FMR, through its control of PGALLC, each has sole power to dispose of the 255,160 shares and sole power to vote or direct the voting of 205,260 shares owned by
the institutional accounts or funds advised by PGALLC. Pyramis Global Advisors Trust Company ("PGATC"), an indirect wholly-owned subsidiary of FMR, is the beneficial owner of 1,305,580 shares as a
result of its serving as investment manager of institutional accounts owning such shares. ECJ and FMR, through its control of PGATC, each has sole dispositive power over 1,305,580 shares and sole
power to vote or to direct the voting of 1,104,680 shares of common stock owned by the institutional accounts managed by PGATC. FIL Limited ("FIL"), which provides investment advisory
and management services to a number of non-U.S. investment companies and certain institutional investors, is the beneficial owner of 75,000 shares. Partnerships controlled predominantly by members of
the family of ECJ or trusts for their benefit own shares of FIL voting stock with the right to cast approximately 25-50% of the total votes that may be cast by all holders of FIL voting stock. FMR and
FIL view that they are not acting as a "group" and that the shares held by each other need not be aggregated for purposes of Section&nbsp;13(d).  </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
solely on information set forth in a Schedule&nbsp;13G filed with the SEC by Franklin Resources,&nbsp;Inc. on February&nbsp;11, 2014, reporting
that Franklin Advisers,&nbsp;Inc. has the sole power to vote or direct the vote over 7,705,157 shares, Fiduciary Trust Company International has the sole power to vote or direct the vote over 25,000
shares, Franklin Templeton Investments (Asia)&nbsp;Ltd. has the sole power to vote or direct the vote over 1,190 shares and Franklin Templeton Portfolio Advisors,&nbsp;Inc. has the sole power to
vote or direct the vote over 109,879 shares. The securities are beneficially owned by one or more open- or closed-end investment companies or other managed accounts that are investment management
clients of investment managers that are direct and indirect subsidiaries (each, an "Investment Management Subsidiary" and, collectively, the "Investment Management Subsidiaries") of Franklin
Resources&nbsp;Inc. ("FRI"). The voting and investment powers held by Franklin Mutual Advisers,&nbsp;LLC ("FMA"), an indirect wholly-owned Investment Management Subsidiary, are exercised
independently from FRI and from all other Investment Management Subsidiaries. Charles B. Johnson and Rupert H. Johnson, Jr. (the "Principal Shareholders") each own in excess of 10% of the outstanding
common stock of FRI and are the principal stockholders of FRI. FRI, the Principal Shareholders and each of the Investment Management Subsidiaries believe that they are not acting as a "group" and that
the shares held by each other need not be aggregated for purposes of Section&nbsp;13(d).
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
solely on information set forth in a Schedule&nbsp;13G/A filed with the SEC by BlackRock,&nbsp;Inc. on January&nbsp;28, 2014 reporting sole
power to vote or direct the vote over 5,641,857 and the sole power to dispose or to direct the disposition of 5,891,176 shares. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>34</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>

<!-- ZEQ.=3,SEQ=36,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=654141,FOLIO='34',FILE='DISK132:[14ZAE1.14ZAE79801]DS79801A.;11',USER='HYUNG',CD=';7-APR-2014;08:30' -->
<A NAME="page_ds79801_1_35"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
solely on information set forth in a Schedule&nbsp;13G filed with the SEC by The Vanguard Group on February&nbsp;11, 2014, reporting sole power to
vote or direct the vote over 124,182 shares, sole power to dispose or to direct the disposition of 4,854,493 shares and shared dispositive power over 117,782 shares. The shares reported include shares
held by Vanguard Fiduciary Trust Company, a wholly-owned subsidiary of The Vanguard Group,&nbsp;Inc. that is the beneficial owner of 117,782 shares, and Vanguard Investments Australia,&nbsp;Ltd.,
a wholly-owned subsidiary of The Vanguard Group,&nbsp;Inc. that is the beneficial owner of 6,400 shares of our common stock.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(7)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
13,500 shares of common stock underlying options which are or may be exercisable as of March&nbsp;31, 2014 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(8)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
31,379 shares of common stock underlying options which are or may be exercisable as of March&nbsp;31, 2014 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(9)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
31,379 shares of common stock underlying options which are or may be exercisable as of March&nbsp;31, 2014 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(10)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
13,500 shares of common stock underlying options which are or may be exercisable as of March&nbsp;31, 2014 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(11)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
302,436 shares of common stock underlying options which are or may be exercisable as of March&nbsp;31, 2014 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(12)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
13,500 shares of common stock underlying options which are or may be exercisable as of March&nbsp;31, 2014 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(13)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
776,267 shares of common stock underlying options which are or may be exercisable as of March&nbsp;31, 2014 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(14)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
239,750 shares of common stock underlying options which are or may be exercisable as of March&nbsp;31, 2014 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(15)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
435,193 shares of common stock underlying options which are or may be exercisable as of March&nbsp;31, 2014 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(16)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
527,680 shares of common stock underlying options which are or may be exercisable as of March&nbsp;31, 2014 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(17)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
102,500 shares of common stock underlying options which are or may be exercisable as of March&nbsp;31, 2014 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(18)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Please
refer to footnotes 7&nbsp;-&nbsp;17.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>35</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=37,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=1046783,FOLIO='35',FILE='DISK132:[14ZAE1.14ZAE79801]DS79801A.;11',USER='HYUNG',CD=';7-APR-2014;08:30' -->
<A NAME="page_ds79801_1_36"> </A>

<P style="font-family:times;"><FONT SIZE=2><B> Section&nbsp;16(a) Beneficial Ownership Reporting Compliance  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;16(a) of the Securities Exchange Act of 1934, as amended, requires Celldex's directors and executive, officers, and
persons who are beneficial owners of more than 10% of a registered class of our equity securities, to file reports of ownership and changes in ownership with the Securities and Exchange Commission
(the "SEC"). These persons are required by SEC regulations to furnish us with copies of all Section&nbsp;16(a) forms they file. To our knowledge, based solely on a review of the copies of such
reports furnished to us, and written representations that no other reports were required during the fiscal year ended December&nbsp;31, 2013, all reports required to be filed under
Section&nbsp;16(a) were filed on a timely basis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Transactions with Related Persons  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It is our policy that all employees and directors, as well as their family members, must avoid any activity that is or has the
appearance of conflicting with Celldex's business interest. This policy is included in our Code of Business Conduct and Ethics. All directors and officers of Celldex complete a directors and officers
questionnaire at the beginning of each year, in which they are asked to disclose family relationships and other related party transactions. Our Audit Committee must review and approve all related
party transactions, as defined in Item&nbsp;404 of Regulation&nbsp;S-K. Our Audit Committee's procedures for reviewing related party transactions are not in writing. In fiscal 2013, there were no
related party transactions. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE<BR>
FOR THE ELECTION OF THE DIRECTOR NOMINEES</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>36</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=38,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=377930,FOLIO='36',FILE='DISK132:[14ZAE1.14ZAE79801]DS79801A.;11',USER='HYUNG',CD=';7-APR-2014;08:30' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_du79801_1_37"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="du79801_proposal_2__ratify_the_appoint__pro06310"> </A>
<A NAME="toc_du79801_1"> </A>
<BR></FONT><FONT SIZE=2><B>  PROPOSAL 2: RATIFY THE APPOINTMENT OF<BR>  PRICEWATERHOUSECOOPERS&nbsp;LLP AS OUR INDEPENDENT REGISTERED<BR>  PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2014    <BR>    <BR>    (Proposal No.&nbsp;2)    <BR>
 </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee has reappointed PricewaterhouseCoopers&nbsp;LLP as our independent registered public accounting firm to audit the
financial statements of the Company for the fiscal year ending December&nbsp;31, 2014, and has further directed that management submit their selection of independent registered public accounting
firm for ratification by our stockholders at the Annual Meeting of Stockholders. A representative of PricewaterhouseCoopers&nbsp;LLP is expected to attend the Annual Meeting and will have an
opportunity to make a statement, if he or she desires, and will be available to respond to appropriate questions. Neither the accounting firm nor any of its members has any direct or indirect
financial interest in or any connection with us in any capacity other than as public registered accounting firm. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B> Principal Accountant Fees and Services  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes the fees for professional services rendered by PricewaterhouseCoopers&nbsp;LLP, our independent
registered public accounting firm, for each of the last two fiscal years: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="13pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:46pt;"><FONT SIZE=1><B>Fee Category

<!-- COMMAND=ADD_SCROPPEDRULE,46pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Audit Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>585</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>393</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Audit-Related Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tax Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>All Other Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>190</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>785</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>410</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><B> Audit Fees  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Represents fees, including out of pocket expenses, for professional services provided in connection with the audit of our annual
audited financial statements and of our internal control over financial reporting, the review of our quarterly financial statements included in our Forms&nbsp;10-Q, accounting consultations or
advice on accounting matters necessary for the rendering of an opinion on our financial statements, services provided in connection with the offerings of our common stock and audit services provided
in connection with other statutory or regulatory filings. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Audit-Related Fees  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Audit-related fees are for assurance and other activities not explicitly related to the audit of our financial statements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Tax Fees  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax fees are associated with tax compliance and tax planning related activities. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B> All Other Fees  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All other fees consist of fees relating to an enterprise resource planning assessment and accounting research tool. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>37</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=39,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=275113,FOLIO='37',FILE='DISK132:[14ZAE1.14ZAE79801]DU79801A.;6',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<A NAME="page_du79801_1_38"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee is responsible for appointing, setting compensation and overseeing the work of the independent auditors. The Audit Committee has established a policy regarding
pre-approval of all auditing services and the terms thereof and non-audit services (other than non-audit services prohibited under Section&nbsp;10A(g) of the Exchange Act or the applicable rules of
the SEC or the Public Company Accounting Oversight Board) to be provided to Celldex by the independent auditor. However, the pre-approval requirement may be waived with respect to the provision of
non-audit services for Celldex if the "de minimus" provisions of Section&nbsp;10A(i)(1)(B) of the Exchange Act are satisfied. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee has considered whether the provision of Audit-Related Fees, Tax Fees, and all other fees as described above is compatible with maintaining
PricewaterhouseCoopers,&nbsp;LLP's independence and has determined that such services for fiscal years 2013 and 2012 were compatible. All such services were approved by the Audit Committee pursuant
to Rule&nbsp;2-01 of Regulation&nbsp;S-X under the Exchange Act to the extent that rule was applicable. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee is responsible for reviewing and discussing the audited financial statements with management, discussing with the independent registered public accountants the
matters required in Auditing Standards No.&nbsp;16, receiving written disclosures from the independent registered public accountants required by the applicable requirements of the Public Company
Accounting Oversight Board regarding the independent registered public accountants' communications with the Audit Committee concerning independence and discussing with the independent registered
public accountants their independence, and recommending to the Board of Directors that the audit financial statements be included in our annual report of Form&nbsp;10-K. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE<BR>
FOR THE RATIFICATION OF THE INDEPENDENT REGISTERED PUBLIC<BR>
ACCOUNTING FIRM  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>38</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=40,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=709076,FOLIO='38',FILE='DISK132:[14ZAE1.14ZAE79801]DU79801A.;6',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dw79801_1_39"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dw79801_proposal_3__advisory_vote_on_e__pro02562"> </A>
<A NAME="toc_dw79801_1"> </A>
<BR></FONT><FONT SIZE=2><B>  PROPOSAL 3: ADVISORY VOTE ON EXECUTIVE COMPENSATION<BR>  <BR>    (Proposal No.&nbsp;3)    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, and Section&nbsp;14A of the Securities
Exchange Act of 1934, as amended, or the Exchange Act, our stockholders are entitled to vote to approve, on an advisory (nonbinding) basis, the compensation of our Named Executive Officers as
disclosed in this proxy statement in accordance with the Securities and Exchange Commission's rules. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
described in detail under the heading "Compensation of Executive Officers&#151;Compensation Discussion and Analysis", our executive compensation programs are designed to retain
and incentivize the high quality executives whose efforts are key to our long-term success. Under these programs, our Named Executive Officers are rewarded on the basis of individual and corporate
performance measured against established corporate and strategic goals. Please read the section of this proxy statement under the heading "Compensation of Executive Officers&#151;Compensation
Discussion and Analysis" for additional details about our executive compensation programs, including information about the fiscal year 2013 compensation of our Named Executive Officers. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee of our Board of Directors continually reviews the compensation programs for our Named Executive Officers to ensure they achieve the desired goals of aligning
our executive compensation structure with our stockholders' interests and current market practices. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are asking our stockholders to indicate their support for our Named Executive Officer compensation as described in this proxy statement. This proposal, commonly known as a
"say-on-pay" proposal, gives our stockholders the opportunity to express their views on our Named Executive Officers' compensation. This vote is not intended to address any specific item of
compensation, but rather the overall compensation of our Named Executive Officers and the philosophy, policies and practices described in this proxy statement. Accordingly, we are asking our
stockholders to cast a non-binding advisory vote "FOR" the following resolution at the Annual Meeting: </FONT></P>

<UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"RESOLVED,
that the compensation of the Named Executive Officers, as disclosed in the Company's Proxy Statement for the 2014 Annual Meeting of Stockholders pursuant to Item&nbsp;402 of
Regulation&nbsp;S-K, including the Compensation Discussion and Analysis, compensation tables and narrative disclosure is hereby APPROVED." </FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
say-on-pay vote is advisory, and therefore not binding on Celldex Therapeutics, the Compensation Committee or our Board of Directors. Nevertheless, our Board of Directors and our
Compensation Committee value the opinions of our stockholders, whether expressed through this vote or otherwise, and, accordingly, the Board and Compensation Committee intend to consider the results
of this vote among the many factors they consider in making determinations in the future regarding executive compensation arrangements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stockholder
approval of this Proposal No.&nbsp;3 will require the affirmative vote of a majority of the votes cast in person or by proxy at the Annual Meeting. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>THE BOARD RECOMMENDS A VOTE FOR THIS PROPOSAL NO. 3  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>39</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=41,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=265140,FOLIO='39',FILE='DISK132:[14ZAE1.14ZAE79801]DW79801A.;6',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<A NAME="page_dw79801_1_40"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="dw79801_stockholder_proposals"> </A>
<A NAME="toc_dw79801_2"> </A>
<BR>  STOCKHOLDER PROPOSALS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Stockholder Proposals for 2015 Annual Meeting  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any stockholder proposals submitted pursuant to Exchange Act Rule&nbsp;14a-8 for inclusion in Celldex's proxy statement and form of
proxy for our 2015 Annual Meeting must be received by Celldex on or before December&nbsp;12, 2014 in order to be considered for inclusion in our proxy statement and form of proxy. Such proposal must
also comply with the requirements as to form and substance established by the SEC if such proposals are to be included in the proxy statement and form of proxy. Any such proposal shall be mailed to:
Celldex Therapeutics.&nbsp;Inc., Perryville III Building, 53 Frontage Road, Suite&nbsp;220, Hampton, NJ 08827, Attn.: Secretary. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
by-laws state that the stockholder must provide timely written notice of such nomination or proposal and supporting documentation as well as be present at such meeting, either in
person or by a representative. A stockholder's notice shall be timely received by Celldex at our principal executive office not less than seventy-five (75)&nbsp;days nor more than one hundred twenty
(120)&nbsp;days prior to the anniversary date of the immediately preceding annual meeting (the "Anniversary Date"); provided, however, that in the event the annual meeting is scheduled to be held on
a date more than thirty (30)&nbsp;days before the Anniversary Date or more than sixty (60)&nbsp;days after the Anniversary Date, a stockholder's notice shall be timely if received by Celldex at
our principal executive office not later than the close of business on the later of (1)&nbsp;the seventy-fifth (75<SUP>th</SUP>) day prior to the scheduled date of such annual meeting or
(2)&nbsp;the fifteenth (15<SUP>th</SUP>) day following the day on which such public announcement of the date of such annual meeting is first made by Celldex. Proxies solicited by our Board of
Directors will confer discretionary voting authority with respect to these proposals, subject to SEC rules and regulations governing the exercise of this authority. Any such proposal shall be mailed
to: Celldex Therapeutics.&nbsp;Inc., Perryville III Building, 53 Frontage Road, Suite&nbsp;220, Hampton, NJ&nbsp;08827, Attn.: Secretary. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> ANNUAL REPORT  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Copies of our Annual Report on Form&nbsp;10-K (including audited financial statements), as amended, filed with the Securities and
Exchange Commission may be obtained without charge by writing to Corporate Secretary, Celldex Therapeutics,&nbsp;Inc., Perryville III Building, 53 Frontage Road, Suite&nbsp;220, Hampton, NJ 08827.
A request for a copy of our Annual Report on Form&nbsp;10-K must set forth a good-faith representation that the requesting party was either a holder of record or a beneficial owner of our common
stock on April&nbsp;2, 2014. Exhibits to the Form&nbsp;10-K will be mailed upon similar request and payment of specified fees to cover the costs of copying and mailing such materials. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
audited financial statements for the fiscal year ended December&nbsp;31, 2013 and certain other related financial and business information are contained in our 2013 Annual Report
to Stockholders, which is being made available to our stockholders along with this proxy statement, but which is not deemed a part of the proxy soliciting material. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>40</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=42,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=74335,FOLIO='40',FILE='DISK132:[14ZAE1.14ZAE79801]DW79801A.;6',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<A NAME="page_dw79801_1_41"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dw79801_other_matters"> </A>
<A NAME="toc_dw79801_3"> </A>
<BR></FONT><FONT SIZE=2><B>  OTHER MATTERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of the date of this proxy statement, the Board of Directors does not intend to present at the Annual Meeting any matters other than
those described herein and does not presently know of any matters that will be presented by other parties. If any other matter requiring a vote of the stockholders should come before the meeting, it
is the intention of the persons named in the proxy to vote with respect to any such matter in accordance with the recommendation of the Board of Directors or, in the absence of such a recommendation,
in accordance with the best judgment of the proxy holder. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="50%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>By Order of the Board of Directors</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;AVERY W. CATLIN<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2><I>Secretary</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>Hampton,
NJ<BR>
April&nbsp;11, 2014 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>41</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=43,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=215728,FOLIO='41',FILE='DISK132:[14ZAE1.14ZAE79801]DW79801A.;6',USER='HYUNG',CD=';7-APR-2014;08:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<div>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="92%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="680" height="880" src="g24982bci001.gif"></font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:4.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">THIS PROXY CARD
  IS VALID ONLY WHEN SIGNED AND DATED. KEEP THIS PORTION FOR YOUR RECORDS
  DETACH AND RETURN THIS PORTION ONLY TO VOTE, MARK BLOCKS BELOW IN BLUE OR
  BLACK INK AS FOLLOWS: Signature (Joint Owners) Signature [PLEASE SIGN WITHIN
  BOX] Date Date To withhold authority to vote for any individual nominee(s),
  mark &#147;For All Except&#148; and write the number(s) of the nominee(s) on the line
  below. 0 0 0 0 0 0 0 0 0 0000206968_1 R1.0.0.51160 For Withhold For All All
  All Except The Board of Directors recommends you vote FOR the following: 1.
  Election of Directors Nominees 01 Larry Ellberger 02 Anthony S. Marucci 03
  Herbert J. Conrad 04 George O. Elston 05 Harry H. Penner, Jr. 06 Timothy M.
  Shannon 07 Karen L. Shoos CELLDEX THERAPEUTICS, INC. PERRYVILLE III BUILDING
  53 FRONTAGE ROAD, SUITE 220 HAMPTON, NJ 08827 VOTE BY INTERNET -
  www.proxyvote.com Use the Internet to transmit your voting instructions and
  for electronic delivery of information up until 11:59 P.M. Eastern Time the
  day before the cut-off date or meeting date. Have your proxy card in hand
  when you access the web site and follow the instructions to obtain your
  records and to create an electronic voting instruction form. ELECTRONIC
  DELIVERY OF FUTURE PROXY MATERIALS If you would like to reduce the costs
  incurred by our company in mailing proxy materials, you can consent to
  receiving all future proxy statements, proxy cards and annual reports
  electronically via e-mail or the Internet. To sign up for electronic
  delivery, please follow the instructions above to vote using the Internet
  and, when prompted, indicate that you agree to receive or access proxy
  materials electronically in future years. VOTE BY PHONE - 1-800-690-6903 Use
  any touch-tone telephone to transmit your voting instructions up until 11:59 P.M.
  Eastern Time the day before the cut-off date or meeting date. Have your proxy
  card in hand when you call and then follow the instructions. VOTE BY MAIL
  Mark, sign and date your proxy card and return it in the postage-paid
  envelope we have provided or return it to Vote Processing, c/o Broadridge, 51
  Mercedes Way, Edgewood, NY 11717. The Board of Directors recommends you vote
  FOR proposals 2 and 3. For Against Abstain 2 To ratify the appointment of
  PricewaterhouseCoopers LLP as our independent registered public accounting
  firm for the year ending December 31, 2014. 3 To approve, on an advisory
  basis, the compensation of the Company's named executive officers as
  disclosed in this proxy statement. NOTE: In their discretion, upon such other
  business as may properly come before the annual meeting or any adjournment or
  postponement. Please sign exactly as your name(s) appear(s) hereon. When
  signing as attorney, executor, administrator, or other fiduciary, please give
  full title as such. Joint owners should each sign personally. All holders
  must sign. If a corporation or partnership, please sign in full corporate or
  partnership name, by authorized officer. </font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>
<!-- ZEQ.=1,SEQ=44,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=110862,FOLIO='',FILE="DISK133:[14ZAE2.14ZAE79802]2498-2-BC_ZAE79802.CHC",USER="HYUNG",CD='Apr  3 14:20 2014' -->


<br clear="all" style="page-break-before:always;">


<div>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="92%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="680" height="880" src="g24982bci002.gif"></font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:4.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">0000206968_2
  R1.0.0.51160 Important Notice Regarding the Availability of Proxy Materials
  for the Annual Meeting: The The Notice &amp; Proxy Statement and Annual
  Report on Form 10-K is/are available at www.proxyvote.com . CELLDEX
  THERAPEUTICS, INC. Annual Meeting of Stockholders May 28, 2014 9:00 AM This
  proxy is solicited by the Board of Directors The undersigned hereby appoints
  Avery W. Catlin and Anthony S. Marucci, and each of them, as the true and
  lawful attorneys, agents and proxies of the undersigned, with full power of
  substitution, and hereby authorizes them to represent and to vote, as
  designated on the reverse, all shares of common stock of Celldex
  Therapeutics, Inc. held of record by the undersigned on April 2, 2014 at the
  Annual Meeting of Stockholders to be held at the Olde Mill Inn, 225 Route
  202, Basking Ridge, NJ 07920, on May 28, 2014 at 9:00 a.m. local time, or at
  any adjournment or postponement thereof. This proxy, when properly executed,
  will be voted in the manner directed herein. If no such direction is made,
  this proxy will be voted in accordance with the Board of Directors'
  recommendations. Continued and to be signed on reverse side </font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>
<!-- ZEQ.=1,SEQ=45,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=369678,FOLIO='',FILE="DISK133:[14ZAE2.14ZAE79802]2498-2-BC_ZAE79802.CHC",USER="HYUNG",CD='Apr  3 14:20 2014' -->


<BR>
<P><br><A NAME="14ZAE79801_1">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dc79801_1">ABOUT THE MEETING</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de79801_1">PROPOSAL 1: TO ELECT SEVEN DIRECTORS TO SERVE UNTIL THE NEXT ANNUAL MEETING AND UNTIL THEIR SUCCESSORS HAVE BEEN DULY ELECTED AND QUALIFIED</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de79801_2">(Proposal No. 1)</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dg79801_1">Compensation Discussion and Analysis</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_di79801_1">Summary Compensation Table</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_di79801_2">Grants of Plan-Based Awards</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_di79801_3">Outstanding Equity Awards at Fiscal Year-End</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_di79801_4">Option Exercises and Stock Vested</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk79801_1">Employment Agreements</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk79801_2">Pension Benefits</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk79801_3">Nonqualified Deferred Compensation</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm79801_1">Potential Payments upon Termination of Employment or Change in Control</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm79801_2">Director Compensation</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm79801_3">Compensation Committee Interlocks and Insider Participation</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm79801_4">Risk Considerations</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_do79801_1">COMPENSATION COMMITTEE REPORT</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dq79801_1">REPORT OF THE AUDIT COMMITTEE</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_du79801_1">PROPOSAL 2: RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2014 (Proposal No. 2)</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dw79801_1">PROPOSAL 3: ADVISORY VOTE ON EXECUTIVE COMPENSATION (Proposal No. 3)</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dw79801_2">STOCKHOLDER PROPOSALS</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dw79801_3">OTHER MATTERS</A></FONT><BR>
<!-- SEQ=,FILE='QUICKLINK',USER=HYUNG,SEQ=,EFW="2219467",CP="CELLDEX THERAPEUTICS, INC.",DN="1" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g24982bci001.gif
<DESCRIPTION>G24982BCI001.GIF
<TEXT>
begin 644 g24982bci001.gif
M1TE&.#EAJ`)P`_0```$!`0P,#!04%!P<'",C(RPL+#0T-#P\/$-#0TM+2U14
M5%M;6V-C8VQL;'1T='M[>X2$A(R,C)24E)N;FZ2DI*NKJ[2TM+R\O,/#P\O+
MR]/3T]S<W./CX^OKZ_3T]/[^_B'Y!```````+`````"H`G`#``7^X">.9&F>
M:*JN;.N^<"S/=&W?>*[O?.__P*!P2"P:C\BD<LEL.I_0J'1*K5JOV*QVR^UZ
MO^"P>$PNF\_HM'K-;KO?\+A\3J_;[_B\?L_O^_^`@8*#A(6&AXB)BHN,C8Z/
MD)&2DY25EI>8F9J;G)V>GZ"AHJ.DI::GJ*FJJZRMKJ^PL;*SM+6VM[BYNKN\
MO;Z_P,'"P\3%QL?(R<K+S,W.S]#1TM/4U=;7V-G:V]S=WM_@X>+CY.7FY^CI
MZNOL[>[O\/'R\_3U]O?X^?K[_/W^_P`#"AQ(L*#!@P@3*ES(L*'#AQ`C2IQ(
ML:+%BQ@S:MS(L:,T#R9`DA#I0:0(D"3^3Y8P^0&E2I,P5[:<R=*CS4(UU]3,
MV8*G2IDC@\X<>K/H#`X40':8X$$#!`X?*$B@$.%"!0D1)"B=(`&"A@\2.D3-
M\`$I4I`4,$C@FE9"5PT7NE+X<.'"!PT5HF*=<"$"VR$^4S0U2KA(AP`6/CPX
M,`$``0`8%@``(*#!@`$%$(#,`*!``0$<$#S8(``#W=(`&'BH/`!```0*`!P8
M<`%!@`,`*#@`L$$"@0\!"!1(T""`ZP0C1&;PT.%KAJ\:.GC`P&&P!J@;-"QO
MNIS#!;'=,6QHF:'[ANE?$QQ@;@&JB`X7E%*_NP&#A^>%\[=(P."#@0<%S-7`
M`1]@$$!)`3C^0$%2'W#&U0`<<$```1"(@`%MG6%0V@<4?K!`@!)P4(`"&130
MP`,`-.`;<`\LV%(`9)G`V`0#>'"9!P1,0`$`#F@`@`<!>BC```QPIH`%!&#V
M`0(,'*#`;Q08I\$""S0@@``5&(!8`A^2!20!#@!Y)0<&$#";`@&,I]^:)V"0
M(P$;!&!:!+\96)(`PFE68&<$*"!"<2)I>,$`$"2P(0$1?,"`;`-8@,!D"'R@
M@`(#&@"<<.MY(.<(#R0PW@0&?+B``ER&BL"`#)A8@%A<DG;!CRL"0%8`#7Q0
MP`4*3.!``@58D&:5#2S``0`/!"!!@0%TP`$&`'`XP0%3U0@9F]3^CE2FGPD8
M0,$`#^Q9$K$+@L3L!(V9!L$`,VGH:P<%R/H!H9+V&F*.KW9`)6<$@CN7!]."
M-.!X'0B`0`0`6%`!`!'8YL$!.?*(009-3B#`!0%\(/&K<`D<50$$-`<`<@`\
MVP`#"O@H`0,45,"L5)Q=(``%!9#[F[N!55L4!(B5M8``#X"D00$ES8:9SQ/R
M+`(%R(F0P0$8K)<!`>E-\`$$>"*V@-3$/5!K`PHL?!G0'ACPU0D,/"!B205P
M\$!_$B!7P`8G-D"`MAL`+62W"%"0*W#]+2GUMNM90%L$!S1PH0</"'#L`P-@
M:X$%;L=H\^12U(Q"S3NI-*D*)%&M)N7^H.^0>0^6_V3Z#R`]3M3J)T&0&$LN
M`<5"Z:%W%)-@J\-.5$JRGQ13YCOIOGOLLZ^@%.<\E62\\K@'13Q,TB4GU%"_
M3T^33[`S)SOV[]%>^RH*0'5!?SQQL$`'?I[`0?HBK/_"!;72%3\)\,L@KFYV
M>9^"^8A?'E5>,1D?ZT8`/PXD2G\G:$#^$)``R]7/!.Y3002\5(((@B0K(9J!
M;^SR/5L@`"H6,!P"-&,!`R3J`P=K6@(:6,(3<J"!"^!28[Q3`*U0Z@$*.$!B
M(%``#%`-)`X0P-0(D)</.&``&A!-!DBE`1P>8`,BTT`"%$"!`UQ@`Q``TP<Z
M4"L,5(5"'JC^%03&MX"2=+$J`Y"`!2`#@0KDL$(QC-^"()##WAS``0Z`6@*T
M%A4*B.A$!/"B!T;H@0@HP`!U8:![],:`#8P*.11`P*U0F!LD0<`#"E"-""+0
MP\A\8(K,@4UCIM3(!&C&D$R+`%PZ!!(&C/`#`^I`5R;0`+(T8`.3*F0.O](`
ML71@A!(R``([:`H$C*<"#H!`WGX&H/%HX``2PF45FUF6!'0`3@MHVS4?8(`2
M.1("%+@EMQ*@MZ,QX)DE$@L%S@DT"B1N`@BPP`,DH(`%7,`"!T!:.#'0@`;,
MQ4,7F"<",I`WY"R``MT40<D<((&!(F`"GLIFR7+%@!**``(12(#^/.EI3PHL
MX&<+\P`$Z,F7"3"`G\F$@-;:>**\0<4#$K"2!=Y&Q8%:\2Y/+`!!9QHC-W7*
M`GB<5$P?<,\/$H`##("`2AL`S@8X`)X7^*<$%@`Y4/6S*TQ]`,0<0"I:NJY(
MZ4LJ!!S@3V)Z\)@+`$OX"(!#LKSPEXJ"65NK"5<&3.!\;*6J03/`3PUPRY]]
M"^$2EP3"6F(+`@R8:B$KY%1^9J"6D&U`8NX"FR0J:@)^.JB?T+*`<T;*KL):
M0`0BX`'17C)24XM`&;L"2Z+6,JT$PN@"QB/8?F*`GX;+0%K;AI)\DM-/=LUL
M8M[ZV;N.P$V(#:<#F$3+X28@-)+BJVW^'_L`S*H$HYB40`$>\(#1GI-D_#Q5
M<V%I@"(NX+;]?)U98P$290[(`G0D`,04T+,M!C)2]B19?=]*()2];51>P>]M
M^W.`J[E)!!=8U0$,D+X+(#*MIZIAUT;*M7P:KDA%ZJ<#9L*`M!X2F@9@P`#*
M.8(:?M(`"-```<:'76,>0#T7A4`91\I5;>D0P@H8P`3H="0=2I9C\$,O/>6[
MQ0(<$6D`70`"-@3=0Z8X4DHI\`1"F.!:5J``5NPA)#T39-S"KP!I;5!F4EP`
M!O2%CAZ80`&B<H#O)B8#`Q#+QFXEV?760@-^;`D%O$0!-4VG.7<I29]/HH'!
M;*`#&)#.H*'^4Y*OG,4#\6F)73A0`9)<@`/CH71T'-V!#O39`^<)-:@W(+D&
MY*4#%8"*!BQPZ+%UKR6I+E`'-L`!Z6P`BLIL'Z;+4FL_3F?7'+!`=#X@;$C/
MND"F*32H/;#G$6R@`JT.-*0+W9*O,%O5)'CT>.J"8-,D>FP8L(NR;RUH]S1(
M/'?)2ZW/HSVZ).;0Q.Z;A9(M9SL7)"6%:EX,+G``!'#0?OI.PC!7,CKIF:!N
MICF=O6O!.X7GSG\&_TG##:Z[VP7<!KR;^/)",CV-.UQX.=&X\"Y./1I8;N`+
M%P6U1Z"=XHG@/"M'^<'OHJSD^/EST[&`N"2WK"NR7,[#=G9=OG/^@D[/[@*W
MQ<#*/XZ=%9PG!36OB=)-5Y/J5`?B(_G<2*@S'Y2\M'TA3_DN'B`650M@PW(N
M"7/4_AZQ0!,"OCQ)]%[B.^FA1'M/G$J8C;AFOJ?+1-Z!31%3E:JQF>D#&P#`
ML43BI&!EVNM3ZY;16R*=N8?1,\DDBW28-_<-?%`S(IG[3*A:%K8K3ZG)@0H%
M!""UM"O%)`G@Y[ZV6.^6Q&X#!**)6!J`Y16/H`)IK;D"3EU[Y;%=[+/X<8$=
M("<K2<"O.#31`@AD@4-.(``5:`!2%?<S0LKOD^@SP`'DC!RW-,D`UY>G246@
M@5W=I5,%X@H#$K6`#%@@S*1GJ@@DZ6G^'0_%BAHP'FUC`!N@'@U@2AZ0+7A!
M(?V6-C.!>@[@*'?$)%-C`!M&21B0&:NB71>H&&6"`9&T1Q5R4F`A'$EQ2$L$
M-0A`&]LB%=LU`@*@4IXQ`1S0;^[Q,SV45F25)DKC&26"``2@)R4">(=$)V;3
M;VHRA!OP`+Z'?+*0*\B1*[44*7D3*6(S4-;D3FD46M95A81%;+#5`=#T`!6R
M)(644;TA8^:S?B`!764!97W$7:%19B+``$$(32+061E`3XLG`OU&'&!A)1B0
M``[0`1"@(](74T"B*.J%>@>58@<@13;"0VYE36OF7Y18%I;B;^$T,2>5-&/U
M0A)@`"/C%[K^LCX14"N$`C5Y^%AIT4]3%#\'=1_%]5$]4E$A9#AU)BF/<TX.
ML%V0%8MY^#A7Y82S0%&20DL9@!P/U1\?]%S6U(RJM89IE0#K]T%@:"N_Q`&H
M]P'KX0"&)%)J>#7D\X;M@UI1L2QEY&FR.`&3)RE(PU05(A+86&2.8@'VTEV(
M.%*H1R"DUUYP=%<O]%:$T@".9DW]!3.(Y6@$0D4Z=`#VIS@717;66`"C=8@3
M0'8*@'H%.3;U9SC\]``(,%)Y.!>614X?A6'$"%F3I0#WY%1,95L'2)*2\I)U
M)G/&R`D'U1]45"LY!@&>A`#HLSX=P`"\$DD>Y4B$$I38,1Q`@P#^XN<>KI0C
MJ]50X41+(_!"[8,<>]@TD4A0;U.'^?,_LQ4SY!)5^S<<6+@`*W9(#0!/@Y0`
M>Y@HGS66$3""Z_16R+$8]75-N.(A/B0:(]``98(K3V(:!3`V:A8@OR276.$U
M%C`!%>(`!]`M(+$`8_4PMQ0J/>494@2$,P5N'`,WC\5!&;A=\'0`$'`BSU1_
M%C*:"I23[&5\QO=2QV-ZA[9VD&=\65EKG[0<-K=YMK=YS"-Q*%%V[A$AR6$2
MPDF<[39KY+9L6\1NOC0>O%F<M.D28@%J]2:<:@=O)U$=)?%T)$9Y[@%HRA-U
M*`&>M*=V;6AN6P05RE)Y)N&;=S<"G3;^GIM7=EIG=,4IF[<P3,2C<'#G`QX7
M!#B9`YCT;Q&'<1+W`CB9H``*"B-W`P4W<@?J`LE#=UC7<,"S/0X7`[<SH"3'
M.J5S<J>SH24ZH:Q0,_&A<PVJ$I%&0#X1:<N"=52G!)"F-*Y&HYQS%]8F/5T7
MHR>@/_K#`1F`:`.4HY*&`N5A'QS'<1K0HRQJ"DB*:6J";G1Q'HD9`;2&;AV0
M`4^W1035:9<&)%_A<R2`C?>';*#6$N=!=&4A%N=QH[ZY;M9):G1::%.*>&4Q
M;+Z)>`EW`6[5'1>0-!50:>4Q`OX6(X3ZIZ;A`1R03/&Y125Q-<"YJ)@&I6^Z
M;$0GGN;&5YO^86U$MP&F&:FL=C0*@`$EDVDS*IXE41WQ$1H98&[!Y@$64$5D
MH:8M\3"0"J=D6*6G`!(+5D]K!@$O)E).D@&(X4^-8P"AL8+;V6]')9($"!D2
M\&*U)QIW99`?$BQI]@"4V3?AY"%5E"-=@4G7-Q?7A`#01"0P0P`6@#+95"MR
M>1<<\S@+T"CJX6`'D'M^84I!XHV\4@'WUR@C)"\<<RSS>C9*]J]C]*\<P'MW
MU!(-))F_Z(]\%6;C0R%NDIARTTC_:A6947T,)!8`<B$YM#Z5F8<8P%V1L1BJ
M<8<H,1S^9!EQH:U'LZ^.(DD6H%T$T(?"6@K&Y"D(R7OQ&#-<Z&'^ZX>';9IB
M:T,`"2B&O">TA4-'D%69KO-C3)AP!]4`=XE)HR6VW5(6_051@*E;'[`A"P!\
M,28"M"1AADA:N8=1"B!+93A^HQ5"<HL5,S:/&[D`R:1`*&5*6D.H839:_A2%
MC_4P'#L@6C-<J!4!(5:T4F-(,2)8R$%.V]4Q8*@U=F6!!5`!!C59_;18YU,X
M,0.WO(=9>-LU=[FD0^L)STA<)X(!I_(`@^A(ZT=.QN2`M;$!-I:!O_1+)S*6
M7PA43H58[-(`.#)6:K)&N7I2"M`5@QB[15:`2'8U,94!!L"P(2,")S.E>2-:
M71-3&&`I4R-CXKA_J862X6BW&)!4FY3^`!K032<5D@GP5;<59D"B&6D3B15%
M3WE(ADXU04M3'MJU8Z9*`!2@`;Z1.D52C120(V'2$@\%41*B4M[D;[W*-5BA
M`)YWO"*@+>8K4O0TOV4XNZ3``%Q4E--1.#%LKQ301MTR8X?D'@,BPI/20!KU
M3+7B(HHB/A&[1T9D%\^RPDLR'D_R'`9`B!0@-456F45IMM!DD-JWQ"?1Q!F5
M-X4H*11H,>'$;%*L&@O2-O'DO#IROWF#8&6D&0^@'3T#&XCS'!O67MU"(QN&
M4/M[-`QT20?03@.P8:ZD'9G11&6V&?[6+2Z,K+,G6?-J,2:4@!7;$H<T%1XE
M;*0H$H6"`-G^)\9L_$\LC`L:D%3K4:06FD![IP)NB,K^LLH\@$#>D[Y4.@,2
M*KNV/,K$(`$.H'5$JJ"C@<LG443^@SB^;#U($!A"C,QI<,NZ[`AK9W<*1Q(%
M9WL/6G)"<3S,3'<;&CL9NJ072G$I&J4F*LW,/*(3Y\W9G*/_21-RQW'9@YW/
MG`J\9VXH4RN!$0%SA`(5,'LE$#XJ<+<%R@*QB<H%7=";)#E%4#_>$YL1)**P
MQ*`:&M$R,5HJT`%ENP(%I,3S?`J)=TMT*(5+8K^U$B9CY(U4A&*)T@`I=C05
M0$?&)#*))T\+\``Z5RM-$B4OW0%TPFJDTDO3MR]&,T)R]DN1LL/^'<`MI84`
M:A%"I*).4@,!CY4VX6+3#[5%G>5(7=,!"(@DI)75.21"SZ6JC40RD"1)=K$C
M'6!),U$!0<MO:6&14<$?2=TM4R1G2.5OF*5#[[$YYY6^B>+6;;.J^70!B%):
MD[(!A*Q3!5(A$U`!-.)#@;06.10?4W1`'1T*5WA_)R,!XJI458)/]S<>X*@W
M&I`KA9,^&*51\Y1)20%-5J14ZNJ2N"M-3'T`6?)"2"(!')0`\*-4?2-6*S56
M5)4!622N:H9+[_9<HL4`;I2NU:LG28U4I,++-IV^2S-3&R!6+95G@2@`H?F(
M)2)NXZ=33+-%!F`!?6%-;$6`M!0`4W+^`5RUD0C&0V351F%&,M7K3__!-#HD
MW_ILB01U9;RK(O84J4)Y-4S=C+CU`-F74NR3V9\@E,AQERJB-9JI-Q'``!>(
MD9>43=O5-[*U6+!4*\\X-5J!F668X.N'C!^41!STD>6!?]+E`.AE.(BUFM65
M61S$25'\X=AE6N>H*/PQ7M`57-&EMKS5$HSQ6Y?%XW3ECY.&6ASY`.=EC2D&
M6:=2AFLS5KF%?T6N(*1(5:I-+G3[Y)<ECT,A8T3%M`Z0`61U6W&NMLXLX8:P
M'@"B4XGU8P%"&D`BQ3(FF0EXOV6UOA,6`5SU&[W20#"C'CCH*,"71&5V`=4(
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M5@&%1FKNEAQI@6F-1D#OIFC6B?*(MFLF[_`-S^_9UCY)86S126K^ZU2.YPX0
M82,UW\P$)TK.6@`2S^(I1Q\*(&<\R%SU0(&B$SW-SNRA,=K.VPP#2X_U/QJB
MW)/+4X_NPG-U45H=X,D3]5'G:3_WBN%+D'<DMA<[8K&JS>9Z)#$<QZ=V<4?W
MA$_0,U59$$LA/"2NDE*4`D`G2K6'E=$!3^R`.R(51,)WR"H:)B;WA5^E5+2Y
M_/;AKJBVUKC5]?=4D4)._NA<[+(DI;QGL1=[L/SYMI^,SGAK%L9/_>N-'M42
M'XFV4`A0B(>0OPF2D#58M[_\\-@?OAW(,356W^&4Z,-Z)V+CYR(L^#7E1M0X
MBJ*9CZ6VO<3\G\]V_-F>[[F=UBF<3W?^G\;W=-MI>J5'_O1?_W8@H%7@^=80
M=O9?!L:7GR#PB:/H>677F9_'C9ZJGB8LJR4ZIZL9Z^(-=B*1>BS6Z49<,IO.
M)S0JG5*KUBLVJ]URN]XO."P>D\MF\<-P^"0.ALO"Q79Y$`/(!W$X4`X:!\7(
MAD%!`5Q'@D:"VH5"P<))`<;'`4%#W@%"Q.4"1J7D18!"!X0!@L=#YM!2A8""
MQP&'Q(2$Z>H9;J[N+F^O[R]PL/`PL=/%VL.$P<:'1L&)\\E%`N5%`<=)!``>
M"0="<P&BM4M&P<9S1,!%QG>"Q?6'10,'M;>(_?''0^F&QFWWF@P`*#"8\*U!
MAF(*%S)LZ/#^(<2($A\RL"`"PP`$$S(L$`%'!(6."BH0T/2!PH!_%M9@-*``
MHT8-`21QX.-@`@$%G0;PF=7H0X5O\;Y5/()S@A,+WRPX@-#`W<2H4J=2K6KU
M*M8M)Q98H-#@ZXD&$L)&.*&`@H0&$!B<H%``@44<$/`P@(!!+=L/#1XTV.!@
M0`$'@BV"_="IX(>Y(AXX,-Q5K8:?*U[H:\RU`-^N'2=G[>SY,^C0HD=#\78-
M0J$)J`NH+F!@4P&V#PH<:!!GPH,C(AH@;:#!+NH#JC.P2["!`M])^MQ,L'!G
M-])WI[P9X%`3`3/>..*][=``U=A%&A('(FW^//KTZM</^\?%O7O^)_&)//BW
M:OY\]OKW\^_OWRH$"002P0*=3*``4A&<M8$$0#5003P;+?#=!!V(4*$(!+Y$
M`@8,7(+!A!]T^!T)`2*%U%@<46CA!PHF=(&''C1XP04<*-#@=O_I^!X1\`DS
M1'[`!+DCD:0YT\@Y%JQC``4&:,"'DP=DD,!:E%#``0$7=!#.!UM:N*62S!R1
M`0$6:5!F,V6NX@P&"4S`UBEG:@F/,Q$4D.8%&P`@CP0'5/!*D?OQH!L2-.3(
M&6>Z338#947<PL-]BPXZ*9!-&/K"H(4>L:BF2!!Z*:.'%@IDI9Z:"NJFJ!J:
M**&!NJI%6PID8(!S#5B0P0",8>0``Q_^.`"`!ATL0%`SW_STP;$8-1#(*AL(
MY:P(T.)@C0/+/I"!`L4BFVT\'2'0`;08($"06!Z,]^IZ"``@0``8%)"0KP`,
M,-`'"@"`@`8#!#!O`_H"T-&3`&1+@0`<D(F1B`1L4P(!`0#0*P7K;O-`1Q^4
M8YL(#`PP@```[`-``.U:0`"R!`SQ```$8.`!`1U?HA<``!ABL@<%-"#O3`KT
M*D$"%4@\@4P."T5!R`-T@#*[%DT@@``-(@"!!P,X8U$!@0C4X`(I13W`2?*F
MS(#$(8&<$L817]+G$1`XW!BZ;5_!@`&)4)!`!APTF8`'=[O@E`AMC`=!8Q)P
MH]J%"FAP[@C^@(N@>&*YK9*<`HGPE=C9W(BE".7Z]`%!)PZLX39ZL6%@`0<`
M*+>``1A0X($#DA!`P08,")"!SQ7XK(CAF/F\0`8"6!``!W?8F00`$EA@^@3M
M7KD`MQBH$P`,`R@PP`44=,!``1HL0')M58/4[@,#<!!`!!><N\`!&*@/@`D!
M4-`[`_104TKR&4`@0"@46*!<.LY\E?T"S.$^HO7C`"%R"P.$(I`#>,!A)R'`
MZSQP@0'$3P'I6UUL_/<43-Q)`B1C`?D(,B30D9`-%]C*`1S0(0S0H@'5RXU:
M1$``@-'F`PFL2`,0@,,#/*`\(G#&-\[Q#2#>0@$ZFQ`"1B%$&R;^@"L+2,"X
M./"6>FU``2YL(K-*.)H"I$P`&/!BQF06``N\1C<1X)I`!D``X[0K,<*9X0/*
MA#_H%:&-`Z"`SQ0F`0900T0`^$`!)""!<:4L`(!+&0'P()!OF*4C'1@CQP1P
M+K`94@/L:^`D$EFO^3$I90-`B+P$T,<)I`P`%[B9&FGQ04U"@'TB4!>\OL@`
M!BA``/4R(K<T";8"!"`HB`31*YHV.YR,H`$"*$!<M*C,(F"`11NHP$8VD`(-
M2+,#"<&`'+#9#`I,XCCO\Z8&[+81'&B`F]N\P#97]@+5K2YOS*`=.KVI/MA9
MK`(G3$BPXI','C%AA,L4QB,N4('QG2[^==9+0*^&U2*280``I(S`!PB`M05,
M0!(ILX`D`Y`!15C(`Z9K8`6(5CUA<4L@'Y!`(2@@TBLEL`$!$)-$CS`;$4E2
M`.5C$>KR9,D-Z"F3>`B@#84S``F8SI+Z0^=)\3>)!2#``0'HP`4$``/\Y>%U
M(O#@$;Z8BO!A"60$L)`F%6#0+3WE3CIK:,<@@!(D4.`":O/G/^,JU[GR(A(!
M:-D78\:84E9@`^PR96(8^L>(;>!X`2@85A&@CC^V$@"?>V3,2$;*AAWRKA=@
M'V0_,%D`1("/@!2*)I/`RX69SE-&/$("8M9'3?;.81:8`-<8D"6<]3$")#-+
MMJ9H+X&QP3?^`F`&!#Y(4VM$E6`;&!^$=%G*=T"4LPM@`/,2PQJ)32EDW**K
M%BMP@%?TX65'8,`>3HD9H!S`(FRQP`.@2"O#)*0/'0%O>76#O<;T(2X,2,CV
M+(*H"\6&`S"4X"/8@8`W-&`/^]3N)1#<C#)B=R$9L`"$.X"!"UB`IQ`>*`LJ
MP"(.3,(#ZES'!SA0@1-PF`7-5&=D.$0C$BNI`M2$\(DO@DX.M)BGX^F`!2RD
M31)88#P>9M$/$8<LI(I(#B)F1HD]T./1[>\>RFE&0FBL8^74"%D6*G$)3J@"
M#&PTR$5N!H1)EP%F1$8#&6CF12(#81.LN<%:1!`'O'.!;PG"'`;^,T`&_'2`
M#23@LB$Q\YZ57-1P0,`9X03R.?*L76<)&@,:P#.7EG"!93RF#A_80*#SS`%#
MQWD$'=@SOK"3``PH`--`=G-5X'J?N)8*U:X^@P:LB!0.J)5#HK2+*"D`B'H1
M9`()Z,"3NG0`">SC?>H;0`)P=)%<)R,/&D``L4&4!SGTJ`$$.(Y=.N()$>29
MILE>@F(\``$)4``I"SCUJW^QZD9!H=7RL=025OVH(C0J/^NF-[[CK6]W]S-'
M7;`/O7W$J72W+0,>J,"#-%"!BBWN`=B`@$ZNAX$*U*6[B6E,<!'PE0M03`*0
M8-$).'=N!DR<-\C^BO[ZN(0)V.TK=\'^@V(:EQBVH-M#NTGHZ'H%5X*'P042
MCL_.BR"'%@`!!G$&.K6![FET6PH;U'YWCYY^#ZE;@>A=8CH.@A3T5C7!'U0`
M5PK$Q'//G*!-WYJS(3S%`*3RK@(/>#8".,(!FS-@+`5P>U\08)P&%.#;0VC[
M`S`M(";Q!7M])@^A5F(<#_8*(P>P4`P#Z/>,B?*4`1BU!TDT=E]\*X!T\%2E
M(I7U[=CCTD(9M^H4@(TD',$"V4H4I-*&!]'#8`04Q]:FT$VJHM>$!1T%"K-`
MSJ@9$+_VT3K][%NM?$F5H/C,]ST*%+68+]%^!N3P"@627WQ,-;]+H.?WYGFQ
M@2$<MT>A/\'^^(E^`VQT@`Y79H8'^O%T&EAH_.WW_::'P`"Q"P+^XP]Q^878
M#,C?"QR7/QB@"4A3^/G"J`'`)7`$>3B``&Q$KZB>#6F`(&4`;PA``W1`MBS+
M*PS8YT#`!$!3163/;""%K]A2OW`#F3P`&75$!:0&6\P"3.@%:XB``ZA,1N!-
M`QB`"MK0!$K1-:`4E0`+ZKS,!!`$`KS+!"G`*3E&8%@0B*1.'IC"516"//!4
MQ51`1GC`*]`"W-Q8`@S`A'VA(]C&&K@%,GG`#ZH5;?#*<56,K;P%WHC(6Z`&
M4J3"`K@5;\!A;5PAMRB#(7@A6G#@73!%7W``PRV@+\!>[A7="NC^WA.P2L!U
MR1``V0VDG[TY8E9\BW&(0"=05`B^R;1IE@,PQCY\`X)00]VIA0,,PN),@&HH
M``$8S!T\0SP@Q#?`0SX$!I,D``<T@()X0`1`7-U<0"+IHCP$FX`4`&I(`]XP
M8DCQ!@+D"=[P$+S,A7$<HZQT0$BP@4$`T@94E&U(0"P:P.+TA8",&S?$P@,4
M8P0HB'(X10O$@@/P##M,B;C-`W:D5[)]QUFXHPB<Q3<@@`M,0YM\Q%I4#6.D
MQ29XP`(`CBQ>')^E1<VP`09$@`'D#4%NG2=JP:^-&B!E@)?<2!DZ7"'0BITT
MR.-%@`\5P>.16]\\W3M<`ADM129(%S7^Y%#V<%U(=@9""N-%Y`JIB6.OP`,]
MS*.L?`,IULL$J`4$?-HLJD8#,``%Y,L>68@\X%XL=`L@;=RO[0,D.`"!C,<$
M=197(D2V"(A$,0!7OEX??D0?3$F(S=+B0)PQ*LAX4%P>F"(#H10$'"/4C&!A
MU@L\4`(I<`[K$(@<0(#C?,M@QH$P4@.Q>:!!4(`"#*:EV:(<($BO(.0N9L!]
M[5^6:(1@I`5G3N14&J8'#B8@U0L+,9!AW&)0ZH(S=,"W$)7Y"$`3*HAB4F4^
M*,#Q:";_C8!`&&>7W.$)V.6W&`Y;R(IOP`DS9-]MCL9S4IN`L$&N2%$"?-4K
MJ=1!2`\L(`#^`2P<!ZC!Z2WA6B@"1T#;19B,+;[,1_0)A13`'178ZWAAYWT;
M'EI`KP@C4^$(&`[5F1"`!D3``4C"N[0!MXP;)$2`\62$,RP"L7R+;A)GS6#A
M21%`(`$%(W6H`5Q/)4S``HA)35`/2L3"2-*#!^!$U4Q:`MP(1'W#W(P`186F
M"W0E0G3@(S!)*D8E9^(-%`F%!]T=X?1+'V+E)5"`4%SG&;2$,([+LA!C`[1.
MY,3#&A3%69`E)3(%YR3D9BP..GT']J`3]EB$L`0"&4&I:%`?MQ%E_)%8^C4?
M#_P?V-5>^PF?$1R=P94`'8C=9(33/<B`-*%?1_TI"ZR>]WF`HK+^P/]9!PL0
M*OMYG::L@`)R`"=Z7Y><2_L!R?VYH;)=6D<=JA)TB9@HX)=X'V1BZNH1GUBD
MRJJ.R@IH*@W<Z@Q@@.#T4:N"GOTE@:@"I9O^FUY`P"E!`&!4B_KLA0/D6&+@
M`12FA0-4@`%<`JMPA0'L@P:RS59<@`0<8PLE@XE20F[4"[P,*VD0H[_EF["N
MZQ7@QQ@`'-2Q*[W.&PZXGH^TFQ/83KZ=`+[J*S\Y`>Z(";_"Z[^B*QGXAFI@
M!W(\`#@JZQ'<Q*4UT3"B`D0M"Z%\QTV,#%R2``400&Y4%%PV2?SPG3MX0%X@
M[&?(*[OU*[SJV[RRV[K=&TANG;VZZ\W^`IS2T2O/`FS`\JPE3L'.MJO*PLHE
MYJR_.0`E8D'HN6O1=L8JJ!-E'`Z'^-.0@.04G)!'@%^_B8`%,,J.M1L&]$.T
M2`"02>T7Q(?6CL#:#FW5"NWH.:V^&<S3*@3+QBS>UNUG;)JFTH&CU<QX:%.<
ME:"(C`="<L#:0NJBBLB5F0"U4:T$(1G5E@":E5C[H1EQ7(3D&MQ/ULP[45O^
M8=D&Q!(S7$L20(#!=9FC8D.660=KL@!M)$3[.<F73%,+/%G\W1A/>9C17=K_
MB0E48<-/_NWP2F[?<AN2C:[G>MC\&4P"?B[1[>ZE#0'DYDF(C0<'F**CZ2U#
M8"WWHL<)N('^3MQ)2!!`!.#/!!Q`-B;`LC3"`%#<#%+)IE`#;NR@4ZI/Q;Q#
M]DB`+6)`3ORD#1%`_!0``2QA1BP+;;R6^I:G`2!K(.C)!<#HN62"4I27%&6)
M,O@@5DHD`\R@+6Y`@8%1B]BB/!SCI1D2WNS1`%@`WC!E>>E!>1SI$KJ/M4%A
M0?"%F7$+%!F..KB>^:)OW,""2P`5!"RP^D(C_B@``IQ"5O&$;QB2;:7/`E`<
M"7K`'>HO!MHBKF!E(>S#6PC9]X:Q&(L:GX$CWWE<3?#=@73`/,H#:_#.1)Z:
MA"X+-4@GEU4,5["`4[R.4UI$Z7&F`ARC%2L"4E0K:XS"M\;!*^G^IHR\8P>(
M[(UP@R$3A*ZAUTVXHJ_5"U+ML5?$W+><0B*[J#=V0"T46%Z"H2"O@:RX13SL
M`XYP3D(\GE>\\:?QG7&*6BU7S:\)SKD1B'+X:UMJ)B6(FP1L0$HPHE>(HGYQ
MLE-F`(RTR3Z)L31S[U!ZPZ<1A(*D\0-,PUZZR0)X')=IG**\1<U\F@:X$/^*
MH@28F2&,"S7T88AE3X*RI>#4`>*>)_L^0)N(&X&(22S$70P-<T7-0F?Q5&WH
M\Z_QG7=D,E9BQP',6#L+*3=\\MQE<^?Q[XL&$C>L!;8(#B#I)@84\7@L@`"P
M2`;8UK2-RP)8]%ZT"3U8L\9M,]Y,9C_^>-`J'(,W$`N>U=T,HE,KP<LWL_.<
MW2A%F:B(20W13K-2WR9<-K6X09'KW4JUHNR+H@4,7XL>N)BURIP$?-))Y&&T
MN,$P0O4E-(!RP%9CV&(Y38`;8H`:$,=4LX5**50>W$I.Z)\*/-$D:'&>F:F'
M74(/E?6#)8`DL``?P86XBJ*XJ8'K50!'4JD+,-59NT8&H,5)W0$&;#-.OIY>
M&%!=1\`2NUY6U@;*7H]I>X)?+^$4ST:OQ`\>\H$&ELR),H`&]$KOA75UT!)<
M7`*F'0!,]AW5+;5P%ZW5\A/=BHB3I"T5>*^P7FW=F4/+,FWB<`/,AMBX2%^]
MYFVC:*T%C&G^O,V``I2KJ,#;<)<W]V+M+90;>4OWSWI!J%`!01`9>S/!F;5W
MV5%W4H=!8;7W/2AM%C"W>0?X/[&LO,EL=9>*SBK*R\HKTH)>=%L*S?+W[LUL
MO7'?=H!?OK8*_>$L@K.K?6"=@(>X@`M2?O>;A%Z!C<`;B4N:=S6!P_+3LO1*
MUT'4RSI!96_S$]`VCL.X?+O0@Q.!!193(>R9$[QX%9!8M8JXDBLUMI3:`RCQ
MIBT"CC3Y!CSY/RIQE0-%7QD1*7.#`QA.*B"N$H\'WXEY`KQ4$5-W#K%Q:U["
MHPD&@F[FHY4U4U6YC)3)]=`-;RR`TG9`8]B/@ZP.'\6%L)S;#S'^CY-:!&C;
M153&Q3N,Q7.=@$T]P!*?D!']7>K!!<C>TDEMYE.X.0(XW)XDWF;\X+G$6MS5
M1X"8]1.]3$CK`XP@`(0D!O)D"3V(]Y+G.KIFWP3*>CZ>Q6:"Q/T8A-M%0,^0
M)3]S7"\1#B"]5K7R!K";Z)_PS)-T0"+%\+/3@A4]](V\%N]\E4H[J=LY1:)?
M0$@'Q@.D1;KK&@L\WD0B!&MGC!$56F0PB4;T"N>\3K6HJ2245V&;T%YX17H%
M.WLQ0&#WX9<CR%Y8`Z;500X%A8^-0'>?U+!\3D5)2!^XRPS6Q(YVA("D#Y=H
M9IYYPL;KNLE#J5EPCL?)"($8(S=LYC?^0T(B-S(DC)M:#`NSGT)%I>*X2>1J
M]OP:;`!%9>$#[(."%,B?,$-7=L0:'&.$;H(IZH/![\7*C_GB&/PI>5R5&$8^
MSQ*/DN:6S`UNV(IUV]"X;H4&<MF5:APW\`Y"8$"U:*`.I<4=Y\&G0=>?2-W$
MP^;G#`4R5^"%BBE4ZBBRL"4;$`N`G[SB+Y/&!=(KN&,EX$CC8_1<O,(\0M<`
M'(BUE=M$6Y/-1#`!\)`S0*-'2XT1?8Z[K)V$0D!3^5<!$&=Y=42!-2@_W]>"
M$IL27VDFHY2G2=)=4(P.74BU(E57EN8YI."^]\T>8(Y9;,*RDI&/FZM9WX5:
M0']MJT^V,!#^I<^#(3Q8ZVE;'(*$(Y@H[C")MY!#;)0)LO41@'Z`&O2A=R^^
M_&^>W=3->/!4/-3-/;P/W5K'_<<9"%!9UXD=MWU?YJW4%S58J[WH9WG:U*E?
M_;E1,"J*QG/A:#X>X^JSV1PY%$\3@U)^)!"F*M4Y#E.JB\4;[FS"'[,&M58U
M.9Z,+Z/9>-B6L^JXIJ9!9%'Q8[7$\C'T@27EP[9BZ%-Q]D8Q89"WTM)FP6&Q
M@-'SP;91%>FCNLK:ZOH*&RL[2UMK>XN;J[O+V^O["QPL/$P<W#(AD=M9C%/`
M0;N,&\T<O(%PD-S:@M'@Q3I-'2X^3EYN?HZ>KDX,/@VN:N73#NO^+@>_NMP9
M_8XOS]]?*QX]@/((%K2'\."K?0@9)ORV+J+$B10K6KR(,1B=5AL?JE#CJN-'
MD+N>W8M5QV00#RI=[6'I,H6[EM_HD($8\A]'G?*>\0Q"ZB%,FCWA^9PE,J/2
MI4R;.GTZ+!Z"9Z3B*3@33Q^-+@*]+,#:8@$%"/J8M+!2%EZ+J:7D=#A;==D#
M`41Z,)B@P*PWO1889,@+]TXR@3TX')##D`."#@_T.GZK"C*"FUGM!?UPP&<^
M>RTL`+[,N4<$.P(%<DB@N'0GQ7H-(]:+EDF/KWNAVKZ-.[=N=18,+/@PU4&!
M%PP$1"``X?@%!P(D:"AP8,$%"!P*.%/^`>$`@0P;#ASPT&#"`P8H&ESP_4$!
M`@,H&*A2<`"!A^##/SQ`L*"[`0F&43,9D$`&!A3007@+>)```:&`E\%8'S1`
MP`4$()#`@_6U`4%VPV6B``0!9'```PQHD$$#U1T000#<(#@`!A048,`#&'CG
MAV<%9)"``?)9,(`"%W0#P000%##!%P!<(.%B*[@'`07,"2G`!\*]T$8W"V2`
M`)$15(!`EAY$`*,=%`"`00'K=2!!`8T%(5]\"$@```<3%$!6`0TPD"4%ADTU
M@`.[_0EHH((.*HL!#1A``0,O/G"`!0FP=&5X.,Y'`0+I2?!`>!Q058`'!VC0
M@`(=.B!!`T'^"IG`H5S6``$7WABPP0,0-$`!<NQ!P``!94K0P0*B=O/!E0Q4
M0$$#I)K:P`8)R+J`!*+@T(`&ARGPXI"=-1`>-Q(<<($&"71`0+`8<!->!SAR
ML$`,RI:*H`7#F>3D`!,DH($#$2BP@0,0+,`!M71VJL)BD^D;,+IXS3=!M`-8
MB\-O"5Q0`*_A'1:>?`A<`,6W!7R@J)HW!J$QQQ,LT,$`#Q1P7K!#8"OJK%@1
M"G/,,L]\D:$-]%5K!`Y0\%NP)6+PUP<)3.">`I@V4$$\K@78P++%CGS:MP=@
MZ]DS"ESGPP$=9$@K<N89`#$*"!2;0'(J1(ID`P^4FF$'`0X]WK7^&3B<<P,]
M6(`MT+]1<,!?'1QV9078&N(MNFTK$$$$P'E0)A&82<#`O5M+_L`$O4&0P0`1
M,-#)5/)EJ,($!T"`05Y#*QS#W;\Y8\W3>=U5X<,9_\UQM2/.?MA=)"]L7H4*
MC(NMTS?33'SQQA\OS+9V)[#!`@DDDX``1&=Z1@(+8_";`@EK0$`!9!PZ`(F^
M<1!>7@YT(X&A;C_#]R)4KL<>OLY/L$$!"Q0PHP$0:.";'>)F0``"@`IJ!B!`
MD0:P`08`JTRA`$[SGJ<""SC``<#;%OY05J$A&0J`-T(9OPPP@`I((`(>N,H!
M+N0K`RI@0!V8``$R\X$"+$$!$&Q!`2S^0($!'(`,'O">T$P&P!)"$`H%2`#^
M#F"`"%0N+Z*0``)T58H(54@4$$#``UIPF@Y8JF.Q0@`$K.$S;O!/`1Q08&V0
MA\8TJC&-;VA+'<ZB!Q)D90E[*(725.*!-;3@$6_IP3+:^!;P)`-)`9N!&X\`
MA3AH`0I+^`@6J5)'DO1Q&71H@1\581:T(.(9<62"!B"SJ97T`"3QZ$$4Y/')
M/7"`%''PQAM]L$HH7&:.3/`))H.@R"7T4381>)'_*FG'%01EE';<R`C:`AE3
M@@$T:VRF,Y\9LY^@I!>>.8L/(.#'DQA$FSC11C=U,0];;&86TO1(+!R`@"*5
MTYO3A*8[WPG^SZ>D92'T/.,WTQ).EQC$(=]T)3D'TA"%1*6>^CS)._XQSGK<
M8IWQ;*A#'SJ.3FS"%5@(R"T,61`--+(,\\3`!AR'#Y#*8P8BE4-)V[E0D"K4
MGA[P`SBY"0V!QI0)1-A,14T*T9SJ=*?!P(`N-_!+67DADDP0"R(U6@H.8%00
MM4Q!!IZA!#50I8TR;(1,."#4:Z[RJ:70P%62@53&H:!3C",%_Y05UB34#XN%
M88D=0.F#CQ8FE1N@PP7\.(H_D!63+%D"4G]`QQEXX`$^<>I-@O#64])4)L?D
M@/\JB@1.+O64:G@+$2I95R9<]9.?I.E8:5H8#NRO#9NR5`;\Q]/^U*IVM:O@
MV0`LT"4%S8D`V<`!>3JU@&OH;T:9:0!TUL0`Z_@T`,GIGF(,("H#8,8`C0K`
M!417(3#1UAMBZ9'6=$L!&75/`Q(P(@0$0+X01?!#!%```38@@:NE*`7%4MD!
M!D"!$7KJ"[[E%XR&%H#LBI<!XL4!``HT(4L.0%'7V("$O->`$/7J2AI@0/H>
M]84"$(`"%,@O=LR[@08,N#JR/<"C$H"`WTT(N,+5L&?ZE-WD'$@\I1@``O"4
M%PA<S4/A;8`'!'`G#*0W0F(QDR$8RMH@"_EX$Q`.7CJ0.`5X`'1R6,"^'D"]
M$CD`Q%'NF72X@2/,+/E>WBK<Y_;U-]_^'HS)*M!>7K3GL"(/;\D0XAFX'K`=
MD'5`N=(IU83S<C;!9:B$K9K/'T*%.+(@KC$FNZ&:XIQ%P)V!`\IE``VI%P0"
MG"Q1$JCTO'R;C3TCSD_8@5`%*O0!T'G*M_%5P`C*1HK?D<L"0?L.`WX3)/.P
M23%@G-6$22;I&UKJ*PF[-8XF`.0A"WO8,$-4NI2<'*9QI04R!A$&&`"\*4,`
M;^/JF?82-K</&*!$SCI-HDMT+\6H#0,(*!%7RDPTH5%`:D4FE110-C8%@&M6
M*5`,:\0"MG16J#,`L,#V`OT<%40@`9\N%082$($N+.P!&:!3LJ"P&`)=+`B`
M*YO@G,,])5[^X%$4TK;:,!;J!OPEX1^)T-@0H%%U=<=4%]@`F!R;*G0G3`98
MFG/SE-S#PX#,V]\R^9&1\X"-JRS?(S/PA8B-]*33K`4/2,`!BN6!"8@`.A<0
M81F4_!T'G/8!6I0WPT&E@D-IK41M**\'&-`!M*/=Z15"`*NGU@:J6_U!V0T6
M>)!;@3HY@P$@OL`.*:`_.8#-/11L&@)FM-')"$U7STE`S\BM@-_P?0'(^(#H
MNG!Y.3AC`@,`5J\@SB]&$^A%$?C\"-LP-7V8MP:#"19\3M'Y'YX6[H=B0'<.
M4*0',9<Q1-`PA2=0>0BLJ8QI3WNP0#RC4Z#H\X4'L03+-'&E2W_^^H32R5]1
M:@_:2),MV[R^16':3_O@F1Z=.=_X'=,561P4_#)-2#OFN0S:]&,9&-`$0/UQ
M3^KK?_]_"K;Z<7!8]N0#5:!/##5.VX02#M!(.F%)#L!UW_=_X3=3[+<*%A"`
M_8`)P.!__,>!'3@176%-G%$0E>$1[C!/M<$/^810'CB!+.B"+R@S\O80,@`+
M&J`X_4`KP*(*#Z@*C-8-VZ"#_7<\Y;2!,&B$1R@1&H``?K(8HH,Q8%(!R%$I
M&#`G+><\#Z`!70!B+:4`[F$@#D`":R(C?`<L#T!<R8`K-](%,M(AUL!I&=`%
M%(!#8`,#9>,M08(`08B$>\B'?=@44\/^+0M0`6J2`#-B`1?@(PQ`0=S2*-XS
M-`ZX,QM09`"08=,C`4["!/[2'>PC'=FS.:6C;@0"B%@Q%92G)HN!*PHBBHI2
MA'[HBJ\(B[T0(F*A*)*F*.[A,R*7;=I3-.*Q9NE4;@8B1/Y#B\#Q#'BSBT66
M;:>C;:]&)15P`%HG::+P=`F0**5P/K&HC=O(C</0-,EB:B%2>@,".3&0`]`A
M'6=6*A8P(><Q%Y68%VGB`[R(&<=H>P20*WS3<,'%,P^2*C>Q'QY@``Y6)E/R
M&PNP``3@`;S2C0WID`\9"XQP61/`255`(HJ$"HG`!Y8@`GGD6%NP)C^@!8K`
M!F[0`6?@!HO^Q`A-9@<<P)!5]P9+((E+<`&M")$WB9,XJ1/LR$R_H``_F)-!
M*91#J5`G*$TAN(+:=(`HR$X4.)1/"951*9532955:957B959J95;R95=Z95?
M"99A*99C299E:99GB99IJ99KR9;:"']#Y7YGE`\JB!/I%X'\9$XL=1!+V99]
MZ9>[8),1>!&!^9>%.98=D#2E8`,\@`-R.`070&&)V028P%YW0T<4]@(;<`8G
MN0T$F`%$8&"-26'O\)$^0(4JX"*=&1D28`AH`@;THPH6P)!]$$$U,@F&B9MK
MR0$"@#$0@"@`(``?D@``0)RY(@#=TP(9```!-`",ADV\V0@`4`#^`%`Y`Q"=
M4@*<X=(`<2(!X1(``X"<K]$(`^8%$/-B<Q:0!I!$7N!HCA@?'/.>G>$=O21<
M#7<C:3(Z`IB;^PF6+X891O8@EH(!`=`"Q%4(R0D`F`!>'-`]:Z*<H?!TSC47
M&2``2T`G#P``X>&=#W"@K)`KO]$"+_)JF4"B!N!"'R$`3^<!`6`!`L`C+>HX
MQ=$-/XDM(A(J!A8C_*FC98D!$X9`*@(#X8(!`&`%WQF>0UH``M`S#$"D*J"<
M`E"A8S(`WVD!`=`#-)HJZ[&BX`DP9=0%919C([(`!D"%)FJBN"=#E#<`$B``
M&8`GSO5:O"DKCO>3Y]$G-EHA%)I[.\K^IU_90T4$'(='`'XRI$4Z;00XI!1&
M)J$6+MO0I#!@G4,*+C=#)@BIG(<!`-.6`S]0`.[1`C04+"^&IA8P.B8$`86H
M.3=$%Q(4/L-Q(PG0A2PC6A&#*PS0*IL#&'VJJUK)=`F:,1G:`T'40\%)`,$Z
M``.0H:&C<RL`,)9W&`#$K,3U(%;R*$EZG"'H!=@R5.:%,0E)!/=#&HM``$!"
M)Y8G:5Y@&)DA+8OQ-]_Q'#NTJ_$JK^&0E/Z4ETW)E_.JKU=)F.C@?RFHG_R7
MKP&UKP7;"PQ(L-OTEGNI$`Z!EPO+E`BX%PDE%.%$E_-W@OA'L19KKP/;L-RT
M3JIAL"-;"_S^4B6]4&D!NP6U%00](POHTH,NNPHI^Q,M0+/VD+(+M0AX0Q2Y
M<`&$=8.N(`&H%1DRRPKH,EC,(&^7Z"<A"FKK=@=%5%==<H$D:[6JP!;("*M(
M@'M>4`$_23Y=*'6A9@==\B"9@4,/T@S`YV'98`'_!3'`]FIYX7>Y][9*A2A:
M)"6+<0&Y)2=M>[8<T+<0-&5D8+8)9KB_,S0;9R*A<B#9(0&E0RM\ZR$O`(<[
M^R(^U06DLP"-<;F.N1T0H"N7F%LS$'G9$`'+(2IMD`!W`0"@XH!1H#B.-P$J
MTAB'(KBY19'JX3]^@D/WHH-^4@G[\C#]=HFXZ%66DKR-8#G#(B[^?:NR5UNP
MBH<W]S$!S^&;9%`J+'HC1B-O\O$@$/"U/)-P"-)#<MA=6`)4(-(!*-.(?U$!
M,0*O_-.^C((]F8`M>$$!VA,@9K:_W54Z@-<`/6,JXZMSIE(I"]D`W/L7BS(=
M':*(P-=T=%2*$W`Q3T<W/C0?O>*$V"`*V+(S:@-E>-8QWI(!Z$0!?L<!X2,*
MW)`IE3`9E"<61E.(VD,D_O,Y`_>_*O`=K3(V<ZH!E(>+/[!O8$0"$.``U`*A
M0RR]3>Q`#1-JY#&H`<($^K:_/I-YH88)@A8!$H`@>AMJ))0`Z%0ZK'$7K_,B
M4]:2CS*N@NA@!>"`R5%"Y>MD))0N)&3^-'",BTTR`21D*:$F=5V`>];X.G?U
M5<"'R&-ALA\`C0X`O?2H/4`Y*XZ</>(A9<!#<TN*%\'RA/GQ+;OVF>=S!LK2
M*W2<.,#!R,P3,*'F+$OVI9:2.`<R0OPBQ.CZQZR!FDCP&QD`.='KQ/+:-(PB
M0@GY%YT[2G0R85.$,=`9:@OP'/K#-U<C-`:@+W[\$<T)'WVS:WUKS"W6+T[F
M50UW,R[D15R`(`VG/^8<((:2>_ORKL""*T+R`9*6S"K#=QV"#)4F`7V,`#\6
M0\F`CN(\')Y:"BHBD/CA=W@C`]QP'OBA`K"3'KR<D.Y";@^R0C=C)A!3.NC<
M*H+VM1&C`JW^*R\@AC\!DROIM61.U!?IAD6WK+S^!JL5\"/<\LN_K&.Z-`$8
MLY!TY`)/90<CT`%*]@5GT"!%T"U,0)$W8$@M]184R3C"M--R8`%OX1R-L`)%
M$@,8DUE$4-1;?=6=H)DN`-8MYU0B\)%'D`$\L"EKO=8^Y0-7`@7`A@,5\%0;
MM1)Q;06?(`4DH%'%@KQG30(30`@?60)N39N?\-.9Z51-X%*G@`74$JY4@`4L
ML"D^E0<;50=RT)*$X`>54-.?K0P@31$VVWH9L0!,')C;HGC*X`LD,U"^#-HD
MRY<K59=.>7]J45`("+!-F;`/BWT&A;$P99<1"]PRE;'OUTZT'=O^(^M8Q_0%
MJQ$-ZTNT/5BS>(`'>G"O07#7KP`9+G$4JO`(`0M)V2T//:D#YK(,)$#=^9?;
M0Z5*ZG<9ZJT-I)`4RVW?M^`=%'(6U,G(`!"N)>,KG!-,=:1]6N$8RM*@V`27
MXFF,JLS@S-8%D'$6G>&R\:`!L;<979$9#BZ7T=!`!KY"ZBD3H1;A:Z$92GD/
M"<5T$@"9Z#<-8%1'HK893,86V>3>$+%^]RV];#%Q#)H7<P%2AH$"/7`?^7$-
MQ\%U\;%D^G,->!86&',S\3$D1=(;`KX!_:8>-U)_+AN_!H0C"!`#6EQV^>E;
M%A`!9/(D&R!IYV'E_4;2G^D;G<".TN'^)P-LG1%$`%<2``D0`,#B+D1R<+C7
M;V4RQ.SX*`OP*997`!U2TO`Q`V/J+0I`+'@B0Q#S='*P'O+!7Z=J*8ZN"O0&
M(J+U8AS*,0=7XWEA`4V"8T']((XBU#INM<REWR"3+$VGTRWF=%Z<BF52>A],
M0S$P`2!BC%YQ!F:V<=!K*)>.&7^3A=V58%2R0PV0N@\@+WZARA=@,8/(*,6"
M)91R&,D.[7^S`:V2*LI^`%C0CT-C>U^$<M*.+ZL=[2Q.[4<&B-">8=T%<DA<
M*OO\(G>"O[8*?*=J@S(&*E]*;Y/1=&4C=7:R;RH@`0/@/.>5AMP>/`JP)C=3
M,0@"M7<!0[#^;K5NATA00'G/LV9L$K7G(3:"PPUCG"AZ4X]O7>S*Z!>_83.3
M(#`P,'`*Y`<]'`'I<A=J[N>F4RM(S.VFDVYV,CS&*!]=W+I($S`IT$#I9!Y7
M\B@9PB_^H67)830.)F]3X_19OR\F<2J)3">M0B<)%_`'DF2NC!W89(WQ%B35
MPFD07F;QB_+\!2K+<H/]X1HCGQZ;[/$??Q02$`H:0!?0%NRXCA];?D1)Q`!8
MZ!L)5&W#_N1_KW4BEQ<1,#4F40!?F])\8R("5P#R$BH$H#CIA)H#8"CI88T7
MX!Y/%'2_H3R<[_E=#/HF\?`!4D0WI)`.3P#L\2U8GR:D;UX63"S^F^_[P$\&
M0;+/0N(I5V$8OY->7*#V+'Y"V<!H!I``O0&K3O0W7Y&T),X$#S.0UEDI.!`B
M-24E7@@@GI(@5QSX)-O=0&%*+]$14H!4>PT%;\5)NF0%A0$"G_AU'NF5J:AM
M(]=UGV=F[;AQ<Y9O"2=Z.!M3)S.+>3*RV*?F@BT_K)$TMMF46K,JZ73+)7.O
MIFT5*XE*,]2'HVPK@RBD9T)!3&1MK'3H:;G)V*!U;6C0B1B.="A<R&@0';)1
M459:7F)F:FYR=GI^@H:*CI*6FIZBIJJNLFZ:F(C">LJR,D!DTE+FNG;N[H[D
M_N)J0APX<`J'1C#HMCH_0T=+3U-76U_^8X<F`U'Y?KYV7WI7P@9S-^N)`Y];
ME@^W:R8+R])NUS]O9^OO\_?[_P,,>(J>NG25,)C@@*%2D7<(R2UD5_!3#0V;
M&C;IH.&'I@X4RK!X$\X%))&4%%[*P`2=RAT2\0F,*7,FS9HV;V+J@(/$$(UM
M!)UADF2%$9U9$/S((.&#(5@6%G#XT0%#BHT\D;99TR3!%1DJVTSQ4E5&0I(B
M,EA4,(&9"0UQW!"AP.P#@@L-/K:UV`&NB`4#=EAD,$$!V)]$8E!8@`&J5"-G
M(\`QL6%A`@I,QS3^D,`"!26.-0)ZB',TZ=*F3Z.V=L!``0X'#EPX,(#"@PD-
M)"SX<%=&@@'^$30L("#AP0`+"@X0B''A@8,"!AZ(P#`@@8$.#Q#`GGZ@0P+D
M,19D@``A`_4$!#8\,-#`PP`%!"Q2:/!AP9W9$B!X.)#(``$+3XL+-A<&#!!@
MFW,19$!``6P),-R!&+S600/.W>(!`0M84``!&30PP0(;:"B!`MQ=,`%TS4E'
M'2,'W/+!!1`T9P`$'!"```0%1-"<`_(AL(%[-T+P``8.$.!#D05D<``"N:76
MI)-/0AEE:0=X`$$$"G`0`7[Z&0`9`Q5@^<%3,ES@@#$-6)`!80?\8,&.:3)Y
M00)T:0`!`P500)A:N;'Y004,['@;`A\P0,%S!5B@WP*.>(!A`^+^>:"`E1_H
M]X%X,L17@&T2S&77`0^@B4$##6!P`6'S9<"`!:(ZD$`"H,+95ZH7B/J`!(_B
M)^FH$"A@D04-9#"H`A04\$`!,?R*9JJ:W0*>JAGDMJ>L'<Y)WZ"JCEJ&E-MR
MVZVWWYYB@`8-7.G!K1L@A<`Q&P0@GXM(<0`H!*->$&P'K?DY*@:+B3!F909@
M@(!<FE&0@`?X>H#'8!H,2E\!0<HYGP7]`F"!;1HH$,%O!H@PKQ`')#;O6GTY
M,"^IHMZ56%^B[MM`JQ!8P,"^3"K`(07Q.7!K!`V@N\$!;L[U*[0$"[>>F/KR
M"^&\+"_F@0$%1Z68`W=P5_!\%6S0P)S^^8#;M==?@TT:=@8O4()Y&#Q0IB/T
MC="``!14H*26CC"@I'+B9<!A=/*!Y^IF\HW8@-U]5?!GI+IE8&@$'!!&JAX'
MM'"V!@4L"81YX6%'&P7'?#`!`C:.EX$#';P&':%XB]X!`B,ZD+>[P')0P+$/
MQ.>!>8Y`_D"+P=KUP8@/@"S"BZ$[X#3()4.`D)((>."``!7HGCP%`S3006X-
M7+"``<6[&[;WWX,?/C\]H@,.!52.-,XL\(Q$SB^\KF-0_/.T8P_7Y&#BBSSZ
MSQ]_^>(#,(`"'&`I*+`2>,"L?35IGD6X=C]]/'`5$20@!2MHP0MB,(,:W"`'
M.^B]"0($A![^'"$)2VC"$Z(PA2I<(0M;Z,(7PC"&,IPA#6MHPQOB,(<ZW"$/
M>^C#'P(QB$*D!CA((<(A(C&)2I32$16XQ"=",8K<^L,K_#"$/0AA+U?@R!^N
M()F$(.&*.A%!5,@H!RFB,8UJW`>[X$,`#!```,<Z``#JZ)XZ#B`&&0!```!`
MI=E\`)![A`X"`#"#/A[2`@*(R!H;Z<A'JJ)8=&%``GB4&PH`8",!B$"I3("!
MBED@DW!,`)/VR"8!!*!SLLL#`"X0@(4T$9*RG&4:*;`A`61@D98B0!,,Z8$`
M!$```Z`!``8`@+DH```VP(``&*"`!0C`=JX:5``NH$M:8C.;VK3^$'8^4(!C
M5.Z3A^3D!3P)2@`H(0*\]*0`(""C`6A@``(0)KNL:<`#:C.?^D1C`P"0APL8
MTP`MP$``9B``/@I`CWSTHPG4.0)F!@R@$N#E!X13'&,>4W[[W"A'@ZB3<EQ1
M$&2\@@VZR`<9<$00:X@*$_8BABO@LZ,RG6D.RQ'+6#3I?C?5@P.-*$&:`K6'
M!'G)1)Q8CYVBXA<37.I`0('4]4$UJ%*UX`66J:U$7)4*@8B@+!SS4%DTA'Y.
M):HG.&"1CI@D'1C1!`;,2L8X4`$2AT#')K[B/WFX(")KS5\WTDI6C4XUL-UR
MCA3\^0$,]*1YD#DK$!!2)Z;TA"^)>`O^)$C``:P(`@$P6(C5B@"+'&1%""=`
MP1^0H)&$_$`2/XA*0F#1E3#L@00JRXME*^L1)AEE*)W-BE$4(0()B.@Q8(%%
M7>X"VJZD0;0DJ"Q**B.%RN)`,EI8@A@="YG;ZD$108#$#TA;E$&Y-0@V"$0:
MMJ`&KPHVO4ZB#@<F2@%3$>`""*@DKUHD@NXHP`(/R(#L'&`L&44G.!)HSL/H
MXAT98(<`'+A.`HC4J`-`Y@-3\UT%-,2AEA''$=+97@8"`(&)'D!-,:.=9DR0
MH0)L0`()0-*%3BP@`@WX0/Q=D`@(%#--W2AF!&NGD@I0`1DP@$`F>!&!*^2;
M_R+(`)"KL>S^'&$>!VR@1D#:0'`0)#M@&0`!9]VP?!SP.?W.N%,1FM#V%N`!
MVKBS>C[@S\T&4``)7/9G(F!>(TS4``"K-\^H40#V/#2!7Q7(!YBT##<>H(`-
MV`5[B8Z5B^X,J@J(2DV4:A.?-F`G/#4@GL:23*%`52J7M6S"8B),9=94)0G$
M<R_T<=<"?ERE!A#@?/,I59S,!"L.*9IF%M```8`7GZ&IA3#5N8\(U!*T-PUM
M/N-:U:@44,EB7\`NDD:`FIJ%`=$]!WN_:E4"&*`EX]#)3D_;4;29M`!GSPO2
M#4A;`RIL++E`2E*YDD`!!-<Q!]B"`?3>M)[[39IA(0!7QB[7K:K^%]<('*`"
MH[H9TLRM.Z1EFGGXDF]^#"7?BPW@5K"```#BQ7!2V:;=PM.LP'(CKMMDR!$<
M?\,")F#6`@3,:O3)$\E,UK*4F1L#\;R/PJ'EM(%1Z5*^\U"_&E[L"R<Z`1#(
MPWQNQ@"&.4T##%N:RTQ&`=N\3`)PLP#S0`:P`TQ@1S<[%24A\*=],>!>ZR$`
MQ+R=Z8QE.@$3P/$*?K8CZ6C<WWJW2=D$=G4(=*=V=I@`!"BP%-T8@`%ELITQ
M0N<NSX'.=?,9'*$,D`"&*:`N!O"`X"R3$(Z!J#7$8A$$''%8`AA@`GJS``%Z
MQ8"AN<:UK-D`)7_&C`THF7.>@_!^4Z?^9--A3S<)UX!`E92`"AR#,!,XO*K0
M-SS)GXYXJON0""9T`(NX30(=,,"XS:ZD!S"^>@>@_ND-H/W55>8!V__4"E;7
M@=:-BU`3BT"7.&#FWB0.]1-S-J,HM8&2"1^A[=T`SL11-0-:``,LW(<"0$<P
M*%7YN(-!>``#F,Y0<4/VR(\[S``%IL,6;`%=D87[L,\K])3_F&`(F@"&I(\&
MFL`"-B`X8"`)=H,!YL\]7(H,UB`!ZF"WI`I^%-5?\54;&-PF;("KF6!"#&$\
M@*!`R`+64(0MC,0&".!?12#^6$*I[&`6GL8]W,/_P$,7CF#_'"%/G6`9&M4,
M6J$$GH,'DB'^8*FA!'X@0111`II#%:)A+P3A`Q+5'+JA%OKA-90-*VC`X8F*
M)4`%'@)7"%Y">RW?;QT>%3!`"^A7"#K..CP``1R`P9""!/A5)DPB-]C2?&65
M(7*$^O5%2L$#L00BJ.@!`C!#!P"2)R2B.3S`Q"#`4@!+'_[A+E[#ZF`)<!3*
M4E"`!<2-Z6D`);65I/@,!#S6K^3!`G3;!T@`;'S`E52'",Q=6RV`Z4#`AP`>
M=S3"CY7>`@3)`I@9"0#>H-#%H`B.#5R*"CX3>S0+`\"""MK"8*#'DK7C94''
M!%02Y]6%!"R'.;I(MYW5D.&(Q!2#.T)'?%A``F``L3B"B$"'B"#^P(`$B;DH
M0`$$0;==@.J8S@C`R$+$AGR8`&N("0`8$`)`QP-\2'K@P*M(P7%(@.WTX[,=
MC0:,WV5Y@*%1``3`0$CRXE!.@X^1RW((P)58#[%<AR<ARL\<"QYDS(C8P@-8
M);YQP``\0`)D@`&PGAYY)53:`)Y,@'H@#^%%B@3TR%]L!E,P(.<\RD/>P0HH
M0,+HQE5BR%9*2HTI'9*`S&`,1IYT1B4=0,`4"D`ESUW`W+!`)2S)`%EV@+X!
M'#8*P-GH"U1R0#?V!U16F(\4(P$DC#^*B.#TWWQLY4+\R0A`8P9$@%363<P%
M)@80IFP6S&@6IBM.P)!UB.Y`BZ5]SH?^;8XN$N5PG@+S`)=_M5S!28>A*4=N
MR!TS4$D$`)?+E,G)\(Q6T@<S8(6_V(8>&,S<K5OA34`$-(ITVN6BM,$":$G'
M3`#A44K;K)OOW!R'N*+I,$"'+,2@6$FDK">E.)-EQ*=L9LU@$(H_SH?IM<&<
M=,Z';4G'W,*VS8QF7-QS#ATS&!NEJ(X':,PS#0L5J-R#YH8)#,NCV`J')H:&
MML@!_&==;NBY40#GA>0"A%@Q4$#`J%BD<"5QZJ@S!%TW-L=2O-+!/$ITM$<C
MY`8#(`#,_5(&V(6AJ*B0`F4!^$4,Q,Z2C(D):!8&U)L%X$;<.-MZ*LK$4%D$
M*&@W3LX!F&3^Y]2%-,K.GT3`^3B`Z:$GEA9!`1@#?_W,=4!9`]Q)]GR*`Q#H
MHCC3AES`674'G^H<Y;@+O44`IEG`P:R.EEXB\6WDP%";`?A%3ZX8;522&Y@>
MGR:`(URI9O"7E0Q'@_5`G2*`?G6JEQ7(5C8`!_`I:%8?1U*``&S`!*!I`;#I
M82'HC@)K*2P$#K078C&%9,!9O^07#+S!!$1$"S1$!10J4R2K!G2&:]7D6CV$
M4OS!Q`RCU`U4$W17#4P,4TP,!C!=&CQJOYPK:@J@2T2')S$=NIK`!#B"!OR&
MG^0F"RS$#G"&`62`LZ8!JCT$O2:"X4V,2Z08LM2H%'2&(@QKPT;^9`(LA4!^
MP,T`@<"2@$@LA`5$10O\V6'):[TR2HW^@+U*0;Y*QL2<F0D,HQ*$W<5.8;#2
M;#048A,]U5@))T[%PJ$JXA*N@N",R!TBPS5\Y<_6;-)J`V"I#].R`U[Q0LZ>
MX0^"H!TZ$1#NX3NTX4KHX0^:PQN"[1JNPP<J;=F6%5IX%2&PCRZ2K1?P!!.$
ME-N>`5IP1&-8A=GB+7%F(C3:P)R:X1N:P`W^%JTJ0'`%C%/DD9\(P+NLCI@L
MKGPU;MY*+B\69ADAW(;,W?41BP38`8=,X`44B8N$[@6PQN'5:P`L!9780EN2
M`/"4`/!P1)SV9)]\0-KL[.3BKGJ]!IK^WDO"4(W`/(SYW<8"#(>6W<;E'2^'
M5$C'B$AB_(``-.`(8!962-J<)86"YF[V$B!FN<9\&*C#/,#KC8KGR&:5E(N5
MU*70!>XMF,=WE*OT<@16Q$<K_L#\2JWVXB\DO48"((7@_`4$(,`;70=T\.D&
M#`";'LM$)7`!#$`><.,M4$``N*]!3&\+J(KTMH`*6D?^<G!ZN4'>S,!&=(`=
M(,EAF580K$!WW>U&S,#A04%6N*T+N``1R`)'H,$?='`.^YO@/&+3CJ$.`W'>
MWF\0$_'D#G$1(W$2*_$2,W$3._$30W$42_$44W$56_$58W$6:_$6<W$7>_$7
M@W$8B_$8DW'^&9OQ&:-Q&JOQ&K-Q&[OQ&\-Q',OQ'--Q'=OQ'>-Q'NOQ'O-Q
M'_OQ'P-R(`OR(!-R(1OR(2-R(BOR(C-R(SOR(T-R)$OR)%-R)5OR)6-R)FOR
M)G-R)WOR)X-R*(OR*)-R*9OR*:-R*JOR*K-R*[OR*\-R+,OR+--R+=OR+>-R
M+NOR+O-R+_OR+P-S,`OS,!-S,1OS,2-S,BOS,C-S,SOS,T-S-$OS-%-S-5OS
M-6-S-FOS-G-S-WOS-X-S.(OS.)-S.9OS.:-S.JOS.K-S.[OS.\-S/,OS/--S
M/=OS/>-S/NOS/O-S/_OS/P-T0`OT0!-T01OT02-T0BOT0C-T0SO^]$-#=$1+
M]$13=$5;]$5C=$9K]$9S=$=[]$>#=$B+]$B3=$F;]$FC=$JK]$JS=$N[]$O#
M=$S+]$S3=$W;]$WC=$[K]$[S=$_[]$\#=5`+]5`3=5$;]5$C=5(K]5(S=5,[
M]5-#=51+]513=55;]55C=59K]59S=5=[]5>#=5B+]5B3=5F;]5FC=5JK]5JS
M=5N[]5O#=5S+]4U;8-&:`E)]+2^D(=4"[5ZO[5U+PQ$O=3XPE1*:4&%_0TAS
MP*JDR6$QDA0000O0B@=$6[11M@64DR5T!72=@7^<P7(M@G\D`A7L"QGM6A<,
M!6;30N+HQ06LBA20MF,!`6-1=CGA<&7^)0*D\<0BM(%&^`<J<D`%Z!%F=X-G
M0_8B#,)KHX%CM`6M'"L560%P,P$&6,`!;8!_.$)PM\5GI=29N109N8%P>[2I
M#``"5`"O"(P>`&J^J)C<&4NQ6,``!)DY*`!A),<'-(B:UK<4SIH>W(&DJ(X>
M`%YE1`K@1:1N#*,Y,DE?+$"/3,"%`*4Z6DH"2,JII)@>Q`Y'8@#'8(4)&-IF
M\(L,+`7Z4GC_!<L",(,YIIX>!`R*TT5WZ0:OWJ4"5(!EF`@58%+R.6NF4<6A
MI8.*'I8"(.E*,$#BD0HI:2='"!UWH#BYB``%+,.0?[1F!3@':.)AY4;A$8:5
M6PJ(.FT#!-S^>F2/?'Q$TPV)$5YLU`0X">B'_=5B'W#I+;QY2-5![5I,BUP6
M&;6YI+R`X5'!I?"7J:344D!/LIF+I40`^8U`H1`*QF+`J3AVB?E`&C0`EEC`
M+5P!9W0/_%H*C?-,S#"6%##`)2W%%:6@G%J&JH1)EW=,1=('#(A''EP1)W*T
M9N7YBP,!ECB`!B@H\ZPG064B'T:?`94>\]B2W'$'^NC!W`E'?I#1H#3*FIK`
MG5B$K#K7"*S8L4R``/"N.N9YH[P*.=J7I4`'!G#*I)M`<[P1O[2PI:A8F^J!
M"HK'A,@,B\M.D@N/EG#N\D)`?\@/^9SWJ\1.B(Z`UEWPRW`#@:3^'IH@.OD)
MW:5P'9]VHZ4IG1G4.@P,BH04VFV0#@G(!\03O"%Z*Z\GP-O42ZAV`(QPSI.W
M0'Z=2IZG?"/L`?H>]^4!P5+8!;&U@;=G?/@2;XX*^"W42P0DU`CDIOVEI@S<
M@GA$(B7(^P6\5Z5$QT(4RB%:"FL4[BU$101X3BY@Q02H';ZR3;PC1_7$P&Y,
MNP%)3.T^NI*WR*7\I(V,2F6A?4=C1>&NYQ9H0"MIQGU`QZ5<`(XIP05PT=I;
M@,9L!04(00&XMC=!ALN2"Y+(2-H0K\;(YN0DCF94^@+P.F,-;X>`'3,^C)`0
M[X<9!RPB`8+IQ[5E9>J+1ZL$_G`PS*_^/*0#O.D(5`"U)<`(2]B"#\C<R<FC
M<(J(DJE.<H:E*+N+Y/=2X)L&4,4`&*-)=AODM%J\EVONDP>EQ.4TW@>$D`>)
M+,/<^8AE.&$AB]75^O74VC4>!N%?]\.Z;D`$_!@EK&M[S7_>D(#?*T'P/=1J
M$3ZF@$#F?5;%?9OTK1KT9-_D7EU4K5AT?=KG29R)!+-:41X1%&3)H<QJ-\[.
M,EIQ(I%.YT0M7AX0CF?YV&P@N\IR4OQ0@#R?I+/JN"P?]1+VN6`X$A0H(Q,]
M(Q80@CT<&%L?&((\/6X:%1%X7B=&<'H49TL=%Q$P%QRA;A*8%AMMK:ZOL+&R
ML[2UMK>XN;K^N[R]OJ]5O\+#M,'!O\?$RLNP-+S)S-'2R]#3UM?8V=K;W,0C
MI1X/$@4'#1X(!P:`!@6"AP<'[1!$#1CI&QX*!Q`K(Q#Q@AH8$,3`P`$*"=(U
M^)"`P`X(!?B]T/#`AP]X!22,XP>!G;L/:!XQP(`@@0<-,!S8,["@3<<"%CB0
M2_!(@8(_^C1<*&"`'P($;"P80+"C&ZQJ;8P5&8$TZ5*G1Y=6.99LJBL/3)GV
ML]H/6%,?5I5:;(65;%*E8K^.?0KL:JRR;,%VA:K6J-V[>/-&\\0@@P1^'S@@
ML`BD0P$Z/C@<@+%@QX$Q#F(("E,$B.`&_!)D$&1!`4,*(Q"Z:=G^N,$"#"VM
M#![]88$%T!Q,6GELH/,&"WUW)*!`A,''"1XVN$[=@4$'#1,:>%(PX82"UQX.
M0NBP(4E=O=BS:]_.O;OW[^!Y75A0,0*"0!X*1(#@H7F%R&T0L&+08.>']3P4
M1-"T`@B%"`S@L00$?U74V`KC@<0/;A:0MU`=$5&`&0D,_)5<&^-(<,X*N\&@
M0`4--&B(@A.HE-$$#18AWP>F/4!!7YPIM\`-X=5HXXTXYJCCCCD2<@!-Y@5B
MV'H>1"`$*_&=L,`$'1AP'S\C5(#`B!#(X$&`]_VE0&JN(>C9$B0XX$<Y%AE6
M90-)6/#`!`P\ULH!IJS&0`5$*$"!`P?^N=3F(QE14`$#%B%P@@,-/&#`!DV0
MT!('#0#*XZ.01BKII)1."MH##OSEPP:#$5+-BET^]L!"8'Q0Z@K`K5"J`AL(
MDL`-7;I!4P4MC>2J9R,(ML*?']C*(F`JGH!`*`YDT-)N*,F&*HL3H+9"!C0A
M$B('"U#0`9M!G$/!`JP,:Q=5<[5E$;CAK@756M5H)1=98KD5%U)<D6NNO%VI
M>VZY\\I"+C15F9NOO^C>2Y>_[;X5;K]4]5MNN@>[&]?"L^P;U;AFL<5OQ1<+
M''#$#5M\5L7_/CQ6%1>PLH`"0RV64$87Q,OB"0_08T\!'`CF@*-15M%!`LJY
M\4$&!X!$A`?^#>&QP(2"8%"1%8".<#0_H)UCR`@-G#"!`F5TH(`#%FA`3T6A
M>;`S!0<@4,`%=R:@@08)%/O'!\SIHT($"_@&<*5XYZWWWGSW[;<OUP4>*4H9
M%$XXX9IX4'@&AR\^"0J,+^XXXT5,;OCBB5\>^>%%H$2XYAD@>=+GH&>N^>>/
M;R!YY)MW+GGC&60.^^%5J/[ZZZY;CG@_K(.>.NNH4\X"Z)*;#KSC1=ANN>&N
MSUZX[*<S/[SGMS].?>_/\^X\X[6O3KKUT6/.>_C"0PY[Z\,?+[X/ZM.^@NK!
M(S]]^)IP<#OPS6./$F(=Z'XY4Z2[G?':ES_LA:X.Q/N?%=2W/L7^78]TB('?
M\@[H@_A]K@KV6QWPF*+!U2$F&QT(``!&2,(2.BH#)4PA``)0!0.HL(1.\H$(
M7SC"$])PA`)`C`MO&$,/S)"&-KPA"U>P0QKV\(<O#"(-A_B!(KXPAB&\(0"4
M^$(F.E&%1Y0B%55H12EF\89;3&$.5U``+_8#B2H,8PF[R,,S:O%94F2C$=T(
M1C@*L0IE;*,,W]@K*8[Q`WFD(1MB($4`$"&*=?Q9'%MH1D)*D0\,X",*I3C(
M0#Z1CC2$9!SI,,D;LN$ZR*#`!$9)2E(.H0X2**4J0;,K5992`C3R@"A=.8$W
M$.$#'4@E+6M9!0OHTI6P[,<L:7E*7.[^<I2L),$O59D*81ZSF-<Z9C(M\$Q,
MR/*9M\RE-*M0@6?&<IC`S.8R5]G+:CISE]`\YBC+B4YK@I.9V7SF-,WI@W>^
M4IS;;"4ZOXE-5*J3G<1T9S\?,4Y5`A28D]!`04U)A_:84@BFO&40_KDK78XS
MF#Q(Y3(MBI@++%0($@6F*2=!S5%>])L:-:DI-8&!A>IR!-I$Y^/^1M.:VO2F
M.*T1*'-:*:UD)5\^79=3?DHPBI4%7#_EBE2V`K&I!/4I087+4->%,'79ZZCU
M0BI5+^93>QEU7%REJEFZ"E2C:A4N1,WJR,[JU+%2K*A8?:M<PA(PHJ;UJW>-
MJE"A*M:I)M7^KT]=*EKWJE>IUFNM0[4J7"F6@0K0(12\X0"=*M`##50A`U0X
M26!.@$'.LD(#';#`T,IRF\Q>P`*EJ,!I&X&5#836L9IUK44PX(>8](`Z.AD:
M;Z2"`3HAZ)"G-<-D:X;:$6@`#[%%C''Q4+-!6!8%2*(@3Z=+W>I:][JM6<`!
M-C`!`BQ@'@D8``(HP`$`P&!;#:A/2\!4A0,`Z@).LE,"%.`H5>D#`AH8P-$T
MP``"'"`0-;,3`FS2`0+T"A,@.0`!&'"!:`4(`)&!P`(0L#1<(J"_%HA``A#0
MM0-,&`+AU8P&!$`3"I2$/0;&4FA*(@0&$*T#JXF-!Q3#'^S:6!C^?T47O=IB
MC(+1M18*>RLH>RRXD"V5J1P;&;Z*\2Z^*I7']TH+7Y<,LGG5Q;`]/FS!`,>&
M.VDJ6!^0@`+XX6(>7,`SI^(!`SRC`9CXAC$W\)367M25+I%7:Q5@A0(N,-X0
MC25%BE'4!P3%HL\FCS,V04%CZ`&:3K4&#RM20`:`XN<5@.H?9];5"-93H;O=
M^-,]`K6HP[/3MZA`.!,0@'LM?8+Z)$#3?3@;`JP39EJ53`(+J-9#H/0!!Q1@
MSQH(0-GH\!PW!)@"!&!.$!I`E*X`NAVF^<!V?W8R&.1*.3>A23XH4(`$/&#&
MCI[1H.=32V;O8`0K:H`#KK8`&(\E`:G^&;6\;;&!!#"``>-]@ZGP@&L%J,!8
MNXD%M;8DA@8HH&HKT/!"--*'^CC@$,!RA7D>CBK`4$`!"<`#:@+>EC,O(#*,
M2D`28"$F5>%!!N\S!V%.IH+QO$H6"&'`"?K2ZPPHK0CU\$$#/MB5+[QO")%A
M.`1LHK8&P.`!YWY%9VY"@BW!!R$+\``&%K*!A0P=XS5C@,AGX2)5"2*5Q=EZ
M+"ZNF??)'`7VQC<%+##?9AO\0<A@0P8JQ.M!;Z';`NB,%5+$WM8@8``/\%H$
M""!:9EED`ADH@-1;4@4[@_9#DRX%:LW;A@1QJ@\M(70/ZHW!YFQA,!U`^M3Y
MH:L5'(C08KK^P`4HSVI3A4&[[BY"W^=-^UAL0`$#&,"KM/Z!`?!#`@`@`!L&
MP)P!(`6%"B``30*`CJ!1(``0"``%,B``Q2Q$`&S(DUDF`'T!-&T``*##`@*P
M``%P%P`*``!R7X$!`0B@(LFW@`#XX`J!X'(`/0`_'3``@&!,(/AL`'SI1R.N
M@$(/0``+`0!!,P`40`$#8!&^%@.KX101\(`@80`3\(")5@`%8'`9(&P?0``C
MYPKE!0$-$#08$`#OQP,`\`#Z10'JIP$``$@=J``<((,*$``5Y@H;```%0$8!
M`#<+4%XY&'%/47X)$``]\```H`(:@'NZ)R$!T``)T#+,1WS#@";^!9`!$W``
M,B`L12((+](`0G`:7P(8&K`01#-]'$!XZN8FRX(0.R$#C"$@KC$M&W`V-S``
M1;$"*7)YN/&!*D``$M!@M?,1_@8!$>`U@-0RJ[$!"V8J(6(<@C``0R.)%A`B
M'5`!BA<1$"`@1EA[HO@4B08W@B(`*A""2=`!`Z`AAM4&*!0#`<`!2IB"@$1F
MGM$`)&8$"/`/L1`1**`"%1`/_)!H`E`!#AAF!M86I>A>6'$QU.<!\D<"[)`$
M*7@,(IAP!B8!R^@4"T`3$_"#`F!>[8!L2V$`W'A+))@`_2,!`U%]!^`9!/!M
M8C".B4=K3Q%L+5,6I?B-/-`!,(@`MEC^``_@"/SW"-7G%@_P=T1P``#P(MPR
M@RE88VV0:/[X(T[B-)[1&B;!"CXD`@*0=+UP!)LW(%S@`2T3&,#Q'Z:P`X4S
M/$;@##%1)<?P7!/@42Y`"IRU3J9``B;0!YQE!>?&7!B``8D0C!&`))N2/,'4
M7)`@C2Q`(%B12JT%E$M!E?@`E3+P`'CPDJ/XE:2XD9$D0H.4C7T`?J$X6P#0
M`%/D0P,0`"K@>R00-#U(:VR)8*Z0C55`'^[81_X59@]XC;&`<2S@0O7U"@3P
M)YYQ-'W)?^I"`(`Q>(_`1*V0:#*Q`0,0CP502Q:(`P`0;ZY08&*V!!6P0E,$
M2"/T&`(P8.K^<3?_%P"84(I;,@8:,'CN)0#1,4(_Z)@^=(FM@('W!D@_<F$]
MV`&]Z1:$"1'Y17V30)A]M$)8`0`[H)>E!I;6>9UW(9LT,0`CEXW'H4C65H`M
MZ(JJ%@"LD(T/L)C^5062B1396`F]9Q`SV%\K"`$&5@&XR8RX8ED^I`+5P&P.
M$9\.J3B4&8*I*)GXV2^)5@%.$@#PI7[)."X!H(Y7(6P(8`#(^(#S%8)0XD,/
M.D@DR`K_1VP;F6CH$(X6```"<(L6\8$SIH2O0(0#\(.$&$D.T(,O.E,5F8L)
M`'R1-'*RB2LR1`0,.`QH065;)C"OR"X30V4.8V1`5F4[!C"*A9W^HS@"VME[
MUB&7&S"A,DA_3^&8_0``&J!=#-$2$=&#L?$@DLF,PQ*/.,@`^)=K*`0(?`B9
MGI8`-*&*_7DW*+2;Z">GC$.F6S`"@)=P?`B,X`(1K>$99`J#KX&;S>4!AN1I
M!'`V`(",*[JAOC=C'?"H``"BK6`!`7`M_<<0>\JH;9*!J,FB)Y""%H``H-D5
MP)=K!"":,GBCZB>K1:4`'"8`,],FJ2&;@R$&_=D`/T@">&FES-JL=Z%NJK(0
M`1<!')@$#\"!.]@*&F``4W$`EF4`&A`;!F`.1_,S!T`'HB$+"D`.L@0?#?`7
M"X$9.W&HL6`!'+@0W%8`L^H*WA8#\.'^`&%0`#]QKN/0FMQ&K\#``+\F!N":
M'JI'`.A@$M&AHT^Q)G"S`15`$X32&MV&`$#3`^UP-PO@$21PKZK"#FA38HJG
ML!?*`7F8;$BQ;AR"&ZXR'060;+(`$0Q(-"<P:2/@`/`!$0EP-H/&$XA!'Y[F
MK$J[M-\".`:S"T_FI-*PI$EFG52K"VW%M%J[M=7%,-%0G4/VM#BF,;E0G6(K
M,DD[MFCK#5S;MF[[MG`;MW([MW1;MW9[MWB;MWJ[MWS;MW[[MX`;N-0U.FM3
MN(9[N(B;N(J[N(S;N([[N)`;N9([N91;N99[N9B;N9J[N9S;N9[[N:`;NJ([
MNJ1;NH6KE-W^T`%%692JIWJT15M^$+NNZP>PR[JQ"[NW.[NM^[JT.[NX^[J\
MV[N^F[NXV[O%R[NV&[RW&[RL^[O$V[K&"[W(6[NRN[RR:[NY6[W(.[S.F[W,
MJ[O`Z[K4Z[S4N[O6F[WG^[OE&[W*J[WI:[[AZ[[AN[V[V[[3.[R^N[[WV[WQ
MF[SP>[T`#,#).[[_6[S$2\#YJ[L'_+SU6[T+C+[S*[[RB[[16\`(;+VU2[[X
MF[X7_+T=++S^J\$.3+\93+LBD+JK&SIFL,(LW,(N_,(P',,R/,,T7,,V?,,X
MG,,ZO,,\W,,^_,-`',1"/,1$7,1&?,1(G,1*O,2J4Y04>PT;4)3^J"NX5%S%
M5FPC)U&49ML+-@>F4%NUO;#%R`#&V2#&3RHN94O&9(L+9JS&3*8OME!DVX$P
MMQ!D:5ME9^S&>M'&:[RV;WRV;(Q+1<ESUZ`X&/#$5VQ=<07'21&>63D(2M&3
MN#3%4,97IH`/=8P!A1.UKZ`%=?`^M0,-C.!3A*QD24$'S>6DQOG)M+#*:>S*
M3AK%89O(5U&4%'D-74S+UK4!!F``(\AD76<`)=.C?7`EF'`@K1`K":*MO>R?
ML+`U($$WM_P6%&``0T/)8/&,?;!Y"D`'4X)NSQ48#74`1:$X!-@&U#%7O3(9
MO!8<4]%0,4$A<\4ODE8'TVP5DUK/5E#^#66*7)B,2Z6\*0WER7<%N!G@#-M@
M<XBLRS7%?UF97M(8$DBQ!/8*`9-6E`%P;P\PA.JV`#!`'Q[0&,)1-TZ!0@]M
M#HA0%*L7-(HXA+B@:0Z09K+')JB%`03PT>A'-/`V:!MZ)PU@,LQE&A^1/&!P
M`4*`DBEXT]7<;"Z`K\P69MPJ;0'P</PP"DX!?.J0`>E%H2L``1N@4&G8`,@!
M`(<2`^_*@^S`!H7R>\'I"D[P`!Q`7^:P($/]MX8\S5.KT`S-4R.`0@>QT2#6
M``.`U\_"'+VX!`K@`1B8:R9H&B8H84/7%PQP-(P'BV1]!-]U<(.]`@QP-0HE
M8=@L<(-Q`9'^X=*P"`&=S0JT%1A[^AB!D-BIA*_\T"6)($L\V(#ZH2%L0-OL
M81PM42Q^%AJLD"(LX@2P\&HLLC9P5P0ME90.H-R#]JH"B7"MT"I]4-JQ@=>G
M52&PC8Q_$=!]>]#@+0UZO=<\E8*,@0&8R3-)*QCRT287UQI:?0$90"A^,"J'
MK'MI6)3[FH(]<!KYQ=XC\&L(*`'2_-*#@0$NQHZMT`'5@@`CL-J"@6Y/DMB*
M*-95\F@Q@%^?A"&N(9`<WAHWH(B#1C0AO0$JE@<]<&8LP&$`,R4L8@$6$!G)
M,-DQGHGC]@CRL7.W_0A19Q+(;18(0"L1D-CXD0!IV;=WS0U%Z<7^YMW0I_H/
M]X8ELY``,V@`!*`K'W<:4U</4]>%]-$7)[C35H%"=``!%W9OF"`EFU$.=!/:
ML&`'NZ(2KQ`!&#!(9M`?;+`@OD0"-)`I_3$)R=&'R1,!_^$!F4($2A,*5,`/
M&.``@E`(+=I0$$`C<`(+:H`52U`-?H)+H)`'TY$'#!<NC##G1!#JK]"`.J`A
MIP4WRVK0"%W&Y?WD-W4M53`!!:G><-SJF^$!-Y`"%K`%MBP%89;KII`(7(U+
M&H(J!5D*"')N:Z<3?(RD?9S&UW"4<BRUW2!*5KSD"7W(M![N?!S.U=U0(Y(4
M'HE+%'D,%%#.8IL,Y(['N'3.NS+>3=K^!F_C%C.V`]S5[GX,BWQ0`BS`)%5L
MR/9.#;,>[C5E7"?@'PO=9$^!*#'0!%/S,;7<-::<Q[7`A>]#.2<!!VCC`X^%
M%;O%`XB'`KB$((*^KYN2[R\9'&OS"(-D/Y-P"CB@"2CR+`&?Y.C\U1X9SV)C
M-"WSQ$W0999%!XPXR<F^`J5($D50A59L<X0=#0FO\#0E@TD@:97&"W4)-UK]
MZK*`0M72#R,?&,]HG%<"YZ_@`*EQ`(12)(U";!71`:0"6GDB(0P0Q2VA`K$-
M`\3=X!&!KYC2-3P3=1N]`FZ_<Z%7*O`Z*/OWKC!0'&A+"'(-$B^B.*8Q=4Y`
MZ$OAR4>0E'/^%P$588+&P8/K<0*Q81'(3,7BS0T'_?!6GS<&1Q,>O?5I//OR
M;?MPS'\[@":^(0'`RF<C(;#Z<9H[E2J#8>`/MPH^,$BC!!C6_=.,XRPJ4`+?
M)<_)H"M]$7@4@1R^(:+H%H879Y0RH30P,/-5@ABI(@O2$NQKY['&L@*ZZ,QM
M\2)P74NMT2N<;Q$5D)Z"`&L@L%R?]YDGFJHKV[HO',LSG7H9QM7[Z6&8AB<<
M$HO&(S*I[!4R!0XCT["0>)[F,SJE90`(BD?P/)0.CP-C\"E0%CK:I.R)2!X4
MB,XS,6T(H\\&Q0>$1`3&!P,&Q,>!!<.BQ4(5"L?!AT)&H82$QL3^`L7&AT0)
M@@?$!,8"1H-'@E200TF%XIYHR<?%6\J%Q-1&@<8!CN2'"(0@2PFHB47#!4,Q
MU0I$A]0'!T+5@O12M_>W4$8NN`I.$#EZNOHZ.TV)!8'"P$.#%/>.Q8`\O;U,
M"0:`$AS$="##R`$%"00^$)B@(!2-<U0R:/`@(0Z)<Q\H=##A`2*%"#HH4`B2
MH4*%(!O^V*`RCN2U#1@VE*CX@8J&#+@FZ-PP`<R'!Z$\5/BS85$)""-NG=B@
M8>8'#"@[</ASH4,'9"TV='PGH>,X%1ZD7?`P]D38=FK7[KB!H>,Z<VSGTJUK
M-P:#"+@,+-#@@*4[1(LN'%B0X>\D&%W^"DA@$(E"`P$8'"#X.P!!M@7$9%#5
MY;$'Z-!,`[M@:M;CK=$VKFD]80'B![@K5,\^T0$V']HH;G'P+/HN\-VA$YL>
M7KPM#MGHW&H,[OPY]"4=;DTWJYNSQ^DDKK>@2I7$=`YFN4;RT-5WZ6,64L>H
M4,L"3^/'20A2K;O#H0\.=+$_H>'!-0I\METR+&Q0P6?V!071:;PD-LDM&S20
MWVX-F*!`'@]&M^$W.*`'CES?<,<AB6V5>"(,MW2B80P6F<`!!!L`Z,@>S5RP
M@0)3=##``!)L!%4*_U$3`0,-=!3!`HN@T,$Q%%AP`04(7%4`@A$`<`!-$NQG
MPP$!/%"0`HO^2.$C:!4LT``'%8#Q@P,/1.!!D3I!EH$'%"B@UU$F5'#*A<IY
M1,]3!11`X0D,`*!`*PE8*",$(Z)(A`4%('``I95:>BFFF5):@)(RB/.A-S=<
MH),5R\TG5FTOZ.:H<:FV,-J(K*KZ**U)*,#I1L!LP(`'%VB@P`4-V,F(*186
MF($%$-!#`2\:L$(F"A0XX,"3"V"%2WT''*+L!`"F,&PE'=2S33TI*,N!FXU:
MT(RPG>`823/8](;+'X2LMQ%N)6SB@8`PE8.`#@@<=8$#$QS#8JVE3@``PPT[
M_##$$3\,C:QN^4E.B"DF8``"&'B;3`*X.EK"`X2FL(EL%12P0"C^F:2XD4ZR
MDJ-,:TI()5S"M,HLUAZR/(&!@!I8<(`&QT!C"01(M?!`T@TX\`,#SHH"X0?=
M,@UT4\@(7(Q2T+HF226(3(!`T1HEU6@"%4B09@813*%!!1TL@&31'63SSU)%
M&8FO"A'LD4!42Z5@MPG91`"!`N[=D_,0_RS``.212SXYY94SD`##QGIZU3K,
MS5!0!MADH!-^HV'#R"'C=,#Y;:3C"%BO'?U2`5--(UI!S-7HH,$YJY.`0*.`
M'&)>Z("4M=L-.G#^`>\F0+4!!]-!KQWG3@V_@0.#-<=\;#K,]!$@IH422@?W
M0J[#!J0ROOX,A%"`KHP?'"[()DK-(TC^!E&X8#`=$/`.(`0:T"FT'`X(`!)(
MO1H%HX.93D?0>(#0W(:;J@F"%8_PU1UFPH"G#:(0<#K!*IA!DA(XX&(>H,<(
M1C>;!NR!5R0I6LG8MZ$N`(!B+?(0.W"@OA@@8#H%B)1?[L"4#A1@`D:"@#Z"
M8J9?(:``$J+``0#S@'A4+0`)&$H'6Y$!`D`#`Y**FK`J(*->9&``!L"`!PY`
M``MH@``($!9":E$")R"``9L0B03:<`%XD"$!!S"`!13P1PML8FU?0(#:)+"`
M7MRA.60XQ04&D``*'$T7%Q#0`>0V@$85@`!@8(#:9"C*TIRF!*EASS.0IZI5
MD69`IYD-;5[^^2I6$D@%$X#+:310LQY43"P[&V6!:EE*U$#(E%4P)D!JB#"Q
MX'`=/]C>"WI(.`9$R1%!$`BG$@$X$5!2`$\$1&8$%[9M?`!@GX&`7BQQ`;`9
M!`*?0.<B.D).='J@AZ7X"`$F20DRI!$R@11//><0P`4@H!<$=8@1`VD1))GB
M(@-HP#F2T@MLZ.&-Y?3,)\9%+`D,)HH+^"4P0YH'8RHH-B9#HZN&P\ON*48C
MZ+F.+'OPEF6^"(LFL$GC0HHB&D)C!LGI7,9XB!5+9#1V)S@=`B*A`1$\`1-;
M:$4P6`)5!03!G%5(&@4`9R9PZJE14G&&)!:P!\@\@W#,VU,!*)'^#43D!`H6
M>("-A,4`!12T`73M5DXV4`I"@!4"&+B``?32E(=>0A%%\@`!<#D(`,R$JH`+
M(/-X=2^=AM0#XB'!9:T3FWM9EC>>-8%?24"3C?1,!=\QBY]*(*Q!*,VR*QB:
M1Q"$V<^F``.3=6TQ!'NM4H*4LI3E*1?2DHZ@PH`!6'D@12+PL=\5P`$;V>0@
M/'&4_%#``*Z(%G01H1P*K"P('KN&L8A"K4$48`04\$,Q@/'!#T@!)90P5B=B
ML8$$`*Z-DGC`LB#@`,=P0$OBJA,H#I!4@Y4D!8U@+Q<[D``))$`Y&`!<4`:`
M/\;<A!"^!28&#K#::7$B1Y*8:U0T+`C^(_J(Q"1P;E#XQ('-H$`*$'U`CB9X
M@0`,(`/53<"V5IN"TQ5#0!EF8=4<(%@4I"(*3)H0:W'AM#TE[9:ONC"430#<
MBOTT+D`PPLY`VEN5^B-6O8VI+T]6"AML><M1=LXZ$4$!`%&32&*L&BX^;`$<
M4PO'O.(`,DY!*HR`!J)%<X8U4C#/-PE+!)H[ZEJG%@E$S'D5LBF!KU:AK#LD
M.6K."I8=SJSI%4QY<Z#JA@^N;**7"4=!9H8ISE*=4RRO0`+#&S67-_VH=T@B
M;:S81AO>[*,TITU@#[B`P%BQ`1_A.955H\T4[C"A5%!M`0BBIP(\X1<5\!C.
MO,ZJA/RTQS7^,RU929["GBS0)N="3]:;3F9/;SA3*T,S&9@Y0%4(L(@F#A`0
M>Q`7#/;5@P3<DZ[<<=FIS"WP"Z^H416H!P<PP!/E,<]'ZJ+#!RH`\?7"1R<<
M0/'@DE:U#?A$!1Y;'146,8$([))):&'>'A[N-3XTX$T64<I-J,"D1NF2`CIQ
M[\"AW.D4-3,=GHL!1:>#8Q$`[HR3B`"\14<ZE*)@=F891R5T$'7C,4\@0G,=
MYWBG@PZTNT1FSCG88S"J%%A@AV$_N\[8R[!TQZ#*ZB!N=PH0`0N<CIH'F`"6
M]BT`:OP0&'8(7A4F$(`>0H"*%RV<>-18@5_O20(K&\0BJ<J`"1C^@+TK1SOF
M25125Y44MTTI0BQ;.:`GAW[TF0\I<'VZ/)_KD#,%L$/=HR0`YS(ES;%/:M12
M($VB4L&JV2`$O_">``&E&?A)&D6B3Z_\Y3._^<'9N:IZ/EQ?R8#'6H3H0Q*+
M@D`"@JB069V?S)F`7U7U#:4X>+`H$`!!W41`2>,7^M,*9N?3O_[VO[^)4N]I
MH(H:!AVP(7=Q!#0`F6UHV`<]0'(!7J&,1'89EPDXX`(`0P<@A(],!@5]T.5D
M0P8H#?[=!7M\'6C,'Q'T1P>6X/)!7VFXW7#U7T[UTG!-`=N9H`S.(`UFWARM
M'1>L&^N-W7.,3`P0TL748#N<T.,PP)G^!.$,>(`#%&&1?%J+/$`1'J$03J&L
MH>"K?$H.L2`5;J$M"<"Z%(4@$0$%>*$%@*$EF-D$D*$9<B$;_A8.JAX2@AK<
M558;LD,)*("`W`)`E-DE",@)=`$?XN$D[&$=%B+[6&$R2!\ZM)XA;N$=YN$_
M!$`@0F)4!,00".)I8(`DTE0C=J)S("(+*"(Y/),G;N'PM9@E"L$IZF$`Q&%I
M]"$J@F`ISN(HON$-K=YRS"$MWM\C#F(KEHH@@M`F"@$F.D\J[B(RW@4H<IIP
M+:(6ALI:R&(RJ@`F_L,Q[D`U5N(D$H@F2N,T?F/^V2+/Z>`*=ETP@:/`E<`"
M^*$Q?ETQ1L7^,/+`.Q(B.M;CVXFC8I#CS)#B#%P`8+1`LB"((LQ'"92;E'7%
M:JA4G4B#*1F"*9G,=9@,.G:!`F@&`PC`H05&!@2`9CP.1G+BL01`17ID1MJC
M22K!#2H3E34CQCQC"Y31Y:T`G_&-Y\&%OU2#*;V!>9B63<XD(-@<@CC%=KS!
MM8`'"<2(">Q69\6&-]I?E-!7'<DB%$$EKQ3!4_(;*YRD5GJ#_K4=+LZ,+JZ&
M0^@%=^@+]45<*&"`S=V$JPW"EF3`E]Q$0HA"'BU)0FS+`W@&GAW;7*X"*!!%
MW'3`!-S2B@E"5D0`15`3!V3`!/SC5CXF9.K4,MJ`*(*(2]:&QL'^`,F1ROMT
MP*_%B"!X#X5TIB"``AC,Y#)4H.#P`?V8Q1X$@@E0P&`^">D<&]],`&Q&!2?L
M(@F"'DB21E-N!TD))X%\(&]1C68-TS$=IW&:DC$MIW,B)W,FR'1"9W%29W0V
MYW5:IW(ZIW>:GB.JG3+YE#Z"@UN8W0MHG*.@9O1$P`;0G2"DSJN]SUZ.RFD:
M4VH&3@K`9ASHP4_&IC^FB7CHQ"CP34G4QPV\260"4PD82@!(#(1&J(1.*(56
MJ(5>*(9F*(:B)Q5.YFY@85R<I0P<C@G$)0M<!$>@I5P>@@4X"2!<A"SH@)J<
MYD8P!9XQ2U28#+I40!Z\IFSI`6D6&"'^H1%)A`XRI,E7+&A(34`"K.-(5B0>
M=J23:@:4CB25/NF4=F24KF.67BF5=FF65JF4;JF8:BF6;JF7<BF:ABF8DFF;
MGJF5LBF:/NE#%"(-E:0+J"!87F8R\(8+<)U-I$9$:81!EE*@:@@'P`9M<,5O
MO,@;S$M&=`0'1-11!:>27BJFWJ-*JIL3+D%8S@QTR(RE9BI;1"?5G*JI]D>J
MNI(PL>HKJ6JK2B>K+N>LKJJLHFJL&F>MYNIOSN`&K&,MJ)LKHN2G"H')%1B+
M1(!RP$I"DJJS/JLA5F:'B&@2>```!(O,?>?JF))VX-9'F-)H0:NXCNOIB6">
M?F5+FF/C!$#^`TS(&,8"&O3%K9@%`N!=?]7E)E@`DRS>J)*KO_ZK3KE%IU9K
ML?(`!R3`%"D4*.%A%)734(E-%`%+%+G"`=S)L`(LQF:LN8'HV_'I$.!(!0``
M]WU"14H)(SSL)[@!$"1`PJT.!`@`AVJLS,XLE%D,._Q`S!+!P:Y!)V"D@EW.
M"$@3X"3"!1C134Q`"3D&!-$LTS:M;]FL.OR<=!#(:%5'='9%049(5VC`Q3JM
MUWXMB4@K5WKL$609V)XMVHH2Q^8BV::MV[YM_4%MQZHKW-:MW9Z>.'0M$H@#
MW=ZMW_ZMK`ELY_`CX!:NX0:NV'9#P1XNXS9NSNAING((F/5K<%#^+JD%K-?E
MC.7ZIBAM;HO(T-KN:=\Z+NG"6NF:)^2""+6JRO)<EH&DU`O86`HAPRQ@%C!M
M*_-,U@HPZFY`1/2<XPJD1#*@S]?QKCH`R8UL1?B\KJE=PZI,4(MQ:%E>@]XJ
MP4I4:@O\5=FN;M.Y*)XAY(M\8*P-X?)`"1(&05'6`/A`;VS1SJST:F[L:?4:
MP>(R@VVI5H8(QTS2TNCI"]>2P-JP%Y[4QX.0(+,"QUC\E6`BR](,F4>0B?:.
M+]6(45VJ@(2L5\#UKW]X+I%)A0]<0-S,AH\L0W'X9ZPAJPT$ZRY00.W.WZNB
MP`6\VCIP@`7\``F@"0O\P),0!\YD,+/^2`#[;L0XZ$%^W`(*/T<-(PBR:(=,
MZB=!@N=_%BBU`3&"QMH!M\`RP.\.)"Y*$NX+=%P-<X!(M`"?%:T./(`$A)P$
ME(5+>,;:G`8)[\'%X:9<LM<#T'%"C(![P24=WX5MP8QK)L-%,,\Q](H"4(''
M@(%@QL%1K`E6`,9?LN__]<).A(*]1-Q-6)Y.9().*,+\-HZ/Z))Y.)E8C,($
M)%P<H$M\H''J*#(:T\DCF)`*H\`H3*H>,'(A)PL8<$!CQL::220Z%-BNE=!L
M](QEQ8<&X.O!^(2R\O(.^6=N"H?-Z2&+O@^<4`-;'L(FY&PZP&;9*<*GK<T7
M*O$=3VHY-\_^/?C$'.@&;(Y"&<;&*8A'//-R$!3"+H$&1Q#8M'XR$=0O;/HC
MW[``1GS$M'U%"2AK1]R23Q+"'\3QBVX$"[-P!Y")&-E6BTZ%C_#S$N`-W]0P
M"PC-FOS5"-1"#,<P&""+2(].#!-*G>"P:O@$?-S&?XB"=L0!*+QF?RWOF_G<
M:PK"!2CH"@C+,;B:PVW'(J@)*NA%/*DHSPCT+<0!2O_5Z%#!1\"(*.]P.Q38
M!`B-\/*,*6Q@T70<[@BOBX@$!&P@?_0TB]R!^\;P(%S9,FBOLGZ%`ZO%/U.$
M6D)O4A"8'NBKCWQ$S^`9;/*&`U0`QNU8`ZP-24R%:69%("#F`Q#^Q36Y`$>0
MM1SF0!9R<]/5R"%DL4R:$@4H@FV.=B90]0F@YE"HM6RB!/0@`T=418N"PEX&
MA_:><L)IR#M$@`/D!%Y/352,CHV9A<WU]F".1A#DM`6/6`?,@LC=PBB4!((D
MJB",EF?/3"CSZ$?<LW^V:&..M$?4B&P"=&E5]S6(QRR?MF4%=YV,3DYHP!_\
ME0386([:X48$@9/TPGD#\$\:0CX#PI,,Q0A/%U`\,//LDC+`A@WW5V>GI7GI
M$IS-!1ACMO;2QAXP)I3$#3)$LVSB!G^R,U"0A&SK:]Q@N%_MP4[/AGV73Q`?
M0>A&K@Q8](&W0`2,2E8HW&C/I!NDP(S^SY1#8P\(T_!K9,5-74`A,PM7$+`'
MK@L:U4,0(\4:C\XA3`"/8@"4B\,WJ[3\0,L[/,D(F`Q_UGB).?=;U3@8,(MK
MK[BG[G$%L)$(UW=1:/,)_`5',$N45T&+_H%`,,L(+&9B8$`>/<4>Z1!P_T$-
MX^8/A-80KCEG!C&RO,9?(4@-@\)K,$.P?+#N1EQ">(]JD`1FN[4_0D)H9X6-
M984)S\4>4<&3O,^)LI=?V=QL#[:2[2?]`,($Y28-YP(-+[>NEQV4T"1[;;I:
M,G54!*?<LNWH@A!U<(?0K`=^2.I1V<;E"<WQ,'$>\$Y-Q`Q1X@#^Y$X/#L^Z
MM)L'G$/HH-;^-=".=?S#\)!['W>P:-F`LU>#L_\A^4S[\3`E.VC`&Z@0"VS=
M-?R!+LA$02Z%<O!@4Q0Q>G"<\QR"U>ZD\XP6E7/P"DQJ%3`QI\4,Y_0*Z:B(
M3X2"OJH`OO,!M>W1UG4%A92=?SO[P(+E+23OOF^'!M`$PS/\34"DU,5&:LF&
M"IF'SD\'6$@J4_@D"4`=4Z`Y<I0G.'CQYU:KJL/NYZ@)Q(\@J*U`!"_HT]N%
M;C`F,%.A@Z_%L8]MRN]MV_;`Q=-=,L2V["C6,5%O_+((0$U0[2U%N&IQU6\6
M>Y$$J'Q'O7/>CH%*GF=M@C0KX)O@W*N%HU"\$`Q^IK:XB(B#9F_^GP?/Q!&W
M6(S41!P"]&BOP-PY"&WH\%=HQ17WIAW6,*XCY0J,BEN++P_7UFH.SONP`M!K
M\.G&/N&G;H>$_7^J96/223+4PD":@HOZ.1700RA$P(R?15IP&Y([?E47#$VX
M*).<LN^'0D+0Q#$0/:N)MWAHM^7M>2_?`1C4R0@438I6@0VS@&"&#T=U>1KK
MYD1$ONR_O^IJM!7X<WS>02#P_7BWYPO1#W[DQUQ7#0ATD_>1%D59W\JR%Z-Q
MU$9YW&1U,R5NU:7IS2:MHO&(/&(N'QXED\P@.)\89)-1?2"8B":S9+*6+%*1
MXXA\)!T)[3.Y4-:WBB:)S^OW_+[_#QC^*#A(6&AXB)BHN'CH`4;%B`0&M;=!
M=('S<8&!Y$&T0L%Q<Z(Q=Y$!MC)"E"&A!=HA@[1!,J&18R%3D5/1P>MKL=%T
MJU,2V8*A,J'3D70A][$D\24&(>>!D:$AMH+!:5;4<4=1ZF$WEY&Y"5=Q[/X.
M'R\_3U]O?__GB`$I[WW'=\&",@L3^!7Q9"R4"((=*F2HH2$3D1$?%D`B$4J6
M!F$M'F;9@.L6A7TY>/"2D0QDL7@>!&)`Z`S5+@S+,HBQ:0$;*B9F+DC(("Q#
MLS(3'NKPX.0A#:-@(.!["C6JU*E4JUI=`68H2S#_^&0P@T'K$7X=/-B(]<$7
M1V\?J#3C("'^'`FW8E?<,EN6"E"\'LKZ_6"3;UUWV%88--(7L"-:B5=<$%;6
M;`L/S^YP`+=";=O-FC5'PWPUM.C1I$N;CF?S\#NNHI&JS@/ZM.S9M&O;OHV[
M=59ZK/'%GESO=^XDPLOT*3X\N?+ES'/OEH<-0]?FU*M;OXX]N_9`CBZ\/M9[
MN_CQY,N;/P_5YN!C^J:C?P\_OOSYY_5]CQ2>OO[]_/O[#_W(//I0L@=RB+UC
MX'^='"A5@@H^""%SW:T''A`17HAAAAIR5XB#1R!7G(=%I"9@?GE(%Q859L2F
M05@KK'@0"Y<!QT('%X"##4?B&&=,&21(]B*-"_9()(PP\HA9!\W^Q(89D!_2
MV!B38'#2P4OZ,(EDD$<&V>,&+G+9`@<$0AGDC&5\M6&:N6V9CW$;7,1F'I>Q
M*5D0)0BG#X7X65C@`@(D@$$">'1```(')$C"`BK\IFB0$A!`0#L1Z4&"`]Q$
M10($3@T)2"UQ@48"!@,HL$!%`W@Q``(,,(*1`)\>H8$!";Q"7$67*E!`7&KN
M2IH'"1S0`)%^5'`H$@$=4642&A1PQQ1$9F"0+7H\)X^)>2"@Y`$4.-4*1X8A
M\($"&&R@@`H6_-32!,&FD\"E&2C0#@4!,*#B%A)@@,"[3(#DP!PHD)`!!-JD
MRHD$"\1B0;_87-%EPCQX40(%$?2U0%S^$J!P`PI*0G#'Q0_$,@$#$U/P"0MQ
M/>/!`A.\(0$XI7PPL04*:.!!`07,P5`+%Y2J2:D*4+!J`?QL`$$#&FA0`0-0
M-!"L!1`XL((#P?HR,0<1Y+*%4QR<*]8V&)1JQ@81/";!!-Q.@`!/)10$+J]N
M7^4!`#FM06\K<R1X``"<8-``!`V)BXH&$#!P8P,/*"#`F$$R```1"3S0`&4,
M0##J!@LX=<H$#CS0"8G0^>/'%!T4X`$"%;1+KS$=#`!LN`\DT$8%!&B0P`(/
M!,I!VBTH\``"'BS;,@N:ENY!`Z5J(``$$0!=`005.""X!P9$GD$"AG.0?`02
M($!0"\AKJFC^`Q@P@,&]12>0P0('%!#R^D!3X`"^&C0@00,9T)^`]F/._$#S
MQC^P*F=A10&EX\#C%%`1!7!``PCX6I`P((`#3,"!":#```C`.6-@@`"#HP`'
M4;"`\(70`A4880,80(',,:!4FJI(`U(@+`3,P05`0P"V3*=`W;5``JL2UMM^
M>(\."*``SC/`!`X`@0!<RADJ"UH$"#`NXT%@`A00P`04L#VB&6`]'9B5H`A@
MO`8DX`I(]`2S7N@JW<5&/;R13NB4!"X4MFME,CI`12@@J/`UP`#S4T'N;&4,
M#MBQ40+,%!L,T+,/;$!0,%O`$EHHC$:U\(8L8,``@B4C1LKP"0G^F!.X-&6\
M!*A+`:+\V1,(*($($#`"$>!``:`8)'5QSG='G&6]/C`Y@2'P4!'`7+XHXIA.
M4J94"Z#``A"@!A>4JH(]7``8F.8-:#H0`9&B`*E6U<+<$:!D*V``U,`Q@00P
MH'8?:$`X`?DB3BQ@B4!L)ST\$(`YM'``ZJ/4%@BP@`%4#Y<68)K(J`@!7VU`
M519856PL((`&!``#!Z#)S0C03PS44`/]0B`#:'6F?;11<=?*EJTB(+8EI85]
M!.#`"A.P`:&AKP%:6$`#!O"-%2R``;[[@`!7H$J7?L`"I1HH5B*@E-H)B@$*
M$`<"+E>Z%5A@;(B44=L$5I#!%>`"JD3^@`86H``$\#"K)*,)[3P``0GP,%<"
MFUR/XN:4PV$14`,82BT`0(6CEBH"!PC"`\06I)V]2%5<8`"A1'H!!%BNA*!(
M0+OHE\H+&)8@%8@`TR)0`02V$`+G`ELWMBD&$F#1`@=`X#J9!M,>B9-9'ZB`
MB-R)6D+$C1,5(.+C-J4'">(+`@1P0*0.<+@IFJV`#BA`:U_#NZ\UX`!8?8`&
M@-4`!S!@N/>[8D4PR@)JH<:-?:@!4G9*BSA,IGZ<V(#XJD!%&W&$:*%H@7<Y
M45H8S6^&6XL8"S0@`;U\K"W?A9]99H@4'DP&OQ68X<72\@"<D2(@3RBMOP#S
ME2G&X%Y&`%3^"?H%AW^U8"5\$X8'`MR6GYAW49IP"DC@T!7%SJ"].'4*`S"\
M!36T(2?Y90);X#*W,12M'65`@4!VR@'R&@2LZ`5F:G\<"0_$%Q0P:-$>VF""
M']#5)@UPR-&^8H'[J2`",=VA7EPA@0=XXF,<N,(#M`R$=@3C0Y[;"G6!?(@0
M%@D?//6A,0CG9C3+^4%FH``"""@:Z<(#=!TZT)%P)"0A88E',0(3H`M=*T+_
M2%A-$K01:$$F!JT93)QB-'+*XFA"4SK06FJTI$\[YU`G6M/VE!'-XLPE/&7I
MK(;&@WW:Z!Y1RWK6M-Y5F>'1GEKK>M>\_D^>>,.G7@M[V,06SZO^YV&M8BM[
MV<RNC9X)D^QF2WO:U(X*&Y%]Y@+Q8=&(`'6UOYT<;X-;$,?N1S;&C>YTZT<P
MXCX(7C!MB+XHR=NW1E"TD?5"2DEL&7[8@(4!,Y1T4`A-.W*0@0HS80)=FJ-N
M<D-'*`L<?_OP-R2P4R?02^H/5:#*AY"X(CG2Y1IPNA!"40*HAE3P(Z`I'QC/
M#,.?5/(\Q)QHD)!XN^-<<:V\Y,@33,O+C2`"CI-Y!1YW=6@04``;(AVV@D"Z
MTHE8B/4]G>F4>K8[[@V<RSE3#W#YT6'X4H(9D?!%I^[``^9TIS(P3`9F4!+0
MM0)W$KB]+?](3"M>!"0S8?KN1C"3P&#^-(-;I.5'%G?K+>\$B9ZG94DV6-N*
MN/@B*EC@&>W0^^,-\Z.Y-T:#Z"6#)BZPDLC7"%3P+D/I7[1RMXK`+/R0C.;=
M^I#%OV@H#)N,#>0^%'@O</:`"5Y;?I28V[]H!NXVCD/,8(%O%!Y49*D1[XLT
M%`;[_/E.,MG<;.YVLU0?#G/#-%[.X+=HO,),QO&ZZ,$.G28,8-$:"("W`&%!
M]KN?0_$W1OO_7?4OF3G626C&.E'](I^`"=Q43NI`#EO0`/+5#!B@`*CP$C-D
M&,74%@Y0%.;0"V%"`:;5`10H%/WR%13`8!,0%QSP`+900G?P`&7S.RG4!!$P
M`D!S!^!`$RW^PP$2V`*A`!)F,P<D.`[3L%.AD`QVL`0S4#P!]8,<T`$OQ`DI
MJ`(@V(1-T`0'>`(W@!<TT$HW$`'B$&!O`D,4$&`=8`DQYAB=UWE?H2N.46#]
MI3@#"(4U0#\8E0'SI3VF,`%:)E%0D$JY(!!*4H(?Z#Q-D!-F5Q0=8(-C\$*T
ML`MEL2WM(()I,0&]`(.`,1)9(RDL*%$)&"3-4P.X@!00H%_KL`$/``7I0"OF
M4%XD,P[2XH1M^`$ER`0BTPQ.LP(EJ`(5D$J303]F`7%>6`,3H#T[EHM6V!#]
M(A9?XV(E*`HI@"-S4`%B4F!R<`?F!%WO\$1:LE``N"#56`9Z,PC^VO@BU]@'
M`8)M_)<$8H2-:Z-(1'"`)O,C7A(L;($1%D8$,I`%14`1/K`U!($"/1(+%X,0
MMJ".=/0I1$`#'`"):T,R1',!6A8*S1AZ+Q(7R0`'H,&+PV`,IR!X"T,0\-5D
M,=`\32`,&$!9:O`IGH`4];@RO;@&-2"2YR)R$TD#(P`2]>B$'&,31$=EF.%Y
MS]`-+X0C6!`L*/!^;[`#)NEC04)\+4,.<[`RM\,Y+9,!*/2(.I"/_B80$S"5
MH<"4H/$&38"5`>%O=T,$'6`--M`.%X8!6F8')7`[5Q`7Q)<05OD+S2@+ZQ`-
MG*!B/PF"]8@-BT(&!:&2+?.6WC(")CG^$C=RAJ`P7J8@!BA0%,:1E!XPDVI#
M%(XQ":X@,#=8"J$HDI*)`5#C>_3@C6G!C8+P*),1`%`@;J/9`:7I%:`';.1X
M!!;0-I1"D(S9`A3A"8)SEW%9`KJR+8=QC[T@$),W'1CP`P=)#O%"?(49%RIQ
MD`NQ,B#E+[Z0C$5RFVL`:'`)EYI`#57@$?OP0@ZP%(,9#4_`"9]@F#>YE`@A
M`T!0%!(%AB=P7]8U$@]8%*;%%B4@-@9AE_NYGT3!F^EB7J;P$/_X&Y&YE'"P
M`6[0#G$Q/TOP)GJ8"UL3$(]AD,40FD0W0RGP&`XY!R)@&-,@"V!%E!QQ!2K9
MG4T@"@*1H17^BIN:4#``QP)+@9Y5P!8MP@3M.1$(T9T4\8(W63+QR*$R"@HD
MHSB1B11DT"0"B`H><8'&$#`W<@4Y80M.<92X!C,$,!D`\'-&5XTKXII^0`)A
M^HTM!QOBR!)\M@<)("OOUPF?0$(B)QFZ>0)ST*`440'RZ!B<@QFV2!+%D(%#
M60&#V&1AX0`;)P,LB!`J,0=E(P,,\1!-J!:>P`8Z@S$3603<^6_GA@*<@`)W
M`%(3TU_M4#[^0@XP@12K:F-P8#::L(^A*C8\4`KD4*M8T#]O\HB]F18;^4#.
M@P7`F@HX<J>`<2Z340']%850DZ6*"0<324)0<P),,$7!H#%;TQ#^.O!?X86M
MS"A]1$=C.J`0FHB.E)%"0@:57;@6,!00F)@0GE@EZM*)Q`>@G"`'+]D6_943
M*/"!3X`4N^"J:C`1T?!?36`6ZI@N3@$.>UJD^YD"!9:)02&4-VD$$B,FV@`M
MCP@:?O6#+T%"/6H/$C``$^:EW3BRV_BE>2"R))NR(^(=L+9M.79JI>8()Q=Y
M8<,1@&8.'%6SQC`7<-H6S5"0BA0*/UM^BY9C=V(&IP9\=&<$,;!IDX9W::$C
M=:<Z\`:U8-AJ<L>T9@()6BM['T=T=X"<D&`G3H(617`T5/`%(G409@)IDV%Q
MD*9J/EL"3'MJMO`6*J)];0%IHJ"T/Q+^<U-K&%2P`5^P*"L"<O_`M&4PLQ;'
M`B,Q%$B(>80+)'%;(Y@&MIN+)I*Y:$M[$5I2)990?)V&=]L'#C;W&^(@&9*Q
M`74Q*7=[L^>X"&7*I65PC:!FNQ.6NVTRFO`D=,1A=>"1;8IP<))F>XHTC1D7
MM<F2%FCJ:FW';<UQ:'YP--AQ(]"QC\>@?PV2!YAP<_`0I>&K"!6P?E(J`$#;
M!^:[:!DP?X+`ONBKOIW3O?96O`ABL-&@)XY"92-7!!_F(#D#%\2A@@NA5.C5
M!E5!ONH&-]*6```@``$0````-83PP!$\P1DT"!<LP13\!VHZ7;))"`9)`BK1
M%DM5!3-DPAS^4+PC8`>I@*/=P`EB8AEE&0W[$A"8P<)$277>PX4U$!CQLP)9
MQL!%?!H+'&3%.7GDVQ+%R4Z=(A`7"@CU!FVGP"I/0`36D(7D\$T@M054I0-\
M8X]5P`515@J/<0L6<`L.P`5FAS19$&7>M1$'`3UM08!&\`QS\#*@J*Q(;,1_
MW&SA^VOCR`@D*#'/NJ`4T9Q(\3)'200:@$)`-69-D$K>@`*@YR]8>2\/Z2/6
M=<<8V*BFL(04X*Z`;,H8,KV-0+O;MLI&<&W[=\4-H9T[L`5$^I8R8'9%T#)R
M@`H@L1'9D`U><LD=,#$3%,S%D"1;J:J@L7I-8"-0L`YBHF5I<<K^U6S-Y`;"
M\#`)D5`^PL`$3&`WH4(%WVRL1I@07DQ%&#%#5`08_N`!RT,%[.R\(])*)2`&
MZP`.<:B*Z'6]]NP8?GS-`0UNY18/;-H@4;:\]H`*`LW0#;T(P\LJ6/=.O0K0
MK.+0%XW1>T#%5W>_&>W1'[TA@UPM'0W2)6W2_['106;0)\W2+3T?(AW"+BW3
M,XT>!&V_(DS3.:W3R@'1C"#1B%9J.XUN%=UM9!HA-JM:44MN/O+!L`D=VRS4
MU$'443W4V;P:P:8'S0P;%Y"L<0+4QMMMAP&X?B8G!@*X9MV.L*%HS*O41%<&
M^+=M#O&_F;&_E+$>WC:_41LB]U%I-6K^!F,MM31"E6E17H`=9!PQLT?`DVQ-
MU^&0UXK4V"^2L_%&%<.5``APV0G-!Y9M6-Q3")R=V4W-U\;[TRQP`(^CT<85
M(D^R:9Z6U$97I*D;NL<!DFM-=*/MK##1UK3]:;]9(],!(BN0B-O5#6H3&Q(`
MON<X:.BXV[!-M%_=W)K:%H>W!Q/4#-:M2*I1O9Q"<9^@<(]FSIEFI!,FFT)6
MW*J#TY2VW51Q`0(P+AM11;C]).W]WC(@`/)M+.Y]N#0@`/M[$#W]T"2-&-!2
MFZ[V">6#431!!:M(,BH05BI0/D!P!^9"8T@`@I?AB>^'%"I`EG148V>IB9RP
M$20H##307=O^NCR:4`73L2UZ+"TFKDAW1;30^R*3TPQ]"*N@@0F2]Q/DA8<]
M)P?-(%8T`T,W\,WEDA9<X(@R":\3AI5E(3(P<@%(GI8041`%JK^M`'J>N*.9
MH."4_!(N-LY8L8Z9X8F7D8&:<#'",';FX(E%<`+1L*<X0V/_4B55P@%8%.-L
M7@6O*RWFQ<[D@J<_L^>*Q&`W@(<ICA)%T%\D(`>'L51J`()H2`5?KJGG8J_E
M=0U;5F5D*>*>J)-4KC`\1MC9:W__Y31`/#;O[`D;(.90L;NX&[SV]+O@&`B_
M.Z;34K]5W+*YV4.P\9R/ZBV_HP&<TTJ9PP&9DQ<3$1#;<`)]#!S^Y"`"-_`&
M81.I.D"Z,A*I:"P0-.#-74XS;XDTIZ:5DST#!1F*YF`+H0+N6,*P0B8"&D!E
MR43F-B"D/K&/`74"$Z0&66@+0"699`D%1%#"C^H(4?8,ES("L;>BS/T,$N4%
M&OS<=MP$`Q@7K;0$T@PSQ`P'6HU3:ER@Y3`*/G$OSSYY8=DC&:BL'YF!'IHB
MW2K=9+`#1",XK?>6Z6D&P,06$T,S',.0Y+[N;TU5K3@NR'`CR4017.",OS/$
M@,$$$V,-8G(O_IA\_RO*/+DB`A@&SQTP@WN>2UJ)=,"#:^#Q3[&RK5NRIGF[
M<E>RJ\FE;6?K5?>RA%P@<]`HL)&==EG^`C^`I7<Y!Y9<\#+*-2@@UT=`?.10
M$N95JKZ`S':AKQ6:`^S<FZ;8J"=O&)(?N<EH$Q!`!84JPWO_R;E=`R.!W+3R
M8F3P[,FZ!C\8!TPPL%UP\#UWAF]0F".A#>A5"V9QRP?AI#2`W!#XW-Y@JAG8
M/400!A?0]ZR0"3B2"37Z"S;V$"/17S,`HTC)KTW@%"A`_;0PGQH*%MW%SK?C
M8Z&LG:KP_:N/A%Q`!)-<6MRD`\=J-6/"%I]`$62)!?NB"C<,DB::`5<##?`(
M`I^X4=^59=CGB=XDGNE'BIC$BA^F4OM<7C">QN:3D5A6N26SZ7Q"6Y\(8=D!
M9*)05F2P]&#^M4^N-W?-BG.92R?MUGI2FC?C<&C#7QZ*AL+)[=E\0%Q4=!!2
M=%"P[/5Y7#3,6%S,;?PM95AD;E@H2F%<]'08EN2`4F1P3KPPJ)BH:&1`<%A@
M5'#.L31<`'Y,4*!6''ELR!9=\,9"='C,]5KTN/A^]*C@<%!<=`9C4%24-&0D
M5D]/=-BL84S,35@4T4S&H/#F!&E3%WVU=Z"L!24M03).0X5N%5X0JM!'T`07
M+!9<,B4+AR1:&J"E`,8FVX:+%/2(H.6.PX1NHRYTM*#)`X2/U(2]$K'K0RT+
M%*EE@-E0Q$X=/+H]ZH9/A+*()$+IN!!!R0=L%R#P9(%,@J)['R3^-.6S"!36
M'BDP0'"5@\8)#?1:3##4CQ<-#C;$Z@B+04:C1!.&?8#X9B]?*E\"6.,KPB\@
M`'#[5@$$F"F<%!$%"TZ!QHT[-Y=&Y<OA]L\$E+XJ1\3\H0,>%#4"J['I@1D>
M-1H\K%[-)(.&-BG:;,!!6D2&/QXT-:5X@\FY(AXP<&#16P0SWG]H,/F=Y<_S
MLSG,CC#D@<-N"6QFT*/^04,N#+FSMME>@Q=IV4N0,;\9<A%L9K_E'V<Q*CEW
MSJ"7B]<!5M$)\04S?]"V&FFVN7+;;%ELD)L*IAF!QCEMB+9;<"MT$AUP36EF
M1GH=_M9&<J8\-EX&&!XVW@67G)@?>)K^L;"!(:,5N`$].^"'87U,8%.?;.Z1
MQX0Z66@H&B\K"@B9DV-,485NACWI%PY@M)@&%U*V$,8;CCTIV`[.A+F7?-3@
ML(@4EJ58IIM,P/0F,6^.4<*9=.+)EYIC3-!FGG\"&JB@@T97(6-W[N$GH4],
M4$9(`9!IIB^.-@7IDXTNP8&E=S81QW>+MB#'HK1],5XN;K!@$ZA.<+HF8[W`
M46JG@K7*:J&ROE&KJU#>N@6NL'ZAJQB(SEKLJ\)&@>RN>.JJ[*^KQNHLJ`4,
M8$`!!P2@0)G46HNMMM)^P>VUV?*UAJ*!BAKH:[X,QP]/P\7!`G?I%=C,"@YD
M<":XT/+;K[_^_P(<L,`#$PSJ!@X\\(`#RY1Y<,(([\O$!@HKS'"N#D*;[I^_
MJ"`!P_%,\?$D'#0`04.3)&$R50T`5+#++\,<L\PSTURSS0!C#.IQ&$2*IPW'
M6,-))#YP\(`%$9#PS<060/6"TQ'?'+744U-=M=7^,O+JDUE#76C69IK+K\9Y
M<B!+3!U$P`%6H(Q&U8MI^=%G"4_WU/75=^.=M]Y[\[WW&JTM&@?/Z@+3E`1K
M_V+X4A9(4%LV%9@@018EE`#6DCWWG;GFFW/>N>>!@YGQX(%2U!QL9C"B+^`M
MK/ZYZZ_#'KOLG.<,^ERD:[WL[+OSWKOOOU/MZ;F`KH$Y\,<CG[S^\LOG73NA
M@AO/O/334U^]]8`*/OR?8U_?O???@^^]X*T+"GWXYZ.?OOJSA[YJ\>O#'[_\
M\TO]M]BC:TF__OOSWS^M[=LN>OGS'P$+:$#XA4UT`HS.'^Q3(-KD:P.C.U/9
M\*`OW6A-/;I;`2.T1Y$K72DB5X+,!VU5K-.=$(/`TI<2.*4]8/&J5[F[U4U&
MV*N.Q"I9T2GA=9QAPRW\<%C/D@(_:G5!U)DPB3+,%2/(ET0>!NN`V',>H78P
M&2UT0``=:(4$!K"`O`@``1D@``(<`(4,,,")28E*I[*T!!H<1S!U<^.J*$*!
MS#CACBMX@9;X&(4"\6UB+QRBQ.S$!`W^K(,O.X%CG@Y!QUE!9P;&"9@TW&6W
MZ/A1BG0:'[3,IR4`0,`!$]#6`GB!`-(@(""KDX8)]+@$"!#A*A-XASE\D8Q?
MI.AHD.M,#0!BB_'@DB9)V(`"[)0-$4"#&'>!PFN:68$D=*`DP+PBA[*0K]<T
M@AH1H*8ZF,$`"+"@)7\02C3Y\(66S,&:/TA5*:#QAQZL(`CQ/$P@YLD$9`AA
M#]:$3:1$H@AI(G(.MF!+(EP`3VHD)PL:>`PV_H#(W'AE!K743$O:H!(1),RB
MBT"D'X0I,06\H&@72%7+0I)(1"ITF<U<S2QA<)@*R#.:19"I+Q8`H;31I*.V
M.(PZN/.+G@'^):>D2>=-@FJ#&T0@%Q08)@>:JHX2.,4$06`!/$G""PPHH*0K
M6*H)?G%)_@%P5/CS%0<*P(!BDC()"$A.M2)!$_SP$0(:`.<2+CJ(N0I(`TM1
MVWC`^9@3J,-P,WA`;S!@`0U88AF/4$D2<"I83>2D!Q+`XQ+&H0A40$-`V/B9
M%(`Q.<RL@Q>2S<Q%.-"T++!$`Y.]RPL>T($4/6`/))`&OE![@]1*`!6SS,`V
MCY/4Q_2F3[Q=3@XF``&Y1JA/<UD#4Y1B([F2IB'@W"8RU@$5"%B"JD7`2D_:
M5@Q%>$!RQY6`VO3Z1G`N5260L\!Z4>"'971`&^QE`DXW((%N9,+^KLZ!BF05
M@8$(C`(S"P5P3`!QW%G,DKSKB$`S0%*+NTY6$U"YC@74Y@'7XK%L@97K4FXP
M(.9HH!N<V`!4Q('06O0C!>8X#C"Z<5R"J$."+9Z"?/Q0D&ZJ49--2*#.N`<%
M#BQ``@"P0`(^P`!3HE)#K.(CY48HSVG<$0('V>,,(-<+/V"#RD:`RBU6D&5J
MK$(%=7N!'C_R&\HJ(1&=Z`0V2G"1%U4&$&FA1@<.6X(VJ'F2;,OS5G'2DB2`
M1,[4Z,,T2)P/^BR"`KF=+)A%X)(W,DT%4ZXL-!8::8,"S@?`J!$03"R."+BD
MNWH,!>1P0(,.T,`@E99R)FGPD3"OL<S^!'$TK"FRR`IK0P+2Q$$F8FL(0ZRY
MSG7FP$6P6^`6+#7*%6`P!([V`U.(.1!B_H1H"1V=4'#W*A_X!FI^\Q$98(4&
M#0E$/T)<`_*`XAL<I0H$.]:$<:/BD3J.#A4'Y>,G<"`!&P"`!AC0``:(X)0>
M,,!'+"J?0["@(=W50644+MLD2(.1]5B#G?0@CGCOP!-&6.Y54D%E9+19-&CN
M#(.S0?'X9D(TUYE8("8;-SIWF06.:$A!<O.T6_`BDRUX@'W19K843'C<9.89
M&SJ@6B&HEA=I$D=MDLX4;ZQ#&.:,P%*D$`H;J2F:B4JJ)MP!.7@-Q0,+P*,B
ML*%UE0`CT9S^."\)S&(:^"!#$=!Q>\_N\MI?Z^AV."#O#7X=X'$X-\'C['9:
M^E1AR-T1<MC80!M\0&9./(4ICGCY3?I`Z!=@10,+N`G3$T_B\5`N)1>GS8Y0
M8-B/A#@3QS']52S16=%;9]Y:L%_&*($JRG%@`[%$TR`:T`#.R,<81AA/C5^@
MS@W4TEY&=T*E5X"&BY!T-&1Z9D@DYWP8-"0WC/<%?I"R;/:T@_C;KRMJV0N;
MEKYF_+QAM`N2H$Z@Q,$)A7@.*D:3"-X0Q0CU7"/_`5&+QL<>>2S4MF$`GG%3
MLS6#J4F3KJD`\MG&&Z7'A"T!(N&&Y#1#,4@4X'C`,UD40#05,JW^6&;HEV;T
M5C-YE!747_HE8&X\PIVA0HT\Q@7FBX#,5$N9`(/-`((,'U?,!J-14R\5P?'I
MG!%4QI%4V5:IB4GDW@B\5NZ1QSM!"&D$X2PP0>$LH>P-2U@-RLXLT/($D0FT
M2D>ICU`8"6J4RL)M0?WI3YU]2)C0E!@@DAEBX<MDS_UTX:Q\S5AD1AZN"1^N
M4`[FB@XI49FD#@RQD+$,$"$9(JK`4`P)$0I%D:^X07,((E_P$+$,HB168B`&
MXO(AXB0Z8E/\H"6&XAQ&1@':H9DTD6Y$7PLTD1F$"`>]8GS0A)69XBWB8B[2
M"8\%4/X<#N1<0.)`@PK`TG9)0`4\PBK^7`6HZ<`==<`#Y%8S9D$$1",L#9(N
M8N/O?%4VN@DGU=X=YL`-&`0^J)M/B(`X>@,^))H&/`!8(!\PL",&/,!5A)<Y
M<N,]XN,]>J/[C)468(4X)($\3=F3&1]7!8':-4Z%M<,=(<W<3(,/;&,^2N1$
MGH\6EL^8O$%+J%DR742XZ=H@_$*=?8,TO`!&D(0%E"1,<=\+V-<+%`E%PF1,
M]@_M\2,X\L2*.!\>G,=X%('=Y60+K4`NP`8CH,'7(!8'R612*N7ZU*'HC.(3
MJ$H:1.524F55FB(OBI5-?J)5<F57SN$^]J)7BN58QB18+@I&DF5:JB4W6J2@
MW-M:PF5<'A#^5F[A&CRE7.)E7LJ/61+*6^KE7P)F^-!D6`9F81IF]S0E/][E
M83)F8_9.8H(*6CKF9%(F[]0;Z?AE96KF9O(-7=I;/W)F:(KFU?#E9VKE:*)F
M:@Y,:9*.9*KF:\+FR[0ENH!F;-KF;=9>CN6))^%F;_IF^<PF\=3F;Q)G<4*&
M9V+F[1CG<C+GQ:#B-S9G=$HGJUSF%`WG=&)G<0;G]MA>=GHG<R(G;9[F=Y(G
M9[(F]KAF>:IG;`YF5J[G>\(F9(K58L)G?3JF?/;E==KG?C)F=?X);_)G@#IF
M>`)*>@KH@0+F>0KG>")H@W*E@NYF9CKHA([E=N;)^U!HAL)E>^;^)X-JZ(?F
M(WX"IWZ":(G&)(%N#XF:Z(KB(X3FB16Q:(S*I(MNDH3*Z(WBHH7BB8WB:(_*
M'HHR"X_ZZ)`:$(WNHHH2:9(2$(?:6W<JZ9-JDHBV)I)":97"CY2*IY5JZ9(^
M9TUNZ9?N#Y#6*)6":9E6CY&^B9":Z9I*CW]&Z`FP:9R"C_"DHIS:Z?4P:7)Z
MZ)WRJ>M@J7#29Y\**OL@![\8Z*`BZNQXBFX&*9DFZJ-FCI@>Z9Y":J56#9JZ
MB9I:ZJ9>C9LRRZ%R:JCF#9TJD*B::M_DJ752ZJFRZFKJZ*2V:JQ:C:>.::#*
MZJT2#*FZCY/B:J_*#*W*B:;ZZK#:SC7^IJFC$FNRNN6+=))=*NNS`@RFEHFP
M0FNUALF?1BBR6NNV'F>7@HID<&NX+BNC^HRVBNNY;L&K=B.UHFN[[ABSEJJ[
MRNO_>*M[SNN]H@JP=B.HXFN_8D*AQJN_"NR[DFNPFNO`;BNV7NC!(JRU2NJZ
M*F?##JRTA@F&2JS`4JR3`.C%]JNZ9BK#<FRR/BPALFO()FO&.HG%FNR]INJ"
MKBR^*NR8KNK+WFK,PBK-SJN^N@F,XJR\CNRUEFS/RBK*=NO,"BVK_NS6!.W1
MLBK1GJ+1,FVHVFR:\FK4;JO.7BN_6JW(?HJ7;FW">NRT@NS7<FK2:NS2DJVE
M.BW8C&W:5BK^UN[%`*I!V[IMHNKJ)IG``R0``R223T!MW2)JRU8)'C3)Q@)N
MKT[M7D2#@&"%X1XNKH8MJH`:5_%&Q#XNX@JND_A&`\`+VEZNH)JM&'"7+4"%
MXWYNT\)M&KS<(53NWYZNG*9N&CP``BQ`.#@?G+YNS89NT>8NY'9MGE@`PCQ`
M`]B)Y_8NFR9N_C1``BB:=SB?Y1[OJ<8N'+2.\49OF=[M\UCO]8+I]"9+1SQA
MZW+OJ2:O$#'``"1``AQ`XV[O^%KIVCX!<WV!UKIOX`*LU]9OV?[NCLY`!"#C
M\[IN_CYI^:8!5LB5()BN``_J[D:!Y"R%-`B.K2IPG,*O$XA#>/#^1M5.\*!6
M<+*D1_MN\)!&;B*6#0"',*0R\!:P8Y_,;0"?,(YV,!-XS"H4CA%H\`O?:>9"
M1D^@C0GCL*`2L!A8C@4<F0__,)\&,1SN0$2H[!';J?=JHB4UL1/':0H/BW&`
M,!67:`Q;@04H`+ZTL!;;*1<K@92E0#`:L1BSZ0B+04^85AJKL9GJL&#HWD<T
M@#/0;QP/,!N+01-21!;K,85:L19P@-(!<B`W*!G_$?0B\OM"\1AT1$?XQB$W
M\H'R,92<KP*H;]51<B4'Z"`W`=M\02=[LGTJLB&2<BG7YQSS!8FMB#+ZK2H[
M\OWFB5S5;KWDL2S':!(W,$D@XR6DLB[^J^<C6_!2?0,:!+,PDR<H9R'=*G.`
MGC)0AHHS/S-_,K,8.&LU#VDT6S`U:S-\\C+;NO`WKR<QNP&XDG./LO+.>G,Z
MEV<X.^<XN_-W7O/LM?,\>R<WOZL\X_-TZO,HWW,_8^<EETM`"[1TKO,;.$`!
M(``"%,`#3_%!4R@\Y]$-M,=I\+-$@R>\]IA!:[1QGO)-N$LR?_1M_O.SY7))
MVR=!QTJJ>;1*_V8].P$MQ#),3^@I!]@$;-[S2K!-E_/^T@FH*4!+E"Y)^W1J
M4G038,4#Y!P<'S5_)C43$%E!1(`AO_13LV>],LNVM8Q18[5HRC0UF(#O09R:
M&IV)H-D2&0O^"D7,(1)#P29B(^H.IT"B*V[B#.U*72.E6L\0LKC'4"IB$U!B
M[K#U)GWA!DD+)K(*%"5VI_R07A>V8V_E6@.176?B>/C&![6*7N-UE)JS##L$
M!*NI1A*#`PR2L&AUF?0$!51=S6B<9I3"GQS6/?7,'L@U9'3`%TW!@T5&CJ5V
MF/@`][D,!]@B"0W%!*+92^:`&#X!<V,/'P5W&G3#'+B%$D3WJYQ#9\]A6&]`
M!/#M`^A!2C^D:+W#_9%`>MR(V45'!8R3FG""-3FW";A?OB3!)/#&,"V`FD1<
M&_2,?;N(Q/"W(E0",;1@[+7=:+146=A?/L#'F;'1$I!A)@A49>3^1`VXH"OM
M!'%S6G0TFVV4`$!2%6K!DW]!04,(.`2@%DR0>!GJP$Y<Q(1T5`:X>$==!#7U
M`7JOSHT/@@.\5GY+!>20P/VIA%0,$W]#P3V@P&_0!#UDP@P0.`4PP!PH0A9`
M0^RAX$PQC5N81L_]0"74$BW`1LG`!C`4@5`,`5T!Q66E-6\L@II_`3QA0"G%
M!1K47S=,Y0HT@-#EPM'D2W^<32+-EK>9H/I)433W@3F)KQ#Y[XWX@0NHUG&H
MUB"<0#1%^BOA+GGI4R2@.%T1^23LP2REQ%R@PAP8VPIDGB%D$GD4Q#,6"0X0
MA$%Q0-J00C2YPPAE`WFE@CE`0`0L`Q_^D)<OM,$OY`M-1`H_",4=^\$#O'@/
M;(6).4"$/-N%F89MGY,-;-8D8#HJW)$[H,+%R:&C78!W=$,/U,(=C;LKL,!_
M+4>V:X"F3X0+%$%8`!@?N%4+F(<!/YF]V]>VV8FQV<-[-56LL]=%U,)Y!]HG
MJ,1(?80$J82H]\:O$=MP]$G:I,5.AG+/O5=W']<[Y9QS48,*X$O'6,.S,YZH
M7T4RN,,-\-R:$T1W7QBTY\`M9`-+M$$H8%8W%#)YK<Y]P4#H24Z*30(J(@7/
M+#6I8`55S%M42P%!Y+FJ)+!2=PA"/:.BZ4`%0(5I,=X#4'VFH+BCO=;<V/:>
M@!G/5\`\QE?^!$S")(T9$IY*/$7C4]28MH-'A:T9FB7"+7""LB_5+$D97>U$
M>/F2TMD[U9,9H:%D;@$!X8^%E<W5)2R<-*#"G\G`%%#`+"#:6C0W!#Q`0?3#
M+RP#!,7>HV&90X+]MO7DH)6^&E"`V7<])JR^/>Z$K%D9)[#AX?"`&C;!1SAO
MV5/#X5S$H0U;ED5<VD=!L2'?MO4!2I8Y#]39\O?5.QD''[4@?Y5YM<6V$^R9
MM2V!T+$2):"`YVM8H;B2C6@;SZ08?=0(Y-C"/.X)J6'A9[\2T7/5TS/!WP^%
M']@$WYE*;-G8;+"<U(,`Q3G?Y)E?FF&:YE&4=LT8EFG6)VW<=Z;^ED9J:+E@
M<IH*Q3>L-$Z>6B4C\50V0R:E8]E,O!M*9<*I<"R>C^BCX4"PQFR&XOT\7NY7
MIHOQ:I823!Q+;!@0*2A#4%M7-A=`&Q<=(AL5-AF/'&DI:1!*$1FA*S)1H8]#
M'!L2CR)X#R50:EA5=")W0QT2'($:&[<IN;L?1SU?'D8O82D;%F>1-Q]!G!U9
M'RO0,"TVSZ%3NH,='28U%AJHU3J[@QX1?Q9?'S-J'5?Q&-89AQ09FA,I?QK\
M[>N0H4()#OZF52LH*V$6.LK(E%K!XD*44]7H+%LR85(H,<0L9/A0B9VP1!T8
MF/-`#9W+ES!CRIQ)LZ;-FR\QM<0YTX3^.!TJ;-C,L,D:-0VZV%"X]\(<TIV<
M8JB@ANG0O7L/EZQX$6T-C&40F(Z,MZ3HAPIFK%$P2_8#0H/T3&B`JL+#W$D8
M/-S(F\O<,*:6$/7(@D$JA`GF#IN[@**P.:R(TH3I46?AL'C^-F#QL<H'A<P<
M4AFMUBM5:-&=>8@N>@'-Z*J7B8Z^-U)&A$UI_HR<Y'?3'Z84`FT(>U9"![W`
MB(Z$D:9PBCAFOVY=(B:%$L]KHT%@*2%'AIV)-@W*!(.@!@S4-%NSFQZ+EQX=
M(N1@.DQJ+H,8(F"AK\QL_OWHO)"=(:>E<L(CZJ'S77*>D8%9,5AUX-0^P^!V
MB`\.\:3AAAS^=NBA(BL,]B%I$D!P7`YZ7>#7B!YZ4`1&+`[A!5TSS1BC2X-4
M\]-+/V#(A$QIE%--'#<6&>"+,[DHCY$TV<C&6$Q6XUJ4'W(`&9581H65BUEV
MZ66'F(AXXP8L*=!`2Z/<M$D&*!3EIB(\#C&7#WG!Y&(.BE#PR('HN.`#0?]L
M,@&,U7@@)EML92%92V:991$G*HBX*#`*06II@#NE<9RE=C&1:%^"B'GII:']
M""<P*[+509V)ZBA;H6^RV5PBIBI*$A8O[*GGG\!LINBN:72::+`NM=IKL3+Z
M^N:HT1B7@G,!%@IDH[9RLJ*$R-:TK$V;?NGMMS;IA1Z3@1BGP87^:88;K(,>
MX)8I)ZT6Y:=9-%ZP136J+!.(6<[ZX%<$+>7KP["X$1Q@&E+9*8NI/,!;`I2*
M$%MMNPY?^F:/`Z,#;3R$4IQQQDO"FH)HIL9;:;N(+NOQ";C"8^P0%##P3R`D
MT2PC(1_GFUM9Q.*6K<@!%;M)PR7'1,4R$8CJL;092_PCQ1)3G(MXFZULL-/@
M9JUUE&$R*5+2^?B0+DT3=)>"1FS"H9&](Q6&ZQ",'9+!+4LT,X>O*3QP)@>2
MH)@0QLLH@(($F0F^K@\53`E,=0$1VG@T'4BB2@X40)`=3)00;N@#YEA@>0<-
M;%=-!1)4I"(5I9,53@,3W*,$WEUAX4#^ZJ2ST,)(R@SB`'UN[>K%(^(L@<$#
M:Z!"`1H>0$`>!'_(9VG9WFGT0&>,M2T!1\[;NYE&9_5@4#,O?=9#CX"[Y0!B
M+T@PT@\O/&#0=1F<K]F@U1SF#QJ2!'3/!`NL^(_OG+/&!+9S`<L92QDE4(FB
ME$`7"^S@+!'("^ON`0':E<X##5`?0AYQ`07DH`/*(TG9['(8J""D"A4@'HVV
MQL(6\D1<*QR1!!K@``B,;VPQ2<-MY"&"#CP@'Q[80`:$,($K<."'%]K(!T2G
M$3+0X8>_>!:"*C")#^RH?+#@1$+"$X@)P`!G;D&(!3`@`3\1`3'S*(<)>B`"
M[KVD`D$K`L?^U`".+E0#`X\8U`0:`,>.[$-Y$?A`(#MQ`5%!`'S&V0?EX(@)
MI0!E280$10>&,X=2U0"/<@"%9`!AA3EXH`I9`%AA(#`W'6S*BZ'QQQ=,4`4A
MOF)A"R,#K;(P")'XR$=%F8P%RO%)SLB"&1:`@05VY$`S<B8X5B@#WR:`N[)D
MX1VRJ0%0;M/&M^&+$`C$Q1D.L0D,P`63NMA7\KIRCW#Z@`?$\<<F=6`7D=1@
M3RFH`@[V4"L7VO.>0`H1DPQEP"'4P'\R\0<F>TC*"NB!FV(`X1Q^%!&$82$#
M$9!$0>$D#V94D7P9BHP6->I+,0B)">ZH6T:/$8@ME&,)YC`I[#C^,1(X+D$9
M/*0'/90UC$=8H`*6.]-:]E&Z/.*B,UD01QY?@,EW"!%!@/A+%DJW!3PR<RT<
M6)4I3`71]"35!COUF3_FH#Z.X.9X,/7D%I;"Q.T]U'F)@NAA;ED^9IQ!1;#X
M@0C.$,PNY,@'C%'4!-XA4SM>0#A@Y,1?TQ"'DG*!"RM5(DF<.;*ET*PY]]C`
M0/^PT7?<(P:$F$'K2G"SN"XE%%<R`5&OA,_2FG8AXS+2`"5`.$+@4":>2(M&
M*L##O&(BD(DCU$V%`,L%4".W<)+F+@C'UHRJ8;,]@@%3_%'+JED#FGRS818B
ML9U@/H!OP9Q'/1Z5A<2M9092B2D5,;#^UZ#J:2W,.X0JU6!+FQW!9L]Z!V=-
MH">1##"R2YC!`ZZ4!(/.0!=[6,LE8!2YU"EC#P[PY"PMMY9=/@*4-:6FO7[@
MQ[S"DGL+Z$$+X*2?)?9CHY"J!#W&XS<V.'"GS;BK;22UUXXPY@$=B.YQO&B6
M\T@W#JUY`A7]RI84*M9XU\&%&"RB)RHZQ`&[',]:$O)?+'C1',HX`AQM(`/"
M[%(#C3RMEK6L$R:A9%^OC4GK!K.I*&AJ3NNA4Z$PL(M@!8M1=5+4)B0T9UP$
M:%PL$2R9EP%0DFB"#31"LWK,;,6,B>I9P>J#PXY#,45#BF^:*C0UJ,&!];D)
M8BRE%*4EX1;^,O'*&IZ6PV#FD@9^#&QIRQA,GELP1DIE8<QTBK2<$@T?2:/9
M:F[Y&UT\_>>=T$5JA;`S262SX:6A&1?AD(RG!1UG.3&JU)-!61H.?1XWH\-`
MU:CTR![%*/51NDX[(;45'^6Q4)R:+>9&]9;7W4)Q'7I$!6P-`_!4`TS'Q*#1
M8E9,R)C8%_[L9=KZ&4RZ93&?Z9MIV=I6D@1>SR^)$2:*4U--BE>M@S.\8#GT
MDOZVQB6%L?OC(+])UYBT`1FH.LP<,C?#NUL4-JN)M0U_(9YF4FRFD1=O'&@`
ME!W0YPXY:GPKQXD5\HVL=%N1=QIZ&;Z)[A*5+YU''<OVS*]=W@W^XE5K!K\G
MP.,$I)!['>LKB*&'-K"[JUN#!=SJA161=YY9B&Y5FGK4"G`EFPN2Q#42ZK>A
M9-,CE:L<4/A`!^#ARH8-'`6@9Z!&%.@"NGLPFK"GP.1"QL=I+.^F#21Q_'F.
MPA3B28:TF;=BV'6$><D.^QX:T+G8<*5H(6*EY,/H".+&IVU%96`SBFX#?+CK
MDD'U`#XF?-3O=6"B$H`[$UN)!^[&V`.5)V'J@=?!;:0?)+]PP"_FMOS7M\_]
M[A<)AM\7Y%]UH4Z41\MRC3C"!QK0Z@D`;(D4N(TEEL#^<LK#<H=P0P\8_.Z<
MM\:7.%`.V#478:$9NP0Q;H!V!?1<!D3^/`:A"!%4`NXG)AW@`*R`6/;P'*1U
M/&@P1ML1`:V#03=5">_@`0R@(I%S?TM`#_]G/(R!01<`,2+8!3.P!V$Q2:IW
M`2"(91.&4WE!!3]X&,N17Q8((SJ(&.<A$@]005;@3<AR2"+019)B!`;1127@
M+)8C8>K3`+<7#U:1'WUP9<PP`>KT#\%D$.Z7!FGHA6Q01->W2ZH0@MXWAW18
MAS2A3ZI%6`HP2.;7>S55!B1P.=+$64^$4UED#6\P7PX%%(-X3>Q$B*PU'Q%`
M'245B;_2)@(18\-$18$U4!CX:@@S4QFH5(J@3C\@`Q?0,M'`3&I`62I0.0MC
M")\!*9,56#[^$@->H#ZGT".G0P65<U3`<#W*UT@PM3]9<#IY(8MB4(A)A`Z!
MX`C9E04X\`KK-8CT15GDA2*W5$7!$4$I!D;U\(Q8,8ARM3T2X(W]9H?JN([<
MUV5&$F?D)3:$1Q.!=`1DT$6;0"3TA1!<<(@E1XVQH!$[A'3+X`]5\`-&<'LU
MF`-AX$XJQPF#8!"]1`?>)%.,-4>,0%.R5PMP,([PY$O-L%57Y@.'H`2L4!E_
MD"\:D01\8V6M:(M+Q%ZUD&4]8@,V0(-1$"&[8'F-1%FMP3[/`EK[8"_'TT;T
MH&_R]QT-<"7!$$C&48]8(1`P=3REB`C4D)#,H!F,)17/&'F[*)7^E78-S)`J
M[%B69OEQ[K9/%K``#N`K_V03$'!(`I0#4Y(+@=2!\5!&T2`>]/,]A-4#$8!6
M93@RY[,2?K,65H!&C.%DEP,W&L$E+B(!!H4>&)$;(X$&+O=,DC%`5.$76(8O
M$:@*^348TW,/%@`*9P$WFS4<E"@JIWF9+E&:F'$#4&(!U]4++<`.2#`6+B(7
MFC$2+8D!#D!QH"9$`B(#1Q`%#X1%P7$*3[`0Y<4F@627>^D=$=62G.`=#5`=
M-/8"(90G>NE\O(DBG]$N7A0/(L)[9[F>[-E"(Q<CG;`4]B@V:%<3LQ1T)@,3
MX9%1V81PVY*?<G))++)UI_(Q(&:@!5K^-$Q7*`YA+,,B<9+G<7)VH+9R)_^6
MH!AZ,`JZH!D7<^WYH2`*+N"7AR/#37V(#J'FH2R2H@%B32/"%B&C=>F8H1W:
MHO`9$U&U<!OR*AP:HC[ZHT":0Z-G)!I@@13`A?39<T&JHTO:I$[ZI%`:HGAH
M)!LPB45Q#5&:I5JZI5S:I73XGC="`7KS`,AUHEYZIFB:IFJZIAPRHC?Z94&A
MI&PZIW1:IW;:I>Y8),$48V1*)_5YIX`:J((ZJ.N9EEZV``V`$6;*=4\S,14W
M*@J7=5EG,05J<-32J)CZJ!NJ<+5RJ9F:H)<:JHYZ*O_YJ`3JI:7**9!:<9/*
M+*E:3YZJH`_^"JJKVJFU*JJD.JJ4JJJYVJN\"BFG"J6&6B3Q5T-+$:>$FJS*
MNJS,NF5#6B1P*BYR^A)X-`/66JW72@/6FJW;JJW;BJW>RJW96JW@2J[?VJW@
M:@3HVJWLBD?FRJWINJ[G.J_L*J[>&J_M&J[VBJWQBJW!*JSO6J[ZFJX$*Z_U
MJJWO>J\'JZ_J2J\'6[`-Z[`-VZ_R2K'S"K$7FZ\9:[#L^J]."J8Q\CH:T*?B
M8F\X2DJ7E+(JN[(LV[(N^[(P&[,R.[,T6[,V^[(7D&`W>[-`.*=N<!X[&[1"
M.[1$6[1&J[(Y2Q%'V[)(`7I=ZJ9%0I2]L:C3!9/-FB58%"72Y+'^2]H?5^LM
M6<LDC9BF(+NB%*``^X4F,7@37KNKMIJIL2JI;KNK*D.KOBJWK$JW=ONK>.NV
M0%FINAJIP#J*:YHCG%JWM<JW<RNK=VNJ>INXN+JA<&NWK]JH?QNY@BNKA$60
M3_NL-W*#E09F?]HD5ONU41*V[T@H:%H)I@NVQJ6U3LNEPWHCLH>(R&H3_=FZ
M6(*Z4<NY7IJ[NGNZK\LD,8JFGALC(Q!_UQ44)@L3P!N\1L*[`ZI47!NDSPN]
M-R*],1*A9,MII^LF;XF[%XF]WS>86$(D:]JVY%N^*OJBI)BFLYLE5"LC#[B^
MT3N\[QB[77J]]MLB^!NU'VF\A?0ETLK^MJ7;OVWZO]/+O6EZ5P@,GPJ\O?JK
MI5`KOZ-;(P?\P"\4P2S"P*N;P1JL)N9+)>C;O>^V3^%;$ZQ;O2$<(",<)26<
MIBO<PO[[)5L+O\>+)?.K1"Q,PU6)M1G8PS[*OSZL+1P\(A[<N9G9)04LOD7L
M<T?\(6/;P"#\Q'82Q6U*N&2;6EZRPR11OU8L=%C<(5.\NF`<QN$RQAQRP]TK
M=M^'I4Z,QF+,Q#75OEFJOG*<)&J\(4DLNU/:)9@PK2@ZOGF<0WLL='7,ID1<
MR(4"7UA2QEY:MJ?KQ0[,R$!RR#P!R;];Q9:LO1\">6M:P3H\CTURQI;,(YB,
M$]"1OH1\R@S^^B4QC*HY3"5>O,BN[,E(K+IGRKJN;,@V[+M<^L>[F\*DV\N^
M#,2:O+^M;,RWM+N)K*9Y"L@7+!/]`35/XS/6YBG8C'&>\C'9_,W:/+C@C&O=
MO#+>'#7AW#05\\T8A\[F3,Y0(T[7+,[<_,[GK,4RS%@]@\WIS,[T#*S;_,_J
M[,WW7,X!W<_\#,\)7<\+O<X-?3@]@]#K+-'JO,IH&K\Z+!1QS,PN3,=]K,P<
M72RI?!,?O:62S#73C*.LPUJ$P])ET](OS5IE\](SS=(P+=,M[=(Y7=,Z3=,V
M[=,U'=,Y33@\C=-`/=0PS=-D:-,WW=-&C=1'[=1-S5H+H-1/+=7^.PW5.WVD
MP,RE.6?5.CW41=W48VW50CW30HW38JW547W599W59[W64SW5;4W75WW758W5
M<OW6,>W3A+.4H3S+^^3%'B```'#8B)W8BKW8C-W8COW8D!W9DCW9E%W9EGW9
MF!W9,B/$(>H!`9#9H!W:HCW:I%W:ICW9FXW#7-PEQ)PD/-D"6`;;MR/;L2W;
M-V#;M'W;MDV;H6!YL"T*LWT[MPW<NMW;K^W;M(G;R"T*P+W<LVW<QVW<R2W=
MP:W;N7W=S5W<RFW=P?W;M(UE)^RER/W=Y%W;PGW=V^W=Y,W=WYW<WFW=W!W?
MW0W?Z&W>W7W?]3W?^6W?M4W=U;W?[-W^WN%MTDLLS8(<T@B>X`A^TM%+V,.P
MG3P\N`2-+:UJJ6R0.F*Z'2KW20^PO-FQ`1G$$A"PA,3B!)D0ESUP`0_0#(^P
M=!I]`V(Z`[.38&C`!>SP0T,'/@C#1V=S!^=1"%3@-(T2J9HR/6\R2?,\MQ5^
MIPU0``S@/<O,%LV80T4Q`N(A,Y8"8[:2%(H``07`36\+JZHIN8BKMYF+*'G;
MS1I@``DP<X1UD9[*SXM[IJ),RRD=$Z!#`0O`"Y59J9L0E[#*S4,0`;S%`!%@
M)B4"#`5PCG8!`(_`.@W`.04P0O^PG0AP#PB``-&``!9P`!)0`!^``(.1Z"\I
M`#70``3`/`G^$`Z:CNJ:(``FB!&LXT$2L`!ZTP$'@$%$<0`#3A,8$.D'\&F`
MCC7DNX#,-`F[EXKMM!]=\`(%X'CMT@:H^,68MBLCH^E+DIQ')PD94`#9D085
ML``?P`#"X6>8T"XSP!+G81%<L!+/N7W$4``EUP4=L``,0!5VA+W1G"6MG23]
MTRXC4(]ZLP`F"`$*D#Z3N`$)D``E-Q+WW@`07T:V_DJ=P$W^,+*DS@&:W@F1
MOGYX<@'B3BP:<.\4`^@*L"<8<`!ZOAE5BF7WW@&:[A8)D`((L`+8+NX=H``0
MP'Z<$`@KK@`]H`!8%@`TDP"]/A.8U.&3^$,+/Q<+``%8OKX>8.O^YE#OA[#B
M#-``&^#M!T!&&F#TG;X<477R`T`!;6D`%F``$%-\DK$`\<<_UF``/6#K$+_U
M3P?H&```&V``!<0`#A#I#_#W3R``$]"6;?Y#'[``T`=R\G#H,<#P#<``47``
M%E``;JRL&$TE_4YS#W``ERGN3Z[Q,/\!)R]9$"#N@"X/N3[LMGX!"5`4PWX^
M1D_J'3``!^#Y##`!!F!%$$#Y&A``!X``K-$`HFX'K[``A:$`W<$`Q>\6"F#K
M"A!C,:_Q*7``9!CL%:``B^4`!X`1"6``!?#U6+``DA``?M'\'/)_A'X>NQ\!
M5[\`&8``!WZU\6\0$!!(P1X$2!'J8=#^^RP1\R!`<5W"/=\7*1AD?=['(2C*
M)<CV-=F'<-^C@UGT?C0(Y(,10!0*282302`HE.0#]IDD(K`+YD4;D\OF,SI]
MAF$N'\C#`CFDDHO&Y:%1\_O^/V"@8)I'!H;18&`AQA[@AHO&C`71P4@)Q<="
MA002$=+'A1N"AT7.QT&I18?8I\<$:U+,C-)!0T&%BX<"!0,91ACOFUV%3LD$
M@%8'0<1#KTS-+$)'Q\P%D8:%!@#/RVM&@D).;\,#45&B6)O.P@,%'?/'$\=%
MCA;Z/7Z^OEHPA6<2#@H--+A1D"#(@6D'8$BX0(T#I@\5B%!P@\(#`Q@,.EB0
MT`#3@E4^/DC^^##I5",8$W5PN8!``Z8+"A9HV""APRL8I12\:KCOIQH,%2(A
M@-!A800'0))(:`3T*=2H9@RMDEK&D%,_RB(T2'*20@((ES*YP\!ERX$+DS`0
M(&5JP@(*HV"]*,F0``,%&0K,/,##0H($71M@&,`@@<7"_BIX(-!60P(+#"1D
M:+P*Q@H*"G0`P/2L1X=G"0)DZ("I0!@8"Q84B``V`H1@##"-O(?A@.`&#394
M<A<*@84#IJP2+[[/`[L%/R:\XL6@`8<P#B(PN$#XP_,,&AI,:-#!(O8'"4RI
M=I$G@08-"AZ\TK&*6(83$&:/>2Y!UP8%')5$F#19(@T/2+!`&-?^&?>3!K@)
MQ8`%`T$6@0;L*&#/@15:F$8&%R!2W")9^3$/!C!XD`,N8'VP"@<><&`!!QNP
MX88&&>30@3T8J#(&!$IY<-F)H3B4@05@B%A:&QYXT`:+-#S"@Q`8H)B-D1^X
M2$.*(WZ`U0NF3.GB+S^L,B4*V(2AA!L9>.EB)?AX<`$/:YKYPR\>8#/<A77:
M:0:%*$"000,1E$&A%E&.(6(99ETT*!]YBJ$HHG^BL$$#=_XDZ*%B2'IIA4U6
M=:`AE>DC!P/<`&4!`79A*FD$"YVZ*JO%V1015!8P>F>,K=IZ*ZXU=&GA!K^4
M9BFAA`(;I;"!OB`BL<,&&RBS-!AKI*#^T"XJ[;'2$HMLL-4V:^VRBP)[[*'6
M:FMIN.`^^VVQXQIK[K?>1KLMNI6B6RR\]IP[[[`79>MMOL^FF^RT\4;K[+KO
M!MPLO\EV2R^Y!^L;+L+=5HILONS:6Z[`$>^;;KD;U^LLQOY6K'#(#XM\,L3]
M/FPQR`Z#R_+$+T1GR*Q1+>)KIQGHO+/../.,P<Y`\_QST#D/3;3/0@M]=,]-
M,[TTT4-#S335G4(-]-543]TSUEH;S37257<]===';YUUV&5+7773:K?]M-E1
M%TWVUU:O37?92_]R=M%LU^TTW',+OO;@<3N-\]9_WUVWVWW+S;C=>CON=>.-
M`SXYWHN'O7G^X8FG';C8=MM-CYT:[+TW&+^D?CKJIZ_>.NNQI_YZ[++#3COL
MM>M..^ZZ^U[[Z[/;_COPQ+M.?"C#&\]Z[\?_WCSJN$/__/+56W]]\=1#/WWV
MN]^^//?A2X^]ZN0'C_SXYI._/O7M^Q[^Z1M>.$UZ]6M7/_XQYF___OW[K___
M`BA```XP/??#WP']E\`",G"!""2@`!W(0`7N3X(2_)\##WC!`6:P?QLT(`7S
M=\$/3A"$(O1@"$NHPA6:\($M5&$'*\C"%,)0AC;$(`U?Z,(4DA""+>QA>C:0
MHEP1L8A&/"(2DZC$)3*QB4Y\XB!J!D4.3;&*?Y`BJ[!H145LL8N'7OPB&,,H
MQC&2L8QF/",:TZC&-;*QC6Y\(QSC*,<YTK&.=KPC'O.HQSWRL8]^_",@`RG(
M01*RD(8\)"(3J<A%,K*1CGPD)",IR4E2LI*6O"0F,ZG)37*RDY[\)"A#*<I1
IDK*4ICPE*E.IRE6RLI6N?"4L8RG+6=*REK:\)2YSJ<M=\K*79@@!`#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g24982bci002.gif
<DESCRIPTION>G24982BCI002.GIF
<TEXT>
begin 644 g24982bci002.gif
M1TE&.#EAJ`)P`_4```$!`0L+"Q(2$AP<'",C(RPL+#0T-#HZ.D-#0TQ,3%-3
M4UQ<7&1D9&QL;'-S<WQ\?`("_Q45_QX>_R0D_RPL_S0T_SP\_T-#_TQ,_U-3
M_UQ<_V-C_VQL_W-S_WQ\_X2$A(R,C).3DYN;FZ2DI*RLK+2TM+N[NX2$_XR,
M_Y65_YN;_Z.C_ZNK_[*R_[R\_\3$Q,S,S-/3T]S<W,/#_\O+_]34_]O;_^/C
MX^WM[>/C_^OK__/S\_3T__[^_@```````"'Y!```````+`````"H`G`#``;^
MP)YP2"P:C\BD<LEL.I_0J'1*K5JOV*QVR^UZO^"P>$PNF\_HM'K-;KO?\+A\
M3J_;[_B\?L_O^_^`@8*#A(6&AXB)BHN,C8Z/D)&2DY25EI>8F9J;G)V>GZ"A
MHJ.DI::GJ*FJJZRMKJ^PL;*SM+6VM[BYNKN\O;Z_P,'"P\3%QL?(R<K+S,W.
MS]#1TM/4U=;7V-G:V]S=WM_@X>+CY.7FY^CIZNOL[>[O\/'R\_3U]O?X^?K[
M_/W^_P`#"AQ(L*#!@P@3*ES(L*'#AQ`C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)
MLJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-FSASZMS)LZ?^SY]`@PH=2K2HT:-(DRI=
MRK2ITZ=0HTJ=2K6JU:M8LVK=RK6KUZ]@PXH=2[:LV;-HTZI=R[:MV[=PX\J=
M2[>NW;MX\^K=R[>OW[^``PL>3+BPX<.($RM>S+BQX\>0(TN>3+FRY<N8,VO>
MS+FSY\^@0XL>3;JTZ=.H4ZM>S;JUZ]>P8\N>3;NV[=NX<^O>S;NW[]_`@PL?
M3KRX\>/(DRM?SKRY\^?0HTN?3KVZ]>O8LVO?SKV[]^_@PXL?3[Z\^?/HTZM?
MS[Z]^_?PX\N?3[^^_?OX\^O?S[^___\`!BC@@`06:."!"":HX((,-NC@@Q!&
M*.&$%%9HX8489JCAAAS^=NCAAR"&*.*())9HXHDHIJCBBBRVZ.*+,,8HXXPT
MUFCCC3CFJ...//;HXX]`!BGDD$06:>212":IY)),-NGDDU!&*>645%9IY958
M9JGEEEQVZ>678(8IYIADEFGFF6BFJ>::;+;IYIMPQBGGG'36:>>=>.:IYYY\
M]NGGGX`&*NB@A!9JZ*&()JKHHHPVZNBCD$8JZ:245FKII9AFJNFFG';JZ:>@
MABKJJ*26:NJIJ*:JZJJLMNKJJ[#&*NNLM-9JZZVXYJKKKKSVZNNOP`8K[+#$
M%FOLL<@FJ^RRS#;K[+/01BOMM-16:^VUV&:K[;;<=NOMM^"&*^ZXY)9K[KG^
MZ*:K[KKLMNONN_#&*^^\]-9K[[WXYJOOOOSVZ^^_``<L\,`$%VSPP0@GK/#"
M##?L\,,01RSQQ!17;/'%&&>L\<8<=^SQQR"'+/+())=L\LD4[M"*REFPS(7+
M?<#LALQGT-P$RS8CD3,8*N^,\BLR,.#S$S>44$3.)!!A0@,],R!##S*3<$,/
M(81P!,TR**!``@D8?87*5??0@-=.Q&`"U58;0;,("+S@A`-&.VU$V$.$[<#9
M"SQ=`@Y/[.!``D_W,`+7"31PM10?*/#T#@P(;8390MA<@@-JRXV$#`LXOD0,
M;@<]M!`R)/#!%I;W\`("(P@A0@)N;WXV"&E'\4#^`@LLH,`'.X!PM!$/*,"`
M[0_D?O@0.P0O1`PB&''#TR0D'3D1-']P0.I$#&Y[`X%#_3ST2L@PN]PR9*]]
M^$O(G#/Y491`MA!T4\&R^GV\`(#*?/.]`\[WPWP#SCBHS(`"0Y#!U*#&MP&&
M@`#:ZX$(`/"`'MP``*V[GQ!>$("GO2""`Q1"_X@@/P4L``$0C!S?1-B#$?9`
M@!K,GP-[H+4>E.!I4Y,@"4W8`P,T,`$`S.`*C9```%"NA":LGPS>][00[@"%
M+,SA!-TV`-V-8`<O$(`,-NA`F66P`0A`X@("4#L!Y%"%.QCA#@8XQ@SJT``,
M[`$)`"``^@U1"`88'0'^B7>_&'AM>3T+@-N.J,,>'`![]'.9"N'80/GUSV7[
M,X((`E``,@XR?XZ<HP/?N(,0J@X`!%`9`0"0O$&FD)"F<]LA76:_GL'L@HU[
M`0QN@``FH)(!+X@!*YE02<.Y<`%&,`$ND<@$ML6@`#`@P@(^<,$%',`*-U!`
M"%XP`BF&0(Y$^``TKR#-!#JAFBS#`==H2(5J\H&""@R``0;P`0`4X&D,&$`!
M`)"Z%Z!Q`$:CX"8!`(!C(F"<E%OD`0```AC04P`C7.``GA:`8#:`G@[`@0#H
M*0,',$"-`S#GTPXJ`+)1<(0!L%HY^>G`=39@`"H[`#[]&%$2F```!A#`0PW^
MD#H![+.1I@O``!9@@"$P@)X/:(`!]IDZ&*PS`3J4P0`>D$G!%?5O+QC``0;@
M-@,D#P"R+``"!)"\!:B3G3UH7`\(8#4"F""B`1"`'`F0-)6Y$P`#,($\K::R
M%IH.`#U`0$1'D%1SRA(`9RN``PR0-*'&8`@&2$!-MS:`'GSU`%)T`#VQMTF@
MXF```P@`%GL``@(8H`!\@R`.#I"``BR`92-`J0EDL,X!)(V"D9W:37TH@P#<
M%(!99:/SAH"`!A3`>>E<9^K2B<;4U8ZR!:"L93&[`SUJ#P0%,(`)3'"``NAN
MHU:3`0C/J5@&/@"7EXVLV]9X``3@LK+<`X$<LS;^@K8)X7LR^X#N3JB`\K8.
MO4-()@-25X)=;BUU"1#`,L_V@<*IC&V*(X((%H"#`D2P!PLXFQ`0<`,1,,!J
M#1!=#SY@-/7)(&TA"*9A8=N#&)#``&0-&@)`4&`"[#8!#;Q!"-Q;`@1T$HNC
M4[%[2TP]TWTP><@#`>"@MH`'/&"]0AB!CZD7`A*@K@<PJ-J.1?#7$B1M!%MS
MFS?W(#\%0C`!:>7H`@2`/)`N-70!Z#``0G"#`QQ@!S#()UP7^(('S,\!`_BK
M$#Y0``8<$ZIK'$&>2X#7)/9``""(@7)',``<$)IE\H.L94TG`!C`0(H-.``K
MX1H#-?>@``>(@5!#$`/^+O9@`%8#0`/D9S4#8$^=VKO!``RW9>D&UP"40\!#
M6<:`F@:@DP$XVP!$H.=+`Q#4/8"J"73'``1N,08A$``+$_!IW0$`!FN$`7A-
M$`"7?3F_K,ST$!;`51"(]-('")\``#>`FCZ@``TP-K,_@,`AD!-P"E@DU9)F
M`%P*P'`'B/5#17T#HO;``<$<<[`;6M@&!U"E91YH`L(<@S''0&6J-IS\]`P`
M&1R:T":4WPT<$%P$<QD!QOXX`KDFW'\'/-1[I*P-J_8``X2@M3"(`:1;N=<=
MJ'396PWW3/^\3``\5`9RCJ8<;?X!$@17!`K8.(?G+$>%%AV!2%=Z`(&:@!W^
MZ/+2('@!64-P`!Q\(`3>CL'M9&``&8B@Z\0K@``4O&T1W.`&(*CI`1X@WQ@<
MX`.DE0$!GG9F'"#`9=Q&`-X1O(`;,(`$H1N!`Q2P@P8X()D-%"L)"##JO><4
M\CT(0-&#^[L!)E.5YVSX"$#0R@0PP`3Z)4+;3@?'!6@=Z`$8?2L78+0'O%QQ
M)0BN>*V)ARJ'H+`M)(#N<.C`7`M@CU!M.-_<^@(%&"#,OW\KU0I[7`0.H)E!
M@ZWO9```OIF>^X`?@`,68$E2,Z""5)/L04=P`-T9TG0*.$"8G?O6Y?\:Y5O%
M/WB'(/P>$!^\`5`XET4$"&<`K915"A!%*J-CKO7^:?@W.`007,2'`Q5D.PX8
M;#'0</<#05NC/96$?$'#;+1F3DK%-TUD6`'`-Q2D,B#T5R<E5+K#,KNV``EP
M`"?%-PR(2\`6``K`<3450N#E-SWT5&9#3S9(!,!F1,DW/T1``*,C/QLH`Q\U
M?D;4`P_`92%0<3@'`L#';.#5@>P&-7_#2<'6.BI'`F;V82*P1@UP4&P#:PNW
M5;K30B?X?=WG9VHS87)49@MV`SC4`.E$1GHH!'P85WZ7``Y5:(382B'P`$L#
M`[!5`@T`B1,&`GEC4W_4`,=G4R3@`"30:_Y#``J```QFB+-T0JU$:'(V:B+0
M0$0@;0Z02;MW`R\@`B;^)@*C0P`,\#=G=DQQA4XC8`"[6(,[X(O'M'L!]`(?
M$&?-=T)`=8#8=$(SI0`#%5=_Y7K-*`/'M`!)4TUV%(N4-4UYX'O`]VMS&%PW
MH$?`)C^P-S4MM$`P`$X')'WS.`3@!0(!4'&V)03HQGW>QP`/I()957:QA&C5
M=FG,EFP9Z#8%,#I9*#C/5F7T1T%3XUD7&$)<E7EXTVY"T']@&%P!``(R\`+9
M(S\+%593HW7>54/'%'RAYCUM!%X+@(X`8'@`E)%+J#()(%=D4US)PXX6.`1N
MQ7_N%T(A$&9ZQU&^5HW\IV>:QWU^U)+WEWDB^0+[DVO`E7F4@Y.=4UY0I3W^
M_9=1;P5[--1_*UA)#4600>='`!``^3B'7HA`'?B%ZX9``;"5^+>`!;`#R;4#
M)D8"7!:/-90W)"F'?M9_IA>0EX9+2``"ZW6*#(8ZG&,",*->A,ALAH@`)!"/
M;'>*;?@`S:A&DPA`ZG6)G,,`>/<")C!"]=51!!!#",9V?5B(TB4XC28$)`"(
M&F:%;/<`(H"+8D-[[24"NF-@%V25!YA%6>5>QPF9N0-DA@=+!Q"/NY0`?G=>
MHP,VH_8"#6`URHF-NS1[M7=[CJA[XF@'9@57T4=\)WA3W'9,BJ4`]51_L04"
M:\2=ZEE85;9`FK-_/:1I*(5&0`<`?T>#?E0`\OG^0JZE-8AVAPUG-`-@>I*V
M1C,)5_=Y4(895P1`?@]U@B%$3F+#10)04X`5`/7EA84%9PYP`+%#<B:X7BWH
M1P@@<SKH;-X39P=@;#Y'`,=$<DD(H`SF3R0Z!/%)H'C85@#D,OT75P`@GY2C
M5P]*-3Y7!+OV0!D(5]U%HY<F`"3P`*O&HF58<@)P-P(G;`:09%_9D;I3I,<$
MA4204B2@@96D:5RD-2.D<2JSC%O8A925HDTJ3G]&ID]EAEQ80U,9H79V`X")
M18:C=B?Z::-#?$M%?KA$`@]5!-[DG/WE8:XX!)F:G#NPJ5T:0`=87`_5D";@
M53!@`#?P=2%PIH=7`@;^H)H.@#,V=#H"4&,*L#YQY8X+``-W9W<F8`#V(P",
M.4%-9`*VV&`+\$LED%0C`&4WL`#8$P(BL`/)^30)Q@#8`P)/=(#'%`(!9CH%
MX&%<]@+A&9RH%SL*H&'-^)W%A(K_I@"H-P(E$&X@H&R[]SEO$#2&U4#6:H5&
M,XKB&CCE16(GQ#1(UH.4E0"M.)(-)(4.]#LL8P(_A*Y/$P.U\U?%`U0B8#5>
MYV(3I#5L)X4L\V,GQ``)0`+_!3<'27H/^P$*EDSJE3R.F%5/<[.AZI@<Z4*H
M,P)64P*NR#8/D#T.8(:C)P0FX(K3.E^C<[/8(S8*T(D*1)Q)AS:\B;/_MF/^
M`M"I0W"P?-,^6$L$-PLU'W!DF#,U7W="`,"K-PN0$MNT0N:SR1,""$!W6KNT
MIH-B'ZNUXOJK9*M@;`,"*B.Q1("&(W`#AL,X%N1!;$<"0":Q?:NW8:.WC=<`
MK;BWOFDUI3,Y5&.S1B.%*ZLR)6!Z?V5DGV@U=_.Y#M0`)-"!N6D$):!@.+!>
M(<`W_:6P2N,UM2L$")N[I`1DRGI"MD,]#2"SW9@`U&,]XH,YS5H"L<-D18"P
M0J@[(&`T*R8$"U!C$U0[49M,(Q`#B!@#B1MO8B-A.)`V(#`UTAMAH].[E!5&
MYJLR1K9,+Y0\\+N+),"[0!:_9*9`X8._,>AX^SO^89I9`IS#JX0PE(XP?@[@
M4BWCO:+&>WXPK,\V!BXC`I#%3=,0.H"(5:Q@`J5X#C##,GW+KR6<A^5#/+3D
M/J"S-5'+/3HS/";`-;@SPRK<PMNSPRS,PT3``T<@PK(IPU,`,T"L/>*ZFT-P
MQ,/3Q#UL,RB,P;NC!/R*PSE\!*OCL%5\Q6$0Q5N0PO_&O40\QE+LPE&PQ770
M,VR`QF?,!VQ\*F]<"7%\!4R<#7,\%,Y;O'W#PCNPECV,!";@031X-CDC2$<`
M/^REO$0`=T/P`&6E1D8C0PX$9#CSQU.,P[5H=CN,/`G$:4[`2T=0QT\@RDM,
M!4><`SE@!4=,RMG!7"_^4`+!:(914)M1``():&%5L$#)$U>@:6#Q=8!VMLA]
MI$`_]`7]<W5%T)K;IL!(0'M_<`(GD!\F,&N#6+H)<#:P/'Z%2X.ITU`-H``J
MY3+`.V^*[*GB.,XA,%_-,TQ!HSDN5#BZH\PE<*GR^@`'.`1JM0,T2+C^ESI_
M\W,/(#<JZ[6YXT$RL+X=9C7H>F1VA*Z&18/),\\AL&/.S`!W.[U:0XLNU3HH
MD,HNX`)0LP$UT`,UP`)"T`$MT`,ZD`)"@`(CW0,KP`(:$,TZX`$;D-(G<`$=
MH`,=,-(I4`,ND-(]T`$=(`0L8-(ND`$80`,Z0`$3L`(]L`$7X`%%H`(9H`'^
M-M`#.<T!.M`#*=`"%\`"-(`!T=P=J>J81+4_-F@"Y]1,T\QL#:EU)0`#3#4"
MOBP$#C"C*FNH6L>QE,6B#_"TF6:@-L0X!B98NF1+VE--\GRLH:-8&92GXOH!
M<,=WQ;.^#?``,>!5_]8`R53,(N#9EFA[8H-?JE1V2_,"#\4ZOS2@D!M<KG=Y
M#/M?HLUL<S="'<#2%W`!/<`"$$#5'3`!/%`#$9`!,!T!(TT!+ZT!%3`#4]T#
M$J`"/.`!%E`#&J`!*Y`!,T`!/3#6/3`#UST#/8`!-6`#$L`"*S`!-<`!&L`#
M'<`!.9`!12T$*T`!,]`!,UW=4MT#%:#=%*#=%J#^`MWQ`@6`=`,P-0?D`'!&
M`IG+0@XF!)((`^E*6X'#8`EPC9%,60CP3+JCG+T:8-Q8S<?*=+<$X0"YF96D
M-8H]9U7S1V=S=6C&?D>+2S>@BXLWI!U6`E&VVE,SDLO(.:-Y0LI(`)RC?6D6
MC+OH?*]87]MH-$`\`QQ@W1I0`QT@TSFP`1K@`BF0`B+=`1N``B[``3T`Q!J0
MTCEP`3K`VSUP`:G<`Q:@`R=``5W=`QEPY3.P`AV-`5I=UAZ@`BH0S1.P`1V0
M`18PYCU0YD-P`5F]YFD^TH@.S8:N'<H\/91%F)0)`@VDSP.&FT%.RT(0;I^>
M3-I*R.&H>A7NA]IJ-(S^?:P+.#K*W(DMMKYGYD<KOGLP(#T?,+>V/`(?T`!B
MYT"S>IQ#\+K>>DR`&&.9\P+3R9VJC6"GM^R,V:X.P#;':8;$SGZQ200<@`%'
MG0&\C0)D30/>G@,MD`$;D`,:$-9#H`$F;0-UKN:*+@1O[@%RWM+XS0,ZL`$;
M`-60KM5^C@(]8-\T,`/B+02(K@-@W>9LG@%9_>@`SQW*[$]`5P!SW0`X(`)K
M1ZV7!II>Y=`WH%PG.]@`])UDXTTJ\P#3::`D7\U+-XB\3.!F>(J/1NI?AYJ*
MZU!NTW[:.&K17JULE578PP#!U4S!1.`>%@!`SIUZ=_17RNNS-\T^;U-.(_3^
M"/8`)I3>.J`#$@#5-!`!XFT!1:T#$\#2^UT#CF[?%K`":7[2%D`#UYW=*Z#F
M-0`!+#W4]4X#6[\"$9`#*5#G&<`!-H`"+`W2Z3T#'N`!)U`!;J_G\?[H98T^
MU\')*I.T@;RKE!78CH,YBLS)E4X$.J:P""V]$,ZKXXRP(A!,\%.+R:Q@F-->
MSR,\$U3,\#,[;O>8'@0#=+7+C2=A1!!AM;@_NRPX&_[*%G=APA\"RV5V!:M`
M?_7-T[3[S'0#XLMV/'`"0.S2+3W2*P#2,`W2,\#2+9#2&Z`"'`#P*ST$*"#?
M6CW2)T`#0G`!+VT#0MW=U^W^Z`[5@V[^#\\"&?#^\"B@`4#0Z?50NMZJUG.Y
MAJ72$!J53JE5ZQ6;U6ZY7>\7'!:/R67S&9WV?CYJ]QL>I[)2+%7]7E_I4ZG5
M?H5N167%HL.%KJZOKH4ND64O@R+E[F]QI:4%4).13L6NLX\E\PYTT*]43G65
MM=7U%396=G6GZ:D6"Q=*5Y9WR[<'^$HX2MA8BG@(F*='AX?'Z#GZF=F9NME(
M9::Y![J;>MH[)V,;G!E:9\?(&OO<&MK<F=N;9^=\%C]??Y^_W_\?8$"!`PD6
M-'@084*%"QDV=/@08D2)$RE6M'@18T:-&SEV]/@19$B1(TF6-'D294J5*UFV
M=/D29DR9))-UJ;FK&)G^FSC/[%0&QJ<57\F"<F&VL^@P*L"8Z@1J)JF6J$O3
M3.79*B@QJV6VYH(Z$VQ8L6/)EGQQ%FW:%S*4J74+!8;;M#"@R$W+-IA=M'#U
MOJ`[I*\)O#OZON!KUT2,NGT'%SYL5S%@QFW[/I;[MT?AQGUQQ>@;.?/DO)6'
MQ#"!&+1FRGHMN\6L>C3K(7'UOCXM5_!JNZW5IM:;NX>,V[M+#W=[8\@-XVYQ
M2$:\678/S[63!\8E_+ENN<A[T,;]FO,0&8YCV^6^"H<``.L!!&C_O@'@]>[?
MOQ>`ZP#[^O0/*%//GK[W&)@-P/G8NV^(_/1[S[W^@OFO/OWBRZQ``P%`L`?^
M!0.LS\$=(-QPO0E?6)#!"W$QH,(`'4PO1?CDV\]`#%&D+\`&AV!1/QH!$#%"
M'65L<3T#_%M01QXW#!!#!7M<K\,/2>212/M.!!(`(1^,TD4*+:POR1PM;-+"
M(E]<TL0$J;320RS=FY"!""/L<LOW1!@B!!@C-(Q%$+,<T4LIAYB11!M[$,'-
M#0WKH<T:#81R2??F[`'%/@5-4U(`#FW`S1B;XS-31UW9`=100<4!!U!W(574
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M[;G?GCOPO06'^^^^<\H;[\,;IRIQ9`I7G''(Y38<\[[M'CSNRO]>._*R11^]
MZA<0,."`U%5?G?7677_^'?;896<=]=EMO]WUVG'?G??>??\=>-QU#S[XX8D_
M'OGDE;_=^.69=Q[ZZ*6GG8&NGAJ!Q.RUWY[[[KW_'OSPQ1^?_/+-/Q_]]-5?
MG_WVW7\?_OCEGY_^^L\?`#-62F"/@`88^!^``13@``E80`,>$($)5.`"&=A`
M!SX0@A&4X`0I6$$+7A"#&=3@!CG800]^$(3_0<`K%+`>!5B/="E4(3YD$"D3
MM()%!<`;+FC(DQJN:H8YQ$G:.G?#Q>$P;D#D80]_(D0=UC"(-D1&YXY8Q!\N
MCHA);&(4F8A$ORDQBFDSHA6G.$4D5C&'..1B$XV8DS)R\8I?/&,6J3A$-&+^
M<8Q.A*,<=4C$,C;NC5XD(Q9W^$0[^A&/89QC&^>X1BI*48V#6L^CT*,>*ZT0
MDI$D2"WXQ$A5I.F1DM3D)OF1ICFA4`LL$A(H.5E*4WJ!12&`H2-/V4I7RH%%
MEH0E*U]92UMR13VRC`,F;]E+7]I$/:HD)19$^4MC'I,*L5QEE9#93&0JDQ7%
M=.8T>^E)K-"2FMET92J9&`=I:A.<I;1F-+$93G-&<IR-9.8YV;E":-*BG.V4
M)]G2J8H8SA.?9%/F,*_PS7Q*I8JF\MM0BH&Q(`IT5_O2',)H==""/E1>@8S8
MXYIR.(`U%%;__,(^X;E.C6+!`>L1@"JQ%R`9-&#^`5%80$I-%5+W&$`QA-*/
M##Y`@%H1X`%0R(\`<MD#`1QJI3U`@'X20`+]M&$((1U!W%S:'AG$H$0D(($,
M'R2#D/(4``Z0@0":$P+Z.*`6V*M2_N)6@#D%`*D,2.D-2@B``3SAHU()YC(S
M&=<IA%0$,<#4#40@@/%XI@<*4$!#!1L%!1S`-`<80`]"X%<8Q*46`GC``P00
MA;,,H`$O0(ZEAE!8`F@U+C=H[%.QIY@=%,``"8C;8>/2``*,R"]QZ0$(%AL,
M`,#@!J8[@&9A`(`>&/4#,:A3"6X``!'<@`&UE<(`5.D>PRA`M0@@0`EB@``,
MV54H/64%+[%+!0(\BC#^C!W`#6(@`[84%@KHK85Z`4""$8S7O'AYP0`&\$(I
M$``$R@A`7F5P@)0.P`$XB(%B0C#>&QA5,268KE\[.]@>F$``)@@`#,RK&!`0
M0+^'0N\+`A#8E`)F!U!-P`MF%04"J%(`!5!M`E(:@$/AX%#=K<([[1E/&>_`
MQ3BI$WMD6%A<^+C!<1O`"(S*GD<2@*K+S>^5V#.@`NA'J@<B08)26@`'#*%-
M!2```(*;(\9BN`<XX&Q@'3RB'N"WFR50STBIP-P>`$#!)5"K#`"P,1E;@<9R
MX.Z=E0%G9<RIP`Q5+YE_@MX>#/F]P2C7!PQ0`*2:>,D[`(!]$S!8`K2!5.+^
M96P`FB.#`!B@`0.@Z@*^^X`YC>@&HYHMF'&LX3+[M@`Y'<((S(N<&#Q@TE-`
M,P!D,`+4,8#.W.DUGY?24WYFUZ/$3@`!V$*H'8B`U>L=K+1\+.U9`V`'(<"P
M+J!Z%@"`9@AH#G.."3V`_)I*VPGJCP@&L``$+."G/:BT93G]$Q.TMP>XQLN&
M??L!SL*V3J8-@"HO>F95<K:$\1F``IK#@,H>>YIYCL,-;"SC&VAHJ74*`'U.
MVA[W='SCO,;4Q@.0<8^OYP6I'<*R[QOI,4.W!T\.>0("+1U+)6!`?[KRO'$Q
M(O=XJH3N:8.U*52+!;PGISA0TF!#D&2#O]DPO1W^T'S7\UI"$WM(JMQNQ>_\
M`A-P1SEG,8$)=C`>KY-]/&-'N]C!?AJUX\`$`-L!V2U[GA<`K+S=.7MB<EL7
MR$)A/-(!-V'<#AS3Q%@ZC8%+"?`"&!/\Y04.`@QR[IZ7QL2]-.#F<SUGF>S-
MBZPI);`OULD@<3CP$N+G)"CG8I&5;I)>(&D2ICKK"GO;_\ST;Z"XYXE=XM5[
MA:*X\@HN4LTWJ10_H9?[/12'`D3*P3[W;M@SUG=`WX*/000RQ,507[C5`=S$
M!#G=P0(TWX4;),``<.V!OP&0`.2$__53,,#L8<#5^/]I]I#2^NUSH=V.UO[.
M1H``"&"II*,$8"`$;(W^!(2+.X[KM^A"!D``!)#CPJ(`108$!`)@O'J@!$*`
MAD+@"62@``K@"4:`,+Q.!#H#!'IM8T1KRM;O^Z``>P0CM78`R;H/!%YPUA+P
MT/(+!&(`!@)`N%+C!\,MOR)0!M!L!T:@`&/`O9:J!![`!&%/]NY/#7#@I6PO
M`1R@`51+D9Y,2`@%#&W+,)@+"Q\``62H`J&@`!A`AA#`X7J@`0)@`&_@!@:`
M``+``?8'``;KVS#E`H-C``1@J&+LW@8```Y`!@8@`$[HVAI`!L)J/19@1!#1
M2@Y``!`1![X+>W"@MQ`@``0`.=H$$57)W"`E`)YL3C!Q`-:M/19`VT;@`!S^
M#.NB[PJY#KN@"@:@RL(J:W\8RQ=]J]6>3C%P;;:4R^`28`00@`0$(`@-PP`>
MX`-D:$1P8`%42\QD@`'ZPP$PK`'Z8W]B['0HY`7830HR$`"F*[!4*W4HQ`34
M+!A```=09P`48T1DH+ABH+CF)-0.300@;`A*#L)()0!,8`0J*^8*0+-2[YG\
MK\9X3\9```!6"@!\<+',+-#,3-+*,+\6P``8H,/2#1<&0`0^X-U>(,+:#_U"
MP`$$`+H,X`868-IXC0%4B[8(3<P,HQ9.;`@0#1EA8%..K@=D\NG.C`G![$_6
M([\T\MMBH-[,C`!)`,Q(TJB@JP!,P!REX\DJD@K^';+S`+"[$&`6$^``1J@"
M,?(B`P!4`,`$VVL$.@PCD?+,1&!_\DH(X\TPIC',Z`+FLK$F5RW?PO#;TFNQ
M]B<&LK*S8A"J9.`:Y6VQC.HLN`JY<,#1"(6\L$W28D#2<HKEO@LE0ZR]4)+R
MOBPYV"*D&-*8;+$J<#&N/"TRH"K;+M*W,A+;`@L`GFP$;J`1$T`M$?/0#F[`
M?$LB+^2%(J4_<&V$:-(F%VL>^Y#<N@,1^_`8HR`&HA,`<@HY%W$2A^#HW,H&
M\ZL`%``V-W+]YF/*3C$!;A,`5*D["0`':@X$!,`!#.##J,_8:(_T9(`N>NX&
M8"PO>J#O_#,8OB[O>DW^/^T0\30K,T"%Q`QP,V[D-#)#\(+#,,JK!&`K"N`N
M,@*O&,9N,")T[L#-ZRB)+3Q#0!LT.(AK-I`#!XA+'QVO%CA4.D8`\7K/*[V)
M-?D/(&J!!#10.G6T(CCJ(<$22%E/#6K"ZVHT<ZSP*XH4#%03#?S)25OO4_8&
M-:>TV(R+2=%@^K`T"\`%BNHF3)\/HQ['3*UPB"3GH<[42_OI1N%`2MO4"K`G
MY]JD`+6`_7+J!;8L`'00"F+`D9##WP2`D7@2"M`O0\$0W*IS(@7U0F2I^@8`
M8.B4.]E23N5*2[>.F:Y4HVJA3MQS$]<S.#Y`'F]@"DT5%[#'"28M`1#@!EK^
M\FP$@`%BH"S?;`2<;2BU5!(S22QE0`%22@2>2Q$'SE8M\R<$D`#I)!UQX`:V
M+/\N=<;>]`WB%%K/T0`0@`G3T`.O4RS3XPD>(,G*L2=%(`%4ZP,0<A="@"T8
M+=$.3:H(@,TXT,KD\M(XL,,.8$YR[0,.H%V_*PJVL`N'``10A\A.9\FJ=6[N
M4Q5VCTBAM19`X`!8T@%"P`#R2S'\3=X&)!J[*0&^CU,.5@J,R@32[<R6#,WF
ML1R140PW#A=R<OT,("O%+3ANJ[<L;/X<8&(K%F'Q3&'U+$>A%004,G5@H`#R
MBP'HL\/>LK2D0`$D->8&1`34<@J,:JG64-S0;`'^]!!%/@DP/B!J:2C'(!;:
MC#!N)%*MN)+18"!U4N[<=K9OI%7Z?O92*W``A(0`WS(SI/8`"*`^N5,4PRT^
M.E$*[NU1]L>\`@`OT"P$*NW)]D\!V@#F1C(^#.`#[M'3&D\L*ZU6*U``^D-F
MW39#YRJ:LA!TSW&QYHTD=1.ZA+`\_?3>0I$MMVH]%M#^AN#)U*,_NI,63Q$*
MUG`(9(H`D`/-#O)"%$-W`6\P;2XVY6VP>+=T=P%N;Q$BW3;P!BPS;"TW*:P'
ML(<7L.,=V4(&#C#,"L#NO.Y"8;0N&H]"I2`&5#0S\.(&&"]N1A3P$A0?Z<)Z
MU^)YBR%ZTX!:]_<*\D/^UK;@,/6!4[UT]W3I].06@!>#*QHX(;CI@,.,@2'8
M@LVF?Z.T@E4(H5X/^;;4^+C`SC"'%YIC!\Y#%T:8H%:8306);4`8^(1B8PR*
M.R8GFS@/1Z=WDS`%J[0J!J&@`=3ODA9`?;L`)3EP0HI!`=BB`4:X+GYX*',.
M"X`-4?JV"IR2/A;@^K;@,ZT`!JXU,IH*L8)!/$4XB;4)2GMB@TG',\1R+3AL
M")M`,6AJ!7>!UD+@4%#PA4B`!Y\-.6"`R"*#!#"#!/[X`4*@X++M`_YB":>0
MPZ3C!6,`!'1R!'``UR9P>W70($N@WJ3M!;3.`0>%.R[9PV`@!6<#D^MBTF#^
MX-Z$J0.%30)MK03<Z\%&0,)X09(/I5Q_PB,3J[9,4(^[(Y5_2QX#2P!(`%1$
MX)0Y<&2?RFNWV)1P&$[7.(7XC3<'@"V8J_H^P`'J4;_P,-<2Q0'2$Q&AL7FY
M4+6VRK[$S#,(50$,0!<^,CY+P$-"\3YZ2],^E<O>S`1N-P82@*?Z8T0(@!$O
MJDT"T=$X\&]ML#UNH`$Z%P`&Q*OR4"<I1!\!=<I0I)R+ZP$05>,48*`+&@KJ
M!!$=8$0$(#Z(#L?RU:K6XP.,*@]?"!-#L4=O<Q$W#ILAY4)(+004H``FF&J$
M%)9(UY5J8=XH1`9<-BK9T@YWH>1ZP`'ZX[!^B[/^KE40D4RA!P4I)>VD"K*I
M">0!;H`M**M6T(K.2%,`ENH?WRPX?XNK<*P$$B!P:[.S^L,I;X#1$,4+BRZP
MA*0;?Q-1)*^W9NK>H!$!0BS?9A-!#N#*N!<*9%61QH\6"6TG\XLF'80DAS(!
MX'$'VB#08-5#<NJSAM*KG;B4A#J'&W:3^(T,>S!7$Y&&..LF"VL-2=;?;D$`
M!C:E;0L&=F"H=B0*/L`]OH\H`PO89A/#GC,SH4J17K($='9$KJ@OA9#.FG&I
M*`D`FJ.P]#(`$(`LZ_,>:X$!$&!L&4N&CC9K2;-D^7K<=%(Y"8L6>?*]*>X`
MR+(!2%9@%PN]"NL4;^#^M\^XE:I04U5;DS9,+8?1S31S1+1.TN)CO->1`_UL
MX;JC<VUJ_0:P\;"P0I]MS(*C[%":4,QK/<\ZW7CR`Y:J*7U+S4J%+G!.#ND:
M47P+)<\+M>@-.6"N`GGR10%#:N70`$;D"0:``?`V+E=N0#!%%PA`M7!-L@W+
MP8R*+=Z;&.?N/I!K>?U-Q-L`S<1:D914G#+X#/YWDX@NNLG3#-N-`0C@+["0
M$2=,WKRP._'GS#1VL.ALA'SEME"R`0ZKAE.GFZ=L*X4$+;<WY/*UO-8#!MHD
M'0]7`WM\*.OV.IL@TCMC/6)R.0G=/=K6Y]PCWMJJ'K=J=;,-S(*0#AV]1]W^
M@S,GNTW48[]LBS&]\-2YTM-W`*9;*$B:XQ0YN0L-`)HY*8W-H)B`>FJL]S\?
MC$2#P;TNJM5>X#5!`P9*`&#H>7VQ</]`+#A&0(B;@-;J8IV[[U#B-S(PS^LV
M!=J+0T!GP[Q&K[=J]-DGE$/#5WWG;NSD%S"D?48/M.^*(]^A('[Q@MB+XWNA
M`.U`X\!2@^X>S+[&KBZ$#=MOZ=?+0,RUB3R_@%!X72%J`5,F^X);KV=WB9J-
MJ?*^('ZW0MBIP#2.M"K>H.1%Y^%+[^,W7N5A?A8$'#]EWN9+HN7'(.)OGN<Q
M0II5_N5[7N@50H)K?NB/WN?!'"J"'NF;/B!^W@W^@MWIIQXB<EX,=I[JM6;E
M8YACH/Y(F;Z[MC[K_P&UIUF'W0!B6Y4L'X"6CXT)N\`!3'N)ELBAH^#MEQ0G
M;M4F*H<*XKYOJGUN$*#\PJ!RH6`![K3PD6$;MU#NSC$S<NKNN;X*1.!.#=]/
M<8($#*.)Y_X+EA$!$,#+UZ\^8\``V&*8$O]Z*I\+*.G10(H$H2#SH5KNX4#K
M_#X+8G\5&J#7]Z'LIQ7LS<^\=BL20:#U'Y@-8/A&R,"_?^+XI^+XHXD*9.#.
MKR`$#@#`Q8`$<B[R/FSYI>`&/A(?:VJ$I?_!6`J4:N'YH:`$9I$8%N`)7-4,
MJM^\!%#SQ)O7!/:VJ@+^A=+_"TS`BJL`"&2'&ZYG7)1ZB)NQZ7Q"H]*G#&%<
M3HV[WL*4_8*=V#"Y'-X)`"$S^XE+&]KRYQB48!Q`1E/B\'DZ,/4T])!\X.GU
M@!PT-.A]'"1XX3`D!"X8-#`]%"TR,)#L.(`8,,CT\/D9O2@@@"@XV37D&2U*
M]E#>]4#>@C32/@B"O#2]("`<$+\\.!PX],`\/!@$]LC@.6P]&R(.`BS<.!@L
MQ$`E'\B(-GW$[,R2]\0H*!B0K/YMR1LUD#0H+T!A0*@)B!(W$B`P,*('`P"@
M`(ZP-ZK4J28B#B!(L"E$1F(]0C!RU&2+`A)(>H0C!>Y%@`(O$C1(H,#CHIG^
M/4:`Z.:@XK`>6Q:(:$+"'A0'"-9P0>!E!$8L)I4&,^*@4R0F(Y`1`P$CR@@#
M&3<BL+D#9*-$1D0<"TKI@($_UC#],<'(V99BK?0T","@;@D!!$PH:-#1)Z^E
MO@J0`*F1:U,F)(XM]#DH`"P$1A,0B[&`49$]?E\`/F#B@Z"I,A0P$F1D;=L>
MRZ9-M88H0<4YML^D"7J[S!L`<7:W05`Q1(`8-[K<0#?([15!!SX.@($CP8@0
M"7#$&#!"!"$A-W8$"'7`WH<'/0[LL(,#1H"@`4+L0)O\E*,=!%[<:%#`"7'I
M,T-T-P1XY`487W33A0""'CN,P84])#S'4@FB,!#^0P`3/@!+`2.(`@MZ(@P0
MPW0BR+#?`G^8],0+SRV@1P+VQ!`'`WJ88`5+,KQDQ`-FG5>.`3*(8)X#S#6!
M0#E/[!A/`3O$@%X)`"49``CQ/6?$#38]P$`/!3"`PPO[?7`=#`.L4=<-<80`
MT!M3,M5#`D$5L``.->Z2P`XO$##6@=0EZ%.#+P#`B!=2,)!F#R4T8L(.6&H)
M`@'IT'9%>@KL`$D)0Y`@P`X,).$&HULR<,.7=:Y'IF0EV+D#9HCNL$,R/=1S
M)@@R`!#*`\S)<-]TL_[HQ)M;+K`#'XIH*82!,<`@@)8.:/G$E<0P$\.2TVVU
MBG($R/D2@UZ$H&5=OSK^^MT8PMW2K1,C-+`##@;$8.&$S&XI`@XA"-`9</>Z
MD1N^8/3VV[YAC/&!6Q^(<!4)(BPBAB!6@##P*QY]\`K!)"2PAA4]H#9"10C@
M@$"U$2MAY0+6'?R!`KX84843`AL1L0(35QSR>2"(\-AV;L&0@#XAF.?$:`<\
M9P)`?H[0+(,C)*"%`=,IXO!YNQ`@0K5:].!`4(#=]-P'SVP8`@D&P/#"T`JT
M8Z<3#80@0QQRP>J1&+4Y\8(=>=Y@Q9.[Z'&QRDZ0\`"72@BBD<<M$RG",S+8
M6;>5+"8Q1',(>-2`""(,',*5'_7<1`R"#;!D%`N8%!^`2>S0]]\@`W[%=!7^
M7=EI.9Q&4?H#!&@Y;MU'LOQ3`R.@"U`,:88HMI4W"+T'0%N@#,T2%S=QDG#-
M)4"SS4%><4KQ=8UD>KH#.#"A$WN/H0!3B8U0`!,_)8%Z^.,7;/[W:0H0@_"'
M-@`#\PW^>V]ONN4?.QS]@Z$.`RM8'ASP@$Y5SPC/:5C+0+"`BKBL`<P@C>*,
M$`("Z`5PD<+;T]X"DJTY``8,1`GSFM;`!4AP2#>H(`)2^('TN$5E&F&`VP:Q
M@`/:[7@8$X&W=MC#)21MA!%SE1&Z(H`J-0%HQRC`*<"F`"(4@!E)*IXB0F""
M@32A6^6YPMT"0I0MC.`%2'-`C8CPG!+``F07JZ#^$0)#,X`H1X,0Q(<1&%"`
M8PS@!0Q*F16<M['I"()@(QC8'S2R`+?=@$<MD@S5%A"-$E2H`4EPHPB@Y);G
M:?!\7!@4$[H0!07,B(=*V-A!(+@@AKS,@/*SS)->(+Q6H6)H=]L"ZJ[$QB,D
M`9,<:^$$89C`63Z!D@"!`0,$((!!6>-BF!1?6QS@@,@<@3R7K`@S00A-5+#R
MD/,K@0->F3H``@<-``@*]L")B_^94PH!&V".?%+#YY7(A+OH%E(4P!W=&.<@
M=20&#I9D)P4@960R.PW%M!"#$ERL!+^A92(^T*W(Q$`&'3,"=8S0CA#`XB-!
M7$#2FK`W$ZSM-R:@H4C^'TB`(HP*`;Z<Y],^0!316*2C52/$`RSCDP,<B1A4
MU(Q2J("0:CW`&5$@P4FM1(`81.H&2U)<\7:T1Q(VH8L.'*6D!,H%L\2H+B.@
MU!K[F,N%+0HIR:`<X7;!T2=$K0G/_.0+8'``@&@SHZ_8Q32ML20&>$$&"QA%
M<V#W!*E6!JQ67>06F#$\OQK@!8BKQ3"&=KU"5`FC3VW>5R4E/HNN%`M4=()4
M0]4L0Z6LHV.0!'I6@;V3L(RJ:EM17?0HF9.<)VRR[)+[2F2O=,IA?[AM0K]V
M"X5UEC4!7"(``F_2P@400)X@"TG49#``!2`$JH<:0`,48!X!(>`3XWRJXA3^
M,-PD.``F?5A9Y6X@`.A:H8)C0N]'"A`3L\5@G(S$6'91XQK:,>")>/J$`DY1
MTV8L9(%.*T`(L;6`H>&R"?K<01Z+J*P#:*F+Y]D/%+S;!!@`P`LD*.Y'&+&`
M`02E`9G`Q"FBF*+E6HEY9P(E`@!BNXY]H@!EXF`3%#`LE#Q''/+8V`Y@D`GH
MTK6L\>5?RB"<7UC@@$=<2,(`_F!C6+$8(*F]2@,6L*074".MF<C$DA5AKS,M
M@`$M_B;'ZO8)`B`%%W>T\@U&0(`JUZ-J";!R+(T@88P%!FQ$I)J.%Z,$[#PW
MNB-\'B3;[(05BQFNF8#<2-SKIC]^@+H%X)$X9!#^`K=0&;D[>("D>>3F&+M2
ME@!!2Y7=Y]LVB#/-N!6GOT[M&H]61`:",,$(CA0WC95#UBD[!0Y$H-A3E(X$
MG7%;#$0PJ*V8X`8ED`$#W>:1%XC`UK2^@:VM$>M3W&`H6V"29()=!%F+$7M^
MYBT).%2.D0+I%)"T=&U@0"(C;$4&UXZ'/60P`@Z[MAA;@)N].T5M@B@9WE-#
M!1-D4.V41:0V)1C!#>0-#1+\V^'5ZO'W(O+JJ;4#)6%T.+QO"P.#7]@GN*Y+
MQMOL$8[KVDVJR=X(!G6G)QC'-:<0D34L'N_:0-O@6\!!R[6PX7PP85853T)F
MZE(MGO_ZKQI;Q0BDD]/^I6-G-0>?MD\&+G*=PWO;0_EV1:K5\!L0J>;V<.W"
MX1:/A<"`Y%N`01C=H+&&7YA$&8]!VU44;29Q&R5=)U$Z7,T&W?JVMWX?/-7`
M\`GB&6#EKBXG03*:A3MOEO!3*)'942WYR\_U\F00@>+#J7DRW$#5GQ_]J<5)
MY'2RFO26[U]^YGSPSR\*F4_`WN\8^0+1$Y[Q'WF&ZGL_7RC$/@NZSWWLOC#\
MPI\!@,?WO1F6SWQ^Z2OPZ'P^\JEO?7,Z/_G7W_[UL\_][X-_]*;_/3C-ZYOP
M^]W[Z%\_^]OO_O?#O_WC]VWJU7\O^(PD"_E)%Q6N"07B64,-`5_^E4'V&6#^
M%IA`Y0T@&(3`;57?[$5!DCE!.0U?.=V`0-0%CIP=^37?!-Z$K56@@O$(XU&@
M%#0@&91`$M3;0N@>#+R,!YH`MQ0?&\"2!]H@8?37#4*!O9&?F7A!"A[*\&E@
M"%C=;NC>O/"'`W(@`7[$;2W?\6W!"YR;%Y`@%&P8(V&/[MG?Y^G6%MI&ZKD:
M)@F?(I`#XP$3!-Y-[K`?_MR&&-Y&$9I!3J1=6=T9OGA2&<`A&[AA%LA:<AP*
M@CW!B;S>$"&1W]4(#'2>%-3A7P&$K$U4%+`,S:73WC3''+#A'*!6V$V>`L8?
MX.V6X)T:%GS`@464;G`(*C!%8O$@O<V/E3A`F#'^@0(0@#@@!C1\0JX]5)N)
M@#VMPB=L1;2M0A+L(@@H(4J\8JB<!4"%0#D0$P-L!=WM8E",P'D1CP+LQ!-4
M4DF<731JP2N@46V0P!552"&,XBELE1[`0`QQ2&3LX@LEXY1,X"LLQ)D<@+\9
M0`&8`"N(0$6YQB?4$!+BPAJ$8P,X8Q&)#^PT(S$P&P-P2)5-0F1L50CPW<'P
MHBT6I$]X8PXZ`3#*`%%,B12"@`!\`!KMXC6]P',56V>L@8+(S!Z4@,D,BM!4
M@^6X!C^M@0R\(NF$P)`X00S<(L80P#4U8SG0G465@-@@362\P$\J`(BYT@<(
M0#;(RUFH#7$EH$4>B;'^[94"5LJ!Z=1+/IDQ@H+CN0D/76.E5*0).!`QF(QN
ME,1>,4EDQ`?V/,DB?:"=N1DZ`,@KQ.1>,<&\C((4PD"8$20Q/,DU_B%B;M_X
M>>$<@,?YA6&E8,95L`(N-)CDQ`3QR)(_`"),Q$"8]$!0B<T32<M0,-&0X8B4
MO$0P&(`)*%2;\=Y,9$D,A%<4>"9H.H"-?0``1%1KRH7!20E@!`,!)(;'A(`!
M8`]3Y",3L0<(`,8S6(8).("F-($=#04!7&`!)$&&O(!1*,%"!.4>,<MGP@)!
MQL`#R)2;=),UXIFMS<,-8-@'L(+&^.8!3$T%*8Z5E0`),!%,@D!QJ(UK_DC^
M?(71>&"9>%3-3.PF<#IG`GQ`@,K%5D3G=-J+-JS!<4)5Q.!)/@*`?%8D2E!#
M*5V!(NA!E6P!O;2<`:1@:X:`B7A!F*&"AX31B_1``#R`V\``8O!G#)""L[5F
M"3#1-C4`K3BG=04HD#+;CV@H<5'5*%7"#AQ2B9@F,1A``I3`<>I>;K[`UWR$
M`-Q;G,D8&K5:`8C&7+T,,3T#O9"`7CV`3SY#E9K`<2).$:!1,2B$_00%;#$D
M3/2`"(P30L7`U\3I?H#'`\C`$(E`"8A``'0DY+3)5;@;<G*?)^(6*/K6\U#;
M["Q*MOE!/YE0%W'38#(2#H@*'OQAD-GEUKC@'F3^%#?=2L,=@JI80]+$1#H,
M'ZDNI4J9F@+`P)#(VP<T`%+9&1SM0/E(XDA0VP7)3ZN:@K\XSD\017DX@#TH
ME7-\G#7^`>+L`-A$%$ZAIZT60Y4HE3S18:L:T(."G0[A9Q\1!4,ZCIO0)FD<
M:OW`P@U$#0YLP4%LJR#,1#NY*KH"J]HT0>*I""PL@)&8"XIA39W5A2>-"XE.
MEB+T3(W<`L9$A'DD@)V`S@B`0Z/ZH1/,2,N$$"!N*"Q1$:((JS6(!C[BZZFB
MF,J-*`,Y$D\2RWF0$O#!Y^Q(;,O43$8UB1/$D?C0!K+L!PB8AS$87(QTS)$L
MP`@\@#W<H4_@0$=.VB;^'<$+\,,N](Q#*4"G"%25H(ZK!`4"+-MQU$P!M$-C
MYE[T?>+T^19ZR`4"0,+N>0T(&,JMG.JA=!,@*D9-'0HL2$.7T<^JUEDA&)`!
M0%=%]=<(-8``!``A,%[?"LYK=>=;(<11MJJ+G0((#```F(U%'4--R9:=U8\.
M/0_ZV)DS)<%BH>X"```3U,T.%$#B/A!#!,#C2L9C,0P=:6W>DL#A)BXT59#*
MZ.DN2L9,B,,\6&EENL8!`,``F``@6<%/A!KI3@-Z':7I=AX"X`3O6"G>$!&H
M#@WJCDMZY`W5I!;B;-!R)8;7/(<(S&[&$F,)"2ZBM*(1\*=O:";IBNH6<$S^
M"1```)A/91)B)2I!>I@'KTK2L#;I)5Z*W`H8SY)5,KU-&Y4/1_$IRY@`MF0L
M(6"20TEGQ"[*<>E!UUYMUJ96Q-0N!U4)`]EK(D2"3-Q"I'FNVOH=I::3I>Z6
M1FQ0XEV)`N"`8'@!`W41=VB&9%30SZ;A'S"`6S"#J.;MOVH!$^QD#DJ-$226
MLUQ,#%@!$U'4>;I%$9PLL6YI&YT2;/&JD`KL3:D&4$@%NI".%\-*NQR`86DK
MP:+$351+%KO&;\33"-%ALTBQ3ZB&>C%.'4'(QH"Q%@B+FB0"0DV'[%8$9D#Q
M(+<*EFG!NV[D42!5LZ!8%T6>'_E$'+!D"27/"(3^%U$`5-60+4*9!VBA!!MM
M@03IR(WJ4#SHQ@/0ZUD$J]XDEFX`ZZJJ425NJPGQ:N"&I@<OS/8"6P3O0J)V
MU,\6";\^AD>9T(I8\^"4)<;P9%T8K50XV:`8R0*C#M>JL@@\U7)!4T_EL6N:
M,?<QYF[5WZD=``X<6-$,P"DP`$!@:)#M2HON[4A0`UKLQY?<'DZ52`BTZ/Y&
M\5Y0%RE,@N?BKP!(9'_)WK8Z@'7L!\6@"V_>`'4=)PR,\7G<*`$\K<XT05`9
MC@!4[ZF^(CZKAATE"%QU2DT5C8<TCJ)H#9KEUZ%0]#[:"R@]AGFDUHFBP\DZ
M--JTIA/L%=*X:!N]`$+^.2U+?[12CRX7C$<#?``./(?--```X`BS,IA2>\$#
M-"T##`#Q4&"#&0`PZ\&&B"\CG819%XT`D&@'6=``T,P3*9332NI)MDJ#;>N;
M',`(/*)'R=A"WR^4H9$]1`_\[D0`1,Q2CP,)=&T,$$`ZOO4:C&)=]RDZX)52
M*;07ZY):.X$"`$4Q*=<?[-4^%N(8H`<F[",AC)!L\VF5CE$=@37?%`#E--E-
M4,<#,&INKI1#?4F0Q$$%.93?D$##X(A(!E7#<0_2Y&'O=6';0N:IA<*F^4-;
MQ4.N/=O)W0IH*-OW.),,7*7=AN9"R(`TG((,=`IZI\SJ;@TR@4XQ2-!W\)[^
M1YUW`MZ)/\#.O.95?!-=`TRM,PD@@*RI8A%X$>%5"=@+0X)`-2Q;$UQ14!3;
M*DACZD:%:TB0V7%'I[C2!!Y0>5O#ZC*#[.'"A)=QA:."NH'"58)=`PQX%DF.
M3]B#EP!X]#9X>]-X$Q1-5(>FV2F*:PC"B!L"?,\W9U5$T;BS*Y4.^GX`NAQ)
MK\*C.YE6-^Z.R.V@>Y^XLP!K?(]W`II`/[A<F->"U!##[SJX:[9*]RB6-7AY
M(=2%/1BJ$^``L+H2LH0W1G93<9TBG=_$*$2A1Q0K7Q5"=YH%UI03NEA.IT!2
M.,I:L,K/*A`##-0'E]=DWQA0-T&#*J6,,U5W[\W^'W:W6OPIWZQV!N-=>>PP
M&FM]'FRANAR4X.R]>FFU0=I<7FK-^K[HNN_5Q8WW.N'U!NZ!$Q@.G@TOX1.N
MWA%@T?\MH)T90"000UTX7Q;.X!@"@@!&N[8;G[<SX;YLH4)1.[C/5R).@1=F
MW^3\GOUYWP$R80A"8;AG^PYV>[J;.[Y'`9`6X[)[G@ZN7ZE7JML.>\$;?,`?
M?,(K_,*GD_F=GCGI,,-?'K9+?,5;_,5C_,4+/.H1/&[U'162@1;"S;O3^P-V
MH$]P8K?G0[75A@U7V[6S`3)5X9>;/,#WW1*BPKU+03F("L[KO!20H+(S4KL8
M^11$[VW,NY6`@/]!H+[^UV#)`SP43"W`MQ:ZE]-G@CR\)<A66+OFE`-^4$W/
M;UO&YT^Q^_R^1'PZ:<1AST'D+5[3[T&SR`'(;(';QWP/]<\>[B"'@5YZJE/*
M+Z'B+"+4?]X6F;`4Q!$8*'N5$<79^QU+CJ&L9X$E%%>D#8E000'+2/[@"SW9
MCP3;#GQV[]8&:P79C&0Q?,"@*)9"QX-\GHUV%I'0Q<V5^H1"%P&UO<`'5$M4
MEXE"U\6\3&7MXQ]\CL96B%AQQ0<($(5B+;U'I3X@.P#LW\2#^HP@]'SHX9\X
M=`I.I+PAZ$:QRK[/L$.D%/]J^+[>[8'N*^1!R;Y:"IT(1,T6O.34C`92P4W^
M.G)2V+B^10S`ACFC[@-!3UCZP(1'F"ETZXU`LEXL)MR9A$[H[C4:]8A&H:EX
M)(=!R][GTUM8CU]AXA7JFM$R$V@*'WY>Y::G'IF"!R8DOR,LH1<9D9"H#RNI
M$A"<&Q`2(9S'G9Z;I#&R'2<F!+D>SA#/L(^IMIX=$1PRL;\7`A'6)@,R@RX9
MD#HU-BN<$!(2AM20U9X7-YD_0.IJZVOL;.UM[E0!`)%N\3*<[]YQ="^!!AD!
M!)`$D!Z0`Q"%Y06##X6"A`\"-ST8$.B"@,$'`P%[%#@0(L:!!P\,X("Q[D.]
MA?4>1C1PXP:"#PX*R+AA@"..%P,:?$`0PL&`<$?^#B0(\:['S`<,$O0PH<\!
M`4A"%A#L81"A%4_$TH#88=*!`1D#"ZY,2"U?B'L]$CA`6"*6$)T?%@SHT4`!
M"`2S0#XH<..%`H'Q$`#H$8*``XDP[(9$,$_`&K-HY2WP-Y26$'KPEJ5<V?(K
M"`$A3``XB,`K@[,VOP[]("/!00/0%@A15K0!B*H!%(QPP(#>&LQH(>T2\@]$
M@[[$%G@5TL#U@34%"H!8T"`-@9`'Z@9P$,-!9GF^$W\M>K#`BQL$$ACQ%*)>
MKNI=V>CCI^!?C!$#<A8`64!7`0=/4:ID.3L.UU\)$MZ`_Q0*Y@<&B,HK!.`Z
M0B=Z0GA!``:@$.(`-SS^H:4G$!C(;0T%3&@*KP(::.JDAW;8H0#>TC'Q1!31
MV>&;F%+,9D4`SG%1&P1N:,H3&?I"P,$=&X"D)%J4\F(T$?IJPL@'_W!`GGE<
M42Z*7A!0,B@0'HBA`%JF>(#)*A\:H@$81CL"AREP:&"TT(1`8(<$ZCCHJQ*(
MW.G((PCQ!,OXA.`*!KA$6(:G.4>98@>T1IQ"!@>C*$#"`THP4`8%2NAH$"\:
MX$_"7D+X4PT;O<#RHQY@F-.S%PSPI*1##(UEI!>,C/,(4$UPE9TY/SJ,C7#\
M#`,N`XQ`P(02_C1!@1MOZ@('&6*H%8%;D1B"@'D>Z"'2KPXX=HH#IJE1!D_^
M2H`V!.->J/6`':Q-98HKC!RAK]V.8).)%SY8-UTV?IST`Q%&$#/;2C\PKBPG
MAQ#SDP*,@*+*LAS0\P%(21.A@6`'5M23&*(\1,U$C\@0K!)$D%8!&![X%UP0
MF`2WAX@^D'9&EEN>$4;[7`:DG!AEOJ9&4`=)``?V#D!@)(@',?(#>;J%BV@A
M/"/C@/]Z'NZ%T3RI,8&F?38)90$"6*:!G@U04,P2&GB+NGD,\'F9'=6\@>K:
MUACB:+=S%FH$J-G@+>RQ[4+@``,D?H/O!/H:(>L$T.4I:JU((&#O`Y1[(.ME
MP@ZSVB816P(!`_3;X0;E4F)<@=*D/F3MS5ZH^W#^6)5[M5(9!L#<YUL7T$3O
MQN&Z#8>=:#>`@9QA(""`T#PW^X!FA8CA9WXJ;U<(WX&WHD8UR<0\>81-T*YQ
MY6(8P/DCE,IQVA*5?LSM[]O]/@T11'";;1+BNUMLL"4>/(`$,)$6EDHG%U&@
M``*89HAE2,TS&6/;5VZ``\8=H`!*P-`+',";]CU@<0I<F7!L=D$,:H-F+<J@
M-VK603(P"X%"6!O/#N,)!GCE?"!PVY#F\:=2A1`*"PC*VTBXD[31D`J#,`*?
M0E)#U.5/8F-#'?2*@L!I($U@+V3$DZYPCS_HL"X-B,'1_D2V,:U):#R)!)),
MX,0V(6ES?PC3`UY`12?^*H>%M=&4MB[1ER_6PHE&1-6#8G"Z5YVJ+ZL+FY=V
M>(1V5<A=44!``[H@R#H924,R&$&CQ$B-[:A)>25:Y`@654!F*4!;E8OC#B=A
M258@\@7*P9_.DD8T&))2A4-+G]O25H+X!`5<DT.=)ZH0A0?0<`U2!%<,Q/0"
M/XW`!&0Y0B=-6$#$2.P`)$#%^*85`Q^1)CY,2@5/#*!)$&:S@QO4)LUDE,U&
MG0]4N(F!".#2KIP1PQ-?]$@!2)`C:A8%"KB@6X9B$(`1R"":3'O&`$CPEA+L
M8``AP($#1*"]>IH`CVA,U`L*YM#1'.`0S#)!X4P0F:_(JIWO=`P9$C"GGIC^
MK@!WE&AV]'":*)"!9R6H8B\,T(!C7%$@G?F``'9@D!B$Y`8#+:@(^"20)SB`
M+FM<R@*>\+@=X*!7U<FI<5PC@YK>B@$-HH<+@_@)J*S.!!%E0$X5MADKF!2:
M3!()$\3*`((:R4(WJ&AUH&H<CX0P!#)X0`"B93=`UJBM1F063>AJ5Z+BU%]L
MH%I;2>A.>.+U0+RSB3N/-QBOI',$'L-8I:XDTCO&SQ<P#<$#1#`:AXK4"AHA
M``R"IH"O/N@)4RW*Q1[4'''U1037*4']UIBACYCNI:W[)[6NXU#::%.X+V.1
M-F'T31"N*UZ;<-L#/CH%$!@!!VXC08EVL`"%Q4#^)W7H'BLJZI@XT2,F'_#N
M1YGD&7\8S3%Z,1XDL+O#(BW@!?+XP&'J>R2#6O>]VD4`=]]0HK=L[+K970`"
M%+8#F?+D%$J882%=>P,'I(4I-VA``A9`"_2N(0;RP,$##E"D'91`$SVH+N[Z
M^T^4$<M,%J8%A"7LV@]LA0GL#140<S('YOVHP@MP;0C`X$L#'Z&<7P&RPCI\
MA`<@8`%3H+"%F3`"('JFOR.(@0DT$5TR)'G):;#O#J3,A2J/N,D\%H*6#1>%
M`M=!0:-`R\JTVR8A^#@5U#6!E6M#"_96=&,TC@$0KUO(-T)B6-@<1(0AL689
MD'D3$6;2?4<1XP0\@!7^(@B<5Y)1ES\,:P&3!91-G(`8_PY7U">B6<PRZ,U1
MI[H6?E.UBX*[C7AV\'3B:G6MLP&#4-M:U[OF=:]U#2,.GMH<OGZU-HI-C6X%
MD!O'QJ(UF/W',M#FV:.@=K3_Y^QM/-L3#;B>0JJ-[&:#^]OBF':XLQWMI&6,
M.N5FQ:MM68W@'EO;@-@%L\L-;7J/V]WHQK:X]9WO0?I:X-<`=C>'/?`.NA;A
M"S>1#&!P;X9'7.(3IWC%A0T.XQY\N!"W^*@Y[N^6?;SCZ1`YOU\T<I23/.41
M+W@V:5:`E<=<YC.G><UM?O.*<[/DXT"U-KT3N`0`AP2ACC?`N^$)%',AX$O^
M+X/210Z"/QQ[OF5X0/'((*E_C6/:$":#`Q1>C:!X_66,H.:\81#K?KO+$TI/
MA[+*/0)-I!8Q01\Q(-YR@'_='8C+W>$9"<Y!6>A)X<QV.\OX;CRH`+*%9`LN
M)*;^;WBG0@'\/`):E`P%$H`!&S`]PN'Q7983-B'7YB9#YL?]#+?MG&4Z!^%Q
MA0L*&4"(6T("(2SVM^PT+)X;RZO&5LF6MGQO6O79.)_:B&\D([)L==D>?FW0
MSHT&>.U%FT-2BMT"$$!<%@=96>#:@B("RI#A!@)`;AF*O\6;?-T:T0<BBO+(
M/``PZ0;AG_;WDGJB8=U>(`M`%%N*0:-$6;YJ2+[^W",]<"LE:O"]7_N&]L.@
MGALN([*'!FB(,`@Z#L,,XZ"'`UB&&]B2W8$"".L;*$B$N@"!`2``:.@"J#$`
M38B*`Q`[0%BC,U``!!@Q$MB;,_N*J:+!R'*``]BR5W%!>+B8'?!!!D`)[J$8
MPF"*"=RR)@@Z(WB+CB*.':FBE@B4::D)!8@!&(B;E2D+U6`3!T@`;$JT%VR6
MQYL#J/)!22.Q`OF`9?"E,^R!Y]B)&^RO9Y`',Q29'?@`[R`T>B`T[VB`):&.
M.QRQ!]#":QN$;'D2*&,`"L0!G7B`ZKJI++.O-:"-2QN$U?BJ*D(9B)`IM#*0
MI*'!9>*?!6"%!E"-HAC^PS)<@#DD@]@;)1+R0-XI*'IHD#1((AB``038&R,0
M0%E)Q;H(LGF8B6F@AP2P@@:@C*GSK`*9AII@@`:H.R_X14U```'XPAY(DS@S
MP06:AVB,!;10`%.`@A$0FQ>$"!RQD#9,FT$LQ(K""$E4`$N!14LI)@$(1T6L
M!?,PB;7[Q='#H)9K/8T3+N`+`?^Y@0S!`7Z*)GS2`@6``@4(AP"P!!'H!=>X
M1L5J`Z-:BH4PG0%H%4V("&H@ALE#E)$J%1D@`0%0-S88B1RA,'DH@3T:#?<X
M!@&@!4]`+5GH!9H@@Q?P'Z!2,"_H",4I%1-8FX]9DQA`P1M@`)@[@@+@'1/^
M&(GZ(3%E8\F%4``<J*B;\@I!\BZP:1``*`$S<0`8D,D?+`JQ7(:[L*:DVI&Z
M,8!9^`"ZV)WKJXMEB#U"J9^4L(^K1!0#\(JJ=`LL(8,0B"@K,$$8^`AY`(`N
M0)J^>+6-`;?.4I^DZ0LF\+V>9(!RR;(U6,L=@('$8X3$*P"OW*NW+`/BN(D_
M*`<0N($BZ0$!P$A5$@H3,"024P[/_!('L`(%T)0T,`Z_%*38NX&*P8%7.<RK
MG`?`#`#[*`&9O(X;U+\0`("M0)>@C+'K(Q1BD8BB"#$!4$X`(`%<7`A=>(Z;
M@$ZW@(ER@0*('(%RT820\"A(\,[![+P`0$O?:!7^$5E&`VP9;G*Y@]2F"'0;
M?%F7$G""&D$2'&`-^$22-K$6$9`4:.*-!3`MKY`7S1R$&T@SF&R;CCPCWHB!
MKUL>!FBDR2*!7CFCXSD".C(5-<G0JQL-_I@L#`V:3\B34,G-P4*_RBH+$0"!
M<``96$&^0UB-1LF725DGL(&?(7"`!HB)/BI,)\4=*&B=!P@HRYJCM>$1R!R!
MVL**)"J::8D)<VHMXSL"`76)`@R5OG*^]HQ!5A,_4R&JXEL=$I"6\WL&K""`
MN91%)14")B4!)W6MC8%3\2DA(P$5_&F7/&B<JZJ4$`@'V8DH82C3LR#3H+Q)
M>8H>!`"#DMD,-0435I/^0E9L%WXI"^)P$"-(@`9X2:OJHR=I"MQ!HC++%\MP
MT!&:EF52MW99*H"!$P-!(`-+AC,9T-4KKFQR/5$S(J584.`@Q*4TDARI4@>`
MA,H4B'41&:X0"`T]HY)LI5BX/Q#XG01+BEW24!AX("J0MH[\5D*L22D5'1+J
M5OGBT24JB0>8IO_SA"W93+QZ`/*I/N#S0],BG20=TM70!T+D(#X"$P-I'Q[M
MHP+P%X-B4S03``&`@3/2G];")`0BQ)48(!+5S3"(*#&%%0+P&4KUGOH9&J:H
M/L3(.FIX"^B2/R1Y%1P(`.Q:``'0A.[8"HV2FT]`/@=Y6(W5!9?]10/@3&S^
MG=FDR4TV>($'4`!*!%4XH:(44DNXP+OX8!A9'5N24)V(FJ@P3=G_RQ]2C`+N
M:@IHRL9#(!K^(Z&%T`]-F-BZ$9VIJ5L1((%J?2"Y25>MV:%V`3ZBJB7"6@"1
M,2/A*KCFR[8#S29I55`1,*P=0-$Y(:J/'(FDY1QT^0,&&#$#L%%\,8$_J4:U
M3(6V``3=<`/Y*E6MR,&V32$$&%V>.,+$Y(^+21.>B<H2J:7390209`/GBC-V
M\8IYX0DGN@DW.,4%.`M";=-E=*(7V(5AJ0TJ`ILEV13>H=%G8%._FZ(7X!T"
M:#$LR<KQ7`WCV;Z8^,@R6UV%X:N+R1-/6,8UK0O^2:/9.D6RYRNFNWV&.8'3
M):J"9+`+S4N;2T':G&'?Z^V\KI.6_*7/1Z7:3[!::S$06A3`5Z%!D!T-.(L"
MAJP#DA@AW^.K'1A.H4#3G`"+(I`8[=&\B0R:!(B)1@F:C[@I\@RB8-F!]'T&
MF%L3%DY3S451M2J3US54KPA*8RFF)VD5'U5.X2I0$!J_#X+`0R`J8DB`#ND^
M(\&%J=*''B"`XM@8$5B'#7R&0F*``<BIME@C"PL<+U`)QZT+&,,0#=40O'NI
M>2B#Y9&O$E#CR!F-FCB3(!8"$7C!(.,]JQH<2.3`/C8.!4"M-%F>YZBPYYV)
MIP@[`&@6GC$.%0X0KHG^M06@1@-P`#P:#04HCC5^B5+F6`5(Y=RMFR*)L`!X
ME^B!@0&8WC7YB`;@-OO@'-^0*(Y-/O;U`@<8`0+P#1SUW^I3`.1@@`U]@>$U
M`>9P@(^L9!^,NDI-6C*(OC-)30^A@@XYY@Y3B>%P%V1274O4F9P!E5;Q#10L
M,$UF7!?Z`+)XE90@C+Y("04('!$IA%>QWW+Q#0"H(<Z9*M^$BUW`.MPPCJ?@
MPE2NY&<P"?!(&P8P(\T:0P\+!V8!9JZ!!"_F&K0T$A*P8V[T#]/4YK=EC'S@
M%O;(!]LE2`;,N"P6+LU#E'0+`Y^*A?\IITD(TY_&$3)E!4=H!"80`9)PD([^
M8048N%#$R!B>?LSWC87JB@5O0U'F80)'$+/19>H8H(URF@:KAA7#^>K2J[N.
M.8P8N!43$&LR0%%A$N#L4T%6R-YG$(%%Q.IWD@$R(:%!288;<!!@F@:]'H*#
M^@22:(016!OES&L)&;I#X`03X&EW20:H[KQVNS9D*9FHYDDPJ.I::-#)`@4.
MBH&AXP(W:&OQRT$M*(..010HP+6Y[H*'8QY/T`N%B&UWR5XP*,U0D>!!\"G`
M)H41(!,<$.XQ.90_H.)4X()VXX+#P#4JSNWQ7<IW6J-=T.Q/L-T;X()ID`40
M)%-8H1M&D)"E1!?H!B;#)B%APNRXYH[_B>KAC07^IDZ%S"V#PH[J1!FZ$;5I
MC#/0G.XXI)49-,`Y%+$ERYBXDB"!(DPPXXK3='@!:U1P@:-&E%CB<\-P7K/B
M#G*]R949>8,5;CP]E?,XFY%7$W&4$>_P=/@N\L*]D]N&2U.]>WOQR/-P:J`P
M)=,\%#<1'1]R&(_<F];Q:WA`'C^Z$RDV)#>V0;(W$@<Y=A,U_;.U>MLWIMOR
M%%]P<F/Q%:?Q77ORC@/Q#,+B\EMR-5]SE2-S%6%S.(]SA#-S`4]S#!(!]3N"
M65"I8".;I93%/Z`RD*L3XK"2*U"W/:\&&1"[[NB"$K""<%!MZI!T*4_`J9H&
MNI(B$B@.^>H[:O0-;G3^\D'XGV+K0"EJ`J.:-&I4/WVB1@;H;7X+O/\R0-K0
ME&!>GA(87D[X/&S@-"K@H#ICLTVKC4]_]<,QA#"8*C"`L$Z'\F)[`,TC`BZW
M=`98]ISP-C(8@56_@E0G@T0_@KF*MEUX@1S4%Z8H`ZA!]D_()6RO=-(+]L^3
MMG;C(&F(@A:Y<B$W.IYP<V=S5H,L\`XB0$`@P#\M`P)$26ROAA(8@`]`5`*X
M'Z_8!>"CAA@8\!T`@-$@"<ZQJI5%AXS,`P*`@@((`4F1A]+MF#.#AP:MK3N-
MP0#>A)&7E#480Q,8P[)8QNA+P,(D4^#(!J3%[&VHA]4F`!6B:IO=A@4```?^
MR1EV]2BQ02TOX`)FD@%)J81>^/ATA0(#``%)&<AL"S\A*`!HX0:L)X`I,(\;
M!/(CH/F<=ZXS"A2AI0V\[&LR0,#GJ'DL'('"1`T1V?J>N'`4H;UM0%IB@.[7
M._H,@AEF=9&?!?@,:I.-9@+PC`GHZ<`4PD)H>B^75+22N([3R(D?H\8SXP_#
M&1%]BGCBJ"TFL(=@&R4Q:22%(7<4EAC?RUS'[4PB0,`#<1#/JH2DJ1\>L]W%
M3;]C[TPWV`(%T@08$'UO/Z^^F$BA.%^-N>^K^IY%WW9F#RMU\:E`=Y1SM_R.
M\:@`A`O36?<4@@L(*]V8T)<9I[9@_A>D+54<&17^+,P7K7`0KG<`WN=K89'P
M)SIW(""9'(Q8[]B[(1*RW@NA.(H8"U)O9'26D(MF[P/J'8Z?3V^'3"ZXI>Y1
M<;L-%(;;V<E0;)$F:L@Y@/!RI(3D(",CTK.PQ_#RPG!4$HD$T[#PD-8CU-!P
M0Z+PI_EEMD.R`()VM2#:Q]HC@X!T8U!0<K,U8K+PL0.B)Z60.GH4P]!@)!/2
MH'CD2S7X(."@2FQ]C7V$(P#0G/T-O@U@`%X.7F!@\A&E\/&"*=9D`%)"AX1S
M\!&#*4,0@H-$00(<#`*0&(%@1XP#)4P<R'+%P1TI(!Q82>"@1`,!BQZ\RX1D
M4H-!##Y$`B.FQZXT;7K^&$A0`@2Y$`)&E#!@A1B:!CG1](E1($&"AVD^9+(C
MHL`5`S')@3!#J@&3&$QO0DS3!X<L-(R<]5!P55(4.P_6*!CY(8'+$2^8[AA3
M0@".IST$--`899Z)6FD0Q-B!!D$FE`5"E$A`3J\!`CV(O%BGB>OC/[&*ENK1
M,K`=)VMZ(/!2QFL#$R&@%AKE0($)J8L*'"P`408F10X@CV!JHL"-$1(7;:F&
MQL&('@\<B'"#;8$)M5Q-[!CTN9B`&W<K%6"+P$H!!YLK'U'^W#/H$2),RW*6
M#\:"WF@8V'H0@,'>X4C0A$X]1*V#!'L_R+@.PP$DO)6&`G"L]%(;`3Q``@'^
M-WRP``P/1#$*4".,4(`,,0`0PB!'/)#`"[=M0D`)U9B#8AKB>)-BB^*0TV*,
M1T3W%0E,:&B`5CT<5\P8SL1A`@*1(+`9&694\1T,M<4!X1UTI4&"`R-1A41V
M1.)89`D./#"<`B.L`0:!F1VQ$E$I562D3IOXB$0!,,1`WPB4'$$38@(PT`1#
M;Y!0'AGDF5%2'"#,F48!+^QPWB(FW%%69$X(D``""!B4!`Z0R$*`"#L`I,0(
M`S2!$HPR*"`"A=X=44L"`Q`PS`<B@%(,J:8F9$`,,BBQJ"9=?7::?5"IU)EG
MFS&P!PB?F3#`'VB0,,:3I]Y3!ZHR-$!?5X2PDDG^%5'@@$,B!+R`@UHRJ#4*
MLT<DH,`#AEJ#Q@,,(,I%KL(>,9IO]75+PCSV(L$`GB,$X*%X'XH@`DBG;GK#
M<FNHLL!P-_@8VHFA97B$@!3>H&FW)12@*9ND8+8&4290R,`("<!PZP'R\AO&
M%P[$0.$L-\3P`0&;)BICBCMPPV+.X7`#H\\HTNAE`0(E,*0O4#W;P`$+-!#)
M`5[8EPDP7[W@P$M"*8+&"`W<@48(RSRR<`\)8'AT`]5H],)((T7Q0!AP+8Q&
M2U+/V,.3*)U(I@+`$:O):6EJY2$39!`,E:L%]\"``4=S71_@E34GQ=?$U'/'
M?XD<@)$L;0%`P*(!%%#^@'UAG">;LSA'=Q@2BB^-RM()[&"T4`IXD497[^AX
MQ][`WA'=#0H`=,0(!Q3<\@O#?PP+SH1LM8@E>RB7>0(W,&&]++$@X``"B]Y>
MVBB[`"1";\I/I(D(7T^^K\`-X"2"`;V=H8"0PBR2DS,?,-259H>/L#2<-0`*
M4)M(5[R#DOI\X71W8$"I)K(#!1P@#W_PF%%`%@\,,LYX0D$7[NY@+2V=KQH.
M$<P!</`PH:5H12HLQ\[&T4)S$&E/B;)#0D9`H1@D:F3%6\,,77>DZ<7@`;\J
M$NT@0CL9.$(&,$)4"1(U-<Q$PD!D6V!*5L(''VY&%N'+VZ_2H+YJP,Q#B^O^
M00S(9;HCO.!38MB#`O@$%6HMC@$MVT&1S*B`@-WN7$VHS36P^)T'-F\'HF`6
M@1:@E@_\`74+$.1"^N*%/!P.5CV`@:R*02LOW.!$E,O;`A:@%5\A85Q'(.4F
M+)>W+38A!'.:A"0(Y0R*N61:T]M#$F21F@KB[PU;",&$PC(%53B+7*-X`$B^
MX@7#G<L.6JI-`<H&`I`0\2NV],7ST@`XQCV"$J[LVQ%.D;M%(?"+1P!!&&3)
M$+]5T@&^_!`#>V>&ED0'BPP@`8WNR"^H%&<?FJ#1"047PVR\$'(!M<:+"OJ-
M'R(`!PLP``Z_%AU,F"QH0`E!4J*0#X"$[0`WL%;^'N7`SG2P9`#&`0&KJ$F<
M*C!@`#MHZ$-9LH8',(:'*)D;2S"ZF0,HC0P@N`$,TN"`ZX@`!(@8P`=&``(K
M&(!+?O%*Q*X@BWR1X`'DT*$(:'(0J<F`I"%0V1UB8-01A,`*#\B.)"-%`K&A
M,&`J<6@(Y$2K!X@`,5]A2`-Z,88=$``&(4B%CPJQ'A*0KB]%2H`BIIFNB79$
ML(RIF?JB\(([6JL'!6`,`GB"@)\&I)Z"^<YOOG"=IS7&-4,UPE)O8P5;?@@!
MDU"+M29;&1($X%:R*.L(X+,H'`"`F$<(*I^(ZI(/2!4SFD#K4+]@UI@)+'>?
M%>Q0C<HXY'P%`293A`S^%B75!^3UM#CY:F%"\,Q-`.2`YU'D#=AZGP200)(@
M:I`)<O/<$!`("5V]KA8UF,<09*H!8_$0&BH*WO,J]RL-6^DFKX-0;`PTP08%
M&H.O,0)5C(!\#6C9A,_P@9'D3R4->,`GG.")^F3$!%XH01-DX*Z5$4)]P,6,
M%Z9@`A)0N&6CM,(+*&/C00Q'!AN602XD[`0/O2`&I$F#+QT@I1@HJ3CLQ/!(
M-/$((Z.A;2`@'B1"8()!"`<6#Z@7$K!6G`:(8A)<*P.2N8/B--R`R<8I!I)C
M8.*\,>,,](DQ#'3L#!GC(`0.6$X:(ER)X409!QE^P2WV[(`7D(L$'6X""%;^
M%F<U*JO0D9F"+2-=O'K2B<E/GDL#?KJ#^2%AO<T@08EQAP.'F2'5Y2S9=;^S
MX1X<64J#(/23=X!*#+.Y":36Q(6]@NDK5/C#TV(K")YL1OJTK1?Z^[0F5N-A
M*X@`(''>@;)C\(*515F*WIA$G.CHXRND(=2WL`*@P[V))FC$PV8\9BF1?&+5
M)J'+C_@I;_CVX!ZP$-\)/FB^_YUO?@/\&S`8CL`'SN`;B.(:!T<1#GLKD8:/
MHFL40C(Q2,!6A&=C&/]6`O%01$Z-"U3D)">&PDNN0A8BW-\H'[>:T.<5F$^\
M10+G-[XE[K,;?#SFC@(.BB3N\Y?S?.@[^*`"7>[^*!2][P`-V'F*&E``I@<=
M%CA':,.-SN"SO)R3HQ2ZSW!>]9&WT.9(%QIP\#GSM+=\P6'_NH-;#O>XRWWN
M,6I[R>U.][SK?>]\[_LW5#YPEOM]\(0O?-_Q;OC$*W[QC-?X@A'^0G(@WNPT
MM\:B2.S"LN>LZ%Z7.=#K\T&^B5[L,E>[#'9^>B?8X>!<UWQ,T-[XV,M^]K0G
M/.`!+OC9RV`,I@[HY[-8^K'+FL9Q5R8?%17#%QR@I[5OOO.?#WW(\RSX"+W!
MVQTOUIR\0!DVWHQ/U3S4@*55T;#0*,%4X1PU[@`&)1#!S%X`@BQL?ZPJB7\Q
M'GT$E)V_,2*MS_Z=8`+^WF`KKS=J(=`=]!=!"1`#.'!G]G<&!&-EW,<'#J@A
M)2!?-T`/VK!_[V=_+\`J5D8`@$("::4*,8!_2?`"(K`H-",O)I@K#G``FA5]
M,TB#-6B#V;!O`Q=Y),<YQO('!B`8"U`24%$RHT0`="120@(B8P`>\I,U3:!0
M.&``!X!E`\``VE5!"5!6!K`>-B,"RX<TC+-4,*A$F3)*3F@`31!US"9K)$55
MBZ*$!O`("&`21'(`<KA&'4:%.X"&>:*%#*`6@&@L81`"`U`6!4"'',.'Q9$C
M,&`7VJ6"=[(9)"``:]``"\(:(4"'6O<"`*`<7_@+7]-5:1$)"Y`L-XB*J:C^
MBL[W>#IX?0,W,_IV"2Y1."L1+M6`"+>D@N?1%HOP&);3`!(1A8*@$C[2$G)8
MC$=03WLD+`P@"@M018;0&U(B!L9&"<?Q1%+02.3R4W3A$/EW6;T1C-5X+I@#
M"\U""0<P"%J20$_Q2!CT0S/2!*^`/\SX&4]P!C02(C%X!KKQ#JL(D`$ID(,G
M#@N'>P$`0R(7`@8`A$.23,*#,9E0#5F#`*2U-$PH/63B0UY`)(;3$K]S-]U4
M,D!X`!6I1-/S"%'`,+DB3Q\4&K`0.Z4D"PH0``)@!A<T)@O@/1J905\Q`@2`
M`$#H%%#!.AT6=0=0`"#PCR#Y01'5"+<1E";YCS?^@(A3R!0JZ8OG,Y!;R95=
MZ7C3MW*O"'!:N1(T(@L@,#9@U!NN(B<R^166(`HA$#);)#Q-@$4MJ4$ELU!>
M\5K1^!UQN9&6029B1@E/@`B6D@Y]8HX=12K:N%Q>DBBB)##-9)!W>5]5,H^Y
MHI?$4S=K0`L?]YD5<V?!XI6E:9JG*2.MB'MB^6]MH61<*`9TN0V1F3=,8`("
MH`C9(1M*`8TPX"8P(%(5)@,?(``[X)&=@9<?F4?=`R=1D$V]R5%?]IM)>$<T
ML7UY1#LFA@`BX(@F@`-YQ",O$``C,"TCX)LPX)N+$IW"<EG#^34O691@10*6
ME&6=428;)B#(YXO,^27^O\,X"OAPQX"!8X!%88&:!XJ@"&I]W?"5":EQFIA'
M8?`!F\%NAH4:EU5D^T!=0:020I$K-P"#Y4%H=@`#+<-7Q`$0)RIK/U56"I@W
MFA4"1B!:?."A'[(9:%`1,+@'&DH?3V2AL<`6J&``K2`0N?(!Q/,`FP*("V`'
M(T@&``%_F!$I87!C^1<&7X@[7X@#(N`A(,"B2_!3*KH#'P"F&,8])/H':Y:@
M:\JFIEF0U%=0N4=WS(@BDZ5X+YDB']FF>\JG?2I[JOEO<NIXQ+```Z9@]+(`
M4P>GYH!X#><[#.=R*S%Y*%=S?FJIERJ0@)IO@AIWJ9<B"QA[@%%W3H>II6K^
MJJ<:J&#IB@Z*JJWJJJ\*J[.GJ0_&J;%JJ[>*J[D:>-,WJ2B"`P@9-+HJK,-*
MK,7JJ[RZJZQJK,O*K,V:JR]DD/^V@\Y*K=5JK9@ZJPQ6J]?*K=WJK0!Y>ZD*
M0[WZK>5JKN?:=^&ZJ:R)KNWJKN_J=VRWJL$*K_5JK_=*<NI*J^R*K_WJK_^Z
M>=P0K>NJK`!KL`>+L,2@K]K*KPGKL`][K]F:8-,*L15KL?#ZIN1:#ML:<$=W
ML0SV>R*GL6LZLL)'<B7;L8HGL5;7L!_KLB^[K"L;IPZ&LMD`HL:$LU&R>IFF
MJ)HW>AX[=)UG"+$6M)"J>>QRJ&?`((O:J-BP?9#^BI:99TR;D`E]E09M`WLR
MXIU`ZPQ+RR\L@F\XL"C4,0A@5[2EUWI)ZRAM@T)Y!#;E8`(W>G,6`25)2GKH
MHSQ-H`H"9PEVT`?4H'9P2G;$@+78,"T_582BRK5XVP1YN[CX-K6)M[#]UK((
MU8D`@+D`$!\`P%8A,#M\AP8[``"14+,Q)+JP-'`D```R:`V5I721P```0%F,
M<0<BL+HQ]```$+KL,KI@DP`#VT^,`0,,FGBV&P,/HV*'FKL-=[K8I+M(B[0.
M@77$8+NW,@Z)JG&VR[JC,+S#@0#`BPTEP+F8<3=*EVN$)[.^5[D()0-Z50`X
ML`.V6P+&Y+<M<QS(1@C^&9%A1H`UY<-,#E1*CM`8)*`EI82_9`(2%Z*TLE5/
M\J$-#D`]TV("QW85U*$.R.`$QM%T(*,IL*"_&+PCO*!&<L4=`#`:@$NV6,$`
MW!$1>*!NZW&CV)@$3T8"_G$`NS4(,'`,\D<LKJL),G`(]5=.(\`GC".[?($$
MMALE"[<++(P$YC3#@_`@`@P#`S"ZH-(P(2$?O?O$B^(JW@8E`&"3G2@V15`,
M_5+!(W%L,@`)PR`26T"V^YO!8+89N\!N0.PU$/$@Y@0`1O``?EP^6]#$W1&,
M,T,`5ZP2*[P9DV`"O2NJL4MEJG`<4"$V#_`',0`U1D`S=J3&()P^G-L``+#^
MDVJ4:%M"/$`<Q"IB$B^S";WQ`'O0QD@!`//+;OYG$0R*?V@I5V:$QMK@+@MX
MPPHXG`"!REX``BI8A'^F:BMLH'27@ZM9L`-'`$JQ(Z)L`+NU"+*K``"@``4P
M`!#1B9`2``-0S7=BQ#?L(P.@')PKOEOP`7T,9?`\`.0L`[,L``.0``B9)T`)
M,!N"B*!SM6*<S^1LN^8<N^A<20(=`(P1`MP<`&O0T'<BNGTVR\1QNV2R6P1`
M#HV\"S,ERAI=,0-PPR_#(=D<`X<\`'$K``PI%XT\A05[`P`P'`D``$T0`%U%
MS@L@NSZ,!K8+E-C<R`@`TDAP`(S1B<XA`"LMTY?^FX:7N,UAD+MWZ,AGX(F4
MQ<U6_%D@H+EY-`X(`-`RL-(&P$9JU-5B7-0<TLB(`0!$5=:,8;M!"=0!(-3D
M,+QRS9D$$``)P`VVPJ`(F2&=*-0$"@!%'0`.`#1L+-<@_<Y232@ZW<T`8`9:
M39.1<,TE8GUW6)PC4-,;`H0`0,V:T-!/(,9AT-/6#-2@<\CRL@/SK``#0`ZQ
MBP95K=4(D-369MJ\1=-"S:!57=FW$-8#$`<#@`X`$%0`,``OH+ILC-H`L"C7
MW-H5?0?3W`,#4(FN7;HM],SB2J\(Y\.VNR@$P!BQ*P;C>R+#&PG>K;J#T(EA
MT,A_\`+<\#4W$!^4M=W^T\V=#`D#(D#.V*S5*`;/0;DA8:#3NVO>U1QCX[O>
M*B'3]1P)#9V[$I'<Z:UOO=N[Z%`?<FU&)1V[`-,#>9WA%S*^7+HABB#>VNL2
M++4S@*B[OUK?"9"H4Q@"]<R'X;W3GUW-)+ZZ`B`+&[)PF@VB`6#$\RB[H;P)
M`$!6`6!]Y-")<]*\WNP$#*H*KMN)9K#-8H#BE?A5D)W-/]6[AZ+9)4SELJO9
MWZT4V#SB]6R0FHWCB"#3/5#5.^#A(XZ4^I8*L-WA.[[6KOWDA!*[FV3",9T)
MJAL@M'L`5W[+;![F7%>]]=P,I3T(TCU8M!,T<)XACRR[S5O5)6K@/2#=Q=#^
MN[8['+T+WJARY<$(``!!5+8[",9;U$<P6$[>B2QBX:/3OH,'K1K'L0PV6-7\
M4Z.NT\VCN>XVO(K0B01\NR;>O"XQOJ/EYK&V$PJP)<4![6X.T0``HIJ+N2E=
MT@->"0Q:[.+[4R:N6PW`Z$]^B9B+D"-XNZ)KB8QAY/?`#9D;"2ZM;_&.N<7Q
MO/FW[;*KZLJ>N4%)S3[L:T/J)>DR!KZ^T[0K!>,;VE8L[V##W(!(WPL_+?R.
M[9AK`@\]X<'"[IRN%+%>*,*[[^.=N6PRO'\PX,V[``3@`'\^\OTNW?9.W.4N
MR2'>Q^5>U0N:N0N`Y:H`VR^T\UBN6XVMNZ)+[MC^CI#&0[O7G+EG4]-HGLWX
M5KTC#D;C*]U<;.=J5`!BK`B_;O0QS2(PKQ1H,.Q/'NIKT.G7C)"#S1<U/PBA
M/=]&/+M/+NM&O?6X&:^J"LWU#7"[;N*#9>?MTN9DS\T&+N%3CAD:/@?3H1)V
MP?@W\$%[@8<,N2A57;VYJ\DSH^'YGM!1@-X(OM:);VJ%[^``<!2KONZ]F_$.
M`-P7KA:6`A@"T-I?X^&64LUO/V2A3].\;N5D_Q8K'@#D$(MGN(=3>$Y*(=Y(
MO/"`DN.O?RA>$2DE$N1?(;OBK;I6@`@[\_$F7!\5KA1ECP2C3O6_3MM35B3C
M_[S$G;M^?@@,*MZ:_5/^LRX+MD_UH[;Y;![JI%O[A\(7A+8#=@X$@40/![L%
M#+T7@-%S]AB`70_@N`$>O1NL5R@X#X+IJR<"R&0`46\AW<FF3C-:W8N;N82O
M@>`D))_L=MIN&J2NF@`6>F!`>D8`N+R>8IAZ0@!&J)HF>PP&=G;(#&]Z0&0@
MN>8."*;^NKY@ZN(F0W':N`)U=WE[?7^?<`3J@(N-B88!CY>!"_K*(GL(^MIZ
M/@`0#,[LE``$#`3Z\)P,M0]Z2M1V!!2<%`#:I;\"!YX)!NP4+\]V``82`CBH
M%((-`!Q/EGP+!RV7H0,`SLGZ%J#/.P0%!N!(1<12CW?QN%T[<""`B04"<)C^
M,8%I9,D>81XVN")D``!T_DPL,8!`C0D`!1Y^B1+'28)M1F5(HV;362!,`[0-
M>8"-I(E`)``0."ACP#<`!*\5B&&`9A*1!2Q-Z;=H6K<U3SXN(5C-Y\X`CJ;(
MFFNSGP-,!!XR2+.FVKBVUQ"0?%%I#5$"`1`$`!`CC::.(A6_0%(S!HB?-SRW
M?,$2;9-04*106601XXVF-W>J@42'L,UQ4^8,=H([6MLETP"0@2ODGK6L1IM@
MB@QJ8UNXV&JNT:?'23J[(6[40SO"IX`76&/(`D[&-S$G31<0!\6,?7LGPLR[
M9[8.@#+Y[D,09.0@:7YT6780H0$'<G&"L1`^&,/^BB=,8$"31QZ8H@0'IC!$
MN!#.N>I!$C39X8,2E%A0A@<8`&&'&QP@HX0L*%$#P5)@6-")!D?(2PT1/CCH
MD0')B+&4'AX`L0<+=S&A@09*V,$!(1_0I(0C27ABA`;T>Z&!$59T@@0&>G2@
M`1&FB`%)_TP@X,<QJM3/ORQ%T"\O@1QX$)TCA7SBA@?>L@.$!@H,0:8=]GP@
MJ1Z,?.&#*'<+\A*"4"Q0BP<^&%%%%F/\DJA&_YM"43]C*"$$&0C\;[]2_)L3
M22U"#00'$$`PP0$<"HD!R#J?1'**.QL@8P<_DZHU24*Y_/`J%A]`=`0&4EST
M"1B.7",&*U`D@X0/1EW^U@H<DD5HP5)'%%2751GP]I(404"466]?V%8_*5,,
M55$0UF764CL^:`#1+6%XMI1N!VT354?]`ZT!<>\KV!?Z&C/8&/CL4]CA8F3)
MLST<2%C("1`<>-B7B`_6A3'V-`J'J/M&5M@$D#0NN.2466[9Y9=ACEGFF6F6
M#SZ)8V:X9I(]#J##CI^(P\8"!D6GZ-UX61GI74:.(8`HE=ZE$JB#YH;I'BHA
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MK7Z6$YX(9'4\R;T.<O`AR`1MUKC5<6QM!U@$#O1!B:=ASCU34XU2`M$)AXE`
M#,<;QVX&D+&'C:\C*DN;`_`!@P"09Q[?$@!!EI"P7RP!`$5TR7W,H#U>9"<`
M!="1&8I8Q#6`AST-2,($7ZBW!>[,#!'410.^8$+^"H[Q:[*C6>SJ@[CFH4)6
M)B#!5D:0.X24((A.>`$$>9&.`[R@'PV00?"(0(*DO&`$)*B>%@3IQJTL;P1;
MP:,6Y$C''<B14$*ZP1OIY[P7E$"0FY!'"@UP@QHQ:`2.FF128%`G$XSR!@]I
M)*$>B0Y"3B80)6CC"]BHB_L5393:TPCT"#5*1M`Q2JA(@VE*P!T!&O)]5\$?
M*G[UGD[>P'FI3.4.HI"@`H1R!%XT!1-DP!@8O-(.A3Q@)01"`B100HYY,2?]
M&%D*.G91EX_TC&">8(80C&8AEQSF=ZI#24A:)08"&,"O8"""'\F`D:$8@0C(
MD$59QN^/=7J$14F@2ES^=C.8!\E)+A5I(!$X[Z,<K<X=HX$*.19T`":XY*!6
M&8=47E)[R00F&2^'L-DU#H/W*4``'C(`!`Q#`3X9@&36X`!_$*`.G@G`$9'V
M$&Q089O^P!H`IN6/``S`BQ)A*@*@L4Y,#*,).`@(8_I1UA"F`42$D(91I-,$
MYSA!&X_QSC<%`-6!%"04/'DJ#+!2Q!A`(J]6,0H!AJ&]M70!J$747G>02B@!
M)&,')@@`97?`D[R"*`H`L)<W2M,%?TS5#$/U+-8><UD9W.`Q->R!`+*`"3(@
M8`%*)2)6(_.0'<*PB(*"R%?MX-<#$$4O]`.J$Z(P#$=<HR8!0`4`CGO8Q#K^
M!;J>W4%-JL"-%ZH$*Z`J8A.B0)%>318`"6B#/W9@",7M`S(O,*CB=G6I802'
MM9)I@@Q^>EG*I)8`LBJ``!XB`-."];\!'C"A+OL5QO(D.#V0[F02(ID5%;$`
M=?1K`#A;WB+6"+$U601.,W>SG:9Q9_^]R1",8H(UI*,!_9`*5I<`(@<$@&GZ
M`.$YKD$'$H0!#D>3Q1"N\1VL7C4Y0ZX8`8;@8`'<!'H>?$D!;(G53)R0.MS0
MQFH5L80HS3@0!`"K`!9A6T\L.0J$&C(.TT$MH_@N'YQ8LD_R=,>;-$'`Z%A`
M=L!:@G9,A0S@&-(V!H`/%ILB*6AYQ)`'\(6A8DW^`3#P,OV&[`0'5*0`60"`
MJVP3C9_>)$\<6T+&C*)D)P@@8V.(8A&M@A6"1$$&J_PF";`2I30[.!H"M`0F
M3)`&-S'$CEA-!XIH.96DC.2U8"6!`G;0%%6C1B-#-H.S#KB;\HX:K)70\Y)C
MD``9`.0&9B7PDM.!8IOX.=P]B`PZ>]!=DMQD>0!0\V1B0!"?R+4/LB"!9_I,
MYC.DP8^G72V(,Z=3FI&N9DWA6&$*\`[^U$'+6,FK9)38YGPL`A-TZ.8P"&!1
M3P.`DPV^35JTH<DS,.`9%SM`"1#P@06(P``?FTX//]F%`SC\J0V>P@=:@6%8
MR.$,AH#&PYG@\5I/'(7^')1#PJN@&QL)L1-F*$1J+`'"1<#@``DPM&&^4$.S
M/I6LW'C!`%Y@`!'LD<9EA@0/&3&+M!.DN-70!GF5\6-6F7@H:4^J`=Z14:%'
M-!J\\9UG=9//6C>\YP9!35?\4<<G-*7N]L:*[XQ2!:X1/7:7'<9)/BQQU'2A
MWG6HAL$]7Q)O)'C'G8>UT&45`J1SH@]:9H439N-S3QI"$8<$N.-$W-/V[$`R
MM8O9).IX$J4FQ;-7R`)6.AX"&#0O;&G11\65_H*\<T,6&8LU5E0TY#10"P0"
M*`!8G3"`!Q1`A@;Z_@-NL)-(3=D25:;KDGL`&4@HG_F4('4KE*PI*?A\_IW^
MBO>0IX+-TNJ3C$[8J*#%L$`+8"`-LN`&R"`!6F@JT@OJJLVZLJLP>N,+A,H.
M7N`*$"`&3*`$BF8'#"`!VJ$$AZ#,Z*DIZFCIW*(@QNP%-JE`/@9(SL`S9`7[
M%(#&I@;[H"%*IL*+TB%*!B+P>"X7C.*2``#8#B(*Z*AW&%`+R&`2KB$'(^'Q
M"L@SDNQKH@X;EB_7'DT4K@O\$``?)N'@QJWS"&.'/`L$DX0/TJ[C@/`&MZ']
M8@&K3F(*E&H"IZ`C1,F@;J]R<F]F"(YFVJ+M`B`*%.`=FH`L'D`;U@"H0L"\
M>*_4[,"@P$0?<B,32&``0"`*M$<6/&O3("&">,+^`0QJ!]"I$E@$!+HBXGA"
M5GB"-JBLY#P!(J(@$@]@$E'F)4XK[0P@"AK@S_CD&R91,,+A`8:A0!;K$-7.
M$!:`$8<D`,8O`("M&F^@$H+QM-I@"J+``8QBX0@`%6EL(YK"#,`Q.`SA`QY1
MB91*$]X1!K$B`<:B#SXF3.HCUQ0,`QT`!`K@9Y;@J21#*ZZ+U*8J)A[B]+C@
M"`C@`6I"B4YQLJY*B,:*O)I@#@S!U!0`0[*@`:CQIVZ`)P0%L93J',8!OQ8`
M!`(@\X*F([)I_`;+LXQ"R!0`KHIN'YFB\_;"$P8@!!C@`'``]"*Q(8=A1!1!
M&K7A`Y8@=^I#&&%P``_^``%$X!R'+A!GACX6)V<TJ&8:X+Y.SA02``<8H`!$
MX!.UH`%V\2NS#2A(8`<.H`D8)!@=S!%*()1DP`!<:BP/0$[2#@06@![1X0`&
MQ4,*0";`<@I"``%LA"6G8$NT9!'NTK`<@0'@$KG\XA\-)`$,8.:JAN7J)`84
MP``>9!"(1@84@"VQQ@1!0#`#(0%6[;[P,FC&LBSADN5B\Q$VTWE`4^R<8!+5
M`@0,``00P!%8C@%,``%D(.R2@C)GY``,0#\^P`O0+Q!`,TS"\A(20%,(P%6\
M$IA$@`"PXRM!(,E8K@`8P(MD``$2``'4<U`*H0!,A'X2X`",9)]84SX38#7^
MO8DP#5,&Z+.6JBXQXK,N@2<[9^0B$D`X6.X_TQ.LWC,^3<``A`=#"M/VG``!
MUF7\#,!;3,`YWZ)#]PBYO!)$QG-(1M04''0LG]-$Z><_LTT!A#,I%N`?S3(]
MZ=%%0_-!$G,*7/,1+D(!9*4N!\@J74;@"'$K<>H#',%A.(9D/.-GB#1*I71*
MJ;1*5T?$:(9VMB>GI$<7/L!"MTAN6E"+KB8FYF?W"H=XC.=X#.=,CV%\VG2&
M"$A^Z#1.U91-XZ9.PT=.NY1,V71-I0=LMFA0K?1EL/1(2:Q0V0,."@8-%/51
M(352)752ET&G=`]DD)12-753.;53/?53>>%0&2?^44&U5$WU5%$U55<'*VNF
M$%7U56$U5F5U5N]#5+625&DU5W5U5WG55(UT5'VO5X5U6(FU6$',@K:495S5
M6)FU69WU62OG5V\U6*&U6JWU6K$5=.)C6K.U6[WU6[_55F%&2\&U7,WU7(55
M6D<G4]&U7=WU73UU$&5F6>&U7NWU7J547KD57_FU7_V5@E@U2]GU7PFV8`WV
M<=354`?V8!FV81W68<1587'U82FV8BT6&"+69>CU8CFV8Q_64J]R83UV9$FV
M7S.V9>`#YDIV95FV7@,64:FU965V9K'U9%F&7&DV9W766A-68T5V9X$V:'/5
M9E,&9X7V:)%65D%V7G_^-FF=]FDUM6<CIVFAMFJMMDKU=5RI]FJYMFN/U8QF
M!HUBUFO)MFQ;9VECQFC-=FW95G6(5F,VMFWE=FZC%6R!-5GI-F_U=EVWE6_'
M=F\!-W`-!FUA1FP%]W`1%V)EYU*U]6\3]W$AMXSZ]F74-G(M]W+?8[T&KO<P
MMW,Q5VJ5=6L]=W3E%HU$1V(=EW15UVQ!-V7B=G5AUVR1E7$K571C]W:AMG7A
MUG9QMW>/]FT?YG5]=WB15G>#EW>)-WEEEE5I]QB$5WFA=V:!%X&0-WJMEV.G
M5V&>]WJYMV.-EWK3J'F[=WSY=79AEGS1MV2_5V$,-WW=EV/7=W"K]WWI%U[^
MLU=^)[9^]?=?X[=@S"I_]S>`[S5K45>`#=AD%_=\#WB!759S0Q:`&3B"O;5_
M:W5^)?B"A_5^_=>",;B#=56#*QB"/7B$BY5P*9>#23B%4Q6$,TB$5?B%:?5E
MYY5S8;B&>Y6"6SAU;7B'096%W:-R>3B(495Y%5B(C1A5?7AB>.J(F;B'[79?
MFSB*.16'?QB%I?B*R8B(F=:%L;B+B32),96+O7B,OW9R$2@&J@>(R7B-`8Z*
M@<$$'D`!&`"/MI>-[?A*G_AAL.,]'*&.[_B/3<>$%29[3B1@K!B0$1EQW%AO
M0B".A$1+Q3>1)9EOA4ACA(=*IL"/)WF3$0>,?6'^#2#JWI!!C#FYE$>LDA\F
M=S1!!OKXD$WYE0W&DWWA`6BK`61%DV$YER<GCPM8EWVY57E982;D`1[`7D99
MAW\YF>5#D`VF`1)@!$*@58Y9F:G99]6N:&T/EZMYF_4FF%'6E;EYFY$U<L(I
M!M#X$DDYG-4Y:;RY8!A@`!1`0*=YG>E96T]785[@IK2YGL/9=$<,F?E9G<TW
M9;B@?WYEGP.ZFA?YDZUA^1@%G!,:EA>Z%Y0/+QICB2,ZHS/7C`UFG)RG%-18
MH^MYHLVF%!!:I'69@%/&`><9I2-:I?'9`11JHP':I7U9AC4&041`!`JII6V:
MGTEZ%\"$CWWZI^E9EGG^P5#<B`%`1&<BV:@!&:EY(09D\$P@&JK_F)F#EPM.
M&JLG6:H/1GVNVJO9&*<?YI(4(%5X+YW)VI3!.A#*1097HJC;FIJ#6A>&FGY:
MF:WK>I,'VI+C1$!N>:S[NHOO6A>H)XT)N["O^+!YH=6T8+$9.XK?NIOY>K(!
MV;%W(YS"R:0E&[./&*;=&9[GLX]I&+1]6;3O8Y/>YK-1.XC-NI=?.Y<UFWZ4
M\@9"8`VZ>K:QN+*=X`-BH+;X")UKFK?'V+<O`;?;TK,OV[B]6*OO8YPXJ93H
MVKDE&;E#=1A4UKHE.;:+EJ:YNY2Q>Q=V.[R->+Q]J+G-NXFU.&U=>[T]&+W^
M5>6]X1N#Y3L8Z+N^);BVLUN]]1NVU^NI?Z&\_QN&QWMD"+S`5?B^=R._%=R`
M:UL&3J6RIEG`']R^`YQE6J5-_JBZ+[RQVQF)IN!D]KJX/QR&:WNX8<G#3[R)
M[WL+XL^_6YR$^9LZH^2T9_R*5=MA&"K&,R3'=3R!848&0`3'@9R]'7BE#6D$
M%B"3'?S(T;>V06`$%.`#1H!:$AS*#QBY">(!K((@_M?$M?R"D1OE2.`%0(`,
MLGS,`QBZ>2:C&ES&V7R!D3M*C,28UWS.Z]>[#88@P&176%S/5=BQIX"5YQA/
M`EW021B[Q^F1(%G1=[B]'R8&2$"F#_K)(3UYD5O^*>--!)H:TS-]>+E<"T`Y
MT4/]@FL[WA[@(#Y=SD_]?26=QXE``0PSS%_=P$-</OP\&[$<U&\]=LM\-!RP
MQ']]P7-=/@2D'\7:U8M]?&.=QZU<1_*\V:&7RS\@/WIZVJE=TX^]/?(:MTU]
MV_>WMDW@`T+P5+1=W'WWV14FG'(-O-6=S+N=/9Y%.*PBW>/]=I$;!#SE4W3;
MU_/=<FM[J$T@/\,]X-/WKQ]&>^0,WQ%>=6L;!_1,7)SZX2%\WIG!RG/"4P[>
MXKL7N;^=V#U>@%/=RZ=$S0%^Y`5WQ^6#E=MR-XQ<Y=^7Y0N'!![``?#DWE->
MYO>6SPLF!.(`!\!\YWG^/F]K.YEP8$3^G=F+7G6Q6P06(%?B7,R;'M@Q?AGN
MS0$TOL*K/GW='#^"?NB9ONL[M\R#)P80W>')_G!]OF#<*'Z(>^VC_.J/`172
MN@,[7N[UG>Z-X;:S4>3UGGO9O6!&X$<,)>\#?W61&T7*<CIM/?&O%[WAAN@A
MGVMK/+VIOO(C=_!=E_(UOVH9/.X1%P86@SU.0P;95\7;(SG?!DP#@?4)59=N
MZH==JF]NEA)N:FPB-_35?F;],XHJLQAB`.Q>XL>1J"J9H1N#ABSQ5OD+QR.;
MU^B`YG0:H(6>P/T2-_1#6FZU(4C>@5JT0`1WPZ5`4`^_0A3((#FI*8)*O[+^
M?F3YBF:CJK*RWET)T*#V[<`$<"`CI:3X[$B)@&#78P!NIELO^3HFFSV8Z96,
MF9*[TDTFC;UVIEA3]NT)9;`70.0DCY4R,;)Y>\E*N!Y5EC3IC4)C5X\6E:`)
M4UF;$Y047A7;3D%!TDT)X]HE9J;F)F>GYR=HJ.@H:2F9`$`(F2DH#JH!:ZSL
M+&VM;2U):M.#%`DJP$,/&L(`P`(,0#+)P4#/`D""<D\!P5-:CTBR@-3S0#&,
M7'$``,@.@$$!@.3.`0!!0(!0CVNR0X]!\H%>$Q&^`$D/!\D,Q$G"`!Z``T,`
MX"$``($`2<^B`1@A[)?%#P`"I%/3Y$4Q8V34I3/^($1(-HX]1FB3(C($@!B0
MZBT$P,"$`%0"2EQ,YM$@0H5$&JI3U^-&.F"WEC)MZO2I)WH_H=YX!?4JUJQ:
M0:$$`&Z5(``*>FBD8[,'`H;9I%!;"$/&60*2D)&(4;%'@P)H[+4#5\;!#KBP
MS@4$(",;0%3RA.E28!CNV%5$+`8X`"+FO01-S"$0)&7H,S.$B;RPVZ`'`'LL
MAQ6>2H#`%7*H80GTB^V:B;L-!#AKIJ`:`85V7PC\#$"*B1TW4J\TG`3'0\\+
MG1FV"RLX'@`\MW+O[OVIU*P[K"[^;OX\>E!KFXS8D<TO@`;+53V[#>[U=',+
M>N!'0R+7:ZB09I\B!RC^$,!@^V4C0P,`W$'$8LBH<=9"BT'HC`#/O`;/'4EH
M%(`">M0721)MU8=:`W!Y4TR#JJ"AAA`2EBB)2.\UL5XV!'AC&!K\!1.``*\!
M(U",Q1``$!HK7N/A1B%2-XTD_$D"I)`,I'<EEEENALI43XU'F)9ABMF=70H(
MD=L"N?$$UP=PJ5&?C6U!:(Z5^"%30BX?D##""Y?QI-%7/>1FD5RH[0?3#0WJ
M$4V$=P6@60\)\,:/<Y(^(\*>)91W0P@.[=#@-,WT$%&%YJ1H4PDCE%`"`!\(
MNF1VKO8P@&8O8=:5%-E\D"H).XSW``'@)(3G"#=<N,<S(<#%`*_[3")",9_^
M,E2`J`,,=D"J(X`Q)K?=-O6E*N4U10\LWII[[BP:132.%`8$T&D\=M''$$LI
MFLB0H?>TZEA[T)3`@`."A5",%%TIH)%"MFHAUF7Q-&$7`C%DPT"+8/6C$0-H
M-%""`B`XX4`"'#,T%$P/1`/+,T+$50`)'RB`5``BX#,5$1^DY=*AQ]WH55@*
MD-"`E=25>^`((2#`(`!G&A`"3*[*U?++38`LLK0]P.2`0+`0;;0EZ'K]=2?A
M8;7#..6"?3;:F)!@``$(,(+#;@J`(<.19)DT1`#_CO7`W06X^@(Z(;`LC`$1
MN6C``0\4L*U!`C1@]`T&N$H"`6",0(`"#!Q0'@C^`00S0B0`64'6`2((X,`=
MH%N[71(E&##`X!_<_8``(+!M-QD&!"-#`@,0`)@,OWTP^&8@6%NPY#U0[BSE
MV[YP0)"J*%_[<PUXLP`.LI>Q@#<-W,&[-P_<(83KL&=T=PB.)[!?HM<[FS;\
M7XM]%;GQVP^VN/=O)<0(^XUGMOX"*,`!8N(D7,I*_0BHP`5J25SYXX0#,0&#
MD&R#*^9Y(`,SN$!ZA(M^5M$@"$.HP#,41(0F/.&5OM0EIWP)%AA$(0QC*,,9
MTA"%*D3@!VNHPQWRL(<^--?\H)+`'Q*QB$8\(A)C<<.QY3")3GPB%*/(P_"\
ML!9#E"(6LZC%+=Z/BA[^!!,7PRC&,9(1/>#"(1C+J,8ULK&-IECB55KHQCG2
ML8YU#")XFFC'/?*QCU"$HQ#UZ,=!$K*0,_1B(--HR$4RLI$$Q",+R>/(2::M
MBI2<HQ!RH8NQ.40`@;HD*$,IRO1H!%97:1``!-`>'.P`!ZY\)2Q9J9Q8NK*5
ML+0E*V%Y`UOB\I:OO,$K>QG,8`(SEL+,)2U]54Q?&I.6N01F+X^I'%XZ$Y?+
M/"8RG2G+96JSEL/LYC.KV4QO@K.5T`1G-K%YRUDF<YS9Q,$NR>G.:XJSEMR4
MYS>-R4YF\M.7Y\PG,:G93E?2<Z#:-"<ZY:G.8.ZSG^E$IS(3^M!R-A2@$R7^
MJ$#G:5&%WO.=^&1H1Z6IS<MLY'U4P8<V@"0`>.2$I4!ZJ4ICNE*9LG2E,VWI
M37-:TY?B5*<QW6E+:6I3EPY5ICH=ZDUY6M2@,A6I._TI3HWZU*CR%*8]K2E5
MLWI4HMJTJ59=:E*[^E6L@G6L53UJ6;=*4ZAN]:ILA8=4A3K6L(HUJDM5JEF]
M6M:WUM6G6K6J5'/R5[]6-;!`/2Q4"^M6P:9UJHJM*V('.]6VBO6M0&TK8-.*
MV;`":2/,V0H.4)J,T9*VM*8]+6I3J]K5LK:UKGTM;&,KV]G2MK:VO2UN<ZO;
MW?*VM[[]+7"#*]SADM8>W,FD"!*`.`,L]P"(<R[^<YO[W.5&M[K.A2YS#X!=
MZFX7NMW-KG7!>]WKAI>\VBWO=+]K7O6FM[GF#2]UP1M?[L)WO.@][W;1*][I
M5C>ZY.VO?^>+7_;B%\#[W>]Y`VS?_"K8NM\5L'SE^^#U0IC"!OYO@^V;X?<6
M>,+U_7"`W6M@Z8X8PQ9&,(;[F^(!WS?%^I5N@E$\WQ?S5\(@MG&(*4S@&L-X
MQ3U&7`$8(`)'C++(1CYR!BWII34H6<G>L224(2AE)S@YCJ.H\E*PO)E.:%DK
M46;%E[=<22XSI<M@V829QS9E383YS$A^,YSC+.<YT[G.=KXSGO.LYSWSN<]^
M_C.@`RWH01.ZT(8^-*(U$ZWH13.ZT8Y^-*0C+>E)4[K2EKXTIC.MZ4USNM.>
9_C2H0RWJ49.ZU*8^-:I3K>I5LWI,00``.S\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
